<html lang="en" class="pb-page fonts-loaded fonts-loaded" data-request-id="8e29eb4c-1314-45ad-b205-af8086655ae8" style="--article-sticky-top: 82.00019999999999px; --scroll-padding: 163.594px auto auto;"><head data-pb-dropzone="head"><meta name="pbContext" content=";product:product:elsevier\:product\:cell;website:website:cell-site;ctype:string:Journal Content;journal:journal:cell;pageGroup:string:Article View;issue:issue:pii\:S0092867421X00086;page:string:Show Full Text;requestedJournal:journal:cell;wgroup:string:Default Website Group;article:article:pii\:S0092867422001921;subPage:string:Full Text">




<!-- if there is any customization for Responsive Project widget  -->


























    
    







    
            
        



        
                <meta name="robots" content="noarchive,nocache">
            
    






    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=1, user-scalable=1">











        <meta property="og:title" content="Tumor-reactive antibodies evolve from non-binding and autoreactive precursors">
    


        <meta property="og:type" content="Article">
    


        <meta property="og:url" content="https://www.cell.com/cell/abstract/S0092-8674(22)00192-1">
    



        <meta property="og:site_name" content="Cell">
    


        <meta property="og:image" content="https://www.cell.com/cms/asset/00a5b8ba-14f1-4ec8-81d1-adef82cb2abe/fx1.jpg">
    


        <meta property="og:description" content="Antibodies generated from immune cells within human ovarian carcinomas, as well as
pre-existing autoantibodies, coat tumor cells and contribute to antitumor immune responses.">
    











        <meta name="twitter:title" content="Tumor-reactive antibodies evolve from non-binding and autoreactive precursors">
    




        <meta name="twitter:image" content="https://www.cell.com/cms/asset/00a5b8ba-14f1-4ec8-81d1-adef82cb2abe/fx1.jpg">
    


        <meta name="twitter:description" content="Antibodies generated from immune cells within human ovarian carcinomas, as well as
pre-existing autoantibodies, coat tumor cells and contribute to antitumor immune responses.">
    

        <meta name="twitter:card" content="summary_large_image">
    











    
    
            
            
        <link rel="canonical" href="https://www.cell.com/cell/fulltext/S0092-8674(22)00192-1">
    


<meta name="tdm-reservation" content="1">
<meta name="tdm-policy" content="https://www.elsevier.com/tdm/tdmrep-policy.json">

<title>Tumor-reactive antibodies evolve from non-binding and autoreactive precursors: Cell</title><meta name="citation_journal_title" content="Cell"> <meta name="citation_journal_abbrev" content="Cell"> <meta name="citation_publisher" content="Elsevier"> <meta name="citation_title" content="Tumor-reactive antibodies evolve from non-binding and autoreactive precursors"> <meta name="citation_date" content="2022/03/31"> <meta name="citation_online_date" content="2022/03/18"> <meta name="citation_volume" content="185"> <meta name="citation_issue" content="7"> <meta name="citation_firstpage" content="1208"> <meta name="citation_lastpage" content="1222.e21"> <meta name="citation_pmid" content="35305314"> <meta name="citation_abstract_html_url" content="https://www.cell.com/action/showAbstract?pii=S0092867422001921"> <meta name="citation_fulltext_html_url" content="https://www.cell.com/action/showFullText?pii=S0092867422001921"> <meta name="citation_pdf_url" content="https://www.cell.com/action/showPdf?pii=S0092867422001921"> <meta name="citation_issn" content="0092-8674"> <meta name="citation_issn" content="1097-4172"> <meta name="citation_language" content="English"> <meta name="citation_doi" content="10.1016/j.cell.2022.02.012"> <meta name="citation_pmid" content="35305314"> <meta name="citation_author" content="Roei D. Mazor"><meta name="citation_author_orcid" content="0000-0002-4784-9808"><meta name="citation_author_institution" content="Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel"><meta name="citation_author_institution" content="Department of Biological Regulation, Weizmann Institute of Science, Rehovot 7610001, Israel"><meta name="citation_author" content="Nachum Nathan"><meta name="citation_author_institution" content="Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel"><meta name="citation_author" content="Amit Gilboa"><meta name="citation_author_institution" content="Faculty of Engineering, Bar Ilan University, Ramat Gan 52900, Israel"><meta name="citation_author" content="Liat Stoler-Barak"><meta name="citation_author_orcid" content="0000-0001-8194-9979"><meta name="citation_author_institution" content="Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel"><meta name="citation_author" content="Lihee Moss"><meta name="citation_author_orcid" content="0000-0003-1111-8699"><meta name="citation_author_institution" content="Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel"><meta name="citation_author" content="Inna Solomonov"><meta name="citation_author_institution" content="Department of Biological Regulation, Weizmann Institute of Science, Rehovot 7610001, Israel"><meta name="citation_author" content="Assaf Hanuna"><meta name="citation_author_institution" content="Department of Biological Regulation, Weizmann Institute of Science, Rehovot 7610001, Israel"><meta name="citation_author" content="Yalin Divinsky"><meta name="citation_author_orcid" content="0000-0001-5275-4312"><meta name="citation_author_institution" content="Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel"><meta name="citation_author" content="Merav D. Shmueli"><meta name="citation_author_orcid" content="0000-0002-9196-7633"><meta name="citation_author_institution" content="Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel"><meta name="citation_author" content="Hadas Hezroni"><meta name="citation_author_institution" content="Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel"><meta name="citation_author" content="Irina Zaretsky"><meta name="citation_author_institution" content="Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel"><meta name="citation_author_institution" content="Department of Life Sciences and Core Facilities, Weizmann Institute of Science, Rehovot 7610001, Israel"><meta name="citation_author" content="Michael Mor"><meta name="citation_author_institution" content="Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel"><meta name="citation_author" content="Ofra Golani"><meta name="citation_author_orcid" content="0000-0002-9793-236X"><meta name="citation_author_institution" content="Department of Life Sciences and Core Facilities, Weizmann Institute of Science, Rehovot 7610001, Israel"><meta name="citation_author" content="Gad Sabah"><meta name="citation_author_orcid" content="0000-0001-6412-8001"><meta name="citation_author_institution" content="Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel"><meta name="citation_author_institution" content="The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel"><meta name="citation_author" content="Ariella Jakobson-Setton"><meta name="citation_author_institution" content="Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel"><meta name="citation_author_institution" content="The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel"><meta name="citation_author" content="Natalia Yanichkin"><meta name="citation_author_institution" content="Department of Pathology, Rabin Medical Center, Petah Tikva, Israel"><meta name="citation_author_institution" content="The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel"><meta name="citation_author" content="Meora Feinmesser"><meta name="citation_author_institution" content="Department of Pathology, Rabin Medical Center, Petah Tikva, Israel"><meta name="citation_author_institution" content="The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel"><meta name="citation_author" content="Daliah Tsoref"><meta name="citation_author_institution" content="Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel"><meta name="citation_author_institution" content="The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel"><meta name="citation_author" content="Lina Salman"><meta name="citation_author_orcid" content="0000-0002-8451-6922"><meta name="citation_author_institution" content="Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel"><meta name="citation_author_institution" content="The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel"><meta name="citation_author" content="Effi Yeoshoua"><meta name="citation_author_institution" content="Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel"><meta name="citation_author_institution" content="The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel"><meta name="citation_author" content="Eyal Peretz"><meta name="citation_author_institution" content="Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel"><meta name="citation_author" content="Inna Erlich"><meta name="citation_author_institution" content="Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel"><meta name="citation_author" content="Netta Mendelson Cohen"><meta name="citation_author_institution" content="Department of Mathematics and Computer Science, Weizmann Institute of Science, Rehovot 7610001, Israel"><meta name="citation_author" content="Jonathan M. Gershoni"><meta name="citation_author_institution" content="Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv-Yafo, Israel"><meta name="citation_author" content="Natalia Freund"><meta name="citation_author_institution" content="Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel"><meta name="citation_author" content="Yifat Merbl"><meta name="citation_author_institution" content="Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel"><meta name="citation_author" content="Gur Yaari"><meta name="citation_author_orcid" content="0000-0001-9311-9884"><meta name="citation_author_institution" content="Faculty of Engineering, Bar Ilan University, Ramat Gan 52900, Israel"><meta name="citation_author" content="Ram Eitan"><meta name="citation_author_institution" content="Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel"><meta name="citation_author_institution" content="The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel"><meta name="citation_author" content="Irit Sagi"><meta name="citation_author_email" content="irit.sagi@weizmann.ac.il"><meta name="citation_author_institution" content="Department of Biological Regulation, Weizmann Institute of Science, Rehovot 7610001, Israel"><meta name="citation_author" content="Ziv Shulman"><meta name="citation_author_email" content="ziv.shulman@weizmann.ac.il"><meta name="citation_author_orcid" content="0000-0002-9604-212X"><meta name="citation_author_institution" content="Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel"><meta name="citation_keywords" content="antibodies; B cells; antibody-mediated immune response; ovarian cancer; cancer; autoantibodies; MMP14; MT1-MMP; plasma cells; HGSOC"><meta name="citation_reference" content="citation_title=Autoantibody signature for the serologic detection of ovarian cancer; citation_author=K.S. Anderson; citation_author=D.W. Cramer; citation_author=S. Sibani; citation_author=G. Wallstrom; citation_author=J. Wong; citation_author=J. Park; citation_author=J. Qiu; citation_author=A. Vitonis; citation_author=J. LaBaer; citation_journal_title=J.&nbsp;Proteome Res.; citation_volume=14; citation_doi=10.1021/pr500908n; citation_firstpage=578; citation_lastpage=586; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=FcRgamma activation regulates inflammation-associated squamous carcinogenesis; citation_author=P. Andreu; citation_author=M. Johansson; citation_author=N.I. Affara; citation_author=F. Pucci; citation_author=T. Tan; citation_author=S. Junankar; citation_author=L. Korets; citation_author=J. Lam; citation_author=D. Tawfik; citation_author=D.G. DeNardo; citation_author=et al.; citation_journal_title=Cancer Cell; citation_volume=17; citation_firstpage=121; citation_lastpage=134; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=FireDock: fast interaction refinement in molecular docking; citation_author=N. Andrusier; citation_author=R. Nussinov; citation_author=H.J. Wolfson; citation_journal_title=Proteins; citation_volume=69; citation_firstpage=139; citation_lastpage=159; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=Motifier: an IgOme profiler based on peptide motifs using machine learning; citation_author=H. Ashkenazy; citation_author=O. Avram; citation_author=A. Ryvkin; citation_author=A. Roitburd-Berman; citation_author=Y. Weiss-Ottolenghi; citation_author=S. Hada-Neeman; citation_author=J.M. Gershoni; citation_author=T. Pupko; citation_journal_title=J.&nbsp;Mol. Biol.; citation_volume=433; citation_doi=10.1016/j.jmb.2021.167071; citation_firstpage=167071; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Ovarian surface epithelium as a source of ovarian cancers: unwarranted speculation or evidence-based hypothesis?; citation_author=N. Auersperg; citation_journal_title=Gynecol. Oncol.; citation_volume=130; citation_firstpage=246; citation_lastpage=251; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Digital health nation: Israel’s global big data innovation hub; citation_author=R.D. Balicer; citation_author=A. Afek; citation_journal_title=Lancet; citation_volume=389; citation_firstpage=2451; citation_lastpage=2453; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=QuPath: open source software for digital pathology image analysis; citation_author=P. Bankhead; citation_author=M.B. Loughrey; citation_author=J.A. Fernández; citation_author=Y. Dombrowski; citation_author=D.G. McArt; citation_author=P.D. Dunne; citation_author=S. McQuaid; citation_author=R.T. Gray; citation_author=L.J. Murray; citation_author=H.G. Coleman; citation_author=et al.; citation_journal_title=Sci. Rep.; citation_volume=7; citation_firstpage=16878; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=T cell interactions with B cells during germinal center formation, a three-step model; citation_author=A. Biram; citation_author=N. Davidzohn; citation_author=Z. Shulman; citation_journal_title=Immunol. Rev.; citation_volume=288; citation_firstpage=37; citation_lastpage=48; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=IgA transcytosis and antigen recognition govern ovarian cancer immunity; citation_author=S. Biswas; citation_author=G. Mandal; citation_author=K.K. Payne; citation_author=C.M. Anadon; citation_author=C.D. Gatenbee; citation_author=R.A. Chaurio; citation_author=T.L. Costich; citation_author=C. Moran; citation_author=C.M. Harro; citation_author=K.E. Rigolizzo; citation_author=et al.; citation_journal_title=Nature; citation_volume=591; citation_firstpage=464; citation_lastpage=470; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade; citation_author=J.L. Boland; citation_author=Q. Zhou; citation_author=M. Martin; citation_author=M.K. Callahan; citation_author=J. Konner; citation_author=R.E. O’Cearbhaill; citation_author=C.F. Friedman; citation_author=W. Tew; citation_author=V. Makker; citation_author=R.N. Grisham; citation_author=et al.; citation_journal_title=Gynecol. Oncol.; citation_volume=152; citation_firstpage=251; citation_lastpage=258; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Antigen receptor repertoire profiling from RNA-Seq data; citation_author=D.A. Bolotin; citation_author=S. Poslavsky; citation_author=A.N. Davydov; citation_author=F.E. Frenkel; citation_author=L. Fanchi; citation_author=O.I. Zolotareva; citation_author=S. Hemmers; citation_author=E.V. Putintseva; citation_author=A.S. Obraztsova; citation_author=M. Shugay; citation_author=et al.; citation_journal_title=Nat. Biotechnol.; citation_volume=35; citation_firstpage=908; citation_lastpage=911; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=The genesis and evolution of high-grade serous ovarian cancer; citation_author=D.D.L. Bowtell; citation_journal_title=Nat. Rev. Cancer; citation_volume=10; citation_firstpage=803; citation_lastpage=808; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Tertiary lymphoid structures improve immunotherapy and survival in melanoma; citation_author=R. Cabrita; citation_author=M. Lauss; citation_author=A. Sanna; citation_author=M. Donia; citation_author=M.S. Skaarup Larsen; citation_author=S. Mitra; citation_author=I. Johansson; citation_author=B. Phung; citation_author=K. Harbst; citation_author=J. Vallon-Christersson; citation_author=et al.; citation_journal_title=Nature; citation_volume=577; citation_firstpage=561; citation_lastpage=565; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Interleukin-6 increases matrix metalloproteinase-14 (MMP-14) levels via down-regulation of p53 to drive cancer progression; citation_author=J.M. Cathcart; citation_author=A. Banach; citation_author=A. Liu; citation_author=J. Chen; citation_author=M. Goligorsky; citation_author=J. Cao; citation_journal_title=Oncotarget; citation_volume=7; citation_firstpage=61107; citation_lastpage=61120; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=The extracellular matrix in epithelial ovarian cancer - A piece of a puzzle; citation_author=A. Cho; citation_author=V.M. Howell; citation_author=E.K. Colvin; citation_journal_title=Front. Oncol.; citation_volume=5; citation_firstpage=245; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=B cell epitope spreading: mechanisms and contribution to autoimmune diseases; citation_author=C. Cornaby; citation_author=L. Gibbons; citation_author=V. Mayhew; citation_author=C.S. Sloan; citation_author=A. Welling; citation_author=B.D. Poole; citation_journal_title=Immunol. Lett.; citation_volume=163; citation_firstpage=56; citation_lastpage=68; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Matrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory lyme arthritis; citation_author=J.T. Crowley; citation_author=K. Strle; citation_author=E.E. Drouin; citation_author=A. Pianta; citation_author=S.L. Arvikar; citation_author=Q. Wang; citation_author=C.E. Costello; citation_author=A.C. Steere; citation_journal_title=J.&nbsp;Autoimmun.; citation_volume=69; citation_firstpage=24; citation_lastpage=37; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Neoantigen-driven B cell and CD4&nbsp;T follicular helper cell collaboration promotes robust anti-tumor CD8 T&nbsp;cell responses; citation_author=C. Cui; citation_author=J. Wang; citation_author=E. Fagerberg; citation_author=P.M. Chen; citation_author=K.A. Connolly; citation_author=M. Damo; citation_author=J.F. Cheung; citation_author=T. Mao; citation_author=A.S. Askari; citation_author=S. Chen; citation_author=et al.; citation_journal_title=Cell; citation_volume=184; citation_doi=10.1016/j.cell.2021.11.007; citation_firstpage=6101; citation_lastpage=6118.e13; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Clonal evolution of autoreactive germinal centers; citation_author=S.E. Degn; citation_author=C.E. van der Poel; citation_author=D.J. Firl; citation_author=B. Ayoglu; citation_author=F.A. Al Qureshah; citation_author=G. Bajic; citation_author=L. Mesin; citation_author=C.A. Reynaud; citation_author=J.C. Weill; citation_author=P.J. Utz; citation_author=et al.; citation_journal_title=Cell; citation_volume=170; citation_firstpage=913; citation_lastpage=926.e19; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Macrophages as regulators of tumour immunity and immunotherapy; citation_author=D.G. DeNardo; citation_author=B. Ruffell; citation_journal_title=Nat. Rev. Immunol.; citation_volume=19; citation_firstpage=369; citation_lastpage=382; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=The origins of ovarian cancer; citation_author=S. DeWeerdt; citation_journal_title=Nature; citation_volume=600; citation_firstpage=S42; citation_lastpage=S44; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface; citation_author=G. Di Zenzo; citation_author=G. Di Lullo; citation_author=D. Corti; citation_author=V. Calabresi; citation_author=A. Sinistro; citation_author=F. Vanzetta; citation_author=B. Didona; citation_author=G. Cianchini; citation_author=M. Hertl; citation_author=R. Eming; citation_author=et al.; citation_journal_title=J.&nbsp;Clin. Invest.; citation_volume=122; citation_firstpage=3781; citation_lastpage=3790; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Fc-receptor interactions regulate both cytotoxic and immunomodulatory therapeutic antibody effector functions; citation_author=D.J. DiLillo; citation_author=J.V. Ravetch; citation_journal_title=Cancer Immunol. Res.; citation_volume=3; citation_doi=10.1158/2326-6066.CIR-15-0120; citation_firstpage=704; citation_lastpage=713; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Checkpoint inhibitors in ovarian cancer: a review of preclinical data; citation_author=D.W. Doo; citation_author=L.A. Norian; citation_author=R.C. Arend; citation_journal_title=Gynecol. Oncol. Rep.; citation_volume=29; citation_firstpage=48; citation_lastpage=54; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Efficient unbound docking of rigid molecules; citation_inbook_title=Proceedings of the 2’nd Workshop on Algorithms in Bioinformatics (WABI) Rome, Italy, Lecture Notes in Computer Science 2452; citation_author=D. Duhovny; citation_author=R. Nussinov; citation_author=H. Wolfson; citation_publication_date=2002; "><meta name="citation_reference" content="citation_title=PHYLIP (phylogeny Inference Package); citation_author=J. Felsenstein; citation_publication_date=2005; "><meta name="citation_reference" content="citation_title=Phage display selection, analysis, and prediction of B cell epitopes; citation_author=Freund; citation_author=N. Tarnovitski; citation_author=D. Enshell-Seijffers; citation_author=J.M. Gershoni; citation_journal_title=Curr. Protoc. Immunol.; citation_volume=9; citation_firstpage=8; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Seromic profiling of ovarian and pancreatic cancer; citation_author=S. Gnjatic; citation_author=E. Ritter; citation_author=M.W. Büchler; citation_author=N.A. Giese; citation_author=B. Brors; citation_author=C. Frei; citation_author=A. Murray; citation_author=N. Halama; citation_author=I. Zörnig; citation_author=Y.T. Chen; citation_author=et al.; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=107; citation_firstpage=5088; citation_lastpage=5093; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Change-O: A toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data; citation_author=N.T. Gupta; citation_author=J.A. Vander Heiden; citation_author=M. Uduman; citation_author=D. Gadala-Maria; citation_author=G. Yaari; citation_author=S.H. Kleinstein; citation_journal_title=Bioinformatics; citation_volume=31; citation_firstpage=3356; citation_lastpage=3358; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=B cells and tertiary lymphoid structures promote immunotherapy response; citation_author=B.A. Helmink; citation_author=S.M. Reddy; citation_author=J. Gao; citation_author=S. Zhang; citation_author=R. Basar; citation_author=R. Thakur; citation_author=K. Yizhak; citation_author=M. Sade-Feldman; citation_author=J. Blando; citation_author=G. Han; citation_author=et al.; citation_journal_title=Nature; citation_volume=577; citation_firstpage=549; citation_lastpage=555; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Landscape of B cell immunity and related immune evasion in human cancers; citation_author=X. Hu; citation_author=J. Zhang; citation_author=J. Wang; citation_author=J. Fu; citation_author=T. Li; citation_author=X. Zheng; citation_author=B. Wang; citation_author=S. Gu; citation_author=P. Jiang; citation_author=J. Fan; citation_author=et al.; citation_journal_title=Nat. Genet.; citation_volume=51; citation_firstpage=560; citation_lastpage=567; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Ovarian cancer; citation_author=G.C. Jayson; citation_author=E.C. Kohn; citation_author=H.C. Kitchener; citation_author=J.A. Ledermann; citation_journal_title=Lancet; citation_volume=384; citation_firstpage=1376; citation_lastpage=1388; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Highly accurate protein structure prediction with AlphaFold; citation_author=J. Jumper; citation_author=R. Evans; citation_author=A. Pritzel; citation_author=T. Green; citation_author=M. Figurnov; citation_author=O. Ronneberger; citation_author=K. Tunyasuvunakool; citation_author=R. Bates; citation_author=A. Žídek; citation_author=A. Potapenko; citation_author=et al.; citation_journal_title=Nature; citation_volume=596; citation_firstpage=583; citation_lastpage=589; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Selective blockade of matrix Metalloprotease-14 with a monoclonal antibody abrogates invasion, angiogenesis, and tumor growth in ovarian cancer; citation_author=R. Kaimal; citation_author=R. Aljumaily; citation_author=S.L. Tressel; citation_author=R.V. Pradhan; citation_author=L. Covic; citation_author=A. Kuliopulos; citation_author=C. Zarwan; citation_author=Y.B. Kim; citation_author=S. Sharifi; citation_author=A. Agarwal; citation_journal_title=Cancer Res.; citation_volume=73; citation_firstpage=2457; citation_lastpage=2467; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Immunoexpression of matrix metalloproteinase-2 (MMP-2) in malignant ovarian epithelial tumours; citation_author=H. Kamel; citation_author=I. Abdelazim; citation_author=S.M. Habib; citation_author=M.A.A. El Shourbagy; citation_author=N.S. Ahmed; citation_journal_title=J.&nbsp;Obstet. Gynaecol. Can.; citation_volume=32; citation_doi=10.1016/S1701-2163(16)34527-3; citation_firstpage=580; citation_lastpage=586; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer; citation_author=D.R. Kroeger; citation_author=K. Milne; citation_author=B.H. Nelson; citation_journal_title=Clin. Cancer Res.; citation_volume=22; citation_firstpage=3005; citation_lastpage=3015; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=High grade serous ovarian carcinomas originate in the fallopian tube; citation_author=S.I. Labidi-Galy; citation_author=E. Papp; citation_author=D. Hallberg; citation_author=N. Niknafs; citation_author=V. Adleff; citation_author=M. Noe; citation_author=R. Bhattacharya; citation_author=M. Novak; citation_author=S. Jones; citation_author=J. Phallen; citation_author=et al.; citation_journal_title=Nat. Commun.; citation_volume=8; citation_firstpage=1093; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Using protein microarray to identify and evaluate autoantibodies to tumor-associated antigens in ovarian cancer; citation_author=Y. Ma; citation_author=X. Wang; citation_author=C. Qiu; citation_author=J. Qin; citation_author=K. Wang; citation_author=G. Sun; citation_author=D. Jiang; citation_author=J. Li; citation_author=L. Wang; citation_author=J. Shi; citation_author=et al.; citation_journal_title=Cancer Sci.; citation_volume=112; citation_doi=10.1111/cas.14732; citation_firstpage=537; citation_lastpage=549; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=First-line management of advanced high-grade serous ovarian cancer; citation_author=R.D. Mahmood; citation_author=R.D. Morgan; citation_author=R.J. Edmondson; citation_author=A.R. Clamp; citation_author=G.C. Jayson; citation_journal_title=Curr. Oncol. Rep.; citation_volume=22; citation_firstpage=64; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Ex-vivo clonally expanded B lymphocytes infiltrating colorectal carcinoma are of mature immunophenotype and produce functional IgG; citation_author=C. Maletzki; citation_author=A. Jahnke; citation_author=C. Ostwald; citation_author=E. Klar; citation_author=F. Prall; citation_author=M. Linnebacher; citation_journal_title=PLoS One; citation_volume=7; citation_firstpage=e32639; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=FireDock: A web server for fast interaction refinement in molecular docking; citation_author=E. Mashiach; citation_author=D. Schneidman-Duhovny; citation_author=N. Andrusier; citation_author=R. Nussinov; citation_author=H.J. Wolfson; citation_journal_title=Nucleic Acids Res.; citation_volume=36; citation_firstpage=W229; citation_lastpage=W232; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors; citation_author=B. Mietzner; citation_author=M. Tsuiji; citation_author=J. Scheid; citation_author=K. Velinzon; citation_author=T. Tiller; citation_author=K. Abraham; citation_author=J.B. Gonzalez; citation_author=V. Pascual; citation_author=D. Stichweh; citation_author=H. Wardemann; citation_author=M.C. Nussenzweig; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=105; citation_firstpage=9727; citation_lastpage=9732; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=Tumor-infiltrating T&nbsp;cells correlate with NY-ESO-1-Specific autoantibodies in ovarian cancer; citation_author=K. Milne; citation_author=R.O. Barnes; citation_author=A. Girardin; citation_author=M.A. Mawer; citation_author=N.J. Nesslinger; citation_author=A. Ng; citation_author=J.S. Nielsen; citation_author=R. Sahota; citation_author=E. Tran; citation_author=J.R. Webb; citation_author=et al.; citation_journal_title=PLoS One; citation_volume=3; citation_firstpage=e3409; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=ColabFold - making protein folding accessible to all; citation_author=Milot Mirdita; citation_author=K. Schütze; citation_author=Y. Moriwaki; citation_author=L. Heo; citation_author=S. Ovchinnikov; citation_author=M. Steinegger; citation_journal_title=Biorxiv; citation_doi=10.21203/rs.3.rs-1032816/v1; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=A strong B-cell response is part of the immune landscape in human high-grade serous ovarian metastases; citation_author=A. Montfort; citation_author=O. Pearce; citation_author=E. Maniati; citation_author=B.G. Vincent; citation_author=L. Bixby; citation_author=S. Böhm; citation_author=T. Dowe; citation_author=E.H. Wilkes; citation_author=P. Chakravarty; citation_author=R. Thompson; citation_author=et al.; citation_journal_title=Clin. Cancer Res.; citation_volume=23; citation_firstpage=250; citation_lastpage=262; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V’DJer; citation_author=L.E. Mose; citation_author=S.R. Selitsky; citation_author=L.M. Bixby; citation_author=D.L. Marron; citation_author=M.D. Iglesia; citation_author=J.S. Serody; citation_author=C.M. Perou; citation_author=B.G. Vincent; citation_author=J.S. Parker; citation_journal_title=Bioinformatics; citation_volume=32; citation_firstpage=3729; citation_lastpage=3734; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination; citation_author=N.M. Moss; citation_author=M.V. Barbolina; citation_author=Y. Liu; citation_author=L. Sun; citation_author=H.G. Munshi; citation_author=M.S. Stack; citation_journal_title=Cancer Res.; citation_volume=69; citation_firstpage=7121; citation_lastpage=7129; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=CD20+ B cells: the other tumor-infiltrating lymphocytes; citation_author=B.H. Nelson; citation_journal_title=J.&nbsp;Immunol.; citation_volume=185; citation_firstpage=4977; citation_lastpage=4982; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis; citation_author=C. Nishijima; citation_author=I. Hayakawa; citation_author=T. Matsushita; citation_author=K. Komura; citation_author=M. Hasegawa; citation_author=K. Takehara; citation_author=S. Sato; citation_journal_title=Clin. Exp. Immunol.; citation_volume=138; citation_doi=10.1111/j.1365-2249.2004.02615.x; citation_firstpage=357; citation_lastpage=363; citation_publication_date=2004; "><meta name="citation_reference" content="citation_title=Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas; citation_author=S. Nzula; citation_author=J.J. Going; citation_author=D.I. Stott; citation_journal_title=Cancer Res.; citation_volume=63; citation_firstpage=3275; citation_lastpage=3280; citation_publication_date=2003; "><meta name="citation_reference" content="citation_title=The use of ovarian cancer cells from patients undergoing surgery to generate primary cultures capable of undergoing functional analysis; citation_author=R.L. O Donnell; citation_author=A. McCormick; citation_author=A. Mukhopadhyay; citation_author=L.C. Woodhouse; citation_author=M. Moat; citation_author=A. Grundy; citation_author=M. Dixon; citation_author=A. Kaufman; citation_author=A. Elattar; citation_author=et al.; citation_journal_title=PLoS One; citation_volume=9; citation_firstpage=e90604; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=B cells are associated with survival and immunotherapy response in sarcoma; citation_author=F. Petitprez; citation_author=A. de Reyniès; citation_author=E.Z. Keung; citation_author=T.W. Chen; citation_author=C.M. Sun; citation_author=J. Calderaro; citation_author=Y.-M. Jeng; citation_author=L.P. Hsiao; citation_author=L. Lacroix; citation_author=A. Bougoüin; citation_author=et al.; citation_journal_title=Nature; citation_volume=577; citation_firstpage=556; citation_lastpage=560; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis; citation_author=L. Piccoli; citation_author=I. Campo; citation_author=C.S. Fregni; citation_author=B.M. Rodriguez; citation_author=A. Minola; citation_author=F. Sallusto; citation_author=M. Luisetti; citation_author=D. Corti; citation_author=A. Lanzavecchia; citation_journal_title=Nat. Commun.; citation_volume=6; citation_firstpage=7375; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Ectopic lymphoid-like structures in infection, cancer and autoimmunity; citation_author=C. Pitzalis; citation_author=G.W. Jones; citation_author=M. Bombardieri; citation_author=S.A. Jones; citation_journal_title=Nat. Rev. Immunol.; citation_volume=14; citation_firstpage=447; citation_lastpage=462; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Scarcity of autoreactive human blood IgA+ memory B cells; citation_author=J. Prigent; citation_author=V. Lorin; citation_author=A. Kök; citation_author=T. Hieu; citation_author=S. Bourgeau; citation_author=H. Mouquet; citation_journal_title=Eur. J. Immunol.; citation_volume=46; citation_firstpage=2340; citation_lastpage=2351; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Morphologic, immunophenotypic, and molecular features of epithelial ovarian cancer; citation_author=P. Ramalingam; citation_journal_title=Oncology (Williston Park); citation_volume=30; citation_firstpage=166; citation_lastpage=176; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Tumor-bound immunoglobulins. Evidence for the in&nbsp;vivo coating of tumor cells by potentially cytotoxic anti-tumour antibodies; citation_author=M. Ran; citation_author=G. Klein; citation_author=I.P. Witz; citation_journal_title=Int. J. Cancer; citation_volume=17; citation_firstpage=90; citation_lastpage=97; citation_publication_date=1976; "><meta name="citation_reference" content="citation_title=Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid; citation_author=G.S. Rao; citation_author=P. Hanjani; citation_journal_title=Am. J. Obstet. Gynecol.; citation_volume=159; citation_doi=10.1016/0002-9378(88)90500-5; citation_firstpage=94; citation_lastpage=98; citation_publication_date=1988; "><meta name="citation_reference" content="citation_title=Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary; citation_author=K. Sakata; citation_author=K. Shigemasa; citation_author=N. Nagai; citation_author=K. Ohama; citation_journal_title=Int. J. Oncol.; citation_volume=17; citation_doi=10.3892/ijo.17.4.673; citation_firstpage=673; citation_lastpage=681; citation_publication_date=2000; "><meta name="citation_reference" content="citation_title=Function blocking autoantibodies Against matrix metalloproteinase-1 in patients with systemic sclerosis; citation_author=S. Sato; citation_author=I. Hayakawa; citation_author=M. Hasegawa; citation_author=M. Fujimoto; citation_author=K. Takehara; citation_journal_title=J.&nbsp;Invest. Dermatol.; citation_volume=120; citation_doi=10.1046/j.1523-1747.2003.12097.x; citation_firstpage=542; citation_lastpage=547; citation_publication_date=2003; "><meta name="citation_reference" content="citation_title=IgG subclass switching and clonal expansion in cutaneous melanoma and normal skin; citation_author=L. Saul; citation_author=K.M. Ilieva; citation_author=H.J. Bax; citation_author=P. Karagiannis; citation_author=I. Correa; citation_author=I. Rodriguez-Hernandez; citation_author=D.H. Josephs; citation_author=I. Tosi; citation_author=I.U. Egbuniwe; citation_author=S. Lombardi; citation_author=et al.; citation_journal_title=Sci. Rep.; citation_volume=6; citation_firstpage=29736; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=PatchDock and SymmDock: servers for rigid and symmetric docking; citation_author=D. Schneidman-Duhovny; citation_author=Y. Inbar; citation_author=R. Nussinov; citation_author=H.J. Wolfson; citation_journal_title=Nucleic Acids Res.; citation_volume=33; citation_firstpage=W363; citation_lastpage=W367; citation_publication_date=2005; "><meta name="citation_reference" content="citation_title=The role of somatic hypermutation in the generation of pathogenic antibodies in SLE; citation_author=K. Schroeder; citation_author=M. Herrmann; citation_author=T.H. Winkler; citation_journal_title=Autoimmunity; citation_volume=46; citation_firstpage=121; citation_lastpage=127; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=B cells, plasma cells and antibody repertoires in the tumour microenvironment; citation_author=G.V. Sharonov; citation_author=E.O. Serebrovskaya; citation_author=D.V. Yuzhakova; citation_author=O.V. Britanova; citation_author=D.M. Chudakov; citation_journal_title=Nat. Rev. Immunol.; citation_volume=20; citation_firstpage=294; citation_lastpage=307; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Demonstration of tumor-associated immunoglobulin G isolated from immune complexes in ascitic fluid of ovarian cancer; citation_author=P.A. Silburn; citation_author=S.K. Khoo; citation_author=R. Hill; citation_author=B. Daunter; citation_author=E.V. Mackay; citation_journal_title=Diagn. Immunol.; citation_volume=2; citation_firstpage=30; citation_lastpage=35; citation_publication_date=1984; "><meta name="citation_reference" content="citation_title=Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expressionvector cloning; citation_author=T. Tiller; citation_author=E. Meffre; citation_author=S. Yurasov; citation_author=M. Tsuiji; citation_author=M.C. Nussenzweig; citation_author=H. Wardemann; citation_journal_title=J.&nbsp;Immunol. Methods; citation_volume=329; citation_firstpage=112; citation_lastpage=124; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=Autoreactivity in human IgG+ memory B cells; citation_author=T. Tiller; citation_author=M. Tsuiji; citation_author=S. Yurasov; citation_author=K. Velinzon; citation_author=M.C. Nussenzweig; citation_author=H. Wardemann; citation_journal_title=Immunity; citation_volume=26; citation_firstpage=205; citation_lastpage=213; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=Unraveling hidden allosteric regulatory sites in structurally homologues metalloproteases; citation_author=Y. Udi; citation_author=M. Fragai; citation_author=M. Grossman; citation_author=S. Mitternacht; citation_author=R. Arad-Yellin; citation_author=V. Calderone; citation_author=M. Melikian; citation_author=M. Toccafondi; citation_author=I.N. Berezovsky; citation_author=C. Lauchinat; citation_author=I. Sago; citation_journal_title=J.&nbsp;Mol. Biol.; citation_volume=425; citation_doi=10.1016/j.jmb.2013.04.009; citation_firstpage=2330; citation_lastpage=2346; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Natural killer cell-based immunotherapy in gynecologic malignancy: a review; citation_author=L.D. Uppendahl; citation_author=C.M. Dahl; citation_author=J.S. Miller; citation_author=M. Felices; citation_author=M.A. Geller; citation_journal_title=Front. Immunol.; citation_volume=8; citation_firstpage=1825; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Germinal centers; citation_author=G.D. Victora; citation_author=M.C. Nussenzweig; citation_journal_title=Annu. Rev. Immunol.; citation_volume=30; citation_firstpage=429; citation_lastpage=457; citation_publication_date=2022; "><meta name="citation_reference" content="citation_title=Dysregulation of germinal centres in autoimmune disease; citation_author=C.G. Vinuesa; citation_author=I. Sanz; citation_author=M.C. Cook; citation_journal_title=Nat. Rev. Immunol.; citation_volume=9; citation_firstpage=845; citation_lastpage=857; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=The role of MMP-14 in ovarian cancer: a systematic review; citation_author=M.C. Vos; citation_author=A.A.M. van der Wurff; citation_author=T.H. van Kuppevelt; citation_author=L.A.F.G. Massuger; citation_journal_title=J.&nbsp;Ovarian Res.; citation_volume=14; citation_firstpage=1; citation_lastpage=13; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=MMP-14 and CD44 in epithelial-to-mesenchymal transition (EMT) in ovarian cancer; citation_author=M.C. Vos; citation_author=E. Hollemans; citation_author=N. Ezendam; citation_author=H. Feijen; citation_author=D. Boll; citation_author=B. Pijlman; citation_author=H. van der Putten; citation_author=P. Klinkhamer; citation_author=T.H. van Kuppevelt; citation_author=A.A. van der Wurff; citation_author=L.F. Massuger; citation_journal_title=J.&nbsp;Ovarian Res.; citation_volume=9; citation_firstpage=53; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Diverse functional autoantibodies in patients with COVID-19; citation_author=E.Y. Wang; citation_author=T. Mao; citation_author=J. Klein; citation_author=Yile Dai; citation_author=J.D. Huck; citation_author=Feimei Liu; citation_author=N.S. Zheng; citation_author=T. Zhou; citation_author=B. Israelow; citation_author=P. Wong; citation_author=et al.; citation_journal_title=medRxiv; citation_doi=10.1101/2020.12.10.20247205; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Predominant autoantibody production by early human B cell precursors; citation_author=H. Wardemann; citation_author=S. Yurasov; citation_author=A. Schaefer; citation_author=J.W. Young; citation_author=E. Meffre; citation_author=M.C. Nussenzweig; citation_journal_title=Science; citation_volume=301; citation_firstpage=1374; citation_lastpage=1377; citation_publication_date=2003; "><meta name="citation_reference" content="citation_title=Tissues: the unexplored frontier of antibody mediated immunity; citation_author=N.E. Webb; citation_author=B. Bernshtein; citation_author=G. Alter; citation_journal_title=Curr. Opin. Virol.; citation_volume=47; citation_firstpage=52; citation_lastpage=67; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Fc receptors in antimicrobial protection; citation_author=A. Wieland; citation_author=R. Ahmed; citation_journal_title=Curr. Top. Microbiol. Immunol.; citation_volume=423; citation_firstpage=119; citation_lastpage=150; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Defining HPV-specific B cell responses in patients with head and neck cancer; citation_author=A. Wieland; citation_author=M.R. Patel; citation_author=M.A. Cardenas; citation_author=C.S. Eberhardt; citation_author=W.H. Hudson; citation_author=R.C. Obeng; citation_author=C.C. Griffith; citation_author=X. Wang; citation_author=Z.G. Chen; citation_author=H.T. Kissick; citation_author=et al.; citation_journal_title=Nature; citation_volume=597; citation_doi=10.1038/s41586-020-2931-3; citation_firstpage=274; citation_lastpage=278; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Tumor-bound immunoglobulins: in&nbsp;situ expressions of humoral immunity; citation_author=I.P. Witz; citation_journal_title=Adv. Cancer Res.; citation_volume=25; citation_firstpage=95; citation_lastpage=148; citation_publication_date=1977; "><meta name="citation_reference" content="citation_title=Quantifying selection in high-throughput immunoglobulin sequencing data sets; citation_author=G. Yaari; citation_author=M. Uduman; citation_author=S.H. Kleinstein; citation_journal_title=Nucleic Acids Res.; citation_volume=40; citation_firstpage=e134; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Shared B cell memory to coronaviruses and other pathogens varies in human age groups and tissues; citation_author=F. Yang; citation_author=S.C.A. Nielsen; citation_author=R.A. Hoh; citation_author=K. Röltgen; citation_author=O.F. Wirz; citation_author=E. Haraguchi; citation_author=G.H. Jean; citation_author=J.Y. Lee; citation_author=T.D. Pham; citation_author=K.J.L. Jackson; citation_author=et al.; citation_journal_title=Science; citation_volume=372; citation_doi=10.1126/science.abf6648; citation_firstpage=738; citation_lastpage=741; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=IgBLAST: an immunoglobulin variable domain sequence analysis tool; citation_author=J. Ye; citation_author=N. Ma; citation_author=T.L. Madden; citation_author=J.M. Ostell; citation_journal_title=Nucleic Acids Res.; citation_volume=41; citation_firstpage=W34; citation_lastpage=W40; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Autoantibody production in cancer—the humoral immune response toward autologous antigens in cancer patients; citation_author=P. Zaenker; citation_author=E.S. Gray; citation_author=M.R. Ziman; citation_journal_title=Autoimmun. Rev.; citation_volume=15; citation_firstpage=477; citation_lastpage=483; citation_publication_date=2016; "><meta name="citation_abstract" content="<h2>Summary</h2><p>The tumor microenvironment hosts antibody-secreting cells (ASCs) associated with a favorable prognosis in several types of cancer. Patient-derived antibodies have diagnostic and therapeutic potential; yet, it remains unclear how antibodies gain autoreactivity and target tumors. Here, we found that somatic hypermutations (SHMs) promote antibody antitumor reactivity against surface autoantigens in high-grade serous ovarian carcinoma (HGSOC). Patient-derived tumor cells were frequently coated with IgGs. Intratumoral ASCs in HGSOC were both mutated and clonally expanded and produced tumor-reactive antibodies that targeted MMP14, which is abundantly expressed on the tumor cell surface. The reversion of monoclonal antibodies to their germline configuration revealed two types of classes: one dependent on SHMs for tumor binding and a second with germline-encoded autoreactivity. Thus, tumor-reactive autoantibodies are either naturally occurring or evolve through an antigen-driven selection process. These findings highlight the origin and potential applicability of autoantibodies directed at surface antigens for tumor targeting in cancer patients.</p>"><meta charset="UTF-8"><!--

    Pagebuild admin UI
-->



<script type="text/javascript" src="https://bam.nr-data.net/1/16e2192192?a=916957862&amp;sa=1&amp;v=1177.96a4d39&amp;t=Unnamed%20Transaction&amp;rst=6840&amp;ck=1&amp;ref=https://www.cell.com/cell/fulltext/S0092-8674(22)00192-1&amp;be=3454&amp;fe=6801&amp;dc=6501&amp;af=err,xhr,stn,ins,spa&amp;perf=%7B%22timing%22:%7B%22of%22:1749593035020,%22n%22:0,%22f%22:2858,%22dn%22:2858,%22dne%22:2858,%22c%22:2858,%22ce%22:2858,%22rq%22:2859,%22rp%22:3438,%22rpe%22:4279,%22dl%22:3444,%22di%22:4497,%22ds%22:6501,%22de%22:6511,%22dc%22:6801,%22l%22:6801,%22le%22:6831%7D,%22navigation%22:%7B%7D%7D&amp;jsonp=NREUM.setToken"></script><script src="https://js-agent.newrelic.com/nr-spa-1177.min.js"></script><script type="text/javascript">
    ;window.NREUM||(NREUM={});NREUM.init={privacy:{cookies_enabled:true}};
    window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{c.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(26),c={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(c.console=!0,o.indexOf("dev")!==-1&&(c.dev=!0),o.indexOf("nr_dev")!==-1&&(c.nrDev=!0))}catch(s){}c.nrDev&&i.on("internal-error",function(t){r(t.stack)}),c.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),c.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(c,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,c){try{l?l-=1:o(c||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,s.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:s.now();i("err",[t,n])}var i=t("handle"),a=t(27),c=t("ee"),s=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError",l=0;s.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(13),t(12),"addEventListener"in window&&t(6),s.xhrWrappable&&t(14),d=!0)}c.on("fn-start",function(t,e,n){d&&(l+=1)}),c.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),c.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),c.on("internal-error",function(t){i("ierr",[t,s.now(),!0])})},{}],3:[function(t,e,n){t("loader").features.ins=!0},{}],4:[function(t,e,n){function r(){_++,T=g.hash,this[u]=y.now()}function o(){_--,g.hash!==T&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var c="-start",s="-end",f="-body",u="fn"+c,d="fn"+s,p="cb"+c,l="cb"+s,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable){var x=t(10),b=t(11),E=t(8),R=t(6),O=t(13),N=t(7),M=t(14),P=t(9),S=t("ee"),C=S.get("tracer");t(16),y.features.spa=!0;var T,_=0;S.on(u,r),S.on(p,r),S.on(d,o),S.on(l,o),S.buffer([u,d,"xhr-done","xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+s,"clearTimeout"+c,u]),M.buffer([u,"new-xhr","send-xhr"+c]),N.buffer([m+c,m+"-done",m+f+c,m+f+s]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+c]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(M,"send-xhr"+c),a(S,"xhr-resolved"),a(S,"xhr-done"),a(N,m+c),a(N,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,!0),w[v]("load",i,!0),w[v]("popstate",function(){i(0,_>1)},!0)}},{}],5:[function(t,e,n){function r(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var o=t("ee"),i=t("handle"),a=t(13),c=t(12),s="learResourceTimings",f="addEventListener",u="resourcetimingbufferfull",d="bstResource",p="resource",l="-start",h="-end",m="fn"+l,v="fn"+h,w="bstTimer",g="pushState",y=t("loader");y.features.stn=!0,t(8),"addEventListener"in window&&t(6);var x=NREUM.o.EV;o.on(m,function(t,e){var n=t[0];n instanceof x&&(this.bstStart=y.now())}),o.on(v,function(t,e){var n=t[0];n instanceof x&&i("bst",[n,e,this.bstStart,y.now()])}),a.on(m,function(t,e,n){this.bstStart=y.now(),this.bstType=n}),a.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),this.bstType])}),c.on(m,function(){this.bstStart=y.now()}),c.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),"requestAnimationFrame"])}),o.on(g+l,function(t){this.time=y.now(),this.startPath=location.pathname+location.hash}),o.on(g+h,function(t){i("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),f in window.performance&&(window.performance["c"+s]?window.performance[f](u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["c"+s]()},!1):window.performance[f]("webkit"+u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["webkitC"+s]()},!1)),document[f]("scroll",r,{passive:!0}),document[f]("keypress",r,!1),document[f]("click",r,!1)}},{}],6:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){c.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),c=t("wrap-function")(a,!0),s=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1],r=s(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?c(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],7:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var c=r.apply(this,t);return o.emit(n+"start",[t,a],c),c.then(function(t){return o.emit(n+"end",[null,t],c),t},function(t){throw o.emit(n+"end",[t],c),t})})}var o=t("ee").get("fetch"),i=t(27),a=t(26);e.exports=o;var c=window,s="fetch-",f=s+"body-",u=["arrayBuffer","blob","json","text","formData"],d=c.Request,p=c.Response,l=c.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(c,"fetch",s),o.on(s+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(s+"done",[null,e],n)}else o.emit(s+"done",[t],n)}))},{}],8:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],9:[function(t,e,n){function r(t){function e(){s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}function n(){s.emit("jsonp-error",[],p),s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var u=c(a),d="function"==typeof u.parent[u.key];if(d){var p={};f.inPlace(u.parent,[u.key],"cb-",p),t.addEventListener("load",e,!1),t.addEventListener("error",n,!1),s.emit("new-jsonp",[t.src],p)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(u);return e?e[1]:null}function a(t,e){var n=t.match(p),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function c(t){var e=t.match(d);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var s=t("ee").get("jsonp"),f=t("wrap-function")(s);if(e.exports=s,o()){var u=/[?&](?:callback|cb)=([^&#]+)/,d=/(.*)\.([^.]+)/,p=/^(\w+)(\.|$)(.*)$/,l=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?f.inPlace(Node.prototype,l,"dom-"):(f.inPlace(HTMLElement.prototype,l,"dom-"),f.inPlace(HTMLHeadElement.prototype,l,"dom-"),f.inPlace(HTMLBodyElement.prototype,l,"dom-")),s.on("dom-start",function(t){r(t[0])})}},{}],10:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],11:[function(t,e,n){function r(t){var e=a.context(),n=c(t,"executor-",e),r=new f(n);return a.context(r).getCtx=function(){return e},a.emit("new-promise",[r,e],e),r}function o(t,e){return e}var i=t("wrap-function"),a=t("ee").get("promise"),c=i(a),s=t(26),f=NREUM.o.PR;e.exports=a,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){a.emit("propagate",[null,!o],i),o=o||!t}}var o=!1;s(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var i=e.apply(f,arguments),c=f.resolve(i);return c}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&a.emit("propagate",[t,!0],n),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),s(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),a.on("executor-start",function(t){t[0]=c(t[0],"resolve-",this),t[1]=c(t[1],"resolve-",this)}),a.on("executor-err",function(t,e,n){t[1](n)}),c.inPlace(f.prototype,["then"],"then-",o),a.on("then-start",function(t,e){this.promise=e,t[0]=c(t[0],"cb-",this),t[1]=c(t[1],"cb-",this)}),a.on("then-end",function(t,e,n){this.nextPromise=n;var r=this.promise;a.emit("propagate",[r,!0],n)}),a.on("cb-end",function(t,e,n){a.emit("propagate",[n,!0],this.nextPromise)}),a.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=a.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],12:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],13:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),c="setTimeout",s="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[c,"setImmediate"],c+d),a.inPlace(window,[s],s+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(s+u,r),i.on(c+u,o)},{}],14:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",c)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,g,"fn-",c)}function i(t){y.push(t),h&&(b?b.then(a):v?v(a):(E=-E,R.data=E))}function a(){for(var t=0;t<y.length;t++)r([],y[t]);y.length&&(y=[])}function c(t,e){return e}function s(t,e){for(var n in t)e[n]=t[n];return e}t(6);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=NREUM.o,l=p.XHR,h=p.MO,m=p.PR,v=p.SI,w="readystatechange",g=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],y=[];e.exports=u;var x=window.XMLHttpRequest=function(t){var e=new l(t);try{u.emit("new-xhr",[e],e),e.addEventListener(w,o,!1)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(s(l,x),x.prototype=l.prototype,d.inPlace(x.prototype,["open","send"],"-xhr-",c),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),h){var b=m&&m.resolve();if(!v&&!m){var E=1,R=document.createTextNode(E);new h(a).observe(R,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===w||a()})},{}],15:[function(t,e,n){function r(t){if(!c(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||s(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&s(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",c=1,s="",f="";return o+"@nr="+i+"-"+c+"-"+n+"-"+r+"-"+t+"-"+a+"-"+s+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var c={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(c.d.tk=i),btoa(JSON.stringify(c))}function c(t){return f()&&s(t)}function s(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(23),h=t(17);e.exports={generateTracePayload:r,shouldGenerateTrace:c}},{}],16:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,u.emit("xhr-done",[t],t),c("xhr",[e,n,this.startTime]))}}function o(t,e){var n=s(e),r=t.params;r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=s(e),t.sameOrigin=t.parsedOrigin.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable){var c=t("handle"),s=t(17),f=t(15).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(21),m=t(20),v=t(18),w=window.XMLHttpRequest;a.features.xhr=!0,t(14),t(7),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,t.addEventListener("load",function(n){i(e,t)},!1),h&&(h>34||h<10)||window.opera||t.addEventListener("progress",function(t){e.lastSize=t.loaded},!1)}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var c=0;c<p;c++)e.addEventListener(d[c],this.listener,!1)}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("addEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof w&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url&&(n=t[0].url),n&&(this.parsedOrigin=s(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)})}},{}],17:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,c=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||c),"/"===o.pathname&&(r[t]=o),o}},{}],18:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(20);e.exports=r},{}],19:[function(t,e,n){function r(){}function o(t,e,n){return function(){return i(t,[f.now()].concat(c(arguments)),e?null:this,n),e?void 0:this}}var i=t("handle"),a=t(26),c=t(27),s=t("ee").get("tracer"),f=t("loader"),u=NREUM;"undefined"==typeof window.newrelic&&(newrelic=u);var d=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],p="api-",l=p+"ixn-";a(d,function(t,e){u[e]=o(p+e,!0,"api")}),u.addPageAction=o(p+"addPageAction",!0),u.setCurrentRouteName=o(p+"routeName",!0),e.exports=newrelic,u.interaction=function(){return(new r).get()};var h=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(l+"tracer",[f.now(),t,n],r),function(){if(s.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw s.emit("fn-err",[arguments,this,t],n),t}finally{s.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){h[e]=o(l+e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),i("err",[t,f.now(),!1,e])}},{}],20:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],21:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],22:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?d("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&d("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();n.length>0&&d("lcp",[n[n.length-1]])}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||d("cls",[t])})}function a(t){if(t instanceof h&&!v){var e=Math.round(t.timeStamp),n={type:t.type};e<=p.now()?n.fid=p.now()-e:e>p.offset&&e<=Date.now()?(e-=p.offset,n.fid=p.now()-e):e=p.now(),v=!0,d("timing",["fi",e,n])}}function c(t){d("pageHide",[p.now(),t])}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var s,f,u,d=t("handle"),p=t("loader"),l=t(25),h=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){s=new PerformanceObserver(r);try{s.observe({entryTypes:["paint"]})}catch(m){}f=new PerformanceObserver(o);try{f.observe({entryTypes:["largest-contentful-paint"]})}catch(m){}u=new PerformanceObserver(i);try{u.observe({type:"layout-shift",buffered:!0})}catch(m){}}if("addEventListener"in document){var v=!1,w=["click","keydown","mousedown","pointerdown","touchstart"];w.forEach(function(t){document.addEventListener(t,a,!1)})}l(c)}},{}],23:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",c=0;c<i.length;c++)o=i[c],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(31)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],24:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var c=navigator.userAgent,s=c.match(a);s&&c.indexOf("Chrome")===-1&&c.indexOf("Chromium")===-1&&(o="Safari",i=s[1])}e.exports={agent:o,version:i,match:r}},{}],25:[function(t,e,n){function r(t){function e(){t(a&&document[a]?document[a]:document[o]?"hidden":"visible")}"addEventListener"in document&&i&&document.addEventListener(i,e,!1)}e.exports=r;var o,i,a;"undefined"!=typeof document.hidden?(o="hidden",i="visibilitychange",a="visibilityState"):"undefined"!=typeof document.msHidden?(o="msHidden",i="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(o="webkitHidden",i="webkitvisibilitychange",a="webkitVisibilityState")},{}],26:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],27:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],28:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?s(t,c,i):i()}function n(n,r,o,i){if(!p.aborted||i){t&&t(n,r,o);for(var a=e(o),c=m(n),s=c.length,f=0;f<s;f++)c[f].apply(a,r);var d=u[y[n]];return d&&d.push([x,n,r,a]),a}}function l(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return d[t]=d[t]||o(n)}function w(t,e){f(t,function(t,n){e=e||"feature",y[n]=e,e in u||(u[e]=[])})}var g={},y={},x={on:l,addEventListener:l,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:a,aborted:!1};return x}function i(){return new r}function a(){(u.api||u.feature)&&(p.aborted=!0,u=p.backlog={})}var c="nr@context",s=t("gos"),f=t(26),u={},d={},p=e.exports=o();p.backlog=u},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!E++){var t=b.info=NREUM.info,e=l.getElementsByTagName("script")[0];if(setTimeout(u.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return u.abort();f(y,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+b.offset],null,"api"),s("timing",["load",n]);var r=l.createElement("script");r.src="https://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===l.readyState&&i()}function i(){s("mark",["domContent",a()+b.offset],null,"api")}function a(){return R.exists&&performance.now?Math.round(performance.now()):(c=Math.max((new Date).getTime(),c))-b.offset}var c=(new Date).getTime(),s=t("handle"),f=t(26),u=t("ee"),d=t(24),p=window,l=p.document,h="addEventListener",m="attachEvent",v=p.XMLHttpRequest,w=v&&v.prototype;NREUM.o={ST:setTimeout,SI:p.setImmediate,CT:clearTimeout,XHR:v,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var g=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1177.min.js"},x=v&&w&&w[h]&&!/CriOS/.test(navigator.userAgent),b=e.exports={offset:c,now:a,origin:g,features:{},xhrWrappable:x,userAgent:d};t(19),t(22),l[h]?(l[h]("DOMContentLoaded",i,!1),p[h]("load",r,!1)):(l[m]("onreadystatechange",o),p[m]("onload",r)),s("mark",["firstbyte",c],null,"api");var E=0,R=t(28)},{}],"wrap-function":[function(t,e,n){function r(t){return!(t&&t instanceof Function&&t.apply&&!t[a])}var o=t("ee"),i=t(27),a="nr@original",c=Object.prototype.hasOwnProperty,s=!1;e.exports=function(t,e){function n(t,e,n,o){function nrWrapper(){var r,a,c,s;try{a=this,r=i(arguments),c="function"==typeof n?n(r,a):n||{}}catch(f){p([f,"",[r,a,o],c])}u(e+"start",[r,a,o],c);try{return s=t.apply(a,r)}catch(d){throw u(e+"err",[r,a,d],c),d}finally{u(e+"end",[r,a,s],c)}}return r(t)?t:(e||(e=""),nrWrapper[a]=t,d(t,nrWrapper),nrWrapper)}function f(t,e,o,i){o||(o="");var a,c,s,f="-"===o.charAt(0);for(s=0;s<e.length;s++)c=e[s],a=t[c],r(a)||(t[c]=n(a,f?c+o:o,i,c))}function u(n,r,o){if(!s||e){var i=s;s=!0;try{t.emit(n,r,o,e)}catch(a){p([a,n,r,o])}s=i}}function d(t,e){if(Object.defineProperty&&Object.keys)try{var n=Object.keys(t);return n.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(r){p([r])}for(var o in t)c.call(t,o)&&(e[o]=t[o]);return e}function p(e){try{t.emit("internal-error",e)}catch(n){}}return t||(t=o),n.inPlace=f,n.flag=a,n}},{}]},{},["loader",2,16,5,3,4]);
    ;NREUM.loader_config={accountID:"2095297",trustKey:"2038175",agentID:"916957862",licenseKey:"16e2192192",applicationID:"916957862"}
    ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"16e2192192",applicationID:"916957862",sa:1}
</script>
    <script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="dada9834-04e2-4bcd-b5ba-cae44d498dfa"></script>
    <script type="text/javascript">
        function getCookie(name) {
            var value = "; " + document.cookie;
            var parts = value.split("; " + name + "=");
            if (parts.length == 2) {
                return true;
            }
        }
            function OptanonWrapper() {
                var optCookie = getCookie("OptanonAlertBoxClosed");
                var isActiveCategory = "false";
                var isFoundCookieBox = "false";
                if(isActiveCategory == 'false' && isFoundCookieBox == 'false' && optCookie) {
                    OneTrust.InsertScript('/pb-assets/adobe/prod/adobedtm-1616606406233.js', 'head', null, null, '2');
                }
            }
    </script>


<noscript>
    <style>.requiresJS {
        display: none
    }

    .dartAd {
        display: block !important
    }</style>
</noscript>
        <script type="text/javascript" src="/wro/o4ny~selected-legacy.js"></script>
        <link rel="stylesheet" type="text/css" href="/wro/o4ny~selected-legacy.css">
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans">
        <script>window.MSInputMethodContext && document.documentMode && document.write('<script src="https://cdn.jsdelivr.net/gh/nuxodin/ie11CustomProperties@4.1.0/ie11CustomProperties.min.js"><\x2fscript>');</script><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/build-b26f3342b722959c7931.css"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/print-b26f3342b722959c7931.css" media="print"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/themes/theme-cell.css">







        
        
        <script class="optanon-category-4" type="text/plain" async="" src="https://www.youtube.com/iframe_api"></script>
        
    





<!---->
<meta http-equiv="X-UA-Compatible" content="IE=edge">












<script src="https://cdn.cookielaw.org/scripttemplates/202411.2.0/otBannerSdk.js" async="" type="text/javascript"></script><style id="onetrust-style">#onetrust-banner-sdk .onetrust-vendors-list-handler{cursor:pointer;color:#1f96db;font-size:inherit;font-weight:bold;text-decoration:none;margin-left:5px}#onetrust-banner-sdk .onetrust-vendors-list-handler:hover{color:#1f96db}#onetrust-banner-sdk:focus{outline:2px solid #000;outline-offset:-2px}#onetrust-banner-sdk a:focus{outline:2px solid #000}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{outline-offset:1px}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{height:64px;width:64px}#onetrust-banner-sdk .ot-tcf2-vendor-count.ot-text-bold{font-weight:bold}#onetrust-banner-sdk .ot-close-icon,#onetrust-pc-sdk .ot-close-icon,#ot-sync-ntfy .ot-close-icon{background-size:contain;background-repeat:no-repeat;background-position:center;height:12px;width:12px}#onetrust-banner-sdk .powered-by-logo,#onetrust-banner-sdk .ot-pc-footer-logo a,#onetrust-pc-sdk .powered-by-logo,#onetrust-pc-sdk .ot-pc-footer-logo a,#ot-sync-ntfy .powered-by-logo,#ot-sync-ntfy .ot-pc-footer-logo a{background-size:contain;background-repeat:no-repeat;background-position:center;height:25px;width:152px;display:block;text-decoration:none;font-size:.75em}#onetrust-banner-sdk .powered-by-logo:hover,#onetrust-banner-sdk .ot-pc-footer-logo a:hover,#onetrust-pc-sdk .powered-by-logo:hover,#onetrust-pc-sdk .ot-pc-footer-logo a:hover,#ot-sync-ntfy .powered-by-logo:hover,#ot-sync-ntfy .ot-pc-footer-logo a:hover{color:#565656}#onetrust-banner-sdk h3 *,#onetrust-banner-sdk h4 *,#onetrust-banner-sdk h6 *,#onetrust-banner-sdk button *,#onetrust-banner-sdk a[data-parent-id] *,#onetrust-pc-sdk h3 *,#onetrust-pc-sdk h4 *,#onetrust-pc-sdk h6 *,#onetrust-pc-sdk button *,#onetrust-pc-sdk a[data-parent-id] *,#ot-sync-ntfy h3 *,#ot-sync-ntfy h4 *,#ot-sync-ntfy h6 *,#ot-sync-ntfy button *,#ot-sync-ntfy a[data-parent-id] *{font-size:inherit;font-weight:inherit;color:inherit}#onetrust-banner-sdk .ot-hide,#onetrust-pc-sdk .ot-hide,#ot-sync-ntfy .ot-hide{display:none !important}#onetrust-banner-sdk button.ot-link-btn:hover,#onetrust-pc-sdk button.ot-link-btn:hover,#ot-sync-ntfy button.ot-link-btn:hover{text-decoration:underline;opacity:1}#onetrust-pc-sdk .ot-sdk-row .ot-sdk-column{padding:0}#onetrust-pc-sdk .ot-sdk-container{padding-right:0}#onetrust-pc-sdk .ot-sdk-row{flex-direction:initial;width:100%}#onetrust-pc-sdk [type=checkbox]:checked,#onetrust-pc-sdk [type=checkbox]:not(:checked){pointer-events:initial}#onetrust-pc-sdk [type=checkbox]:disabled+label::before,#onetrust-pc-sdk [type=checkbox]:disabled+label:after,#onetrust-pc-sdk [type=checkbox]:disabled+label{pointer-events:none;opacity:.8}#onetrust-pc-sdk #vendor-list-content{transform:translate3d(0, 0, 0)}#onetrust-pc-sdk li input[type=checkbox]{z-index:1}#onetrust-pc-sdk li .ot-checkbox label{z-index:2}#onetrust-pc-sdk li .ot-checkbox input[type=checkbox]{height:auto;width:auto}#onetrust-pc-sdk li .host-title a,#onetrust-pc-sdk li .ot-host-name a,#onetrust-pc-sdk li .accordion-text,#onetrust-pc-sdk li .ot-acc-txt{z-index:2;position:relative}#onetrust-pc-sdk input{margin:3px .1ex}#onetrust-pc-sdk .pc-logo,#onetrust-pc-sdk .ot-pc-logo{height:60px;width:180px;background-position:center;background-size:contain;background-repeat:no-repeat;display:inline-flex;justify-content:center;align-items:center}#onetrust-pc-sdk .pc-logo img,#onetrust-pc-sdk .ot-pc-logo img{max-height:100%;max-width:100%}#onetrust-pc-sdk .screen-reader-only,#onetrust-pc-sdk .ot-scrn-rdr,.ot-sdk-cookie-policy .screen-reader-only,.ot-sdk-cookie-policy .ot-scrn-rdr{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}#onetrust-pc-sdk.ot-fade-in,.onetrust-pc-dark-filter.ot-fade-in,#onetrust-banner-sdk.ot-fade-in{animation-name:onetrust-fade-in;animation-duration:400ms;animation-timing-function:ease-in-out}#onetrust-pc-sdk.ot-hide{display:none !important}.onetrust-pc-dark-filter.ot-hide{display:none !important}#ot-sdk-btn.ot-sdk-show-settings,#ot-sdk-btn.optanon-show-settings{color:#fff;background-color:#468254;height:auto;white-space:normal;word-wrap:break-word;padding:.8em 2em;font-size:.8em;line-height:1.2;cursor:pointer;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease}#ot-sdk-btn.ot-sdk-show-settings:hover,#ot-sdk-btn.optanon-show-settings:hover{color:#fff;background-color:#2c6415}#ot-sdk-btn.ot-sdk-show-settings:active,#ot-sdk-btn.optanon-show-settings:active{color:#fff;background-color:#2c6415;border:1px solid rgba(162,192,169,.5)}.onetrust-pc-dark-filter{background:rgba(0,0,0,.5);z-index:2147483646;width:100%;height:100%;overflow:hidden;position:fixed;top:0;bottom:0;left:0}@keyframes onetrust-fade-in{0%{opacity:0}100%{opacity:1}}.ot-cookie-label{text-decoration:underline}@media only screen and (min-width: 426px)and (max-width: 896px)and (orientation: landscape){#onetrust-pc-sdk p{font-size:.75em}}#onetrust-banner-sdk .banner-option-input:focus+label{outline:1px solid #000;outline-style:auto}.category-vendors-list-handler+a:focus,.category-vendors-list-handler+a:focus-visible{outline:2px solid #000}#onetrust-pc-sdk .ot-userid-title{margin-top:10px}#onetrust-pc-sdk .ot-userid-title>span,#onetrust-pc-sdk .ot-userid-timestamp>span{font-weight:700}#onetrust-pc-sdk .ot-userid-desc{font-style:italic}#onetrust-pc-sdk .ot-host-desc a{pointer-events:initial}#onetrust-pc-sdk .ot-ven-hdr>p a{position:relative;z-index:2;pointer-events:initial}#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info a{margin-right:auto}#onetrust-pc-sdk .ot-pc-footer-logo img{width:136px;height:16px}#onetrust-pc-sdk .ot-pur-vdr-count{font-weight:400;font-size:.7rem;padding-top:3px;display:block}#onetrust-banner-sdk .ot-optout-signal,#onetrust-pc-sdk .ot-optout-signal{border:1px solid #32ae88;border-radius:3px;padding:5px;margin-bottom:10px;background-color:#f9fffa;font-size:.85rem;line-height:2}#onetrust-banner-sdk .ot-optout-signal .ot-optout-icon,#onetrust-pc-sdk .ot-optout-signal .ot-optout-icon{display:inline;margin-right:5px}#onetrust-banner-sdk .ot-optout-signal svg,#onetrust-pc-sdk .ot-optout-signal svg{height:20px;width:30px;transform:scale(0.5)}#onetrust-banner-sdk .ot-optout-signal svg path,#onetrust-pc-sdk .ot-optout-signal svg path{fill:#32ae88}#onetrust-consent-sdk .ot-general-modal{overflow:hidden;position:fixed;margin:0 auto;top:50%;left:50%;width:40%;padding:1.5rem;max-width:575px;min-width:575px;z-index:2147483647;border-radius:2.5px;transform:translate(-50%, -50%)}#onetrust-consent-sdk .ot-signature-health-group{margin-top:1rem;padding-left:1.25rem;padding-right:1.25rem;margin-bottom:.625rem;width:calc(100% - 2.5rem)}#onetrust-consent-sdk .ot-signature-health-group .ot-signature-health-form{gap:.5rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:70%;gap:.35rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-input{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-consent-sdk .ot-signature-health .ot-signature-subtitle{font-size:1.125rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-group-title{font-size:1.25rem;font-weight:bold}#onetrust-consent-sdk .ot-signature-health,#onetrust-consent-sdk .ot-signature-health-group{display:flex;flex-direction:column;gap:1rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-cont{display:flex;flex-direction:column;gap:.25rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-paragraph,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-paragraph{margin:0;line-height:20px;font-size:max(14px,.875rem)}#onetrust-consent-sdk .ot-signature-health .ot-health-signature-error,#onetrust-consent-sdk .ot-signature-health-group .ot-health-signature-error{color:#4d4d4d;font-size:min(12px,.75rem)}#onetrust-consent-sdk .ot-signature-health .ot-signature-buttons-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-buttons-cont{margin-top:max(.75rem,2%);gap:1rem;display:flex;justify-content:flex-end}#onetrust-consent-sdk .ot-signature-health .ot-signature-button,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button{flex:1;height:auto;color:#fff;cursor:pointer;line-height:1.2;min-width:125px;font-weight:600;font-size:.813em;border-radius:2px;padding:12px 10px;white-space:normal;word-wrap:break-word;word-break:break-word;background-color:#68b631;border:2px solid #68b631}#onetrust-consent-sdk .ot-signature-health .ot-signature-button.reject,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button.reject{background-color:#fff}#onetrust-consent-sdk .ot-input-field-cont{display:flex;flex-direction:column;gap:.5rem}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:65%}#onetrust-consent-sdk .ot-signature-health-form{display:flex;flex-direction:column}#onetrust-consent-sdk .ot-signature-health-form .ot-signature-label{margin-bottom:0;line-height:20px;font-size:max(14px,.875rem)}@media only screen and (max-width: 600px){#onetrust-consent-sdk .ot-general-modal{min-width:100%}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:100%}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:100%}}#onetrust-banner-sdk,#onetrust-pc-sdk,#ot-sdk-cookie-policy,#ot-sync-ntfy{font-size:16px}#onetrust-banner-sdk *,#onetrust-banner-sdk ::after,#onetrust-banner-sdk ::before,#onetrust-pc-sdk *,#onetrust-pc-sdk ::after,#onetrust-pc-sdk ::before,#ot-sdk-cookie-policy *,#ot-sdk-cookie-policy ::after,#ot-sdk-cookie-policy ::before,#ot-sync-ntfy *,#ot-sync-ntfy ::after,#ot-sync-ntfy ::before{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}#onetrust-banner-sdk div,#onetrust-banner-sdk span,#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-banner-sdk p,#onetrust-banner-sdk img,#onetrust-banner-sdk svg,#onetrust-banner-sdk button,#onetrust-banner-sdk section,#onetrust-banner-sdk a,#onetrust-banner-sdk label,#onetrust-banner-sdk input,#onetrust-banner-sdk ul,#onetrust-banner-sdk li,#onetrust-banner-sdk nav,#onetrust-banner-sdk table,#onetrust-banner-sdk thead,#onetrust-banner-sdk tr,#onetrust-banner-sdk td,#onetrust-banner-sdk tbody,#onetrust-banner-sdk .ot-main-content,#onetrust-banner-sdk .ot-toggle,#onetrust-banner-sdk #ot-content,#onetrust-banner-sdk #ot-pc-content,#onetrust-banner-sdk .checkbox,#onetrust-pc-sdk div,#onetrust-pc-sdk span,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#onetrust-pc-sdk p,#onetrust-pc-sdk img,#onetrust-pc-sdk svg,#onetrust-pc-sdk button,#onetrust-pc-sdk section,#onetrust-pc-sdk a,#onetrust-pc-sdk label,#onetrust-pc-sdk input,#onetrust-pc-sdk ul,#onetrust-pc-sdk li,#onetrust-pc-sdk nav,#onetrust-pc-sdk table,#onetrust-pc-sdk thead,#onetrust-pc-sdk tr,#onetrust-pc-sdk td,#onetrust-pc-sdk tbody,#onetrust-pc-sdk .ot-main-content,#onetrust-pc-sdk .ot-toggle,#onetrust-pc-sdk #ot-content,#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk .checkbox,#ot-sdk-cookie-policy div,#ot-sdk-cookie-policy span,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy p,#ot-sdk-cookie-policy img,#ot-sdk-cookie-policy svg,#ot-sdk-cookie-policy button,#ot-sdk-cookie-policy section,#ot-sdk-cookie-policy a,#ot-sdk-cookie-policy label,#ot-sdk-cookie-policy input,#ot-sdk-cookie-policy ul,#ot-sdk-cookie-policy li,#ot-sdk-cookie-policy nav,#ot-sdk-cookie-policy table,#ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy tr,#ot-sdk-cookie-policy td,#ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy .ot-main-content,#ot-sdk-cookie-policy .ot-toggle,#ot-sdk-cookie-policy #ot-content,#ot-sdk-cookie-policy #ot-pc-content,#ot-sdk-cookie-policy .checkbox,#ot-sync-ntfy div,#ot-sync-ntfy span,#ot-sync-ntfy h1,#ot-sync-ntfy h2,#ot-sync-ntfy h3,#ot-sync-ntfy h4,#ot-sync-ntfy h5,#ot-sync-ntfy h6,#ot-sync-ntfy p,#ot-sync-ntfy img,#ot-sync-ntfy svg,#ot-sync-ntfy button,#ot-sync-ntfy section,#ot-sync-ntfy a,#ot-sync-ntfy label,#ot-sync-ntfy input,#ot-sync-ntfy ul,#ot-sync-ntfy li,#ot-sync-ntfy nav,#ot-sync-ntfy table,#ot-sync-ntfy thead,#ot-sync-ntfy tr,#ot-sync-ntfy td,#ot-sync-ntfy tbody,#ot-sync-ntfy .ot-main-content,#ot-sync-ntfy .ot-toggle,#ot-sync-ntfy #ot-content,#ot-sync-ntfy #ot-pc-content,#ot-sync-ntfy .checkbox{font-family:inherit;font-weight:normal;-webkit-font-smoothing:auto;letter-spacing:normal;line-height:normal;padding:0;margin:0;height:auto;min-height:0;max-height:none;width:auto;min-width:0;max-width:none;border-radius:0;border:none;clear:none;float:none;position:static;bottom:auto;left:auto;right:auto;top:auto;text-align:left;text-decoration:none;text-indent:0;text-shadow:none;text-transform:none;white-space:normal;background:none;overflow:visible;vertical-align:baseline;visibility:visible;z-index:auto;box-shadow:none}#onetrust-banner-sdk label:before,#onetrust-banner-sdk label:after,#onetrust-banner-sdk .checkbox:after,#onetrust-banner-sdk .checkbox:before,#onetrust-pc-sdk label:before,#onetrust-pc-sdk label:after,#onetrust-pc-sdk .checkbox:after,#onetrust-pc-sdk .checkbox:before,#ot-sdk-cookie-policy label:before,#ot-sdk-cookie-policy label:after,#ot-sdk-cookie-policy .checkbox:after,#ot-sdk-cookie-policy .checkbox:before,#ot-sync-ntfy label:before,#ot-sync-ntfy label:after,#ot-sync-ntfy .checkbox:after,#ot-sync-ntfy .checkbox:before{content:"";content:none}#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{position:relative;width:100%;max-width:100%;margin:0 auto;padding:0 20px;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{width:100%;float:left;box-sizing:border-box;padding:0;display:initial}@media(min-width: 400px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:90%;padding:0}}@media(min-width: 550px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:100%}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{margin-left:4%}#onetrust-banner-sdk .ot-sdk-column:first-child,#onetrust-banner-sdk .ot-sdk-columns:first-child,#onetrust-pc-sdk .ot-sdk-column:first-child,#onetrust-pc-sdk .ot-sdk-columns:first-child,#ot-sdk-cookie-policy .ot-sdk-column:first-child,#ot-sdk-cookie-policy .ot-sdk-columns:first-child{margin-left:0}#onetrust-banner-sdk .ot-sdk-two.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-two.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-two.ot-sdk-columns{width:13.3333333333%}#onetrust-banner-sdk .ot-sdk-three.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-three.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-three.ot-sdk-columns{width:22%}#onetrust-banner-sdk .ot-sdk-four.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-four.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-four.ot-sdk-columns{width:30.6666666667%}#onetrust-banner-sdk .ot-sdk-eight.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eight.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eight.ot-sdk-columns{width:65.3333333333%}#onetrust-banner-sdk .ot-sdk-nine.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-nine.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-nine.ot-sdk-columns{width:74%}#onetrust-banner-sdk .ot-sdk-ten.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-ten.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-ten.ot-sdk-columns{width:82.6666666667%}#onetrust-banner-sdk .ot-sdk-eleven.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eleven.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eleven.ot-sdk-columns{width:91.3333333333%}#onetrust-banner-sdk .ot-sdk-twelve.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-twelve.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-twelve.ot-sdk-columns{width:100%;margin-left:0}}#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6{margin-top:0;font-weight:600;font-family:inherit}#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem;line-height:1.2}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem;line-height:1.25}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem;line-height:1.3}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem;line-height:1.35}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem;line-height:1.5}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem;line-height:1.6}@media(min-width: 550px){#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem}}#onetrust-banner-sdk p,#onetrust-pc-sdk p,#ot-sdk-cookie-policy p{margin:0 0 1em 0;font-family:inherit;line-height:normal}#onetrust-banner-sdk a,#onetrust-pc-sdk a,#ot-sdk-cookie-policy a{color:#565656;text-decoration:underline}#onetrust-banner-sdk a:hover,#onetrust-pc-sdk a:hover,#ot-sdk-cookie-policy a:hover{color:#565656;text-decoration:none}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{display:inline-block;height:38px;padding:0 30px;color:#555;text-align:center;font-size:.9em;font-weight:400;line-height:38px;letter-spacing:.01em;text-decoration:none;white-space:nowrap;background-color:rgba(0,0,0,0);border-radius:2px;border:1px solid #bbb;cursor:pointer;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-button:hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#onetrust-pc-sdk .ot-sdk-button:hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#ot-sdk-cookie-policy .ot-sdk-button:hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus{color:#333;border-color:#888;opacity:.9}#onetrust-banner-sdk .ot-sdk-button:focus,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:focus,#onetrust-pc-sdk .ot-sdk-button:focus,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:focus,#ot-sdk-cookie-policy .ot-sdk-button:focus,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:focus{outline:2px solid #000}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-banner-sdk button.ot-sdk-button-primary,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-pc-sdk button.ot-sdk-button-primary,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary,#ot-sdk-cookie-policy button.ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary{color:#fff;background-color:#33c3f0;border-color:#33c3f0}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-banner-sdk button.ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-banner-sdk button.ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:focus,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-pc-sdk button.ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-pc-sdk button.ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:focus{color:#fff;background-color:#1eaedb;border-color:#1eaedb}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{-webkit-appearance:none;-moz-appearance:none;appearance:none}#onetrust-banner-sdk input[type=text]:focus,#onetrust-pc-sdk input[type=text]:focus,#ot-sdk-cookie-policy input[type=text]:focus{border:1px solid #000;outline:0}#onetrust-banner-sdk label,#onetrust-pc-sdk label,#ot-sdk-cookie-policy label{display:block;margin-bottom:.5rem;font-weight:600}#onetrust-banner-sdk input[type=checkbox],#onetrust-pc-sdk input[type=checkbox],#ot-sdk-cookie-policy input[type=checkbox]{display:inline}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{list-style:circle inside}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{padding-left:0;margin-top:0}#onetrust-banner-sdk ul ul,#onetrust-pc-sdk ul ul,#ot-sdk-cookie-policy ul ul{margin:1.5rem 0 1.5rem 3rem;font-size:90%}#onetrust-banner-sdk li,#onetrust-pc-sdk li,#ot-sdk-cookie-policy li{margin-bottom:1rem}#onetrust-banner-sdk th,#onetrust-banner-sdk td,#onetrust-pc-sdk th,#onetrust-pc-sdk td,#ot-sdk-cookie-policy th,#ot-sdk-cookie-policy td{padding:12px 15px;text-align:left;border-bottom:1px solid #e1e1e1}#onetrust-banner-sdk button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-container:after,#onetrust-banner-sdk .ot-sdk-row:after,#onetrust-pc-sdk .ot-sdk-container:after,#onetrust-pc-sdk .ot-sdk-row:after,#ot-sdk-cookie-policy .ot-sdk-container:after,#ot-sdk-cookie-policy .ot-sdk-row:after{content:"";display:table;clear:both}#onetrust-banner-sdk .ot-sdk-row,#onetrust-pc-sdk .ot-sdk-row,#ot-sdk-cookie-policy .ot-sdk-row{margin:0;max-width:none;display:block}#onetrust-banner-sdk{box-shadow:0 0 18px rgba(0,0,0,.2)}#onetrust-banner-sdk.otFlat{position:fixed;z-index:2147483645;bottom:0;right:0;left:0;background-color:#fff;max-height:90%;overflow-x:hidden;overflow-y:auto}#onetrust-banner-sdk.otFlat.top{top:0px;bottom:auto}#onetrust-banner-sdk.otRelFont{font-size:1rem}#onetrust-banner-sdk>.ot-sdk-container{overflow:hidden}#onetrust-banner-sdk::-webkit-scrollbar{width:11px}#onetrust-banner-sdk::-webkit-scrollbar-thumb{border-radius:10px;background:#c1c1c1}#onetrust-banner-sdk{scrollbar-arrow-color:#c1c1c1;scrollbar-darkshadow-color:#c1c1c1;scrollbar-face-color:#c1c1c1;scrollbar-shadow-color:#c1c1c1}#onetrust-banner-sdk #onetrust-policy{margin:1.25em 0 .625em 2em;overflow:hidden}#onetrust-banner-sdk #onetrust-policy .ot-gv-list-handler{float:left;font-size:.82em;padding:0;margin-bottom:0;border:0;line-height:normal;height:auto;width:auto}#onetrust-banner-sdk #onetrust-policy-title{font-size:1.2em;line-height:1.3;margin-bottom:10px}#onetrust-banner-sdk #onetrust-policy-text{clear:both;text-align:left;font-size:.88em;line-height:1.4}#onetrust-banner-sdk #onetrust-policy-text *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk #onetrust-policy-text a{font-weight:bold;margin-left:5px}#onetrust-banner-sdk #onetrust-policy-title,#onetrust-banner-sdk #onetrust-policy-text{color:dimgray;float:left}#onetrust-banner-sdk #onetrust-button-group-parent{min-height:1px;text-align:center}#onetrust-banner-sdk #onetrust-button-group{display:inline-block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{background-color:#68b631;color:#fff;border-color:#68b631;margin-right:1em;min-width:125px;height:auto;white-space:normal;word-break:break-word;word-wrap:break-word;padding:12px 10px;line-height:1.2;font-size:.813em;font-weight:600}#onetrust-banner-sdk #onetrust-pc-btn-handler.cookie-setting-link{background-color:#fff;border:none;color:#68b631;text-decoration:underline;padding-left:0;padding-right:0}#onetrust-banner-sdk .onetrust-close-btn-ui{width:44px;height:44px;background-size:12px;border:none;position:relative;margin:auto;padding:0}#onetrust-banner-sdk .banner_logo{display:none}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{position:absolute;top:50%;transform:translateY(-50%);left:0px}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-policy{margin-left:65px}#onetrust-banner-sdk .ot-b-addl-desc{clear:both;float:left;display:block}#onetrust-banner-sdk #banner-options{float:left;display:table;margin-right:0;margin-left:1em;width:calc(100% - 1em)}#onetrust-banner-sdk .banner-option-input{cursor:pointer;width:auto;height:auto;border:none;padding:0;padding-right:3px;margin:0 0 10px;font-size:.82em;line-height:1.4}#onetrust-banner-sdk .banner-option-input *{pointer-events:none;font-size:inherit;line-height:inherit}#onetrust-banner-sdk .banner-option-input[aria-expanded=true]~.banner-option-details{display:block;height:auto}#onetrust-banner-sdk .banner-option-input[aria-expanded=true] .ot-arrow-container{transform:rotate(90deg)}#onetrust-banner-sdk .banner-option{margin-bottom:12px;margin-left:0;border:none;float:left;padding:0}#onetrust-banner-sdk .banner-option:first-child{padding-left:2px}#onetrust-banner-sdk .banner-option:not(:first-child){padding:0;border:none}#onetrust-banner-sdk .banner-option-header{cursor:pointer;display:inline-block}#onetrust-banner-sdk .banner-option-header :first-child{color:dimgray;font-weight:bold;float:left}#onetrust-banner-sdk .banner-option-header .ot-arrow-container{display:inline-block;border-top:6px solid rgba(0,0,0,0);border-bottom:6px solid rgba(0,0,0,0);border-left:6px solid dimgray;margin-left:10px;vertical-align:middle}#onetrust-banner-sdk .banner-option-details{display:none;font-size:.83em;line-height:1.5;padding:10px 0px 5px 10px;margin-right:10px;height:0px}#onetrust-banner-sdk .banner-option-details *{font-size:inherit;line-height:inherit;color:dimgray}#onetrust-banner-sdk .ot-arrow-container,#onetrust-banner-sdk .banner-option-details{transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-banner-sdk .ot-dpd-container{float:left}#onetrust-banner-sdk .ot-dpd-title{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-title,#onetrust-banner-sdk .ot-dpd-desc{font-size:.88em;line-height:1.4;color:dimgray}#onetrust-banner-sdk .ot-dpd-title *,#onetrust-banner-sdk .ot-dpd-desc *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text *{margin-bottom:0}#onetrust-banner-sdk.ot-iab-2 .onetrust-vendors-list-handler{display:block;margin-left:0;margin-top:5px;clear:both;margin-bottom:0;padding:0;border:0;height:auto;width:auto}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk.ot-close-btn-link{padding-top:25px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container{top:15px;transform:none;right:15px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container button{padding:0;white-space:pre-wrap;border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em}#onetrust-banner-sdk #onetrust-policy-text,#onetrust-banner-sdk .ot-dpd-desc,#onetrust-banner-sdk .ot-b-addl-desc{font-size:.813em;line-height:1.5}#onetrust-banner-sdk .ot-dpd-desc{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-desc>.ot-b-addl-desc{margin-top:10px;margin-bottom:10px;font-size:1em}@media only screen and (max-width: 425px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:6px;right:2px}#onetrust-banner-sdk #onetrust-policy{margin-left:0;margin-top:3em}#onetrust-banner-sdk #onetrust-button-group{display:block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk .onetrust-close-btn-ui{top:auto;transform:none}#onetrust-banner-sdk #onetrust-policy-title{display:inline;float:none}#onetrust-banner-sdk #banner-options{margin:0;padding:0;width:100%}}@media only screen and (min-width: 426px)and (max-width: 896px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:0;right:0}#onetrust-banner-sdk #onetrust-policy{margin-left:1em;margin-right:1em}#onetrust-banner-sdk .onetrust-close-btn-ui{top:10px;right:10px}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:95%}#onetrust-banner-sdk.ot-iab-2 #onetrust-group-container{width:100%}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-button-group-parent{padding-left:50px}#onetrust-banner-sdk #onetrust-button-group-parent{width:100%;position:relative;margin-left:0}#onetrust-banner-sdk #onetrust-button-group button{display:inline-block}#onetrust-banner-sdk #onetrust-button-group{margin-right:0;text-align:center}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler{float:left}#onetrust-banner-sdk .has-reject-all-button #onetrust-reject-all-handler,#onetrust-banner-sdk .has-reject-all-button #onetrust-accept-btn-handler{float:right}#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group{width:calc(100% - 2em);margin-right:0}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler.cookie-setting-link{padding-left:0px;text-align:left}#onetrust-banner-sdk.ot-buttons-fw .ot-sdk-three button{width:100%;text-align:center}#onetrust-banner-sdk.ot-buttons-fw #onetrust-button-group-parent button{float:none}#onetrust-banner-sdk.ot-buttons-fw #onetrust-pc-btn-handler.cookie-setting-link{text-align:center}}@media only screen and (min-width: 550px){#onetrust-banner-sdk .banner-option:not(:first-child){border-left:1px solid #d8d8d8;padding-left:25px}}@media only screen and (min-width: 425px)and (max-width: 550px){#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group,#onetrust-banner-sdk.ot-iab-2 #onetrust-policy,#onetrust-banner-sdk.ot-iab-2 .banner-option{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler{float:left}}@media only screen and (min-width: 769px){#onetrust-banner-sdk #onetrust-button-group{margin-right:30%}#onetrust-banner-sdk #banner-options{margin-left:2em;margin-right:5em;margin-bottom:1.25em;width:calc(100% - 7em)}}@media only screen and (min-width: 897px)and (max-width: 1023px){#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:75%;transform:translateY(-50%)}#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;padding:0;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{position:relative;margin:0;right:-22px;top:2px}}@media only screen and (min-width: 1024px){#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{right:-12px}#onetrust-banner-sdk #onetrust-policy{margin-left:2em}#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:60%;transform:translateY(-50%)}#onetrust-banner-sdk .ot-optout-signal{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-title{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text,#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:1em;width:50%;border-right:1px solid #d8d8d8;padding-right:1rem}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-container{width:45%;padding-left:1rem;display:inline-block;float:none}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-title{line-height:1.7}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group-parent{left:auto;right:4%;margin-left:0}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:auto;width:30%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:60%}#onetrust-banner-sdk #onetrust-button-group{margin-right:auto}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{margin-top:1em}}@media only screen and (min-width: 890px){#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group-parent{padding-left:3%;padding-right:4%;margin-left:0}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{margin-right:0;margin-top:1.25em;width:100%}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button{width:100%;margin-bottom:5px;margin-top:5px}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type{margin-bottom:20px}}@media only screen and (min-width: 1280px){#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:55%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{width:44%;padding-left:2%;padding-right:2%}#onetrust-banner-sdk:not(.ot-iab-2).vertical-align-content #onetrust-button-group-parent{position:absolute;left:55%}}
        #onetrust-consent-sdk #onetrust-banner-sdk {background-color: #FFF;}
            #onetrust-consent-sdk #onetrust-policy-title,
                    #onetrust-consent-sdk #onetrust-policy-text,
                    #onetrust-consent-sdk .ot-b-addl-desc,
                    #onetrust-consent-sdk .ot-dpd-desc,
                    #onetrust-consent-sdk .ot-dpd-title,
                    #onetrust-consent-sdk #onetrust-policy-text *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk .ot-dpd-desc *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk #onetrust-banner-sdk #banner-options *,
                    #onetrust-banner-sdk .ot-cat-header,
                    #onetrust-banner-sdk .ot-optout-signal
                    {
                        color: #2E2E2E;
                    }
            #onetrust-consent-sdk #onetrust-banner-sdk .banner-option-details {
                    background-color: #E9E9E9;}
             #onetrust-consent-sdk #onetrust-banner-sdk a[href],
                    #onetrust-consent-sdk #onetrust-banner-sdk a[href] font,
                    #onetrust-consent-sdk #onetrust-banner-sdk .ot-link-btn
                        {
                            color: #007398;
                        }#onetrust-consent-sdk #onetrust-accept-btn-handler,
                         #onetrust-banner-sdk #onetrust-reject-all-handler {
                            background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-banner-sdk *:focus,
            #onetrust-consent-sdk #onetrust-banner-sdk:focus {
               outline-color: #000000;
               outline-width: 1px;
            }
            #onetrust-consent-sdk #onetrust-pc-btn-handler,
            #onetrust-consent-sdk #onetrust-pc-btn-handler.cookie-setting-link {
                color: #6CC04A; border-color: #6CC04A;
                background-color:
                #FFF;
            }/*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
#onetrust-pc-sdk.otPcCenter{overflow:hidden;position:fixed;margin:0 auto;top:5%;right:0;left:0;width:40%;max-width:575px;min-width:575px;border-radius:2.5px;z-index:2147483647;background-color:#fff;-webkit-box-shadow:0px 2px 10px -3px #999;-moz-box-shadow:0px 2px 10px -3px #999;box-shadow:0px 2px 10px -3px #999}#onetrust-pc-sdk.otPcCenter[dir=rtl]{right:0;left:0}#onetrust-pc-sdk.otRelFont{font-size:1rem}#onetrust-pc-sdk .ot-optout-signal{margin-top:.625rem}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus,#onetrust-pc-sdk .ot-hide-tgl{visibility:hidden}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr *,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus *,#onetrust-pc-sdk .ot-hide-tgl *{visibility:hidden}#onetrust-pc-sdk #ot-gn-venlst .ot-ven-item .ot-acc-hdr{min-height:40px}#onetrust-pc-sdk .ot-pc-header{height:39px;padding:10px 0 10px 30px;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk #ot-pc-title,#onetrust-pc-sdk #ot-category-title,#onetrust-pc-sdk .ot-cat-header,#onetrust-pc-sdk #ot-lst-title,#onetrust-pc-sdk .ot-ven-hdr .ot-ven-name,#onetrust-pc-sdk .ot-always-active{font-weight:bold;color:dimgray}#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:55%;font-weight:700}#onetrust-pc-sdk .ot-cat-item p{clear:both;float:left;margin-top:10px;margin-bottom:5px;line-height:1.5;font-size:.812em;color:dimgray}#onetrust-pc-sdk .ot-close-icon{height:44px;width:44px;background-size:10px}#onetrust-pc-sdk #ot-pc-title{float:left;font-size:1em;line-height:1.5;margin-bottom:10px;margin-top:10px;width:100%}#onetrust-pc-sdk #accept-recommended-btn-handler{margin-right:10px;margin-bottom:25px;outline-offset:-1px}#onetrust-pc-sdk #ot-pc-desc{clear:both;width:100%;font-size:.812em;line-height:1.5;margin-bottom:25px}#onetrust-pc-sdk #ot-pc-desc *{font-size:inherit;line-height:inherit}#onetrust-pc-sdk #ot-pc-desc ul li{padding:10px 0px}#onetrust-pc-sdk a{color:#656565;cursor:pointer}#onetrust-pc-sdk a:hover{color:#3860be}#onetrust-pc-sdk label{margin-bottom:0}#onetrust-pc-sdk #vdr-lst-dsc{font-size:.812em;line-height:1.5;padding:10px 15px 5px 15px}#onetrust-pc-sdk button{max-width:394px;padding:12px 30px;line-height:1;word-break:break-word;word-wrap:break-word;white-space:normal;font-weight:bold;height:auto}#onetrust-pc-sdk .ot-link-btn{padding:0;margin-bottom:0;border:0;font-weight:normal;line-height:normal;width:auto;height:auto}#onetrust-pc-sdk #ot-pc-content{position:absolute;overflow-y:scroll;padding-left:2px;padding-right:30px;top:60px;bottom:110px;margin:1px 3px 0 30px;width:calc(100% - 63px)}#onetrust-pc-sdk .ot-vs-list .ot-always-active,#onetrust-pc-sdk .ot-cat-grp .ot-always-active{float:right;clear:none;color:#3860be;margin:0;font-size:.813em;line-height:1.3}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-track{margin-right:20px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar{width:11px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-thumb{border-radius:10px;background:#d8d8d8}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-pc-scrollbar{scrollbar-arrow-color:#d8d8d8;scrollbar-darkshadow-color:#d8d8d8;scrollbar-face-color:#d8d8d8;scrollbar-shadow-color:#d8d8d8}#onetrust-pc-sdk .save-preference-btn-handler{margin-right:20px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-right:10px}#onetrust-pc-sdk #ot-pc-desc .privacy-notice-link{margin-left:0;margin-right:8px}#onetrust-pc-sdk #ot-pc-desc .ot-imprint-handler{margin-left:0;margin-right:8px}#onetrust-pc-sdk .ot-subgrp-cntr{display:inline-block;clear:both;width:100%;padding-top:15px}#onetrust-pc-sdk .ot-switch+.ot-subgrp-cntr{padding-top:10px}#onetrust-pc-sdk ul.ot-subgrps{margin:0;font-size:initial}#onetrust-pc-sdk ul.ot-subgrps li p,#onetrust-pc-sdk ul.ot-subgrps li h5{font-size:.813em;line-height:1.4;color:dimgray}#onetrust-pc-sdk ul.ot-subgrps .ot-switch{min-height:auto}#onetrust-pc-sdk ul.ot-subgrps .ot-switch-nob{top:0}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr{display:inline-block;width:100%}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-txt{margin:0}#onetrust-pc-sdk ul.ot-subgrps li{padding:0;border:none}#onetrust-pc-sdk ul.ot-subgrps li h5{position:relative;top:5px;font-weight:bold;margin-bottom:0;float:left}#onetrust-pc-sdk li.ot-subgrp{margin-left:20px;overflow:auto}#onetrust-pc-sdk li.ot-subgrp>h5{width:calc(100% - 100px)}#onetrust-pc-sdk .ot-cat-item p>ul,#onetrust-pc-sdk li.ot-subgrp p>ul{margin:0px;list-style:disc;margin-left:15px;font-size:inherit}#onetrust-pc-sdk .ot-cat-item p>ul li,#onetrust-pc-sdk li.ot-subgrp p>ul li{font-size:inherit;padding-top:10px;padding-left:0px;padding-right:0px;border:none}#onetrust-pc-sdk .ot-cat-item p>ul li:last-child,#onetrust-pc-sdk li.ot-subgrp p>ul li:last-child{padding-bottom:10px}#onetrust-pc-sdk .ot-pc-logo{height:40px;width:120px}#onetrust-pc-sdk .ot-pc-footer{position:absolute;bottom:0px;width:100%;max-height:160px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-refuse-all-handler{margin-bottom:0px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:160px}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-footer button{width:100%;max-width:none}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:0 30px;width:calc(100% - 60px);padding-right:0}#onetrust-pc-sdk .ot-pc-footer-logo{height:30px;width:100%;text-align:right;background:#f4f4f4}#onetrust-pc-sdk .ot-pc-footer-logo a{display:inline-block;margin-top:5px;margin-right:10px}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo{direction:rtl}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo a{margin-right:25px}#onetrust-pc-sdk .ot-tgl{float:right;position:relative;z-index:1}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background-color:#468254;border:1px solid #fff}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{-webkit-transform:translateX(20px);-ms-transform:translateX(20px);transform:translateX(20px);background-color:#fff;border-color:#fff}#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch{outline:#000 solid 1px}#onetrust-pc-sdk .ot-switch{position:relative;display:inline-block;width:45px;height:25px}#onetrust-pc-sdk .ot-switch-nob{position:absolute;cursor:pointer;top:0;left:0;right:0;bottom:0;background-color:#767676;border:1px solid #ddd;transition:all .2s ease-in 0s;-moz-transition:all .2s ease-in 0s;-o-transition:all .2s ease-in 0s;-webkit-transition:all .2s ease-in 0s;border-radius:20px}#onetrust-pc-sdk .ot-switch-nob:before{position:absolute;content:"";height:18px;width:18px;bottom:3px;left:3px;background-color:#fff;-webkit-transition:.4s;transition:.4s;border-radius:20px}#onetrust-pc-sdk .ot-chkbox input:checked~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox label{position:relative;display:inline-block;padding-left:30px;cursor:pointer;font-weight:500}#onetrust-pc-sdk .ot-chkbox label::before,#onetrust-pc-sdk .ot-chkbox label::after{position:absolute;content:"";display:inline-block;border-radius:3px}#onetrust-pc-sdk .ot-chkbox label::before{height:18px;width:18px;border:1px solid #3860be;left:0px;top:auto}#onetrust-pc-sdk .ot-chkbox label::after{height:5px;width:9px;border-left:3px solid;border-bottom:3px solid;transform:rotate(-45deg);-o-transform:rotate(-45deg);-ms-transform:rotate(-45deg);-webkit-transform:rotate(-45deg);left:4px;top:5px}#onetrust-pc-sdk .ot-label-txt{display:none}#onetrust-pc-sdk .ot-chkbox input,#onetrust-pc-sdk .ot-tgl input{position:absolute;opacity:0;width:0;height:0}#onetrust-pc-sdk .ot-arw-cntr{float:right;position:relative;pointer-events:none}#onetrust-pc-sdk .ot-arw-cntr .ot-arw{width:16px;height:16px;margin-left:5px;color:dimgray;display:inline-block;vertical-align:middle;-webkit-transition:all 150ms ease-in 0s;-moz-transition:all 150ms ease-in 0s;-o-transition:all 150ms ease-in 0s;transition:all 150ms ease-in 0s}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw-cntr svg{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-tgl-cntr,#onetrust-pc-sdk .ot-arw-cntr{display:inline-block}#onetrust-pc-sdk .ot-tgl-cntr{width:45px;float:right;margin-top:2px}#onetrust-pc-sdk #ot-lst-cnt .ot-tgl-cntr{margin-top:10px}#onetrust-pc-sdk .ot-always-active-subgroup{width:auto;padding-left:0px !important;top:3px;position:relative}#onetrust-pc-sdk .ot-label-status{font-size:.75em;display:none;font-size:.75em;position:relative;top:2px;padding-right:5px;float:left}#onetrust-pc-sdk .ot-arw-cntr{margin-top:-1px}#onetrust-pc-sdk .ot-arw-cntr svg{-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s;transition:all 300ms ease-in 0s;height:10px;width:10px}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk .ot-arw{width:10px;margin-left:15px;transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0}#onetrust-pc-sdk .ot-hlst-cntr{margin-top:5px;display:inline-block;width:100%}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{clear:both;color:#3860be;margin-left:0;font-size:.813em;text-decoration:none;float:left;overflow:hidden}#onetrust-pc-sdk .category-vendors-list-handler:hover,#onetrust-pc-sdk .category-vendors-list-handler+a:hover,#onetrust-pc-sdk .category-host-list-handler:hover{text-decoration-line:underline}#onetrust-pc-sdk .category-vendors-list-handler+a{clear:none}#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{display:inline-block;height:13px;width:13px;background-repeat:no-repeat;margin-left:1px;margin-top:6px;cursor:pointer}#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{margin-bottom:-1px}#onetrust-pc-sdk .back-btn-handler{font-size:1em;text-decoration:none}#onetrust-pc-sdk .back-btn-handler:hover{opacity:.6}#onetrust-pc-sdk #ot-lst-title h3{display:inline-block;word-break:break-word;word-wrap:break-word;margin-bottom:0;color:#656565;font-size:1em;font-weight:bold;margin-left:15px}#onetrust-pc-sdk #ot-lst-title{margin:10px 0 10px 0px;font-size:1em;text-align:left}#onetrust-pc-sdk #ot-pc-hdr{margin:0 0 0 30px;height:auto;width:auto}#onetrust-pc-sdk #ot-pc-hdr input::placeholder{color:#707070;font-style:italic}#onetrust-pc-sdk #vendor-search-handler{height:31px;width:100%;border-radius:50px;font-size:.8em;padding-right:35px;padding-left:15px;float:left;margin-left:15px}#onetrust-pc-sdk .ot-ven-name{display:block;width:auto;padding-right:5px}#onetrust-pc-sdk #ot-lst-cnt{overflow-y:auto;margin-left:20px;margin-right:7px;width:calc(100% - 27px);max-height:calc(100% - 80px);height:100%;transform:translate3d(0, 0, 0)}#onetrust-pc-sdk #ot-pc-lst{width:100%;bottom:100px;position:absolute;top:60px}#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr *{visibility:hidden}#onetrust-pc-sdk #ot-pc-lst .ot-tgl-cntr{right:12px;position:absolute}#onetrust-pc-sdk #ot-pc-lst .ot-arw-cntr{float:right;position:relative}#onetrust-pc-sdk #ot-pc-lst .ot-arw{margin-left:10px}#onetrust-pc-sdk #ot-pc-lst .ot-acc-hdr{overflow:hidden;cursor:pointer}#onetrust-pc-sdk .ot-vlst-cntr{overflow:hidden}#onetrust-pc-sdk #ot-sel-blk{overflow:hidden;width:100%;position:sticky;position:-webkit-sticky;top:0;z-index:3}#onetrust-pc-sdk #ot-back-arw{height:12px;width:12px}#onetrust-pc-sdk .ot-lst-subhdr{width:100%;display:inline-block}#onetrust-pc-sdk .ot-search-cntr{float:left;width:78%;position:relative}#onetrust-pc-sdk .ot-search-cntr>svg{width:30px;height:30px;position:absolute;float:left;right:-15px}#onetrust-pc-sdk .ot-fltr-cntr{float:right;right:50px;position:relative}#onetrust-pc-sdk #filter-btn-handler{background-color:#3860be;border-radius:17px;display:inline-block;position:relative;width:32px;height:32px;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease;padding:0;margin:0}#onetrust-pc-sdk #filter-btn-handler:hover{background-color:#3860be}#onetrust-pc-sdk #filter-btn-handler svg{width:12px;height:12px;margin:3px 10px 0 10px;display:block;position:static;right:auto;top:auto}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{color:#3860be;text-decoration:none;font-weight:100;display:inline-block;padding-top:10px;transform:translate(0, 1%);-o-transform:translate(0, 1%);-ms-transform:translate(0, 1%);-webkit-transform:translate(0, 1%);position:relative;z-index:2}#onetrust-pc-sdk .ot-ven-link *,#onetrust-pc-sdk .ot-ven-legclaim-link *{font-size:inherit}#onetrust-pc-sdk .ot-ven-link:hover,#onetrust-pc-sdk .ot-ven-legclaim-link:hover{text-decoration:underline}#onetrust-pc-sdk .ot-ven-hdr{width:calc(100% - 160px);height:auto;float:left;word-break:break-word;word-wrap:break-word;vertical-align:middle;padding-bottom:3px}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{letter-spacing:.03em;font-size:.75em;font-weight:400}#onetrust-pc-sdk .ot-ven-dets{border-radius:2px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-ven-dets li:first-child p:first-child{border-top:none}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:not(:first-child){border-top:1px solid #ddd !important}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(odd){width:30%}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(even){width:50%;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p,#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{padding-top:5px;padding-bottom:5px;display:block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-last-child(-n+1){padding-bottom:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-child(-n+2):not(.disc-pur){padding-top:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur-cont{display:inline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur{position:relative;width:50% !important;word-break:break-word;word-wrap:break-word;left:calc(30% + 17px)}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur:nth-child(-n+1){position:static}#onetrust-pc-sdk .ot-ven-dets p,#onetrust-pc-sdk .ot-ven-dets h5,#onetrust-pc-sdk .ot-ven-dets span{font-size:.69em;text-align:left;vertical-align:middle;word-break:break-word;word-wrap:break-word;margin:0;padding-bottom:10px;padding-left:15px;color:#2e3644}#onetrust-pc-sdk .ot-ven-dets h5{padding-top:5px}#onetrust-pc-sdk .ot-ven-dets span{color:dimgray;padding:0;vertical-align:baseline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-pur h5{border-top:1px solid #e9e9e9;border-bottom:1px solid #e9e9e9;padding-bottom:5px;margin-bottom:5px;font-weight:bold}#onetrust-pc-sdk #ot-host-lst .ot-sel-all{float:right;position:relative;margin-right:42px;top:10px}#onetrust-pc-sdk #ot-host-lst .ot-sel-all input[type=checkbox]{width:auto;height:auto}#onetrust-pc-sdk #ot-host-lst .ot-sel-all label{height:20px;width:20px;padding-left:0px}#onetrust-pc-sdk #ot-host-lst .ot-acc-txt{overflow:hidden;width:95%}#onetrust-pc-sdk .ot-host-hdr{position:relative;z-index:1;pointer-events:none;width:calc(100% - 125px);float:left}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-desc{display:inline-block;width:90%}#onetrust-pc-sdk .ot-host-name{pointer-events:none}#onetrust-pc-sdk .ot-host-hdr>a{text-decoration:underline;font-size:.82em;position:relative;z-index:2;float:left;margin-bottom:5px;pointer-events:initial}#onetrust-pc-sdk .ot-host-name+a{margin-top:5px}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a,#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{color:dimgray;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a{font-weight:bold;font-size:.82em;line-height:1.3}#onetrust-pc-sdk .ot-host-name a{font-size:1em}#onetrust-pc-sdk .ot-host-expand{margin-top:3px;margin-bottom:3px;clear:both;display:block;color:#3860be;font-size:.72em;font-weight:normal}#onetrust-pc-sdk .ot-host-expand *{font-size:inherit}#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{font-size:.688em;line-height:1.4;font-weight:normal}#onetrust-pc-sdk .ot-host-desc{margin-top:10px}#onetrust-pc-sdk .ot-host-opt{margin:0;font-size:inherit;display:inline-block;width:100%}#onetrust-pc-sdk .ot-host-opt li>div div{font-size:.8em;padding:5px 0}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(1){width:30%;float:left}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(2){width:70%;float:left;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-info{border:none;display:inline-block;width:calc(100% - 10px);padding:10px;margin-bottom:10px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-host-info>div{overflow:auto}#onetrust-pc-sdk #no-results{text-align:center;margin-top:30px}#onetrust-pc-sdk #no-results p{font-size:1em;color:#2e3644;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk #no-results p span{font-weight:bold}#onetrust-pc-sdk #ot-fltr-modal{width:100%;height:auto;display:none;-moz-transition:.2s ease;-o-transition:.2s ease;-webkit-transition:2s ease;transition:.2s ease;overflow:hidden;opacity:1;right:0}#onetrust-pc-sdk #ot-fltr-modal .ot-label-txt{display:inline-block;font-size:.85em;color:dimgray}#onetrust-pc-sdk #ot-fltr-cnt{z-index:2147483646;background-color:#fff;position:absolute;height:90%;max-height:300px;width:325px;left:210px;margin-top:10px;margin-bottom:20px;padding-right:10px;border-radius:3px;-webkit-box-shadow:0px 0px 12px 2px #c7c5c7;-moz-box-shadow:0px 0px 12px 2px #c7c5c7;box-shadow:0px 0px 12px 2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-scrlcnt{overflow-y:auto;overflow-x:hidden;clear:both;max-height:calc(100% - 60px)}#onetrust-pc-sdk #ot-anchor{border:12px solid rgba(0,0,0,0);display:none;position:absolute;z-index:2147483647;right:55px;top:75px;transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);-webkit-transform:rotate(45deg);background-color:#fff;-webkit-box-shadow:-3px -3px 5px -2px #c7c5c7;-moz-box-shadow:-3px -3px 5px -2px #c7c5c7;box-shadow:-3px -3px 5px -2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-btns{margin-left:15px}#onetrust-pc-sdk #filter-apply-handler{margin-right:15px}#onetrust-pc-sdk .ot-fltr-opt{margin-bottom:5px;margin-left:15px;min-height:20px;width:75%;position:relative}#onetrust-pc-sdk .ot-fltr-opt p{display:inline-block;margin:0;font-size:.9em;color:#2e3644}#onetrust-pc-sdk .ot-chkbox label span{font-size:.85em;color:dimgray}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox][aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk #ot-selall-vencntr,#onetrust-pc-sdk #ot-selall-adtlvencntr,#onetrust-pc-sdk #ot-selall-hostcntr,#onetrust-pc-sdk #ot-selall-licntr,#onetrust-pc-sdk #ot-selall-gnvencntr{right:15px;position:relative;width:20px;height:20px;float:right}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label,#onetrust-pc-sdk #ot-selall-gnvencntr label{float:left;padding-left:0}#onetrust-pc-sdk #ot-ven-lst:first-child{border-top:1px solid #e2e2e2}#onetrust-pc-sdk ul{list-style:none;padding:0}#onetrust-pc-sdk ul li{position:relative;margin:0;padding:15px 15px 15px 10px;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk ul li h3,#onetrust-pc-sdk ul li h4{font-size:.75em;color:#656565;margin:0;display:inline-block;width:70%;height:auto;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk ul li p{margin:0;font-size:.7em}#onetrust-pc-sdk ul li input[type=checkbox]{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0}#onetrust-pc-sdk .ot-cat-item>button:focus,#onetrust-pc-sdk .ot-acc-cntr>button:focus,#onetrust-pc-sdk li>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-cat-item>button,#onetrust-pc-sdk .ot-acc-cntr>button,#onetrust-pc-sdk li>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-host-item>button:focus,#onetrust-pc-sdk .ot-ven-item>button:focus{outline:0;border:2px solid #000}#onetrust-pc-sdk .ot-hide-acc>button{pointer-events:none}#onetrust-pc-sdk .ot-hide-acc .ot-plus-minus>*,#onetrust-pc-sdk .ot-hide-acc .ot-arw-cntr>*{visibility:hidden}#onetrust-pc-sdk .ot-hide-acc .ot-acc-hdr{min-height:30px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt){padding-right:10px;width:calc(100% - 37px);margin-top:10px;max-height:calc(100% - 90px)}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk{background-color:#f9f9fc;border:1px solid #e2e2e2;width:calc(100% - 2px);padding-bottom:5px;padding-top:5px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt{border:unset;background-color:unset}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all-hdr{display:none}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all{padding-right:.5rem}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all .ot-chkbox{right:0}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all{padding-right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all-chkbox{width:auto}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) ul li{border:1px solid #e2e2e2;margin-bottom:10px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-acc-cntr>.ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk.ot-addtl-vendors .ot-sel-all-chkbox{float:right}#onetrust-pc-sdk.ot-addtl-vendors .ot-plus-minus~.ot-sel-all-chkbox{right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-ven-lst:first-child{border-top:none}#onetrust-pc-sdk .ot-acc-cntr{position:relative;border-left:1px solid #e2e2e2;border-right:1px solid #e2e2e2;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr input{z-index:1}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr{background-color:#f9f9fc;padding:5px 0 5px 15px;width:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-plus-minus{vertical-align:middle;top:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-arw-cntr{right:10px}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr input{z-index:2}#onetrust-pc-sdk .ot-acc-cntr.ot-add-tech .ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk .ot-acc-cntr>input[type=checkbox]:checked~.ot-acc-hdr{border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-txt{padding-left:10px;padding-right:10px}#onetrust-pc-sdk .ot-acc-cntr button[aria-expanded=true]~.ot-acc-txt{width:auto}#onetrust-pc-sdk .ot-acc-cntr .ot-addtl-venbox{display:none}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0;width:100%}#onetrust-pc-sdk .ot-vensec-title{font-size:.813em;vertical-align:middle;display:inline-block}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a{margin-left:0;margin-top:10px}#onetrust-pc-sdk #ot-selall-vencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-adtlvencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-licntr.line-through label::after,#onetrust-pc-sdk #ot-selall-hostcntr.line-through label::after,#onetrust-pc-sdk #ot-selall-gnvencntr.line-through label::after{height:auto;border-left:0;transform:none;-o-transform:none;-ms-transform:none;-webkit-transform:none;left:5px;top:9px}#onetrust-pc-sdk #ot-category-title{float:left;padding-bottom:10px;font-size:1em;width:100%}#onetrust-pc-sdk .ot-cat-grp{margin-top:10px}#onetrust-pc-sdk .ot-cat-item{line-height:1.1;margin-top:10px;display:inline-block;width:100%}#onetrust-pc-sdk .ot-btn-container{text-align:right}#onetrust-pc-sdk .ot-btn-container button{display:inline-block;font-size:.75em;letter-spacing:.08em;margin-top:19px}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon{position:absolute;top:10px;right:0;z-index:1;padding:0;background-color:rgba(0,0,0,0);border:none}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon svg{display:block;height:10px;width:10px}#onetrust-pc-sdk #clear-filters-handler{margin-top:20px;margin-bottom:10px;float:right;max-width:200px;text-decoration:none;color:#3860be;font-size:.9em;font-weight:bold;background-color:rgba(0,0,0,0);border-color:rgba(0,0,0,0);padding:1px}#onetrust-pc-sdk #clear-filters-handler:hover{color:#2285f7}#onetrust-pc-sdk #clear-filters-handler:focus{outline:#000 solid 1px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl,#onetrust-pc-sdk .ot-enbl-chr h4~.ot-always-active{right:45px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl+.ot-tgl{right:120px}#onetrust-pc-sdk .ot-enbl-chr .ot-pli-hdr.ot-leg-border-color span:first-child{width:90px}#onetrust-pc-sdk .ot-enbl-chr li.ot-subgrp>h5+.ot-tgl-cntr{padding-right:25px}#onetrust-pc-sdk .ot-plus-minus{width:20px;height:20px;font-size:1.5em;position:relative;display:inline-block;margin-right:5px;top:3px}#onetrust-pc-sdk .ot-plus-minus span{position:absolute;background:#27455c;border-radius:1px}#onetrust-pc-sdk .ot-plus-minus span:first-of-type{top:25%;bottom:25%;width:10%;left:45%}#onetrust-pc-sdk .ot-plus-minus span:last-of-type{left:25%;right:25%;height:10%;top:45%}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:first-of-type,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{transform:rotate(90deg)}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{left:50%;right:50%}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk .ot-host-item .ot-plus-minus,#onetrust-pc-sdk .ot-ven-item .ot-plus-minus{float:left;margin-right:8px;top:10px}#onetrust-pc-sdk .ot-ven-item ul{list-style:none inside;font-size:100%;margin:0}#onetrust-pc-sdk .ot-ven-item ul li{margin:0 !important;padding:0;border:none !important}#onetrust-pc-sdk .ot-pli-hdr{color:#77808e;overflow:hidden;padding-top:7.5px;padding-bottom:7.5px;width:calc(100% - 2px);border-top-left-radius:3px;border-top-right-radius:3px}#onetrust-pc-sdk .ot-pli-hdr span:first-child{top:50%;transform:translateY(50%);max-width:90px}#onetrust-pc-sdk .ot-pli-hdr span:last-child{padding-right:10px;max-width:95px;text-align:center}#onetrust-pc-sdk .ot-li-title{float:right;font-size:.813em}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color{background-color:#f4f4f4;border:1px solid #d8d8d8}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color span:first-child{text-align:left;width:70px}#onetrust-pc-sdk li.ot-subgrp>h5,#onetrust-pc-sdk .ot-cat-header{width:calc(100% - 130px)}#onetrust-pc-sdk li.ot-subgrp>h5+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-acc-grpdesc{margin-bottom:5px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-acc-grpcntr .ot-vlst-cntr+.ot-subgrp-cntr{border-top:none}#onetrust-pc-sdk .ot-acc-hdr .ot-arw-cntr+.ot-tgl-cntr,#onetrust-pc-sdk .ot-acc-txt h4+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-subgrp>h5,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header{width:calc(100% - 145px)}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item h5+.ot-tgl-cntr,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header+.ot-tgl{padding-left:28px}#onetrust-pc-sdk .ot-sel-all-hdr,#onetrust-pc-sdk .ot-sel-all-chkbox{display:inline-block;width:100%;position:relative}#onetrust-pc-sdk .ot-sel-all-chkbox{z-index:1}#onetrust-pc-sdk .ot-sel-all{margin:0;position:relative;padding-right:23px;float:right}#onetrust-pc-sdk .ot-consent-hdr,#onetrust-pc-sdk .ot-li-hdr{float:right;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-li-hdr{max-width:100px;padding-right:10px}#onetrust-pc-sdk .ot-consent-hdr{max-width:55px}#onetrust-pc-sdk #ot-selall-licntr{display:block;width:21px;height:auto;float:right;position:relative;right:80px}#onetrust-pc-sdk #ot-selall-licntr label{position:absolute}#onetrust-pc-sdk .ot-ven-ctgl{margin-left:66px}#onetrust-pc-sdk .ot-ven-litgl+.ot-arw-cntr{margin-left:81px}#onetrust-pc-sdk .ot-enbl-chr .ot-host-cnt .ot-tgl-cntr{width:auto}#onetrust-pc-sdk #ot-lst-cnt:not(.ot-host-cnt) .ot-tgl-cntr{width:auto;top:auto;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox label{position:absolute;padding:0;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-acc-grpdesc+.ot-leg-btn-container{padding-left:20px;padding-right:20px;width:calc(100% - 40px);margin-bottom:5px}#onetrust-pc-sdk .ot-subgrp .ot-leg-btn-container{margin-bottom:5px}#onetrust-pc-sdk #ot-ven-lst .ot-leg-btn-container{margin-top:10px}#onetrust-pc-sdk .ot-leg-btn-container{display:inline-block;width:100%;margin-bottom:10px}#onetrust-pc-sdk .ot-leg-btn-container button{height:auto;padding:6.5px 8px;margin-bottom:0;letter-spacing:0;font-size:.75em;line-height:normal}#onetrust-pc-sdk .ot-leg-btn-container svg{display:none;height:14px;width:14px;padding-right:5px;vertical-align:sub}#onetrust-pc-sdk .ot-active-leg-btn{cursor:default;pointer-events:none}#onetrust-pc-sdk .ot-active-leg-btn svg{display:inline-block}#onetrust-pc-sdk .ot-remove-objection-handler{text-decoration:underline;padding:0;font-size:.75em;font-weight:600;line-height:1;padding-left:10px}#onetrust-pc-sdk .ot-obj-leg-btn-handler span{font-weight:bold;text-align:center;font-size:inherit;line-height:1.5}#onetrust-pc-sdk.ot-close-btn-link #close-pc-btn-handler{border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em;background:none;right:15px;top:15px;width:auto;font-weight:normal}#onetrust-pc-sdk .ot-pgph-link{font-size:.813em !important;margin-top:5px;position:relative}#onetrust-pc-sdk .ot-pgph-link.ot-pgph-link-subgroup{margin-bottom:1rem}#onetrust-pc-sdk .ot-pgph-contr{margin:0 2.5rem}#onetrust-pc-sdk .ot-pgph-title{font-size:1.18rem;margin-bottom:2rem}#onetrust-pc-sdk .ot-pgph-desc{font-size:1rem;font-weight:400;margin-bottom:2rem;line-height:1.5rem}#onetrust-pc-sdk .ot-pgph-desc:not(:last-child):after{content:"";width:96%;display:block;margin:0 auto;padding-bottom:2rem;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk .ot-cat-header{float:left;font-weight:600;font-size:.875em;line-height:1.5;max-width:90%;vertical-align:middle}#onetrust-pc-sdk .ot-vnd-item>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-vnd-item>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{position:relative;border-radius:2px;margin:0;padding:0;border:1px solid #d8d8d8;border-top:none;width:calc(100% - 2px);float:left}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{margin-top:10px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc{padding-left:20px;padding-right:20px;width:calc(100% - 40px);font-size:.812em;margin-bottom:10px;margin-top:15px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul{padding-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul li{padding-top:0;line-height:1.5;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout div+.ot-acc-grpdesc{margin-top:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:first-child{margin-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:last-child,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr:last-child{margin-bottom:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding-top:11.5px;padding-bottom:11.5px;padding-left:20px;padding-right:20px;width:calc(100% - 40px);display:inline-block}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-txt{width:100%;padding:0}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp-cntr{padding-left:20px;padding-right:15px;padding-bottom:0;width:calc(100% - 35px)}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp{padding-right:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpcntr{z-index:1;position:relative}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr{position:absolute;top:50%;transform:translateY(-50%);right:20px;margin-top:-2px}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr .ot-arw{width:15px;height:20px;margin-left:5px;color:dimgray}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{float:none;color:#2e3644;margin:0;display:inline-block;height:auto;word-wrap:break-word;min-height:inherit}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding-left:20px;width:calc(100% - 20px);display:inline-block;margin-top:0;padding-bottom:2px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{position:relative;min-height:25px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl,#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{position:absolute;top:50%;transform:translateY(-50%);right:20px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl+.ot-tgl{right:95px}#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler,#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler+a{margin-top:5px}#onetrust-pc-sdk #ot-lst-cnt{margin-top:1rem;max-height:calc(100% - 96px)}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list,#onetrust-pc-sdk .ot-vnd-serv{width:auto;padding:1rem 1.25rem;padding-bottom:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:600;font-size:.95em;line-height:2;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item{border:none;margin:0;padding:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button{outline:none;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button[aria-expanded=true],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button[aria-expanded=true]{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:first-child{margin-top:.25rem;border-top:unset}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child{margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child button{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 1.75rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-lbl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-cnt,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt{padding-left:40px}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-size:.8em}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-cat-header{font-size:.8em}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv{margin-bottom:1rem;padding:1rem .95rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:700;font-size:.8em;line-height:20px;margin-left:.82rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-cat-header{font-weight:700;font-size:.8em;line-height:20px}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-vnd-serv .ot-vnd-lst-cont .ot-accordion-layout .ot-acc-hdr div.ot-chkbox{margin-left:.82rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr{padding:.7rem 0;margin:0;display:flex;width:100%;align-items:center;justify-content:space-between}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:first-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:first-child{margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:last-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:last-child{margin-right:.5rem;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-always-active{position:relative;right:unset;top:unset;transform:unset}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-plus-minus{top:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-arw-cntr{float:none;top:unset;right:unset;transform:unset;margin-top:-2px;position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-cat-header{flex:1;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-tgl{position:relative;transform:none;right:0;top:0;float:none}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox{position:relative;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label{padding:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label::before{position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox input{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0;z-index:1}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h5.ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h4.ot-cat-header{margin:0}#onetrust-pc-sdk .ot-vs-config .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp h5{top:0;line-height:20px}#onetrust-pc-sdk .ot-vs-list{display:flex;flex-direction:column;padding:0;margin:.5rem 4px}#onetrust-pc-sdk .ot-vs-selc-all{display:flex;padding:0;float:unset;align-items:center;justify-content:flex-start}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf{justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf.ot-caret-conf .ot-sel-all-chkbox{margin-right:48px}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf .ot-sel-all-chkbox{margin:0;padding:0;margin-right:14px;justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-chkbox,#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-tgl{display:inline-block;right:unset;width:auto;height:auto;float:none}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr label{width:45px;height:25px}#onetrust-pc-sdk .ot-vs-selc-all .ot-sel-all-chkbox{margin-right:11px;margin-left:.75rem;display:flex;align-items:center}#onetrust-pc-sdk .ot-vs-selc-all .sel-all-hdr{margin:0 1.25rem;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-vnd-list-cnt #ot-selall-vencntr.ot-chkbox{float:unset;right:0}#onetrust-pc-sdk[dir=rtl] #ot-back-arw,#onetrust-pc-sdk[dir=rtl] input~.ot-acc-hdr .ot-arw{transform:rotate(180deg);-o-transform:rotate(180deg);-ms-transform:rotate(180deg);-webkit-transform:rotate(180deg)}#onetrust-pc-sdk[dir=rtl] input:checked~.ot-acc-hdr .ot-arw{transform:rotate(270deg);-o-transform:rotate(270deg);-ms-transform:rotate(270deg);-webkit-transform:rotate(270deg)}#onetrust-pc-sdk[dir=rtl] .ot-chkbox label::after{transform:rotate(45deg);-webkit-transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);border-left:0;border-right:3px solid}#onetrust-pc-sdk[dir=rtl] .ot-search-cntr>svg{right:0}@media only screen and (max-width: 600px){#onetrust-pc-sdk.otPcCenter{left:0;min-width:100%;height:100%;top:0;border-radius:0}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:1px 3px 0 10px;padding-right:10px;width:calc(100% - 23px)}#onetrust-pc-sdk .ot-btn-container button{max-width:none;letter-spacing:.01em}#onetrust-pc-sdk #close-pc-btn-handler{top:10px;right:17px}#onetrust-pc-sdk p{font-size:.7em}#onetrust-pc-sdk #ot-pc-hdr{margin:10px 10px 0 5px;width:calc(100% - 15px)}#onetrust-pc-sdk .vendor-search-handler{font-size:1em}#onetrust-pc-sdk #ot-back-arw{margin-left:12px}#onetrust-pc-sdk #ot-lst-cnt{margin:0;padding:0 5px 0 10px;min-width:95%}#onetrust-pc-sdk .switch+p{max-width:80%}#onetrust-pc-sdk .ot-ftr-stacked button{width:100%}#onetrust-pc-sdk #ot-fltr-cnt{max-width:320px;width:90%;border-top-right-radius:0;border-bottom-right-radius:0;margin:0;margin-left:15px;left:auto;right:40px;top:85px}#onetrust-pc-sdk .ot-fltr-opt{margin-left:25px;margin-bottom:10px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-bottom:0}#onetrust-pc-sdk #ot-fltr-cnt{right:40px}}@media only screen and (max-width: 476px){#onetrust-pc-sdk .ot-fltr-cntr,#onetrust-pc-sdk #ot-fltr-cnt{right:10px}#onetrust-pc-sdk #ot-anchor{right:25px}#onetrust-pc-sdk button{width:100%}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-sel-all{padding-right:9px}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr{right:0}}@media(min-width: 768px){#onetrust-pc-sdk.ot-tgl-with-label .ot-label-status{display:inline}#onetrust-pc-sdk.ot-tgl-with-label #ot-pc-lst .ot-label-status{display:none}}@media only screen and (max-width: 896px)and (max-height: 425px)and (orientation: landscape){#onetrust-pc-sdk.otPcCenter{left:0;top:0;min-width:100%;height:100%;border-radius:0}#onetrust-pc-sdk .ot-pc-header{height:auto;min-height:20px}#onetrust-pc-sdk .ot-pc-header .ot-pc-logo{max-height:30px}#onetrust-pc-sdk .ot-pc-footer{max-height:60px;overflow-y:auto}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk #ot-pc-lst{bottom:70px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:70px}#onetrust-pc-sdk #ot-anchor{left:initial;right:50px}#onetrust-pc-sdk #ot-lst-title{margin-top:12px}#onetrust-pc-sdk #ot-lst-title *{font-size:inherit}#onetrust-pc-sdk #ot-pc-hdr input{margin-right:0;padding-right:45px}#onetrust-pc-sdk .switch+p{max-width:85%}#onetrust-pc-sdk #ot-sel-blk{position:static}#onetrust-pc-sdk #ot-pc-lst{overflow:auto}#onetrust-pc-sdk #ot-lst-cnt{max-height:none;overflow:initial}#onetrust-pc-sdk #ot-lst-cnt.no-results{height:auto}#onetrust-pc-sdk input{font-size:1em !important}#onetrust-pc-sdk p{font-size:.6em}#onetrust-pc-sdk #ot-fltr-modal{width:100%;top:0}#onetrust-pc-sdk ul li p,#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{font-size:.6em}#onetrust-pc-sdk.ot-shw-fltr #ot-anchor{display:none !important}#onetrust-pc-sdk.ot-shw-fltr #ot-pc-lst{height:100% !important;overflow:hidden;top:0px}#onetrust-pc-sdk.ot-shw-fltr #ot-fltr-cnt{margin:0;height:100%;max-height:none;padding:10px;top:0;width:calc(100% - 20px);position:absolute;right:0;left:0;max-width:none}#onetrust-pc-sdk.ot-shw-fltr .ot-fltr-scrlcnt{max-height:calc(100% - 65px)}}
            #onetrust-consent-sdk #onetrust-pc-sdk,
                #onetrust-consent-sdk #ot-search-cntr,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-switch.ot-toggle,
                #onetrust-consent-sdk #onetrust-pc-sdk ot-grp-hdr1 .checkbox,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title:after
                ,#onetrust-consent-sdk #onetrust-pc-sdk #ot-sel-blk,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-cnt,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-anchor {
                    background-color: #FFF;
                }
               
            #onetrust-consent-sdk #onetrust-pc-sdk h3,
                #onetrust-consent-sdk #onetrust-pc-sdk h4,
                #onetrust-consent-sdk #onetrust-pc-sdk h5,
                #onetrust-consent-sdk #onetrust-pc-sdk h6,
                #onetrust-consent-sdk #onetrust-pc-sdk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-ven-lst .ot-ven-opts p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-desc,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-li-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-sel-all-hdr span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-modal #modal-header,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-checkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-sel-blk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-lst-title h3,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .back-btn-handler p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .ot-ven-name,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-ven-lst .consent-category,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-label-status,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-chkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #clear-filters-handler,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-optout-signal
                {
                    color: #2E2E2E;
                }
             #onetrust-consent-sdk #onetrust-pc-sdk .privacy-notice-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-pgph-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler + a,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-host-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-legclaim-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-name a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-acc-hdr .ot-host-expand,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-content #ot-pc-desc .ot-link-btn,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info a
                    {
                        color: #007398;
                    }
            #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler:hover { text-decoration: underline;}
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-subgrp-tgl .ot-switch.ot-toggle
             {
                background-color: #F8F8F8;
            }
             #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-ven-dets
                            {
                                background-color: #F8F8F8;
                            }
        #onetrust-consent-sdk #onetrust-pc-sdk
            button:not(#clear-filters-handler):not(.ot-close-icon):not(#filter-btn-handler):not(.ot-remove-objection-handler):not(.ot-obj-leg-btn-handler):not([aria-expanded]):not(.ot-link-btn),
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-active-leg-btn {
                background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-active-menu {
                border-color: #007398;
            }
            
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-remove-objection-handler{
                background-color: transparent;
                border: 1px solid transparent;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn {
                background-color: #FFFFFF;
                color: #4D4D4D; border-color: #4D4D4D;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-tgl input:focus + .ot-switch, .ot-switch .ot-switch-nob, .ot-switch .ot-switch-nob:before,
            #onetrust-pc-sdk .ot-checkbox input[type="checkbox"]:focus + label::before,
            #onetrust-pc-sdk .ot-chkbox input[type="checkbox"]:focus + label::before {
                outline-color: #000000;
                outline-width: 1px;
                outline-offset: 1px;
            }
            #onetrust-pc-sdk .ot-host-item > button:focus, #onetrust-pc-sdk .ot-ven-item > button:focus {
                border: 1px solid #000000;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk *:focus,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-vlst-cntr > a:focus {
               outline: 1px solid #000000;
               outline-offset: 1px;
            }#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,  #onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{
                    background-image: url('https://cdn.cookielaw.org/logos/static/ot_external_link.svg');
                }
            /*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
.ot-sdk-cookie-policy{font-family:inherit;font-size:16px}.ot-sdk-cookie-policy.otRelFont{font-size:1rem}.ot-sdk-cookie-policy h3,.ot-sdk-cookie-policy h4,.ot-sdk-cookie-policy h6,.ot-sdk-cookie-policy p,.ot-sdk-cookie-policy li,.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy th,.ot-sdk-cookie-policy #cookie-policy-description,.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}.ot-sdk-cookie-policy h4{font-size:1.2em}.ot-sdk-cookie-policy h6{font-size:1em;margin-top:2em}.ot-sdk-cookie-policy th{min-width:75px}.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy a:hover{background:#fff}.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}.ot-sdk-cookie-policy .ot-mobile-border{display:none}.ot-sdk-cookie-policy section{margin-bottom:2em}.ot-sdk-cookie-policy table{border-collapse:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy{font-family:inherit;font-size:1rem}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup{margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group-desc,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-table-header,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td{font-size:.9em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td a{font-size:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group{font-size:1em;margin-bottom:.6em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-title{margin-bottom:1.2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy>section{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th{min-width:75px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a:hover{background:#fff}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-mobile-border{display:none}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy section{margin-bottom:2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li{list-style:disc;margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li h4{display:inline-block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{border-collapse:inherit;margin:auto;border:1px solid #d7d7d7;border-radius:5px;border-spacing:initial;width:100%;overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border-bottom:1px solid #d7d7d7;border-right:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr th:last-child,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr td:last-child{border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:25%}.ot-sdk-cookie-policy[dir=rtl]{text-align:left}#ot-sdk-cookie-policy h3{font-size:1.5em}@media only screen and (max-width: 530px){.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) table,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tbody,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) th,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{display:block}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead tr{position:absolute;top:-9999px;left:-9999px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{margin:0 0 1em 0}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd),.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd) a{background:#f6f6f4}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td{border:none;border-bottom:1px solid #eee;position:relative;padding-left:50%}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{position:absolute;height:100%;left:6px;width:40%;padding-right:10px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) .ot-mobile-border{display:inline-block;background-color:#e4e4e4;position:absolute;height:100%;top:0;left:45%;width:2px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{content:attr(data-label);font-weight:bold}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border:none;border-bottom:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{display:block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:auto}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{margin:0 0 1em 0}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{height:100%;width:40%;padding-right:10px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{content:attr(data-label);font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead tr{position:absolute;top:-9999px;left:-9999px;z-index:-9999}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:1px solid #d7d7d7;border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td:last-child{border-bottom:0px}}
                
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h5,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group {
                        color: #696969;
                    }
                    
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title {
                            color: #696969;
                        }
                    
            
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th {
                            background-color: #F8F8F8;
                        }
                    
            .ot-floating-button__front{background-image:url('https://cdn.cookielaw.org/logos/static/ot_persistent_cookie_icon.png')}</style><script src="https://static.addtoany.com/menu/modules/core.pt5ow5lr.js" type="module"></script><style type="text/css">.a2a_hide{display:none}.a2a_logo_color{background-color:#0166ff}.a2a_menu,.a2a_menu *{-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box;float:none;margin:0;padding:0;position:static;height:auto;width:auto}.a2a_menu{border-radius:6px;display:none;direction:ltr;background:#FFF;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;color:#000;line-height:12px;border:1px solid #CCC;vertical-align:baseline;overflow:hidden}.a2a_mini{min-width:200px;position:absolute;width:300px;z-index:9999997}.a2a_overlay{display:none;background:#616c7deb;backdrop-filter:blur(4px);-webkit-backdrop-filter:blur(4px);position:fixed;top:0;right:0;left:0;bottom:0;z-index:9999998;-webkit-tap-highlight-color:transparent;transition:opacity .14s,backdrop-filter .14s}.a2a_full{background:#FFF;border:1px solid #FFF;box-shadow:#2a2a2a1a 0 0 20px 10px;height:auto;height:calc(320px);top:15%;left:50%;margin-left:-320px;position:fixed;text-align:center;width:640px;z-index:9999999;transition:transform .14s,opacity .14s}.a2a_full_footer,.a2a_full_header,.a2a_full_services{border:0;margin:0;padding:12px;box-sizing:border-box}.a2a_full_header{padding-bottom:8px}.a2a_full_services{height:280px;overflow-y:scroll;padding:0 12px;-webkit-overflow-scrolling:touch}.a2a_full_services .a2a_i{display:inline-block;float:none;width:181px;width:calc(33.334% - 18px)}div.a2a_full_footer{font-size:12px;text-align:center;padding:8px 14px}div.a2a_full_footer a,div.a2a_full_footer a:visited{display:inline;font-size:12px;line-height:14px;padding:8px 14px}div.a2a_full_footer a:focus,div.a2a_full_footer a:hover{background:0 0;border:0;color:#0166FF}div.a2a_full_footer a span.a2a_s_a2a,div.a2a_full_footer a span.a2a_w_a2a{background-size:14px;border-radius:3px;display:inline-block;height:14px;line-height:14px;margin:0 3px 0 0;vertical-align:top;width:14px}.a2a_modal{height:0;left:50%;margin-left:-320px;position:fixed;text-align:center;top:15%;width:640px;z-index:9999999;transition:transform .14s,opacity .14s;-webkit-tap-highlight-color:transparent}.a2a_modal_body{background:0 0;border:0;font:24px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;position:relative;height:auto;width:auto}.a2a_thanks{color:#fff;height:auto;margin-top:20px;width:auto}.a2a_thanks>div:first-child{margin:0 0 40px 0}.a2a_thanks div *{height:inherit}#a2a_copy_link{background:#FFF;border:1px solid #FFF;cursor:pointer;margin-top:15%}label.a2a_s_link#a2a_copy_link_icon,label.a2a_w_link#a2a_copy_link_icon{background-size:48px;border-radius:0;display:inline-block;height:48px;left:0;line-height:48px;margin:0 3px 0 0;position:absolute;vertical-align:top;width:48px}#a2a_modal input#a2a_copy_link_text{background-color:transparent;border:0;color:#2A2A2A;cursor:pointer;font:inherit;height:48px;left:62px;max-width:initial;min-height:auto;padding:0;position:relative;width:564px;width:calc(100% - 76px)}#a2a_copy_link_copied{background-color:#0166ff;color:#fff;display:none;font:inherit;font-size:16px;margin-top:1px;padding:3px 8px}@media (forced-colors:active){.a2a_color_buttons a,.a2a_svg{forced-color-adjust:none}}@media (prefers-color-scheme:dark){.a2a_menu a,.a2a_menu a.a2a_i,.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more,i.a2a_i{border-color:#2a2a2a!important;color:#fff!important}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover,.a2a_menu_find_container{border-color:#444!important;background-color:#444!important}.a2a_menu:not(.a2a_thanks){background-color:#2a2a2a;border-color:#2a2a2a}.a2a_menu_find{color:#fff!important}.a2a_menu label.a2a_s_find svg{background-color:transparent!important}.a2a_menu label.a2a_s_find svg path{fill:#fff!important}.a2a_full{box-shadow:#00000066 0 0 20px 10px}.a2a_overlay{background-color:#373737eb}}@media print{.a2a_floating_style,.a2a_menu,.a2a_overlay{visibility:hidden}}@keyframes a2aFadeIn{from{opacity:0}to{opacity:1}}.a2a_starting{opacity:0}.a2a_starting.a2a_full,.a2a_starting.a2a_modal{transform:scale(.8)}@media (max-width:639px){.a2a_full{border-radius:0;top:15%;left:0;margin-left:auto;width:100%}.a2a_modal{left:0;margin-left:10px;width:calc(100% - 20px)}}@media (min-width:318px) and (max-width:437px){.a2a_full .a2a_full_services .a2a_i{width:calc(50% - 18px)}}@media (max-width:317px){.a2a_full .a2a_full_services .a2a_i{width:calc(100% - 18px)}}@media (max-height:436px){.a2a_full{bottom:40px;height:auto;top:40px}}@media (max-height:550px){.a2a_modal{top:30px}}@media (max-height:360px){.a2a_modal{top:20px}.a2a_thanks>div:first-child{margin-bottom:20px}}.a2a_menu a{color:#0166FF;text-decoration:none;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;line-height:14px;height:auto;width:auto;outline:0}.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more{color:#0166FF}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover{color:#2A2A2A;border-color:#EEE;border-style:solid;background-color:#EEE;text-decoration:none}.a2a_menu label.a2a_s_find{background-size:24px;height:24px;left:8px;pointer-events:auto;position:absolute;top:7px;width:24px}.a2a_menu label.a2a_s_find svg{background-color:#FFF}.a2a_menu label.a2a_s_find svg path{fill:#CCC}#a2a_menu_container{display:inline-block}.a2a_menu_find_container{border:1px solid #CCC;border-radius:6px;padding:2px 24px 2px 0;position:relative;text-align:left}.a2a_cols_container .a2a_col1{overflow-x:hidden;overflow-y:auto;-webkit-overflow-scrolling:touch}#a2a_modal input,#a2a_modal input[type=text],.a2a_menu input,.a2a_menu input[type=text]{display:block;background-image:none;box-shadow:none;line-height:100%;margin:0;outline:0;overflow:hidden;padding:0;-moz-box-shadow:none;-webkit-box-shadow:none;-webkit-appearance:none}#a2afeed_find_container input,#a2afeed_find_container input[type=text],#a2apage_find_container input,#a2apage_find_container input[type=text]{background-color:transparent;border:0;box-sizing:content-box;color:#2A2A2A;float:none;font:inherit;font-size:16px;height:28px;line-height:20px;left:38px;outline:0;margin:0;max-width:initial;min-height:initial;padding:2px 0;position:relative;width:99%}.a2a_clear{clear:both}.a2a_svg{background-repeat:no-repeat;display:block;overflow:hidden;height:32px;line-height:32px;padding:0;pointer-events:none;width:32px}.a2a_svg svg{background-repeat:no-repeat;background-position:50% 50%;border:none;display:block;left:0;margin:0 auto;overflow:hidden;padding:0;position:relative;top:0;width:auto;height:auto}a.a2a_i,i.a2a_i{display:block;float:left;border:1px solid #FFF;line-height:24px;padding:6px 8px;text-align:left;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;width:132px}a.a2a_i span,a.a2a_more span{display:inline-block;overflow:hidden;vertical-align:top}a.a2a_i .a2a_svg{margin:0 6px 0 0}a.a2a_i .a2a_svg,a.a2a_more .a2a_svg{background-size:24px;height:24px;line-height:24px;width:24px}a.a2a_sss:hover{border-left:1px solid #CCC}a.a2a_more{border-bottom:1px solid #FFF;border-left:0;border-right:0;line-height:24px;margin:6px 0 0;padding:6px;-webkit-touch-callout:none}a.a2a_more span{height:24px;margin:0 6px 0 0}.a2a_kit .a2a_svg{background-repeat:repeat}.a2a_default_style a:empty,.a2a_flex_style a:empty,.a2a_floating_style a:empty,.a2a_overlay_style a:empty{display:none}.a2a_color_buttons a,.a2a_floating_style a{text-decoration:none}.a2a_default_style:not(.a2a_flex_style) a{float:left;line-height:16px;padding:0 2px}.a2a_default_style a:hover .a2a_svg,.a2a_floating_style a:hover .a2a_svg,.a2a_overlay_style a:hover .a2a_svg svg{opacity:.7}.a2a_overlay_style.a2a_default_style a:hover .a2a_svg{opacity:1}.a2a_default_style .a2a_count,.a2a_default_style .a2a_svg,.a2a_floating_style .a2a_svg,.a2a_menu .a2a_svg,.a2a_vertical_style .a2a_count,.a2a_vertical_style .a2a_svg{border-radius:4px}.a2a_default_style .a2a_counter img,.a2a_default_style .a2a_dd,.a2a_default_style .a2a_svg{float:left}.a2a_default_style .a2a_img_text{margin-right:4px}.a2a_default_style .a2a_divider{border-left:1px solid #000;display:inline;float:left;height:16px;line-height:16px;margin:0 5px}.a2a_kit a{cursor:pointer;transition:none}.a2a_floating_style{background-color:#fff;border-radius:6px;position:fixed;z-index:9999995}.a2a_overlay_style{z-index:2147483647}.a2a_floating_style,.a2a_overlay_style{animation:a2aFadeIn .2s ease-in;padding:4px}.a2a_vertical_style:not(.a2a_flex_style) a{clear:left;display:block;overflow:hidden;padding:4px}.a2a_floating_style.a2a_default_style{bottom:0}.a2a_floating_style.a2a_default_style a,.a2a_overlay_style.a2a_default_style a{padding:4px}.a2a_count{background-color:#fff;border:1px solid #ccc;box-sizing:border-box;color:#2a2a2a;display:block;float:left;font:12px Arial,Helvetica,sans-serif;height:16px;margin-left:4px;position:relative;text-align:center;width:50px}.a2a_count:after,.a2a_count:before{border:solid transparent;border-width:4px 4px 4px 0;content:"";height:0;left:0;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:50%;width:0}.a2a_count:before{border-right-color:#ccc}.a2a_count:after{border-right-color:#fff;margin-left:-3px}.a2a_count span{animation:a2aFadeIn .14s ease-in}.a2a_vertical_style .a2a_counter img{display:block}.a2a_vertical_style .a2a_count{float:none;margin-left:0;margin-top:6px}.a2a_vertical_style .a2a_count:after,.a2a_vertical_style .a2a_count:before{border:solid transparent;border-width:0 4px 4px 4px;content:"";height:0;left:50%;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:0;width:0}.a2a_vertical_style .a2a_count:before{border-bottom-color:#ccc}.a2a_vertical_style .a2a_count:after{border-bottom-color:#fff;margin-top:-3px}.a2a_color_buttons .a2a_count,.a2a_color_buttons .a2a_count:after,.a2a_color_buttons .a2a_count:before,.a2a_color_buttons.a2a_vertical_style .a2a_count:after,.a2a_color_buttons.a2a_vertical_style .a2a_count:before{background-color:transparent;border:none;color:#fff;float:none;width:auto}.a2a_color_buttons.a2a_vertical_style .a2a_count{margin-top:0}.a2a_flex_style{display:flex;align-items:flex-start;gap:0}.a2a_default_style.a2a_flex_style{left:0;right:0;width:100%}.a2a_vertical_style.a2a_flex_style{flex-direction:column;top:0;bottom:0}.a2a_flex_style a{display:flex;justify-content:center;flex:1;padding:4px}.a2a_flex_style.a2a_vertical_style a{flex-direction:column}.a2a_floating_style.a2a_color_buttons,.a2a_floating_style.a2a_flex_style{border-radius:0;padding:0}.a2a_floating_style.a2a_default_style.a2a_flex_style{bottom:0}.a2a_kit.a2a_flex_style .a2a_counter img,.a2a_kit.a2a_flex_style .a2a_dd,.a2a_kit.a2a_flex_style .a2a_svg{float:none}.a2a_nowrap{white-space:nowrap}.a2a_note{margin:0 auto;padding:9px;font-size:12px;text-align:center}.a2a_note .a2a_note_note{margin:0;color:#2A2A2A}.a2a_wide a{display:block;margin-top:3px;border-top:1px solid #EEE;text-align:center}.a2a_label{position:absolute!important;clip-path:polygon(0px 0px,0px 0px,0px 0px);-webkit-clip-path:polygon(0px 0px,0px 0px,0px 0px);overflow:hidden;height:1px;width:1px}.a2a_kit,.a2a_menu,.a2a_modal,.a2a_overlay{-ms-touch-action:manipulation;touch-action:manipulation;outline:0}.a2a_dd{-webkit-user-drag:none}.a2a_dd img{border:0}.a2a_button_facebook_like iframe{max-width:none}</style><style></style><link href="https://crossmark-cdn.crossref.org/widget/v2.0/style.css" type="text/css" rel="stylesheet"></head>
<body class="pb-ui">
    <div class="skip">
        <a href="#page-body-id" id="skipNavigationLink" title="Skip to Main Content" tabindex="0" class="skipToContent">Skip to Main Content</a>
        <a href="#mega-menu-nav" id="skipToMainMenu" title="Skip to Main Menu" tabindex="0" class="skipToContent">Skip to Main Menu</a>
    </div>



    <div id="pb-page-content" data-ng-non-bindable="">
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="ux3-layout-widget" data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" class="ux3">
        
    

        


    

            

            
                <div class="cell fonts-loaded">
            

            <div data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" data-widget-name="ux3-layout-widget"><div>
    

        


    

            

            

            <div id="a1f1ba25-79af-4194-aaa9-66206104a800" class="widget loginPopup none widget-none widget-compact-all"><div class="wrapped"><div class="widget-body body body-none body-compact-all"><div role="dialog" aria-modal="true" aria-label="Login" class="popup login-popup hidden"><div class="content"><a href="#" aria-label="Close login popup" title="Close login popup" role="button" class="close"><i class="icon-close_thin"></i></a><h2 class="login-title">Login to your account</h2><div class="login-form"><p tabindex="-1" class="message error"></p><form action="/action/doLogin?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2822%2900192-1" method="post"><input type="hidden" name="redirectUri" value="https://www.cell.com/cell/fulltext/S0092-8674(22)00192-1"><input type="hidden" name="referer" value="/cell/fulltext/S0092-8674(22)00192-1"><input type="hidden" name="ecommRedirect"><input type="hidden" name="code" value="cell-site"><input type="hidden" name="UX3LoginWidget" value="true"><input type="hidden" name="isPopup" value="true"><div class="input-group login-input--wrapper"><div class="label"><label for="login">Email/Username</label></div><input id="login" type="text" name="login" value="" size="15" class="login"><div role="alert" class="error-hint js--hidden"><div class="error-hint__text"><div class="error-text">Your email address is a required field.</div><div class="email-example">E.g., j.smith@mail.com</div></div></div></div><div class="input-group login-input--wrapper"><div class="label"><label for="password">Password</label></div><input id="password" type="password" name="password" value="" autocomplete="off" class="password"><a href="#" class="login__field__action js-show-password">Show</a><div role="alert" class="error-hint js--hidden"><span class="error-hint__text">Your password is a required field.</span></div><div class="actions"><a href="https://www.cell.com/action/requestResetPassword" class="link show-request-reset-password">Forgot password?</a></div></div><div class="remember"><input type="checkbox" name="savePassword" id="a1f1ba25-79af-4194-aaa9-66206104a800-remember" value="1" checked="checked"><label for="a1f1ba25-79af-4194-aaa9-66206104a800-remember">Remember me</label></div><div class="submit"><input type="submit" name="submit" value="Log in" class="button submit primary"></div></form></div><div class="create-account"><div>Don’t have an account?</div><a href="/action/registration?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2822%2900192-1" class="show-registration">Create a Free Account</a></div></div></div></div></div></div>

            

        

    

        


    

            

            

            <div role="dialog" aria-modal="true" aria-label="Reset password" class="popup top-drawer request-reset-password-drawer hidden"><div class="content"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" role="button" class="close"><i class="icon-close_thin"></i></a><div class="request-reset"><div class="form"><p class="sub">If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password</p><div tabindex="-1" class="message error"></div><form action="/action/requestResetPassword" method="post" class="request-reset-password-form"><input type="hidden" name="platform"><input type="hidden" name="requestResetPassword" value="true"><input type="hidden" name="codeSite" value="cell-site"><div class="input-group"><div class="label"><label for="reset-password-email">Email*</label></div><input id="reset-password-email" type="text" name="email" value="" size="15" class="email"></div><div class="submit" disabled="disabled"><input type="submit" name="submit" value="Submit" disabled="disabled" class="button primary submit"></div></form></div><div class="success-template hidden"><p>If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password</p></div></div><div class="request-reset-cancel"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" class="cancel">Cancel</a></div></div></div>

            

        

    

        


    

            

            
                <div class="ux3-ads">
            

            <div class="pb-ad">
            <!-- Do Not Modify without contacting ELS-HSOnlineCampaign@elsevier.com -->
<!-- To be kept in sync with Global Commercial Publishing Operations-->
<!-- Start: GPT Async -->
<div id="gpt-Variables" data-adfile="CELLJOURNAL">
	<input type="hidden" id="gptSite" value="cell">
	<input type="hidden" id="gptLoggedIn" value="no">
	<input type="hidden" id="gptAccessType" value="ae:ANON_GUEST|ae:ANON_GUEST">
	<input type="hidden" id="gptDefaultSite" value="cell">
</div>
<div id="gpt-Interscroller" class="gpt-InScrollBox" style="display:none;">
	<div class="gpt-InScrollLabel">ADVERTISEMENT</div>
	<div class="gpt-InScrollContainer">
		<div class="gpt-InScrollWrapper">
			<div class="gpt-InScrollInner">
				<div class="gpt-adinterscroller" data-adsize="interscroller"></div>
			</div>
		</div>
	</div>
	<div class="gpt-InScrollLabel">SCROLL TO CONTINUE WITH CONTENT</div>
</div>
<div id="gpt-DebugDiv" class="gpt-DebugDiv" style="display:none;">
	<div style="width: 100%; display: table;">
		<div style="display: table-row">
			<div style="width: 200px; display: table-cell;">
				<button class="gpt-DebugBtn" onclick="gpt_ShowConsole()">Open GPT Console</button><br>
				<button id="gpt_GrapeShotDebugBtn" class="gpt-DebugBtn" onclick="gpt_GrapeShotDebug();">Open Oracle Keywords</button><br>
				<br>
				<button class="gpt-DebugBtn" onclick="gpt_LoadDebugValues()">Refresh Values</button>
			</div>
			<div style="display: table-cell;">
				<table class="gpt-DebugTable">
					<thead>
						<tr>
							<th>Property</th>
							<th>Value</th>
						</tr>
					</thead>
					<tbody>
						<tr><td class="gpt-DebugTitle">Status</td><td><div class="gptStatus_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Version</td><td><div class="gptVersion_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad File</td><td><div class="gptAdFile_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Disable Ads Flag</td><td><div class="gptDisableAds_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Environment</td><td><div class="gptTestENV_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Init</td><td><div class="gptMoatInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Ready</td><td><div class="gptMoatReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Ready</td><td><div class="gptContextualReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual URL</td><td><div class="gptContextualURL_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Initial Segments</td><td><div class="gptContextualInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Used Segments</td><td><div class="gptContextualResult_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">AdUnit</td><td><div class="gptSite_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">SubAdUnit</td><td><div class="gptPage_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Custom Targeting</td><td><div class="gptCustomTargeting_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad Events</td><td><div class="gptEvent_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Invalid Ad Sizes</td><td><div class="gptInvalidAdSize_Debug"></div></td></tr>
					</tbody>
				</table>
			</div>
		</div>
	</div>
</div>
<style type="text/css">
	.gpt-DebugBtn {
		display: inline-block;
		text-align: center;
		text-decoration: none;
		margin: 2px 0;
		border: solid 1px #122b40;
		border-radius: 0.4em;
		padding: 0.5em 1em;
		color: #ffffff;
		background-color: #204d74;
		font-weight: normal;
		font-size: 12px;
	}

	.gpt-DebugDiv {
		margin: 5px;
	}

	.gpt-DebugTitle {
		font-weight: bold;
	}

	.gpt-DebugTable {
		border: 1px solid #dddddd;
		border-collapse: collapse;
		margin: 5px;
		font-size: 0.9em;
		font-family: sans-serif;
		min-width: 400px;
		margin-bottom: 25px;
	}

		.gpt-DebugTable td:first-child {
			padding: 5px;
		}

		.gpt-DebugTable thead tr th {
			background-color: #d9edf7;
			color: #ffffff;
			text-align: left;
			padding: 5px;
			border-bottom: 2px solid #204d74;
		}

		.gpt-DebugTable th,
		.gpt-DebugTable td {
			padding: 5px;
		}

		.gpt-DebugTable tbody tr {
			border-bottom: 1px solid #dddddd;
		}

			.gpt-DebugTable tbody tr:nth-of-type(even) {
				background-color: #f3f3f3;
			}

			.gpt-DebugTable tbody tr:last-of-type {
				border-bottom: 2px solid #204d74;
			}

	.gpt-InScrollLabel {
		background-color: rgb(0, 0, 0);
		color: rgb(255, 255, 255);
		position: relative;
		max-width: 100vw;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		padding: 0;
		text-align: center;
		width: 100vw !important;
		font-size: 10px;
	}

	.gpt-InScrollBox {
		height: 100vh !important;
		width: 100vw;
		cursor: pointer;
		max-width: 100vw;
		position: relative;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		margin-bottom: 50px;
		padding-top: 5px;
		padding-bottom: 5px;
		z-index: 10001;
		background-color: white;
	}

		.gpt-InScrollBox .gpt-InScrollContainer {
			height: 95vh !important;
			position: relative;
		}

		.gpt-InScrollBox .gpt-InScrollWrapper {
			position: absolute !important;
			top: 0 !important;
			left: 0;
			width: 100%;
			height: 95vh !important;
			border: 0 !important;
			margin: 0 !important;
			padding: 0 !important;
			clip: rect(0, auto, auto, 0) !important;
			-webkit-clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
			clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
		}

		.gpt-InScrollBox .gpt-InScrollInner {
			position: fixed !important;
			top: 0 !important;
			left: 0 !important;
			bottom: 0;
			margin: auto;
			width: 100vw;
			height: 95vh;
			-webkit-transform: translateZ(0) !important;
			display: -webkit-box;
			display: -ms-flexbox;
			display: flex;
			-webkit-box-orient: vertical;
			-webkit-box-direction: normal;
			-ms-flex-direction: column;
			flex-direction: column;
			-webkit-box-align: center;
			-ms-flex-align: center;
			align-items: center;
			-webkit-box-pack: center;
			-ms-flex-pack: center;
			justify-content: center;
			text-align: center;
		}
</style>
<script class="optanon-category-4" type="text/plain">
	//--------------------------------------------------------------------------
	var gpt_Version = '04072023';
	var gpt_AdFile = $('#gpt-Variables').data('adfile');
	var gpt_MaxMOATInitAttempts = 11;
	var gpt_MaxMOATReadyAttempts = 11;
	var gpt_MaxContextualReadyAttempts = 21;
	var gpt_MOATInitAttempts = 0;
	var gpt_MOATReadyAttempts = 0;
	var gpt_ContextualReadyAttempts = 0;
	var gpt_IsProd = true;
	var gpt_StartTime;
	var gs_channels = 'DEFAULT';
	var gpt_ContextualReady = false;
	var gpt_ContextualURL = 'Not enabled outside of Production';
	var gpt_DisableAdsFlagFound = false;

	var gptEvent_Debug = '';
	var gptCustomTargeting_Debug = '';
	var gptSite_Debug = "";
	var gptPage_Debug = "";
	var gptContextualEnabled = false;
	var gptContextualResult_Debug = '';
	var gptContextualInit_Debug = '';
	var gptContextualURL_Debug = '';
	var gptContextualReady_Debug = '';
	var gptMoatReady_Debug = '';
	var gptMoatInit_Debug = '';
	var gptTestENV_Debug = '';
	var gptDisableAds_Debug = '';
	var gptStatus_Debug = 'GPT Still Loading - Refresh Values';
	var gptInvalidAdSize_Debug = '';
	//--------------------------------------------------------------------------
	$(document).ready(function () {
		//Check to see if we are on a development env
		gpt_CheckEnvironment();

		if (!gpt_DisableAdsFlagFound) {
			gpt_StartTime = new Date();
			if (gpt_AdFile !== "PU") {
				//Once the dom has loaded, begin the process to init the ads.
				gpt_InitScripts();
				gpt_CheckForMOATInit();
			}
		}
	});
</script>
<script type="text/javascript">
	function gpt_CheckEnvironment() {
		if ($('#gptDisableAds').length > 0) {
			gptDisableAds_Debug = 'Flag Detected - Ads Disabled';
			gpt_DisableAdsFlagFound = true;
		}
		else {
			gptDisableAds_Debug = 'Ads Enabled';
			gpt_DisableAdsFlagFound = false;
		}
		switch (gpt_AdFile) {
			case 'PU':
				gptContextualEnabled = true;
				if ($("#Environment").val() !== "Prod") {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			case 'JBS':
			case 'LANCET':
				gptContextualEnabled = true;
				if ($(".gpt-ad").length > 0) {
					//Other ads exist, allow the Prestitial
					$(document.body).append("<div class='gpt-ad' data-adsize='prestitial'></div>");
				}
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			default:
				//Cell
				gptContextualEnabled = false;
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
    function gpt_GetNonCMEArticle() {
        var url;
        $('.articleCitation').each(function (i, obj) {
            if ($(obj).find('.toc__item__detials').length > 0) {
                var itemDetails = $(obj).first().find('.toc__item__detials');
                var cmeFound = 0;
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='CME']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='(CME)']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='Education']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='education']").length; }
                if (cmeFound == 0) {
                    var itemLink = $(itemDetails).first().find('.toc__item__title');
                    var linkCount = $(itemLink).first().find("a:contains('CME')").length;
                    if (linkCount == 0) {
                        url = $(itemLink).first().find('a').attr('href');
                        return false;   //Found a URL, break the loop
                    }
                }
            }
        });
        return url;
    }
	//--------------------------------------------------------------------------
	function gpt_GetElapsedTime() {
		var endTime = new Date();
		var timeDiff = endTime - gpt_StartTime; //in ms
		// strip the ms
		timeDiff /= 1000;

		// get seconds
		return seconds = Math.round(timeDiff) + " seconds";
	}
	//--------------------------------------------------------------------------
	function gpt_CheckSSC() {
		//Check for ScreenShot Client
		var gpt_SSC = gpt_GetQuerystring('gpt_ssc', '');
		if (gpt_SSC == '1') {
			//it's the ScreenShotClient, disable MOAT IVT Detection
			$('#gpt-Variables').append('<input type="hidden" id="gptm_data">');
			$('#gptm_data').val(0);
			gpt_Target("m_data");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_LocalSS(adTypeId) {
		window.scrollTo(0, 0);
		gpt_Sleep(1000);
		gpt_ScrollToAd(adTypeId);
		gpt_PreTearsheet(adTypeId);
	}
	//--------------------------------------------------------------------------
	function gpt_InitScripts() {
		if (gpt_AdFile == "PU") {
			if (gpt_IsProd) {
				gpt_ContextualURL = gpt_CheckForNULL($('#canonicalurl').val());
				if (gpt_ContextualURL === null) {
					gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				}
				else {
					gpt_ContextualURL = window.location.origin + gpt_ContextualURL;
				}
				var useSSL = 'https:' == document.location.protocol;
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}
		}
		else {
			//JBS-Cell-Lancet
			var useSSL = 'https:' == document.location.protocol;

			var gads = document.createElement('script');
			gads.async = true;
			gads.type = 'text/javascript';
			gads.src = (useSSL ? 'https:' : 'http:') + '//securepubads.g.doubleclick.net/tag/js/gpt.js';
			document.head.appendChild(gads);

			if (gpt_IsProd && gptContextualEnabled) {
				gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}

			var elsevierMoatHeader = document.createElement('link');
			elsevierMoatHeader.rel = 'preload';
			elsevierMoatHeader.as = 'script';
			elsevierMoatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(elsevierMoatHeader);

			var elsevierMoatAds = document.createElement('link');
			elsevierMoatAds.rel = 'preconnect';
			elsevierMoatAds.src = (useSSL ? 'https:' : 'http:') + '//mb.moatads.com';
			document.head.appendChild(elsevierMoatAds);

			var moatHeader = document.createElement('script');
			moatHeader.async = true; gads.type = 'text/javascript';
			moatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(moatHeader);
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForMOATInit() {
		//Check every 1/10 of a second until MOAT is Loaded or 1 second timeout
		if (gpt_MOATInitAttempts < gpt_MaxMOATInitAttempts) {
			gpt_MOATInitAttempts += 1;
			if (typeof window.moatPrebidApi === "object") {
				//MOAT LOADED
				gptMoatInit_Debug = '0.0' + gpt_MOATInitAttempts + ' seconds';
				gpt_CheckForMOATReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATInit(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not LOADED
			gptMoatInit_Debug = 'Timeout Expired';
			var googletag = googletag || {};
			googletag.cmd = googletag.cmd || [];
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForMOATReady() {
		//Check every 1/10 of a second until MOAT is Ready or 1 second timeout
		if (gpt_MOATReadyAttempts < gpt_MaxMOATReadyAttempts) {
			gpt_MOATReadyAttempts += 1;
			if (window.moatPrebidApi.safetyDataAvailable()) {
				//MOAT Ready
				gptMoatReady_Debug = '0.0' + gpt_MOATReadyAttempts + " seconds";
				gpt_CheckForContextualReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATReady(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not Ready
			gptMoatReady_Debug = 'Timeout Expired';
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForContextualReady() {
		//Check every 1/10 of a second until Contextual is Ready or 2 second timeout
		if (gpt_IsProd && gptContextualEnabled) {
			//Enabled
			if (gpt_ContextualReadyAttempts < gpt_MaxContextualReadyAttempts) {
				gpt_ContextualReadyAttempts += 1;
				if (gpt_ContextualReady) {
					//Contextual Ready
					gptContextualURL_Debug = gpt_ContextualURL;
					gptContextualReady_Debug = '0.0' + gpt_ContextualReadyAttempts + " seconds";
					gptContextualInit_Debug = gs_channels;
					gpt_InitAds();
				}
				else {
					setTimeout(() => { gpt_CheckForContextualReady(); }, 100);
				}
			}
			else {
				//LOG TIMEOUT error
				//REMOVE FOR NOW (SHOULD LOG TO A DIFF LOCATION)
				//TIMEOUT: Contextual Not Ready
				$('#gpt_GrapeShotDebugBtn').remove();
				gptContextualURL_Debug = gpt_ContextualURL;
				gptContextualReady_Debug = 'Timeout Expired';
				gptContextualInit_Debug = "";
				gpt_InitAds();
			}
		}
		else {
			//Not Enabled
			$('#gpt_GrapeShotDebugBtn').remove();
			switch (gpt_AdFile) {
				case 'PU':
				case 'LANCET':
				case 'JBS':
					gptContextualURL_Debug = 'Not enabled outside of Production';
					gptContextualReady_Debug = 'Not enabled outside of Production';
					gptContextualInit_Debug = 'Not enabled outside of Production';
					break;
				case "CELLJOURNAL":
				case "CELLBUCKET":
					gptContextualReady_Debug = 'Not enabled on Cell';
					gptContextualInit_Debug = 'Not enabled on Cell';
					gptContextualURL_Debug = 'Not enabled on Cell';
					break;
			}
			gpt_InitAds();
		}
	}
	//--------------------------------------------------------------------------
	function GPT_GetPageByURL() {
		var host = window.location.host.toLocaleLowerCase()
		var localpath = window.location.pathname.toLocaleLowerCase();

		///Check for Cell.com
		if (host.indexOf('cell.com') >= 0) {
			return null;
		}

		///Check for Cell.com (marlin-stag)
		if (host.indexOf('www-cell-com') >= 0) {
			return null;
		}

		///Check for Lancet
		if (host.indexOf('thelancet') >= 0) {
			return null;
		}

		if (localpath.indexOf('/article/') >= 0) {
			return 'article.fulltext';
		}

		if (localpath.indexOf('/action/dosearch') >= 0) {
			return 'search.searchResults';
		}

		if (localpath.indexOf('/content/') >= 0) {
			return 'periodical.editorial';
		}

		return 'periodical.home';
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForNULL(x, valueifnull) {
		if (typeof valueifnull == "undefined") {
			valueifnull = null;
		}

		if (typeof x == 'undefined') {
			return valueifnull;
		}
		if (x == null) {
			return valueifnull;
		}
		if (x == "null") {
			return valueifnull;
		}
		if ($.trim(x) == '') {
			return valueifnull;
		}

		return x;
	}
	//--------------------------------------------------------------------------
	function gpt_GetAdditionalTargeting() {
		//adds page level targeting of custom variables
		//the id (minus gpt) and the value will be used as a key-value pair
		//eg: <input type="hidden" id="gptissuepii" value="x" class="gpt-Target">
		//eg: target issuepii=x
		$(".gpt-Target").each(function (index) {
			var gptTargetId = $(this).attr('id');
			gptTargetId = gptTargetId.replace('gpt', '').toLowerCase();
			if (gptTargetId !== '') {
				gpt_Target(gptTargetId);
			}
		})
	}
	//--------------------------------------------------------------------------
	function gpt_GetQuerystring(key, default_) {
		//function to read querystring variables
		if (default_ === null) default_ = '';
		key = key.replace(/[\[]/, "\\\[").replace(/[\]]/, "\\\]");
		var regex = new RegExp("[\\?&]" + key + "=([^&#]*)");
		var qs = regex.exec(window.location.href);
		if (qs === null)
			return default_;
		else
			return qs[1];
	}
	//--------------------------------------------------------------------------
	function gpt_GetDFPTestId() {
		//Get any request for a test id from querystring and set custom targeting parameter
		var gptDFPTestId = gpt_GetQuerystring('dfptestid', '');
		if (gptDFPTestId !== '') {
			$('#gpt-Variables').append('<input type="hidden" id="gptDFPTestId">');
			$('#gptDFPTestId').val(gptDFPTestId);
			gpt_Target("DFPTestId");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Target(targetName) {
		//Set page level target if value is found
		if ($('#gpt' + targetName).length > 0) {
			var targetValue = $('#gpt' + targetName).val();

			if (targetValue !== '') {
				targetValue = targetValue.replace(/[^-a-z0-9]/ig, '');	//Only Allow a-z, 0-9
				googletag.pubads().setTargeting(targetName.toLowerCase(), targetValue.toLowerCase());
				gptCustomTargeting_Debug = gptCustomTargeting_Debug + targetName.toLowerCase() + ' = ' + targetValue.toLowerCase() + '<br>';
			}
		}
	}
	//--------------------------------------------------------------------------
	function gpt_TargetAccessType() {
		var currentAccessType = $('#gptAccessType').val();
		if (typeof currentAccessType == "undefined") {
			currentAccessType = "";
		}
		if (currentAccessType.indexOf('ANON_IP') >= 0) {
			googletag.pubads().setTargeting("loggedin", "yes");
		}
		else {
			gpt_Target("LoggedIn");
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_PreTearsheet(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		//Remove Elsevier Cookie Policy Notice
		if ($("#onetrust-consent-sdk").length > 0) {
			$("#onetrust-consent-sdk").remove();
		}

        //Mobile Nav
        $('#skip').remove();
        $('skipNavigationLink').remove();

		//JBS Modals
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.usabilla__overlay').length > 0) {
			$('.usabilla__overlay').remove();
		}

		//Pendo
		if ($('._pendo-step-container').length > 0) {
			$('._pendo-step-container').remove();
		}
		if ($('._pendo-guide-tt_').length > 0) {
			$('._pendo-guide-tt_').remove();
		}
		if ($('._pendo-image').length > 0) {
			$('._pendo-image').remove();
		}
		if ($('._pendo-badge-image').length > 0) {
			$('._pendo-badge-image').remove();
		}

		switch (gpt_AdFile) {
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Mobile Bug Fix on Cell
				if (parseInt(adTypeId) == 5) {
					$('.widget-horizontalAd').css('position', 'static');
					$('.body-horizontalAd').css('display', 'block');
				}
				break;
			case "JBS":
			case "LANCET":
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 3: //MPU
					case 4: //SkyScraper
						//BUGFIX: Show Sidebar ad for JBS
						//skyscraper & mpu
						if ($('.widget-verticalAd').length > 0) {
							$('.widget-verticalAd').css('display', 'block');
						}
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
					case 6:     //Prestitial
						$('#backgroundLayer').css('display', 'block');
						break;
					default:
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Sleep(ms) {
		return new Promise(resolve => setTimeout(resolve, ms));
	}
	//--------------------------------------------------------------------------
	async function gpt_ScrollToAd(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		var adId = "";
		var offset = 0;
		var objLeaderboard = "";
		var gpt_ScrollToAd = true;

		switch (gpt_AdFile) {
			case "PU": //PracticeUpdate
				var hideOtherAds = true;
				$('#modalPrestitial').modal('hide');
				$('.jumbotron-welcome').hide();
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 2:
						//LeaderBoard, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 3:
						//MPU
						adId = "adSlot2";
						break;
					case 4:
						//SkyScraper
						adId = "adSlot3";
						$('.most-read').hide();
						break;
					case 5:
						//Mobile, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 6:
						//Interstitial
						gpt_ScrollToAd = false;
						adId = "adSlot15";
						await gpt_Sleep(1000);
						$(objLeaderboard).hide();
						$('#modalPrestitial').unbind();
						$('#modalPrestitial').modal();
						break;
					case 7:
						//Native Ad
						break;
					case 10:
						//Master Companion
						hideOtherAds = false;
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
				}
				if (hideOtherAds) {
					//Hide all other ads
					$('.ad-container').each(function (i, obj) {
						if (this.id !== adId) {
							var tempParent = this.id;
							tempParent = tempParent.replace("adSlot", "adParent");
							$("#" + tempParent).addClass('hide');
						}
					});
				}
				break;
			case "JBS":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$(".widget-verticalAd").hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="sidebar"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					case 13:	    //Phone - Portrait
					case 14:        //Phone - Landscape
						$(objLeaderboard).hide();
						offset = 60;
						adId = 'gpt-Interscroller';
						gpt_ScrollToAd = true;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
			case "CELLJOURNAL":
			case "CELLBUCKET":
				objLeaderboard = ".js__adToHide";
				offset = 260;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="boombox"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				//Hide the second ad if found
				var tCount = 0;
				$(".widget.literatumAd.none.GPT-ad-placeholder.widget-horizontalAd.widget-compact-all").each(function (index) {
					tCount += 1;
					if (tCount !== 1) {
						$(this).hide();
					}
				});
				break;
			case "LANCET":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="skyscraper"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
		}

		//Scroll to Top
		var gpt_container = $("html,body");
		gpt_container.animate({ scrollTop: 0, scrollLeft: 0 });

		if (gpt_ScrollToAd) {
			//If Adexists, scroll to it
			var gpt_scrollTo = $('#' + adId);
			if (gpt_scrollTo.length > 0) {
				//Scroll to the Ad
				var gpt_topPosition = gpt_scrollTo.offset().top - gpt_container.offset().top + gpt_container.scrollTop();
				if (gpt_topPosition > 0) {
					gpt_container.animate({ scrollTop: gpt_topPosition, scrollLeft: 0 });
					if (gpt_topPosition - offset > 0 && offset > 0) {
						gpt_container.animate({ scrollTop: gpt_topPosition - offset, scrollLeft: 0 });
					}
				}
			}
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForCookiePolicy() {
		var returnVal = false;
		if ($('#onetrust-accept-btn-handler').length > 0) {
			$('#onetrust-accept-btn-handler').click();
			returnVal = true;
		}
		return returnVal;
	}
	//--------------------------------------------------------------------------
	function gpt_InitAds() {
		var gpt_ResponsiveHomepage = false;

		switch (gpt_AdFile) {
			case "JBS":
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Responsive Check
				if ($('#hdrHomeBrand').length > 0) {
					gpt_ResponsiveHomepage = true;
				}
				break;
		}

		//InterScroller Check
		if (gpt_AdFile === "JBS") {
			var gpt_InterScrollerEnabled = false;
			var gpt_InterScrollerInsertObj;

			if ($("#articleHeader").length > 0) {
				//It's an article Page
				if ($('.article__sections > section').length > 0) {
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".article__sections > section");
				}
			}
			else {
				if ($('.toc__section').length > 0) {
					//It's a TOC Page
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".toc__section").first();
				}
			}

			//Add the Interscroller
			if (gpt_InterScrollerEnabled) {
				gpt_InterScrollerInsertObj.first().append($("#gpt-Interscroller").clone());
				$("#gpt-Interscroller").remove();
				$(".gpt-adinterscroller").addClass("gpt-ad");
			}
		}

		googletag.cmd.push(function () {
			var gptBoomBoxSizeMapping;
			var gptFluidMapping;
			var gptHomePageSidebarMapping;
			var gptCellHomePageSidebarMapping;
			var gptInterscrollerMapping;
			var gptLeaderboardSizeMapping;
			var gptMobileSizeMapping;
			var gptPrestitialMapping;
			var gptRectangleShortSizeMapping;
			var gptRectangleSizeMapping;
			var gptSideBarSizeMapping;
			var gptTallSizeMapping;
			var gptWideSizeMapping;
			var gptWideRectangleSizeMapping;

			//***********************************************
			//Start Define Size mapping based on client Viewport
			//***********************************************
			if (gpt_AdFile === 'PU') {
				gptTallSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 600], [160, 600], [120, 600]]).
					addSize([0, 0], []).
					build();

				gptRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250]]).
					addSize([0, 0], []).
					build();

				gptRectangleShortSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250], [320, 50], [300, 50]]).
					addSize([0, 0], [[300, 250], [320, 50], [300, 50]]).
					build();

				gptWideSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([760, 0], [[728, 90], [320, 50], [300, 50]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptWideRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], []).
					addSize([760, 0], [[320, 50], [300, 50], [300, 250]]).
					addSize([0, 0], [[320, 50], [300, 50], [300, 250]]).
					build();

				gptMobileSizeMapping = googletag.sizeMapping().
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([760, 0], [[1, 1]]).
					build();
			}
			else {
				//JBS-CELL-LANCET
				gptLeaderboardSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([768, 0], [[728, 90]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptHomePageSidebarMapping = googletag.sizeMapping().
					addSize([2090, 795], [[300, 600], [300, 250], [160, 600], [120, 600]]).
					addSize([1910, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptCellHomePageSidebarMapping = googletag.sizeMapping().
                    addSize([2180, 795], [[300, 600], [160, 600], [120, 600], [300, 250], [336, 280]]).
					addSize([2180, 445], [[336, 280]]).
                    addSize([2090, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
                    addSize([2090, 445], [[300, 250]]).
					addSize([1830, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptSideBarSizeMapping = googletag.sizeMapping().
					addSize([1140, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
					addSize([1140, 445], [[300, 250]]).
					addSize([0, 0], []). 				
					build();

				gptBoomBoxSizeMapping = googletag.sizeMapping().
					addSize([768, 0], [[300, 250], [336, 280]]).
					addSize([0, 0], []). 						
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([600, 700], [[1, 1]]).
					addSize([0, 0], []).
					build();

				gptInterscrollerMapping = googletag.sizeMapping().
					addSize([1140, 445], []).
					addSize([1024, 768], [[1024, 768]]).
					addSize([768, 1024], [[768, 1024]]).
					addSize([480, 320], [[480, 320]]).
					addSize([320, 480], [[320, 480]]).
					build();
			}
			//***********************************************
			//End Define Size mapping based on client Viewport
			//***********************************************

			//***********************************************
			//Start detection for ad slots on page
			//***********************************************
			var gptMasterPage = gpt_CheckForNULL($('#gptPage').val());
			var gptMasterSite;

			if (gpt_AdFile === 'PU') {
				gptMasterSite = $('#gptSite').val();
			}
			else {
				//JBS-CELL-LANCET
				gptMasterSite = "dev";

				if (gpt_IsProd) {
					gptMasterSite = gpt_CheckForNULL($('#gptSite').val());

					//If there is no master site, check for a defaultsite
					if (gptMasterSite == null) {
						gptMasterSite = gpt_CheckForNULL($('#gptDefaultSite').val());
					}
				}
				else {
					//Dev ENV
					//If the page has no gptSite Value, assume no value which will disable ads
					if (gpt_CheckForNULL($('#gptSite').val()) === null) {
						gptMasterSite = null;
					}
				}

				//If there is no master Page, check for a Page using the URL
				if (gptMasterPage === null) {
					gptMasterPage = GPT_GetPageByURL();
				}
			}

			$(".gpt-ad").each(function (index) {
				var gptPage = '';
				var adSizeMapping = '';
				var gptPOS;
				var gptTC;
				var gptNative;
				var adId;
				var gptSite;
				var tempSlot = null;


                if (gpt_IsProd) {
					if (gpt_AdFile !== "CELLJOURNAL") {
						//Check if the ad slot has it's own site defined
						if (typeof $(this).data('site') === 'undefined') {
							gptSite = gptMasterSite;
						}
						else {
							gptSite = gpt_CheckForNULL($(this).data('site'));
						}
					}
					else {
						gptSite = gptMasterSite;
					}
                }
                else {
					gptSite = gptMasterSite;
                }



				if (gpt_AdFile === 'PU') {
					adId = $(this).attr('id');
				}
				else {
					//JBS-CELL-LANCET
					adId = 'gpt-ad-' + index + 1;
				}

				if (gpt_CheckForNULL(gptSite) !== null) {
					gptSite_Debug = gptSite;

					gptPOS = parseInt($(this).data('pos')) || -1;
					if (gptPOS === -1) {
						gptPOS = index + 1;
					}

					//Check if the ad slot has it's own page defined
					gptPage = $(this).data('page');
					if (gpt_CheckForNULL(gptPage) == null) {
						//Use the Master Page
						gptPage = gptMasterPage;
					}

					//If the page is not null, preceed it with a slash
					if (gptPage !== null) {
						gptPage = '/' + gptPage;
					}
					else {
						gptPage = '';
					}
					gptPage_Debug = gptPage;


					gptTC = $(this).data('tc');
					if (typeof gptTC === "undefined") {
						gptTC = '';
					}

					gptNative = $(this).data('native');
					if (typeof gptNative === "undefined") {
						gptNative = '';
					}

					//Determine sizemapping based on data-adsize
					if (gpt_AdFile === 'PU') {
						switch ($(this).data('adsize')) {
							case 'tall':
								adSizeMapping = gptTallSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600]], adId);
								break;
							case 'rectangle':
								adSizeMapping = gptRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								break;
							case 'rectangleshort':
								adSizeMapping = gptRectangleShortSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [320, 50], [300, 50]], adId);
								break;
							case 'wide':
								adSizeMapping = gptWideSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'widerectangle':
								adSizeMapping = gptWideRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50], [300, 250]], adId);
								break;
							case 'mobile':
								adSizeMapping = gptMobileSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50]], adId);
								break;
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[1, 1]], adId);
								break;
						}
					}
					else {
						//JBS-CELL-LANCET
						switch ($(this).data('adsize')) {
							case 'cell-leaderboard':
							case 'leaderboard':
								adSizeMapping = gptLeaderboardSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'bottom':
								if (gpt_ResponsiveHomepage) {
									adSizeMapping = gptHomePageSidebarMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'boombox':
								if (gpt_AdFile === "CELLJOURNAL" || gpt_AdFile == "CELLBUCKET") {
									if (gpt_ResponsiveHomepage) {
										adSizeMapping = gptCellHomePageSidebarMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250], [336, 280]], adId);
									}
									else {
										adSizeMapping = gptBoomBoxSizeMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [336, 280]], adId);
									}
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'interscroller':
								adSizeMapping = gptInterscrollerMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 480], [480, 320], [768, 1024], [1024, 768]], adId);
								break;
							case 'sidebar':
							case 'skyscraper':
								adSizeMapping = gptSideBarSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								break;
							case 'native':
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
						}
					}
				}

				//Ignore any invalid adsizes that could be on the page
				if (adSizeMapping !== '') {
					$(this).addClass('gpt-ad-defined');
					if (gpt_AdFile !== 'PU') {
						$(this).attr('id', adId);
					}
					tempSlot.defineSizeMapping(adSizeMapping).addService(googletag.pubads()).setTargeting("pos", gptPOS);

					if (gptTC !== '') {
						tempSlot.setTargeting("tc", gptTC);
					}
					if (gptNative !== '') {
						tempSlot.setTargeting("native", gptNative);
					}
					gptEvent_Debug = gptEvent_Debug + $(this).data('adsize') + ' Requested<br>';
				}
				else {
					gptInvalidAdSize_Debug = gptInvalidAdSize_Debug + "Invalid Size Found, Id: " + $(this).prop('id') + ', adSize: ' + $(this).data('adsize') + '<br>';
					$(this).remove();
				}
			});
			if (gpt_CheckForNULL(gptInvalidAdSize_Debug) === null) {
				gptInvalidAdSize_Debug = "None Detected";
			}
			//***********************************************
			//End detection for ad slots on page
			//***********************************************

			//***********************************************
			//Start page level targeting
			//***********************************************
			if (gpt_AdFile !== 'PU') {
				//Logged in or IP Access
				gpt_TargetAccessType();

				//Check for Screenshot Client
				gpt_CheckSSC();
			}

			//Check for DFP Test
			gpt_GetDFPTestId();

			//Check for Additional Targeting
			gpt_GetAdditionalTargeting();

			if (gpt_IsProd && gptContextualEnabled) {
				var gpt_ContextualRetry = false;
				//Check for Contextual Targeting
				if (gs_channels !== "DEFAULT") {
					var gpt_ContextualCategories = Array.from(gs_channels);
					for (var i = 0; i < gpt_ContextualCategories.length; i++) {
						if (gpt_ContextualCategories[i] == 'gx_retry') {
							gpt_ContextualRetry = true;
						}
						if (!gpt_ContextualCategories[i].startsWith("custom_")) {
							//Remove any tag that is not custom
							gpt_ContextualCategories.splice(i, 1);
							i--;
						}
						else {
							//Strip the 'custom_' from the tag
							gpt_ContextualCategories[i] = gpt_ContextualCategories[i].replace("custom_", "")
						}
					}
					if (gpt_ContextualCategories.length > 0) {
						googletag.pubads().setTargeting("gs_cat", gpt_ContextualCategories);
					}
					else {
						gpt_ContextualCategories = 'none';
					}
					if (gpt_ContextualRetry) {
						gpt_ContextualCategories = "*Indexing*";
					}
					gptContextualResult_Debug = gpt_ContextualCategories;
				}
				else {
					gptContextualResult_Debug = 'No segments found';
				}
			}
			else {
				//Not Prod || Contextual not enabled
				gptContextualResult_Debug = 'Not enabled';
				
				if (!gpt_IsProd) {
                    var gpt_DevSite = gpt_CheckForNULL($('#gptSite').val(), "dev");
                    $('#gpt-Variables').append('<input type="hidden" id="gptEnvironment" value="' + gpt_DevSite + '">');
                    gpt_Target("Environment");
                }

			}
			//***********************************************
			//End page level targeting
			//***********************************************

			//Enable google dfp services
			if (parseInt($('#gptLazyLoading').val()) === 1) {
				googletag.pubads().enableLazyLoad({
					fetchMarginPercent: 200,
					renderMarginPercent: 0,
					mobileScaling: 2.0
				});
			}
			else {
				googletag.pubads().enableSingleRequest();
			}

			//Add Listener for RenderEnded
			googletag.pubads().addEventListener('slotRenderEnded', function (event) {
				if (!event.isEmpty) {
					if (typeof LocalAdLoaded === "function") {
						LocalAdLoaded(event);
					}
					if (gpt_ResponsiveHomepage) {
						if (typeof positionAd === "function") {
							positionAd();
						}
					}
					if (event.size[0] == "480" || event.size[1] == "480") {
						$('.gpt-InScrollBox').css('display', 'block');
						gptEvent_Debug = gptEvent_Debug + 'Interscroller ' + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}
					else {
						gptEvent_Debug = gptEvent_Debug + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}

				}
			});

			if (gpt_AdFile !== 'PU') {
				googletag.pubads().collapseEmptyDivs();
			}
			googletag.enableServices();

			//Populate Defined Ad Slots
			$(".gpt-ad-defined").each(function (index) {
				var adId = $(this).attr('id');
				googletag.cmd.push(function () { googletag.display(adId); });
			});

			gptStatus_Debug = 'GPT Complete';
		});
	}
	//--------------------------------------------------------------------------
	function gpt_DisplayDebug() {
		//Clone the template and append to Body
		$(document.body).append($('#gpt-DebugDiv').clone());
		$('#gpt-DebugDiv').remove();

		//Populate the Values
		gpt_LoadDebugValues();

		//Display and scroll to debug section
		$('.gpt-DebugDiv').css('display', 'block');
		window.scrollTo(0, document.body.scrollHeight);
	}
	//--------------------------------------------------------------------------
	function gpt_LoadDebugValues() {
		$('.gpt-DebugBtn').blur();
		$('.gptVersion_Debug').text(gpt_Version);
		$('.gptAdFile_Debug').html(gpt_AdFile);
		$('.gptEvent_Debug').html(gptEvent_Debug);
		$('.gptCustomTargeting_Debug').html(gptCustomTargeting_Debug);
		$('.gptSite_Debug').text(gptSite_Debug);
		$('.gptContextualResult_Debug').text(gptContextualResult_Debug);
		$('.gptContextualInit_Debug').text(gptContextualInit_Debug);
		$('.gptContextualURL_Debug').text(gptContextualURL_Debug);
		$('.gptContextualReady_Debug').text(gptContextualReady_Debug);
		$('.gptMoatReady_Debug').text(gptMoatReady_Debug);
		$('.gptMoatInit_Debug').text(gptMoatInit_Debug);
		$('.gptTestENV_Debug').text(gptTestENV_Debug);
		$('.gptDisableAds_Debug').text(gptDisableAds_Debug);
		$('.gptStatus_Debug').text(gptStatus_Debug);
		$('.gptPage_Debug').text(gptPage_Debug);
		$('.gptInvalidAdSize_Debug').html(gptInvalidAdSize_Debug);
	}
	//--------------------------------------------------------------------------
	function gpt_GrapeShotDebug() {
		$('.gpt-DebugBtn').blur();
		window.open("http://admin-elsevier.grapeshot.co.uk/custom/bookmarklet.cgi?blocking=1&vn=2&url=" + encodeURIComponent(document.location), "GRAPESHOT_POPUP", "width=650,height=600,scrollbars=yes,screenX=40,screenY=50,menubar=no,toolbar=no,resizable=yes", "Custom").focus();
	}
	//--------------------------------------------------------------------------
	function gpt_ShowConsole() {
		$('.gpt-DebugBtn').blur();
		googletag.openConsole();
	}
	//--------------------------------------------------------------------------
</script>
        </div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="912135d6-7135-4d45-b457-b503cacc3c8b" data-widget-name="ux3-layout-widget"><header class="header base fixed">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header js__adToHide widget-horizontalAd" id="9d6062d7-fad6-4e64-81cc-7dd25d99b23d">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 1 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="1"></div>
<!-- End AdSlot 1 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" class="header__wrapper clearfix" data-db-parent-of="quickSearch"><div id="brandingRow"><a href="/" data-aa-name="science that inspires" data-aa-region="cp global header" title="Visit Cell.com">Science that inspires</a><p id="brandingRowRight"><a href="/" data-aa-name="cell press endorsement" data-aa-region="cp global header" title="Visit Cell.com">A Cell Press journal</a></p></div>
        
    

        


    

            

            

            <div data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" data-widget-name="ux3-layout-widget"><div class="col-xs-6 header__left-side">
    

        


    

            

            
                <a href="/home" id="cpIconLnk" data-aa-name="cell press logo" data-aa-region="cp global header" title="Cell Press" target="_blank"><svg id="cp_logo" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 100 98.1" style="enable-background:new 0 0 100 98.1;" xml:space="preserve" height="100" width="98.1"><path style="fill:#FFFFFF;" d="M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z"></path></svg></a><div class="journal-logos">
            

            <span data-widget-id="35d8d734-3aa0-4ec8-9e2d-14babe803594" data-widget-name="ux3-general-image"><a href="/cell/home" title="Cell"><img alt="Cell" src="/pb-assets/ux3/logos/cell/Cell_white-1532516611593.svg"></a></span>

            
                </div>
            

        

    

        


    

            

            
                <div class="journal-logos">
            

            <span data-widget-id="3ffcbf1f-79fd-4ba3-85b5-bef10a63475f" data-widget-name="ux3-general-image"><a href="https://www.cell.com/open-access?utm_source=oa-label&amp;__hstc=109691226.e4e812b53ff324eccbdbdb2e4fb9a6ab.1644503737405.1644524234622.1644587109507.4&amp;__hssc=109691226.7.1644587109507&amp;__hsfp=3253153019" title="This journal offers authors two options (open access or subscription) to publish research"><img alt="This journal offers authors two options (open access or subscription) to publish research" src="/pb-assets/ux3/logos/cell/Supports_open_access_border-1645554937897.svg"></a></span>

            
                </div>
            

        
</div><div class="col-xs-6">
    

        


    

            

            

            <div data-widget-id="2555f6db-b333-4edb-8b15-ef9213f1f0a5" data-widget-name="ux3-layout-widget"><div class="header__nav row">
    

        


    

            

            

            <ul data-widget-id="52432d24-0331-4c9d-85f3-2033edc7208b" data-widget-name="UX3ProfileLinksWidget" class="rlist rlist--inline profile-links"><li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login-dropdown"><div class="profile-links__user-list__wrapper"><button data-db-target-for="loginmenu-249353" aria-expanded="false" aria-controls="login-links-249353" title="Log in links dropdown" class="profile-links__username"><span>Log in</span></button><div data-db-target-of="loginmenu-249353" id="login-links--249353" class="profile-links__user-list__holder dropBlock__holder"><ul class="rlist profile-links__list"><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2822%2900192-1" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2822%2900192-1" target="_self" data-profile-link="true">Get Institutional Access</a></li></ul></div></div></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2822%2900192-1" target="_self" data-profile-link="true">Register</a></li><li class="hidden-lg"> <div class="profile-links__controls"> <button aria-expanded="false" aria-controls="links-dialog-249353" data-opens="#links-dialog-249353" class="profile-links__btn--open"><span class="sr-only">open links dialog</span><i aria-hidden="true" class="icon-gizmo-person"></i></button></div><dialog id="links-dialog-249353" aria-modal="true"><button data-closes="#links-dialog-249353" class="profile-links__btn--close"><span class="sr-only">close links dialog</span><i aria-hidden="true" class="icon-close-solid"></i></button><ul>   <li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2822%2900192-1" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2822%2900192-1" target="_self" data-profile-link="true">Get Institutional Access</a></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2822%2900192-1" target="_self" data-profile-link="true">Register</a></li></ul></dialog></li></ul>

            

        
</div></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasInstitutionBanner none  widget-none" id="51b7fa33-2137-4f58-9e98-9746c4400513" style="display: none;">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><div class="ui-state-highlight ui-corner-all csas-institution-banner hidden" data-doi="10.1016/j.cell.2022.02.012">
    <span class="ui-icon ui-icon-close banner-close"></span>
    <p>
        Access provided by <span class="accountName"></span>
    </p>
</div>

<style>
    .csas-institution-banner {
        padding: 10px 0 0 10px;
        margin: 5px;
    }

    .csas-institution-banner.ui-state-highlight .ui-icon {
        background-image: url("/templates/jsp/css/jquery-ui-1.10.2/base/images/ui-icons_454545_256x240.png");
        margin-right: 5px;
        margin-top: -4px;
    }

    .csas-institution-banner .banner-close {
        float: right;
    }
</style>

<script>

    function resetBanner(doi) {
        $.get('/action/getAccount?doi=' + doi, function(data) {
            if (data) {
                $(".csas-institution-banner p .accountName").html(data);
                $(".csasInstitutionBanner").fadeIn();
                $(".csas-institution-banner").fadeIn();
            }
        });
    }

    var flag = 0;
    $(document).ready(function() {
        if(!$(".csas-institution-banner").is(":visible")){
            $(".csasInstitutionBanner").hide();
        }

        $(".banner-close").click(function() {
            $.get("/action/dismissBanner", function(data) {
                $(".csasInstitutionBanner").fadeOut(function () {
                    if(typeof UX !== 'undefined') {
                        UX.pageBody.init();
                    }
                });
            });
        });

        $(".articleContent .tabs li[role='tab'].showFullText").click(function() {
           flag = 1;
        });

        $(document).on("reloadTabsContent", function() {
            var isSelected = $(".articleContent .tabs li[role='tab'].showFullText").hasClass("active");
            if (isSelected) {
                var isHidden =  $(".csas-institution-banner").is(".hidden");
                if (!isHidden) {
                    resetBanner($(".csas-institution-banner").data("doi"));
                    console.log("fadeIn");
                }
            } else {
                $(".csas-institution-banner").fadeOut();
                console.log("fadeOut");
            }
            flag = 0;
        });

        $(document).on("click", ".articleContent .tabs li[role='tab']", function() {

        });
    });
</script></div>
                </div>
                </div>

        
</header></div>

            

        










        <div data-widget-def="graphQueryWidget" data-widget-id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" class="ux3">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget graphQueryWidget none top-padding-handler noMargin axel-mega-menu widget-none widget-compact-all fonts-loaded" id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" style="padding-top: 115.594px;">
                
                
                    
                

                <div class="wrapped " id="CP TOP LEVEL NAV MENU">
                    
                    <div class="widget-body body body-none  body-compact-all"><nav id="mega-menu-nav" role="navigation" class="mega-menu-nav">
  <!--.skip//a(href='#searchText' aria-label='Skip menu') Skip menu
  -->
  <div class="mega-menu-nav__wrapper">
    <button class="mega-menu__toggle"><span class="sr-only">Main menu</span><i aria-hidden="true" class="icon-gizmo-hamburger"></i></button>
    <ul role="menubar" class="mega-menu rlist">
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-1" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-1" data-item-link="main-menu-link-1" data-index="0" class="mega-menu__item-link menu-link"><span>This journal</span></a>
        <div id="main-menu-panel-1" aria-labelledby="main-menu-link-1" data-item-wrapper="main-menu-link-1" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <div aria-label="Menu dropzone section" tabindex="-1" class="listDropZone">
    

        


    

            

            

            <div class="cover-image"><div class="cover-image__thumb"><a href="/issue/S0092-8674(24)X0012-4" class="menu-link"><img src="/cms/asset/atypon:cms:attachment:img:d5e6:rev:1748270185670-389:pii:S0092867424X00124/cover.tif.jpg" alt="Cover Image - Cell, Volume 188, Issue 11"></a></div><div class="cover-image__meta"></div></div>

            

        
</div>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-2" class="sub-menu__heading">Read
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/newarticles" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Online now</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/current" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Current issue</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/archive" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Archive</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/action/showPreferences?menuTab=Alerts" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Publication alerts</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sneakpeek" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Sneak Peek - preprints</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-3" class="sub-menu__heading">About
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-2">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/advisory-board" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Advisory board</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/aims" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Aims and scope</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/contact" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/editors-and-staff" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Editors and staff</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/editorial-ethics" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Ethics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/permissions" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Permissions</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Reviewer instructions</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-2" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-2" data-item-link="main-menu-link-2" data-index="1" class="mega-menu__item-link menu-link"><span>Journals</span></a>
        <div id="main-menu-panel-2" aria-labelledby="main-menu-link-2" data-item-wrapper="main-menu-link-2" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-1" class="sub-menu__heading">Life &amp; medical sciences
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-4">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cancer-cell/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cancer Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-chemical-biology" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Chemical Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-genomics/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Genomics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-host-microbe/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Host &amp; Microbe</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-metabolism/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-medicine/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-stem-cell/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Stem Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-systems/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Systems</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/current-biology/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Current Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/developmental-cell/home" data-index="11" role="menuitem" class="sub-menu__item-link menu-link"><span>Developmental Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/immunity/home" data-index="12" role="menuitem" class="sub-menu__item-link menu-link"><span>Immunity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/med/home" data-index="13" role="menuitem" class="sub-menu__item-link menu-link"><span>Med</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-cell/home" data-index="14" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/neuron/home" data-index="15" role="menuitem" class="sub-menu__item-link menu-link"><span>Neuron</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/structure/home" data-index="16" role="menuitem" class="sub-menu__item-link menu-link"><span>Structure</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/ajhg/home" data-index="17" role="menuitem" class="sub-menu__item-link menu-link"><span>American Journal of Human Genetics (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysj/home" data-index="18" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Journal (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysreports/home" data-index="19" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/hgg-advances/home" data-index="20" role="menuitem" class="sub-menu__item-link menu-link"><span>Human Genetics and Genomics Advances (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-plant/home" data-index="21" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Plant (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/molecular-therapy/home" data-index="22" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/methods/home" data-index="23" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Methods &amp; Clinical Development (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/nucleic-acids/home" data-index="24" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Nucleic Acids (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/oncology/home" data-index="25" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Oncology (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/plant-communications/home" data-index="26" role="menuitem" class="sub-menu__item-link menu-link"><span>Plant Communications (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/stem-cell-reports/home" data-index="27" role="menuitem" class="sub-menu__item-link menu-link"><span>Stem Cell Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biochemical-sciences/home" data-index="28" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biochemical Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cancer/home" data-index="29" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cancer</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cell-biology/home" data-index="30" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cell Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/ecology-evolution/home" data-index="31" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Ecology &amp; Evolution</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/endocrinology-metabolism/home" data-index="32" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Endocrinology &amp; Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/genetics/home" data-index="33" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Genetics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/immunology/home" data-index="34" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Immunology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/microbiology/home" data-index="35" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Microbiology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/molecular-medicine/home" data-index="36" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Molecular Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/neurosciences/home" data-index="37" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Neurosciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/parasitology/home" data-index="38" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Parasitology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/pharmacological-sciences/home" data-index="39" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Pharmacological Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/plant-science/home" data-index="40" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Plant Science</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 5/6" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-2" class="sub-menu__heading">Physical sciences &amp; engineering
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-biomaterials/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Biomaterials</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-physical-science/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Physical Science</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem-catalysis/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem Catalysis</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/device/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Device</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/joule/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Joule</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/matter/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Matter</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/newton/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Newton</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/chemistry/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Chemistry</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 6/7" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-3" class="sub-menu__heading">Multidisciplinary
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-methods/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Methods</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-sustainability/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Sustainability</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/heliyon/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Heliyon</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/iscience/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>iScience</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/one-earth/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>One Earth</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/patterns/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Patterns</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/star-protocols/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Protocols</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/nexus/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Nexus (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/the-innovation/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>The Innovation (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biotechnology/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biotechnology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cognitive-sciences/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cognitive Sciences</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-3" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-3" data-item-link="main-menu-link-3" data-index="2" class="mega-menu__item-link menu-link"><span>Publish</span></a>
        <div id="main-menu-panel-3" aria-labelledby="main-menu-link-3" data-item-wrapper="main-menu-link-3" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-1" class="sub-menu__heading">Authors
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://www.editorialmanager.com/cell?__hstc=25856994.7201670a4397fa03148684920d4a8d38.1672762013831.1694716659709.1694718909620.146&amp;__hssc=25856994.15.1694718909620&amp;__hsfp=1366844671" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Submit article
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/information-for-authors" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for authors</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/multi-journal-submission" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Multi-Journal Submission</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/star-authors-guide" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Methods</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-2" class="sub-menu__heading">Reviewers
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for reviewers</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-4" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-4" data-item-link="main-menu-link-4" data-index="3" class="mega-menu__item-link menu-link"><span>News &amp; events</span></a>
        <div id="main-menu-panel-4" aria-labelledby="main-menu-link-4" data-item-wrapper="main-menu-link-4" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/newsroom" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Newsroom</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/events" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Events</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/symposia" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Symposia</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/webinars" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Webinars</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/consortia" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Consortia Hub</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-5" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-5" data-item-link="main-menu-link-5" data-index="4" class="mega-menu__item-link menu-link"><span>About Cell Press</span></a>
        <div id="main-menu-panel-5" aria-labelledby="main-menu-link-5" data-item-wrapper="main-menu-link-5" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-1" class="sub-menu__heading">Cell Press
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/about" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>About Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/contact" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact us</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="https://service.elsevier.com/app/overview/cell-press/" data-index="2" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Help &amp; support
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access at Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/diversity" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Inclusion and diversity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-50" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>50th anniversary</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-2" class="sub-menu__heading">Hubs
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/biotechnology-bioengineering" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Biotechnology and bioengineering</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-chemistry" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Chemistry</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/clinical-translational" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Clinical and translational</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/covid-19" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>COVID-19</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/fundamental-biology" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Fundamental biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sustainability" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Sustainability</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/4" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-3" class="sub-menu__heading">Careers
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Press careers
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
    </ul>
    <div class="mega-menu-nav__quick-search">
    

        


    

            

            

            <div data-widget-id="a1f05748-166f-41e0-b01a-ca8ac1cc95d4" data-widget-name="UX3QuickSearchWidget" class="quick-search"><div class="dropBlock"><form action="https://www.cell.com/action/doSearch?journalCode=cell" name="quickSearchBar" method="get" title="Quick Search"><input id="type" type="hidden" value="quicksearch" name="type"><div class="quick-search__toggle autoCompleteWrapper"><input id="searchText" type="text" name="text1" placeholder="Search for..." enterkeyhint="search" autocomplete="off" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" data-group-titles-conf="3" data-publication-items-conf="3" aria-label="Enter a search term" class="searchText searchText-autocomplete ui-autocomplete-input"><button type="submit" title="Search" aria-label="Submit the search form" class="btn quick-search__button icon-search"><span>Go search</span></button><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a><ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" unselectable="on" style="display: none;"></ul></div><div class="quick-search__box"><div class="quick-search__box-inner"><div class="quick-search__box-wrapper"><select name="field1" aria-label="Select a search area"><option value="AllField">All content</option><option value="Title">Article title</option><option value="Contrib">Authors</option><option value="Keyword">Keywords</option><option value="Abstract">Abstract</option><option value="AbstractTitleKeywordFilterField">Article title, abstract, keywords</option></select><input type="hidden" name="journalCode" value="cell"><div class="quick-search__scope-options"><span>Search within:</span><label title="This journal" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeSeries-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" title="This journal" value="cell" checked="checked" aria-label="Search within current journal"><span>This journal</span></label><label title="Full site" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeFullSite-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" value="" title="Full site" aria-label="Search within full site"><span>Full site</span></label></div><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a></div><a href="javascript:void(0)" aria-label="Close search options" title="Close search options" class="quick-search__box-close"><i aria-hidden="true" class="icon-tools_close"></i></a></div></div><div class="quick-search__alert hidden"><p>Please enter a term before submitting your search.</p><a href="#" class="quick-search__alert--close"> Ok</a></div></form></div></div>

            

        
</div>
  </div>
</nav>
<div id="page-body-id" class="page-body-flag"></div></div>
                </div>
                </div>

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="f8c6daf9-9df1-4fd9-ba3a-7f5d7b3d4466" data-widget-name="UX3HTMLWidget"><style>
.journal-logos:nth-of-type(2) img {
max-height: 30px !important;
}
.journal-logos:nth-of-type(3) img {
max-height: 30px !important;
}
.ux3 .journal-logos + .journal-logos {
margin-left: 30px;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 55%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 45%;
}
@media screen and (max-width: 1000px) {
.ux3 .journal-logos + .journal-logos {
display: none;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 50%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 50%;
}
}

.ux3 .journal-logos:first-of-type {
   max-width: 500px;
}

.profile-links {
   white-space: nowrap;
}

@media only screen and (min-width: 740px) and (max-width: 1600px) {
   .journal-logos:nth-of-type(2) img {
      max-width: 250px !important;
   }
}

@media only screen and (min-width: 1024px) and (max-width: 1600px) {
   .header__wrapper.clearfix .col-xs-6:first-of-type {
      width: 60% !important;
   }
   .header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
      width: 40% !important;
   }
}

@media only screen and (max-width: 1240px) {
   .ux3 .journal-logos + .journal-logos {
      display: none !important;
   }
}

</style></div>

            

        
</div></div>

            
                </div>
            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget axelPublicationContent none  widget-none" id="cadc9b41-a542-448a-9de4-8d0803320174">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><link id="build-style-article" rel="stylesheet" type="text/css" href="/products/marlin/cell/releasedAssets/css/build-article-b26f3342b722959c7931.css"><article xmlns="http://www.w3.org/1999/xhtml" data-design="pill" data-has="right-rail" vocab="http://schema.org/" typeof="ScholarlyArticle" data-pii="S0092-8674(22)00192-1" lang="en" dir="ltr"><div data-core-wrapper="header"><header data-extent="frontmatter"><div class="core-container"><div data-article-access="free" data-article-access-type="open" class="meta-panel"><span class="meta-panel__left-content"><span class="meta-panel__type"><span>Article</span></span></span><span class="meta-panel__middle-content"><span class="meta-panel__volumeIssue"><a href="/cell/issue?pii=S0092-8674(21)X0008-6"><span>Volume 185</span>, <span>Issue 7</span></a></span><span class="meta-panel__pages"><span>p1208-1222.e21</span></span><span class="meta-panel__onlineDate">March 31, 2022</span></span><span class="meta-panel__right-content"><span class="meta-panel__access meta-panel__access--archive"><span>Open Archive</span></span></span><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=185&amp;issue=7&amp;pii=S0092-8674%2821%29X0008-6" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div><h1 property="name">Tumor-reactive antibodies evolve from non-binding and autoreactive precursors</h1><div class="contributors"><span class="authors"><span role="list"><span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au1" aria-controls="axel_author_au1"><span property="givenName">Roei D.</span> <span property="familyName">Mazor</span></a><div id="au1" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Roei D.</span> <span property="familyName">Mazor</span> <a class="orcid-id" href="https://orcid.org/0000-0002-4784-9808" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-4784-9808</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Biological Regulation, Weizmann Institute of Science, Rehovot 7610001, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Mazor/Roei+D" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au2" aria-controls="axel_author_au2"><span property="givenName">Nachum</span> <span property="familyName">Nathan</span></a><div id="au2" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Nachum</span> <span property="familyName">Nathan</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Nathan/Nachum" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au3" aria-controls="axel_author_au3"><span property="givenName">Amit</span> <span property="familyName">Gilboa</span></a><div id="au3" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Amit</span> <span property="familyName">Gilboa</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Faculty of Engineering, Bar Ilan University, Ramat Gan 52900, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Gilboa/Amit" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup></span><span data-displayed-on="all"> ∙ … </span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au4" aria-controls="axel_author_au4"><span property="givenName">Liat</span> <span property="familyName">Stoler-Barak</span></a><div id="au4" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Liat</span> <span property="familyName">Stoler-Barak</span> <a class="orcid-id" href="https://orcid.org/0000-0001-8194-9979" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-8194-9979</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Stoler-Barak/Liat" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au5" aria-controls="axel_author_au5"><span property="givenName">Lihee</span> <span property="familyName">Moss</span></a><div id="au5" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Lihee</span> <span property="familyName">Moss</span> <a class="orcid-id" href="https://orcid.org/0000-0003-1111-8699" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0003-1111-8699</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Moss/Lihee" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au29" aria-controls="axel_author_au29"><span property="givenName">Inna</span> <span property="familyName">Solomonov</span></a><div id="au29" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au29"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Inna</span> <span property="familyName">Solomonov</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biological Regulation, Weizmann Institute of Science, Rehovot 7610001, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Solomonov/Inna" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au30" aria-controls="axel_author_au30"><span property="givenName">Assaf</span> <span property="familyName">Hanuna</span></a><div id="au30" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au30"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Assaf</span> <span property="familyName">Hanuna</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biological Regulation, Weizmann Institute of Science, Rehovot 7610001, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Hanuna/Assaf" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au6" aria-controls="axel_author_au6"><span property="givenName">Yalin</span> <span property="familyName">Divinsky</span></a><div id="au6" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Yalin</span> <span property="familyName">Divinsky</span> <a class="orcid-id" href="https://orcid.org/0000-0001-5275-4312" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-5275-4312</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Divinsky/Yalin" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au7" aria-controls="axel_author_au7"><span property="givenName">Merav D.</span> <span property="familyName">Shmueli</span></a><div id="au7" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Merav D.</span> <span property="familyName">Shmueli</span> <a class="orcid-id" href="https://orcid.org/0000-0002-9196-7633" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-9196-7633</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Shmueli/Merav+D" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au8" aria-controls="axel_author_au8"><span property="givenName">Hadas</span> <span property="familyName">Hezroni</span></a><div id="au8" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Hadas</span> <span property="familyName">Hezroni</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Hezroni/Hadas" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au9" aria-controls="axel_author_au9"><span property="givenName">Irina</span> <span property="familyName">Zaretsky</span></a><div id="au9" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Irina</span> <span property="familyName">Zaretsky</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Life Sciences and Core Facilities, Weizmann Institute of Science, Rehovot 7610001, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Zaretsky/Irina" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au10" aria-controls="axel_author_au10"><span property="givenName">Michael</span> <span property="familyName">Mor</span></a><div id="au10" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Michael</span> <span property="familyName">Mor</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Mor/Michael" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au11" aria-controls="axel_author_au11"><span property="givenName">Ofra</span> <span property="familyName">Golani</span></a><div id="au11" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Ofra</span> <span property="familyName">Golani</span> <a class="orcid-id" href="https://orcid.org/0000-0002-9793-236X" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-9793-236X</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Life Sciences and Core Facilities, Weizmann Institute of Science, Rehovot 7610001, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Golani/Ofra" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au12" aria-controls="axel_author_au12"><span property="givenName">Gad</span> <span property="familyName">Sabah</span></a><div id="au12" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au12"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Gad</span> <span property="familyName">Sabah</span> <a class="orcid-id" href="https://orcid.org/0000-0001-6412-8001" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-6412-8001</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel</span></div><div property="affiliation" typeof="Organization"><span property="name">The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Sabah/Gad" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">6</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">9</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au13" aria-controls="axel_author_au13"><span property="givenName">Ariella</span> <span property="familyName">Jakobson-Setton</span></a><div id="au13" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au13"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Ariella</span> <span property="familyName">Jakobson-Setton</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel</span></div><div property="affiliation" typeof="Organization"><span property="name">The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Jakobson-Setton/Ariella" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">6</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">9</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au14" aria-controls="axel_author_au14"><span property="givenName">Natalia</span> <span property="familyName">Yanichkin</span></a><div id="au14" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au14"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Natalia</span> <span property="familyName">Yanichkin</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology, Rabin Medical Center, Petah Tikva, Israel</span></div><div property="affiliation" typeof="Organization"><span property="name">The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Yanichkin/Natalia" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">7</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">9</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au15" aria-controls="axel_author_au15"><span property="givenName">Meora</span> <span property="familyName">Feinmesser</span></a><div id="au15" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au15"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Meora</span> <span property="familyName">Feinmesser</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology, Rabin Medical Center, Petah Tikva, Israel</span></div><div property="affiliation" typeof="Organization"><span property="name">The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Feinmesser/Meora" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">7</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">9</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au16" aria-controls="axel_author_au16"><span property="givenName">Daliah</span> <span property="familyName">Tsoref</span></a><div id="au16" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au16"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Daliah</span> <span property="familyName">Tsoref</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel</span></div><div property="affiliation" typeof="Organization"><span property="name">The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Tsoref/Daliah" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">8</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">9</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au17" aria-controls="axel_author_au17"><span property="givenName">Lina</span> <span property="familyName">Salman</span></a><div id="au17" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au17"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Lina</span> <span property="familyName">Salman</span> <a class="orcid-id" href="https://orcid.org/0000-0002-8451-6922" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-8451-6922</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel</span></div><div property="affiliation" typeof="Organization"><span property="name">The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Salman/Lina" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">6</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">9</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au18" aria-controls="axel_author_au18"><span property="givenName">Effi</span> <span property="familyName">Yeoshoua</span></a><div id="au18" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au18"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Effi</span> <span property="familyName">Yeoshoua</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel</span></div><div property="affiliation" typeof="Organization"><span property="name">The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Yeoshoua/Effi" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">6</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">9</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au19" aria-controls="axel_author_au19"><span property="givenName">Eyal</span> <span property="familyName">Peretz</span></a><div id="au19" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au19"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Eyal</span> <span property="familyName">Peretz</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Peretz/Eyal" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">6</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au20" aria-controls="axel_author_au20"><span property="givenName">Inna</span> <span property="familyName">Erlich</span></a><div id="au20" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au20"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Inna</span> <span property="familyName">Erlich</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Erlich/Inna" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">6</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au21" aria-controls="axel_author_au21"><span property="givenName">Netta Mendelson</span> <span property="familyName">Cohen</span></a><div id="au21" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au21"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Netta Mendelson</span> <span property="familyName">Cohen</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Mathematics and Computer Science, Weizmann Institute of Science, Rehovot 7610001, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Cohen/Netta+Mendelson" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">10</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au22" aria-controls="axel_author_au22"><span property="givenName">Jonathan M.</span> <span property="familyName">Gershoni</span></a><div id="au22" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au22"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Jonathan M.</span> <span property="familyName">Gershoni</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv-Yafo, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Gershoni/Jonathan+M" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">11</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au23" aria-controls="axel_author_au23"><span property="givenName">Natalia</span> <span property="familyName">Freund</span></a><div id="au23" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au23"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Natalia</span> <span property="familyName">Freund</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Freund/Natalia" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au24" aria-controls="axel_author_au24"><span property="givenName">Yifat</span> <span property="familyName">Merbl</span></a><div id="au24" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au24"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Yifat</span> <span property="familyName">Merbl</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Merbl/Yifat" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au25" aria-controls="axel_author_au25"><span property="givenName">Gur</span> <span property="familyName">Yaari</span></a><div id="au25" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au25"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Gur</span> <span property="familyName">Yaari</span> <a class="orcid-id" href="https://orcid.org/0000-0001-9311-9884" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-9311-9884</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Faculty of Engineering, Bar Ilan University, Ramat Gan 52900, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Yaari/Gur" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup></span></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au26" aria-controls="axel_author_au26"><span property="givenName">Ram</span> <span property="familyName">Eitan</span></a><div id="au26" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au26"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Ram</span> <span property="familyName">Eitan</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel</span></div><div property="affiliation" typeof="Organization"><span property="name">The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Eitan/Ram" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">6</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">9</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au27" aria-controls="axel_author_au27"><span property="givenName">Irit</span> <span property="familyName">Sagi</span></a><div id="au27" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au27"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Irit</span> <span property="familyName">Sagi</span></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0010" href="mailto:irit.sagi@weizmann.ac.il" property="email" title="Send email to Irit Sagi">irit.sagi@weizmann.ac.il</a></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biological Regulation, Weizmann Institute of Science, Rehovot 7610001, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Sagi/Irit" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup> <a id="eadd0010" href="mailto:irit.sagi@weizmann.ac.il" property="email" title="Send email to Irit Sagi">irit.sagi@weizmann.ac.il</a></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au28" aria-controls="axel_author_au28"><span property="givenName">Ziv</span> <span property="familyName">Shulman</span></a><div id="au28" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au28"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Ziv</span> <span property="familyName">Shulman</span> <a class="orcid-id" href="https://orcid.org/0000-0002-9604-212X" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-9604-212X</a></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0015" href="mailto:ziv.shulman@weizmann.ac.il" property="email" title="Send email to Ziv Shulman">ziv.shulman@weizmann.ac.il</a></div></div><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">12</div><div id="fn1"><div id="ntpara0010" role="paragraph">Lead contact</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Shulman/Ziv" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a role="doc-noteref">12</a></sup> <a id="eadd0015" href="mailto:ziv.shulman@weizmann.ac.il" property="email" title="Send email to Ziv Shulman">ziv.shulman@weizmann.ac.il</a></span><span data-displayed-on="all"> … <span><span data-action="reveal" tabindex="0" role="listitem">Show more</span></span> </span><span data-displayed-on="none" data-on-display="all" aria-hidden="true"> <span data-action="hide" tabindex="0" role="listitem">Show less</span></span></span></span></div><div class="core-self-citation"><div class="expandable-triggers"><button aria-controls="core-affiliations-notes" aria-expanded="false" tabindex="0" role="button"><span>Affiliations &amp; Notes</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button><button aria-controls="core-content-info" aria-expanded="false" tabindex="0" role="button"><span>Article Info</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button></div><div id="core-linked-content">
    

        

</div><div class="expandable-content"><div id="core-affiliations-notes" role="region" data-expandable="item" style="display: none;"><div class="affiliations"><div property="affiliation" typeof="Organization"><span class="label">1</span><span id="aff1" property="name">Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel</span></div><div property="affiliation" typeof="Organization"><span class="label">2</span><span id="aff2" property="name">Department of Biological Regulation, Weizmann Institute of Science, Rehovot 7610001, Israel</span></div><div property="affiliation" typeof="Organization"><span class="label">3</span><span id="aff3" property="name">Faculty of Engineering, Bar Ilan University, Ramat Gan 52900, Israel</span></div><div property="affiliation" typeof="Organization"><span class="label">4</span><span id="aff4" property="name">Department of Life Sciences and Core Facilities, Weizmann Institute of Science, Rehovot 7610001, Israel</span></div><div property="affiliation" typeof="Organization"><span class="label">5</span><span id="aff5" property="name">Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel</span></div><div property="affiliation" typeof="Organization"><span class="label">6</span><span id="aff6" property="name">Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel</span></div><div property="affiliation" typeof="Organization"><span class="label">7</span><span id="aff7" property="name">Department of Pathology, Rabin Medical Center, Petah Tikva, Israel</span></div><div property="affiliation" typeof="Organization"><span class="label">8</span><span id="aff8" property="name">Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel</span></div><div property="affiliation" typeof="Organization"><span class="label">9</span><span id="aff9" property="name">The Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel</span></div><div property="affiliation" typeof="Organization"><span class="label">10</span><span id="aff10" property="name">Department of Mathematics and Computer Science, Weizmann Institute of Science, Rehovot 7610001, Israel</span></div><div property="affiliation" typeof="Organization"><span class="label">11</span><span id="aff11" property="name">Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv-Yafo, Israel</span></div></div><div class="core-authors-notes"><div role="doc-footnote" data-has="label"><div class="label">12</div><div id="fn1"><div id="ntpara0010" role="paragraph">Lead contact</div></div></div></div></div><div id="core-content-info" role="region" data-expandable="item" style="display: none;"><div class="history"><div>Publication History:</div><div><span>Received May 13, 2021</span>; <span>Revised December 20, 2021</span>; <span>Accepted February 9, 2022</span>; <span>Published online March 18, 2022</span></div></div><div class="core-links"><span class="doi">DOI: <a href="https://doi.org/10.1016/j.cell.2022.02.012" property="sameAs" target="_blank">10.1016/j.cell.2022.02.012 <span class="sr-only">External Link</span></a></span><span class="science-direct">Also available on <a href="https://www.sciencedirect.com/science/article/pii/S0092867422001921" target="_blank">ScienceDirect <span class="sr-only">External Link</span></a></span></div><div role="paragraph">Copyright: © 2022 Elsevier Inc.</div><div class="core-links"><span>User License: <a href="http://www.elsevier.com/open-access/userlicense/1.0/" target="_blank">Elsevier user license</a> | <a href="https://www.elsevier.com/open-access" target="_blank">Elsevier's open access license policy</a></span></div><div class="core-crossmark-badge"><a data-target="crossmark" href="#" title="Check for updates on crossmark" data-doi="10.1016/j.cell.2022.02.012" data-id="article-info-crossmark" class="crossmark__link" style="cursor: pointer;"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 290 58" height="22px" role="presentation"><path fill="url(#horizontal_crossmark)" stroke="#948F8F" stroke-miterlimit="10" stroke-width=".75" d="M287 1H3a2 2 0 0 0-2 2v52a2 2 0 0 0 2 2h284a2 2 0 0 0 2-2V3a2 2 0 0 0-2-2Z"></path><path fill="#535353" d="M80.3 23.58a6.395 6.395 0 0 0-.55-1.43 3.92 3.92 0 0 0-2.19-1.86 5.099 5.099 0 0 0-1.71-.29 5 5 0 0 0-2.46.58 4.831 4.831 0 0 0-1.69 1.54 6.921 6.921 0 0 0-1 2.19 10.16 10.16 0 0 0 0 5 6.921 6.921 0 0 0 1 2.19 4.83 4.83 0 0 0 1.69 1.5 5 5 0 0 0 2.46.58 4.44 4.44 0 0 0 1.85-.36 4.12 4.12 0 0 0 1.38-1c.39-.436.695-.942.9-1.49A7.094 7.094 0 0 0 80.4 29h3a8.46 8.46 0 0 1-.69 2.92 7.179 7.179 0 0 1-1.59 2.29 7 7 0 0 1-2.35 1.49 8.14 8.14 0 0 1-3 .52 8.43 8.43 0 0 1-3.59-.74 7.88 7.88 0 0 1-2.69-2 9.001 9.001 0 0 1-1.69-3 11.41 11.41 0 0 1 0-7.23 9.001 9.001 0 0 1 1.69-3 8.001 8.001 0 0 1 2.69-2 8.3 8.3 0 0 1 3.59-.75 9.44 9.44 0 0 1 2.83.41c.866.242 1.68.642 2.4 1.18A6.229 6.229 0 0 1 82.65 21a6.66 6.66 0 0 1 .78 2.58H80.3ZM85.9 17.9h2.85v6.63h.05a4.15 4.15 0 0 1 1.56-1.46 4.61 4.61 0 0 1 2.31-.59 4.83 4.83 0 0 1 3.33 1.1 4.21 4.21 0 0 1 1.22 3.3v8.88H94.4v-8.13a3.51 3.51 0 0 0-.65-2.21 2.36 2.36 0 0 0-1.87-.69 3.1 3.1 0 0 0-1.3.26 2.821 2.821 0 0 0-1 .73A3.41 3.41 0 0 0 89 26.8a3.88 3.88 0 0 0-.23 1.33v7.63H85.9V17.9ZM102.47 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7A5.349 5.349 0 0 1 109.7 35a5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4A5.953 5.953 0 0 1 100 32a8.748 8.748 0 0 1-.41-2.75 7.768 7.768 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.264.905.352 1.852.26 2.79h-9.53Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.594 3.594 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM122.88 27.15a2.666 2.666 0 0 0-1-1.81 3.14 3.14 0 0 0-2-.61c-.4.005-.798.07-1.18.19-.435.136-.83.376-1.15.7a3.92 3.92 0 0 0-.87 1.43 6.783 6.783 0 0 0-.35 2.39c.002.539.065 1.076.19 1.6.113.509.316.993.6 1.43.273.41.635.752 1.06 1a3 3 0 0 0 1.58.39 2.872 2.872 0 0 0 2.06-.77 3.596 3.596 0 0 0 1-2.18h2.85a6.26 6.26 0 0 1-1.91 3.86 5.83 5.83 0 0 1-4 1.34 6.61 6.61 0 0 1-2.69-.51 5.695 5.695 0 0 1-2-1.4 6.001 6.001 0 0 1-1.21-2.11 8.279 8.279 0 0 1-.41-2.65 8.987 8.987 0 0 1 .4-2.72 6.237 6.237 0 0 1 1.2-2.21 5.614 5.614 0 0 1 2-1.47 6.7 6.7 0 0 1 2.79-.54 7.801 7.801 0 0 1 2.14.29 5.634 5.634 0 0 1 1.8.86c.529.386.969.88 1.29 1.45a5 5 0 0 1 .6 2.07h-2.85l.06-.02ZM128.13 17.9H131V28l5.15-5.22h3.5l-5 4.75 5.42 8.17h-3.47l-4-6.27-1.6 1.7v4.63h-2.85V17.9h-.02ZM147.15 22.83h2.13v-1.08a5.505 5.505 0 0 1 .3-2c.161-.456.436-.862.8-1.18.33-.273.721-.462 1.14-.55.44-.094.89-.141 1.34-.14a8.158 8.158 0 0 1 2 .18v2.24a4.113 4.113 0 0 0-.59-.11 6.343 6.343 0 0 0-.74 0 1.74 1.74 0 0 0-1 .27 1.204 1.204 0 0 0-.41 1.08v1.33h2.42V25h-2.42v10.8h-2.85V25h-2.12v-2.17ZM162.23 36.1a6.999 6.999 0 0 1-2.76-.51 5.877 5.877 0 0 1-2-1.41 5.998 5.998 0 0 1-1.33-2.18 8.775 8.775 0 0 1 0-5.48 6.008 6.008 0 0 1 1.27-2.15 5.894 5.894 0 0 1 2-1.41A7.71 7.71 0 0 1 165 23a5.894 5.894 0 0 1 2 1.41 6.003 6.003 0 0 1 1.28 2.15c.585 1.78.585 3.7 0 5.48a5.99 5.99 0 0 1-3.28 3.54 7.002 7.002 0 0 1-2.77.52Zm0-2.25a3.268 3.268 0 0 0 1.65-.4c.447-.262.83-.621 1.12-1.05.304-.444.528-.938.66-1.46a6.581 6.581 0 0 0 0-3.31 4.416 4.416 0 0 0-.66-1.46 3.526 3.526 0 0 0-1.15-1 3.6 3.6 0 0 0-3.3 0 3.526 3.526 0 0 0-1.15 1 4.414 4.414 0 0 0-.66 1.46 6.558 6.558 0 0 0 0 3.31c.132.522.356 1.016.66 1.46a3.47 3.47 0 0 0 1.15 1.05 3.26 3.26 0 0 0 1.68.4ZM171.13 22.83h2.67v2.5c.097-.362.264-.701.49-1 .251-.341.547-.647.88-.91a4.404 4.404 0 0 1 1.14-.66 3.41 3.41 0 0 1 1.28-.25c.23-.013.46-.013.69 0h.39v2.79l-.61-.09a5.173 5.173 0 0 0-.61 0 3.278 3.278 0 0 0-1.36.29 3.131 3.131 0 0 0-1.11.85 4.171 4.171 0 0 0-.75 1.39 6 6 0 0 0-.28 1.9v6.15h-2.85V22.83h.03ZM198.22 35.75h-2.8V34a3.907 3.907 0 0 1-1.56 1.56 4.25 4.25 0 0 1-2.11.59 4.742 4.742 0 0 1-3.75-1.31 5.537 5.537 0 0 1-1.12-3.84v-8.2h2.85v7.92a3.503 3.503 0 0 0 .65 2.4 2.38 2.38 0 0 0 1.83.7 3.599 3.599 0 0 0 1.5-.27 2.66 2.66 0 0 0 1-.74c.259-.326.444-.705.54-1.11a5.79 5.79 0 0 0 .16-1.4v-7.5h2.85v12.95h-.04ZM201.3 22.83h2.7v1.75a3.523 3.523 0 0 1 1.72-1.58 5.568 5.568 0 0 1 2.33-.49 6.17 6.17 0 0 1 2.66.54 5.246 5.246 0 0 1 1.89 1.47c.515.65.899 1.394 1.13 2.19.257.87.385 1.773.38 2.68.001.851-.114 1.7-.34 2.52a6.568 6.568 0 0 1-1 2.16 5.002 5.002 0 0 1-4.21 2.06c-.419 0-.837-.036-1.25-.11a5.39 5.39 0 0 1-1.2-.36A4.737 4.737 0 0 1 205 35a3.567 3.567 0 0 1-.81-.91v6.45h-2.89V22.83Zm10 6.47c0-.574-.078-1.146-.23-1.7a4.606 4.606 0 0 0-.67-1.46 3.475 3.475 0 0 0-1.12-1 3.06 3.06 0 0 0-1.55-.39A3.141 3.141 0 0 0 205 26a5.518 5.518 0 0 0-1 3.3c-.004.611.077 1.22.24 1.81.138.523.38 1.012.71 1.44a3.55 3.55 0 0 0 1.14 1 3.242 3.242 0 0 0 1.54.35 3.18 3.18 0 0 0 1.65-.4c.438-.25.817-.59 1.11-1 .299-.44.513-.931.63-1.45a7.38 7.38 0 0 0 .23-1.75h.05ZM228.67 35.75H226V34a3.38 3.38 0 0 1-1.67 1.61 5.668 5.668 0 0 1-2.33.49 6.17 6.17 0 0 1-2.66-.54 5.307 5.307 0 0 1-1.89-1.46 6.254 6.254 0 0 1-1.12-2.19 9.48 9.48 0 0 1-.37-2.71 8.67 8.67 0 0 1 .47-3 6.058 6.058 0 0 1 1.26-2.1 4.89 4.89 0 0 1 1.8-1.21 5.738 5.738 0 0 1 2.06-.39c.412 0 .824.037 1.23.11.413.073.815.194 1.2.36.38.166.736.381 1.06.64.32.255.594.562.81.91V17.9h2.85v17.85h-.03Zm-10-6.33c-.001.55.069 1.098.21 1.63.13.511.35.996.65 1.43.288.414.668.757 1.11 1a3.241 3.241 0 0 0 1.6.38 3.199 3.199 0 0 0 1.64-.4 3.398 3.398 0 0 0 1.13-1.05c.297-.447.517-.94.65-1.46.14-.542.211-1.1.21-1.66a5.227 5.227 0 0 0-1-3.35 3.175 3.175 0 0 0-2.61-1.2 3.23 3.23 0 0 0-1.69.41 3.478 3.478 0 0 0-1.12 1.07 4.494 4.494 0 0 0-.62 1.5 7.871 7.871 0 0 0-.11 1.7h-.05ZM242.6 32.88c-.018.258.03.516.14.75a.577.577 0 0 0 .54.23h.3c.135-.002.269-.019.4-.05v2l-.39.11-.49.08-.5.08h-.42a2.75 2.75 0 0 1-1.45-.35 1.731 1.731 0 0 1-.75-1.23 4.998 4.998 0 0 1-2.09 1.2 8.224 8.224 0 0 1-2.39.38 5.861 5.861 0 0 1-1.67-.24 4.394 4.394 0 0 1-1.41-.7 3.35 3.35 0 0 1-1-1.18 3.624 3.624 0 0 1-.36-1.66 3.84 3.84 0 0 1 .44-2 3.246 3.246 0 0 1 1.15-1.17 5.195 5.195 0 0 1 1.6-.61c.593-.127 1.19-.223 1.79-.29a14.77 14.77 0 0 1 1.47-.21 6.896 6.896 0 0 0 1.24-.21c.318-.077.611-.236.85-.46a1.286 1.286 0 0 0 .31-.94 1.458 1.458 0 0 0-.26-.9A1.759 1.759 0 0 0 239 25a2.807 2.807 0 0 0-.86-.25 6.941 6.941 0 0 0-.9-.06 3.58 3.58 0 0 0-2 .5 2 2 0 0 0-.87 1.55h-2.85c.021-.73.227-1.442.6-2.07.338-.54.797-.996 1.34-1.33a5.475 5.475 0 0 1 1.84-.7c.692-.134 1.395-.2 2.1-.2.632 0 1.262.067 1.88.2a5.337 5.337 0 0 1 1.66.65 3.6 3.6 0 0 1 1.19 1.16c.314.525.47 1.129.45 1.74v6.65l.02.04Zm-2.85-3.6a3.45 3.45 0 0 1-1.6.51c-.667.06-1.3.147-1.9.26a6.137 6.137 0 0 0-.87.21 2.64 2.64 0 0 0-.75.38c-.22.164-.395.38-.51.63a2.129 2.129 0 0 0-.19.94c-.011.29.085.575.27.8.182.215.407.388.66.51.269.128.555.216.85.26.277.05.558.076.84.08a4.63 4.63 0 0 0 1-.12 3.418 3.418 0 0 0 1-.43 2.73 2.73 0 0 0 .81-.76 1.93 1.93 0 0 0 .32-1.14v-2.14l.07.01ZM244.37 22.83h2.15V19h2.85v3.88h2.58V25h-2.58v6.9a7.064 7.064 0 0 0 0 .77c.016.194.074.381.17.55a.84.84 0 0 0 .41.34 2 2 0 0 0 .75.11h.6c.203-.01.404-.04.6-.09v2.2l-.93.1a8.403 8.403 0 0 1-.92 0 6.33 6.33 0 0 1-1.81-.21 2.421 2.421 0 0 1-1.08-.62 2.15 2.15 0 0 1-.52-1 7.791 7.791 0 0 1-.16-1.42V25h-2.15v-2.17h.04ZM256.22 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7a5.352 5.352 0 0 1-2.1 3.26 5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4 5.947 5.947 0 0 1-1.21-2.18 8.754 8.754 0 0 1-.41-2.75 7.758 7.758 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.243.916.308 1.87.19 2.81h-9.5V30Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.575 3.575 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM270 31.6a2.154 2.154 0 0 0 .95 1.75c.607.35 1.3.524 2 .5.304-.002.608-.022.91-.06a3.943 3.943 0 0 0 1-.24c.286-.105.54-.28.74-.51a1.23 1.23 0 0 0 .26-.89 1.261 1.261 0 0 0-.4-.9 2.779 2.779 0 0 0-1-.56 9.315 9.315 0 0 0-1.34-.36l-1.5-.33a14.219 14.219 0 0 1-1.54-.42 4.937 4.937 0 0 1-1.33-.68 3.12 3.12 0 0 1-.94-1.09 3.472 3.472 0 0 1-.35-1.64 2.94 2.94 0 0 1 .51-1.76 3.913 3.913 0 0 1 1.3-1.15 5.66 5.66 0 0 1 1.75-.61 10.316 10.316 0 0 1 1.84-.17 8.418 8.418 0 0 1 1.91.21 5.19 5.19 0 0 1 1.65.69c.496.318.916.741 1.23 1.24.341.559.55 1.188.61 1.84h-3a1.783 1.783 0 0 0-.94-1.37 3.892 3.892 0 0 0-1.69-.35 6.093 6.093 0 0 0-.71 0 3.327 3.327 0 0 0-.78.19 1.642 1.642 0 0 0-.61.4 1 1 0 0 0-.25.69 1.093 1.093 0 0 0 .36.85c.294.245.634.428 1 .54.437.153.885.274 1.34.36l1.55.33a20.9 20.9 0 0 1 1.53.42c.479.157.931.386 1.34.68.41.277.751.643 1 1.07.255.494.379 1.045.36 1.6a3.48 3.48 0 0 1-.52 2 4.15 4.15 0 0 1-1.36 1.3 6.19 6.19 0 0 1-1.86.73 9.435 9.435 0 0 1-2 .23 8.823 8.823 0 0 1-2.26-.27 5.265 5.265 0 0 1-1.8-.84 4 4 0 0 1-1.2-1.4 4.445 4.445 0 0 1-.46-2h2.7v-.02Z"></path><path fill="#C72914" d="m21.94 38.74 18.12-12.08v-14.5H21.94v26.58Z"></path><path fill="#EF3340" d="M40.06 38.74 21.94 26.66v-14.5h18.12v26.58Z"></path><path fill="#3EB1C8" d="M31 9a20 20 0 1 0 0 40 20 20 0 0 0 0-40Zm0 35.1a15.1 15.1 0 1 1 0-30.2 15.1 15.1 0 0 1 0 30.2Z"></path><path fill="#FFC72C" d="M42.09 39.23A15.09 15.09 0 0 1 17 23.38l-4.2-2.64a20 20 0 0 0 33.49 21.14l-4.2-2.65Z"></path><defs><linearGradient id="horizontal_crossmark" x1="145" x2="145" y1="7.33" y2="56.82" gradientUnits="userSpaceOnUse"><stop stop-color="#fff"></stop><stop offset="1" stop-color="#c4c4c4"></stop></linearGradient></defs></svg></a></div><div class="core-content-info"></div></div></div></div></div></header><div class="core-header-aside">
    

        


    

            

            

            <div class="cover-image cover-image--axel"><div class="cover-image__thumb"><a href="https://www.cell.com/cell/issue?pii=S0092-8674(21)X0008-6"><img src="/cms/asset/6a99a37b-a8ff-48aa-8a3c-92ee5bb9cbfc/cov200h.gif" alt="Cover Image - Cell, Volume 185, Issue 7"></a></div></div>

            

        
</div></div><div data-core-wrapper="content"><div id="dummy-sticky-observer"></div><div data-core-nav="header" data-extent="frontmatter"><div class="core-nav-wrapper core-container" aria-label="Article navigation"><div class="navigation-menu-pdf">
    

        


    

            

            

            <div data-widget-id="ecff07e8-0bc4-4533-b1f1-49365e2ead20" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><a href="/action/showPdf?pii=S0092-8674%2822%2900192-1" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" role="menuitem" class="article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></div>

            

        
</div><div class="core-sections-menu"><button data-id="article-toolbar-showhide" aria-controls="article_sections_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle section navigation menu" style="margin-top: 0px;"><i class="icon-list" aria-hidden="true"></i><span>Outline</span></button><nav id="article_sections_menu" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><div class="heading">Outline<button aria-haspopup="true" aria-controls="article_sections_menu" title="Close outline menu"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div><ul><li><a href="#author-highlights-abstract">Highlights</a></li><li><a href="#author-abstract">Summary</a></li><li><a href="#graphical-abstract">Graphical abstract</a></li><li><a href="#keywords">Keywords</a></li><li><a href="#sec-1">Introduction</a></li><li><a href="#sec-2">Results</a></li><li><a href="#sec-3">Discussion</a></li><li><a href="#sec-4">STAR★Methods</a></li><li><a href="#acknowledgments">Acknowledgments</a></li><li><a href="#supplementary-material">Supplemental information (4)</a></li><li><a href="#data-availability">Data and code availability</a></li><li><a href="#references">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div><div class="navigation-menu-share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="5f978446-c80a-450c-a185-94d633df2db2" data-widget-name="UX3share" aria-hidden="false" role="group" class="article-tools__dropblock article-tools__share"><button aria-label="Toggle share menu" aria-expanded="false" aria-haspopup="true" role="menuitem" aria-controls="navigation_menu_share_block" aria-labelledby="share-label" class="article-tools__item__share"><i aria-hidden="true" class="icon-article-share"></i><span id="share-label">Share</span></button><div id="navigation_menu_share_block" role="menu" class="share__block axel-share article-tools__dropblock__holder"><h4 class="axel-share__title heading">Share<button title="Close share menu" aria-expanded="false" aria-haspopup="true" aria-controls="navigation_menu_share_block"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2822%2900192-1" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="f1a208d3-ac5e-4db2-9c3a-40ef97ddfa10" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2022.02.012">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</div><div><button data-id="article-nav-menubar-more" aria-controls="article_more_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle more menu"><i aria-hidden="true" class="icon-more-mobile"></i><span>More</span></button><div class="info-panel"><div class="info-panel__left-content"><div class="info-panel__article_tools info-panel__item"><div id="article_more_menu" aria-label="More menu" data-core-nav="more"><div class="heading">More<button title="Close more menu" aria-controls="article_more_menu" aria-haspopup="true"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div>
    

        


    

            

            

            <ul data-widget-id="183a17a2-87b5-4e6f-bb85-6b5cda068c89" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><li class="article-tools__item article-tools__pdf"><a href="/action/showPdf?pii=S0092-8674%2822%2900192-1" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" class="article-tools__ctrl article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></li><li><a href="https://www.cell.com/action/showCitFormats?doi=10.1016%2Fj.cell.2022.02.012&amp;pii=S0092-8674%2822%2900192-1" title="Cite" target="_blank" aria-label="Open Cite in new tab" class="article-tools__item__displayExportCitation"><i aria-hidden="true" class="icon-export-Citation"></i><span>Cite</span></a></li><li id="article_tools_share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" data-widget-name="UX3share" class="dropBlock article-tools__dropblock article-tools__share"><button data-db-target-for="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" aria-expanded="false" title="open Share menu" class="article-tools__ctrl share__ctrl"><i aria-hidden="true" class="icon-article-share"></i><span>Share</span></button><div data-db-target-of="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da_Pop" class="share__block axel-share dropBlock__holder article-tools__dropblock__holder"><h4 class="axel-share__title">Share</h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2822%2900192-1" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>Bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="ae9bf5c5-a2ee-4f5c-8e41-9b21638b1a9f" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2022.02.012">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</li><li><a href="https://www.cell.com/action/addCitationAlert?doi=10.1016%2Fj.cell.2022.02.012" title="Set Alert" target="_blank" aria-label="Open Set Alert in new tab" class="article-tools__item__displayCreateCitationAlert"><i aria-hidden="true" class="icon-set-alert"></i><span>Set Alert</span></a></li><li><a href="https://s100.copyright.com/AppDispatchServlet?publisherName=ELS&amp;contentID=S0092867422001921&amp;orderBeanReset=true&amp;orderSource=Phoenix" title="Get Rights" target="_blank" aria-label="Open Get Rights in new tab" class="article-tools__item__request"><i aria-hidden="true" class="icon-get-rights"></i><span>Get Rights</span></a></li><li><a href="https://www.contentednet.com/salesforce-form/?pii=S0092867422001921&amp;issn=00928674&amp;source=jbs" title="Reprints" target="_blank" aria-label="Open Reprints in new tab" class="article-tools__item__reprints"><i aria-hidden="true" class="icon-article-reprints"></i><span>Reprints</span></a></li></ul>

            

        
</div></div><div class="info-panel__download-issue info-panel__item"><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=185&amp;issue=7&amp;pii=S0092-8674%2821%29X0008-6" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div></div><div class="info-panel__right-content"><div class="info-panel__navigation info-panel__item"><div class="content-navigation"><a href="/cell/fulltext/S0092-8674(22)00201-X" aria-label="Previous article" aria-disabled="false" class="content-navigation__prev"><i aria-hidden="true" class="icon-arrow_l"></i><span>Previous article</span></a><a href="/cell/fulltext/S0092-8674(22)00195-7" aria-label="Next article" aria-disabled="false" class="content-navigation__next"><span>Next article</span><i aria-hidden="true" class="icon-arrow_r"></i></a></div></div></div></div></div></div></div><div class="core-sections-menu-outer"><div class="core-sections-menu"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-show-outline" aria-hidden="true"></i><span>Show Outline</span></button><nav id="article_sections_menu-desktop" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-hide-outline" aria-hidden="true"></i><span>Hide Outline</span></button><ul><li><a href="#author-highlights-abstract">Highlights</a></li><li><a href="#author-abstract">Summary</a></li><li><a href="#graphical-abstract">Graphical abstract</a></li><li><a href="#keywords">Keywords</a></li><li><a href="#sec-1">Introduction</a></li><li><a href="#sec-2">Results</a></li><li><a href="#sec-3">Discussion</a></li><li><a href="#sec-4">STAR★Methods</a></li><li><a href="#acknowledgments">Acknowledgments</a></li><li><a href="#supplementary-material">Supplemental information (4)</a></li><li><a href="#data-availability">Data and code availability</a></li><li><a href="#references">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div></div><div><div class="core-content-inner"><div class="core-linked-content"></div><div id="abstracts" data-extent="frontmatter"><div class="core-container"><section id="author-highlights-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Highlights</h2><div id="abspara0020" role="paragraph"><div id="ulist0010" role="list"><div id="u0010" role="listitem"><div class="label">•</div><div class="content"><div id="p0010" role="paragraph">Tumors in ovarian carcinoma patients are coated with endogenous IgG antibodies</div></div></div><div id="u0015" role="listitem"><div class="label">•</div><div class="content"><div id="p0015" role="paragraph">Intratumoral B cells are clonally related and secrete tumor-binding antibodies</div></div></div><div id="u0020" role="listitem"><div class="label">•</div><div class="content"><div id="p0020" role="paragraph">MMP14 is a major antibody target on the tumor cell surface</div></div></div><div id="u0025" role="listitem"><div class="label">•</div><div class="content"><div id="p0025" role="paragraph">Tumor-reactive antibodies arise from both tumor-reactive and non-binding precursors</div></div></div></div></div></section><section id="author-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Summary</h2><div id="abspara0010" role="paragraph">The tumor microenvironment hosts antibody-secreting cells (ASCs) associated with a favorable prognosis in several types of cancer. Patient-derived antibodies have diagnostic and therapeutic potential; yet, it remains unclear how antibodies gain autoreactivity and target tumors. Here, we found that somatic hypermutations (SHMs) promote antibody antitumor reactivity against surface autoantigens in high-grade serous ovarian carcinoma (HGSOC). Patient-derived tumor cells were frequently coated with IgGs. Intratumoral ASCs in HGSOC were both mutated and clonally expanded and produced tumor-reactive antibodies that targeted MMP14, which is abundantly expressed on the tumor cell surface. The reversion of monoclonal antibodies to their germline configuration revealed two types of classes: one dependent on SHMs for tumor binding and a second with germline-encoded autoreactivity. Thus, tumor-reactive autoantibodies are either naturally occurring or evolve through an antigen-driven selection process. These findings highlight the origin and potential applicability of autoantibodies directed at surface antigens for tumor targeting in cancer patients.</div></section><section id="graphical-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Graphical abstract</h2><div id="abspara0015" role="paragraph"><div class="figure-wrap"><figure id="undfig1" class="graphic" data-figureviewer-ignore="true"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.02.012/asset/c4efabb6-2f43-4312-90d2-755145cd4ba0/main.assets/fx1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx1" alt="Graphical abstract undfig1" src="/cms/10.1016/j.cell.2022.02.012/asset/00a5b8ba-14f1-4ec8-81d1-adef82cb2abe/main.assets/fx1.jpg" height="375" width="375" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/c4efabb6-2f43-4312-90d2-755145cd4ba0/main.assets/fx1_lrg.jpg" loading="lazy"></a></figure></div></div></section></div></div><div class="core-linked-content"></div><section id="keywords" property="keywords"><h2>Keywords</h2><ol><li><a href="/action/doSearch?AllField=&quot;antibodies&quot;" alt="Search on this keyword" rel="nofollow">antibodies</a></li><li><a href="/action/doSearch?AllField=&quot;B+cells&quot;" alt="Search on this keyword" rel="nofollow">B cells</a></li><li><a href="/action/doSearch?AllField=&quot;antibody-mediated+immune+response&quot;" alt="Search on this keyword" rel="nofollow">antibody-mediated immune response</a></li><li><a href="/action/doSearch?AllField=&quot;ovarian+cancer&quot;" alt="Search on this keyword" rel="nofollow">ovarian cancer</a></li><li><a href="/action/doSearch?AllField=&quot;cancer&quot;" alt="Search on this keyword" rel="nofollow">cancer</a></li><li><a href="/action/doSearch?AllField=&quot;autoantibodies&quot;" alt="Search on this keyword" rel="nofollow">autoantibodies</a></li><li><a href="/action/doSearch?AllField=&quot;MMP14&quot;" alt="Search on this keyword" rel="nofollow">MMP14</a></li><li><a href="/action/doSearch?AllField=&quot;MT1-MMP&quot;" alt="Search on this keyword" rel="nofollow">MT1-MMP</a></li><li><a href="/action/doSearch?AllField=&quot;plasma+cells&quot;" alt="Search on this keyword" rel="nofollow">plasma cells</a></li><li><a href="/action/doSearch?AllField=&quot;HGSOC&quot;" alt="Search on this keyword" rel="nofollow">HGSOC</a></li></ol></section><div class="core-linked-content"></div><div class="core-linked-content"></div><section id="bodymatter" data-extent="bodymatter" property="articleBody" typeof="Text"><div class="core-container"><section id="sec-1"><h2>Introduction</h2><div id="p0050" role="paragraph">Antigen-driven selection of B cells bearing high-affinity antibodies for clonal expansion and differentiation in germinal centers (GCs) in response to infection or vaccination has been extensively studied (<span class="dropBlock reference-citations"><a id="body-ref-sref70" href="#" role="doc-biblioref" data-xml-rid="bib70" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref70" aria-controls="sref70">Victora and Nussenzweig, 2022</a><div class="dropBlock__holder" data-db-target-of="sref70"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">70.</div><div>Victora, G.D. ∙ Nussenzweig, M.C.</div><div><strong>Germinal centers</strong></div><div><em>Annu. Rev. Immunol.</em> 2022; <strong>30</strong>:429-457</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.D.VictoraM.C.NussenzweigGerminal+centersAnnu.+Rev.+Immunol.302022429457" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In cancer patients, autoreactive antibodies are frequently present, suggesting that a breach of self-tolerance takes place, as observed in autoimmune diseases (<span class="dropBlock reference-citations"><a id="body-ref-sref83-1" href="#" role="doc-biblioref" data-xml-rid="bib83" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref83-1" aria-controls="sref83-1">Zaenker et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref83-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">83.</div><div>Zaenker, P. ∙ Gray, E.S. ∙ Ziman, M.R.</div><div><strong>Autoantibody production in cancer—the humoral immune response toward autologous antigens in cancer patients</strong></div><div><em>Autoimmun. Rev.</em> 2016; <strong>15</strong>:477-483</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.ZaenkerE.S.GrayM.R.ZimanAutoantibody+production+in+cancer%E2%80%94the+humoral+immune+response+toward+autologous+antigens+in+cancer+patientsAutoimmun.+Rev.152016477483" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Yet, our knowledge regarding the cellular mechanisms underlying the production of tumor-reactive autoantibodies and their cell surface antigens remains elusive. Intratumoral antibody-secreting cells (ASCs) and their B cell precursors were described in many types of solid tumors, and the presence of B-cell-rich tertiary lymphoid structures (TLSs) was robustly associated with a superior prognosis and was shown to predict a beneficial response to immunotherapy treatments (<span class="dropBlock reference-citations"><a id="body-ref-sref52" href="#" role="doc-biblioref" data-xml-rid="bib52" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref52" aria-controls="sref52">Petitprez et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref52"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Petitprez, F. ∙ de Reyniès, A. ∙ Keung, E.Z. ...</div><div><strong>B cells are associated with survival and immunotherapy response in sarcoma</strong></div><div><em>Nature.</em> 2020; <strong>577</strong>:556-560</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=F.PetitprezA.de+Reyni%C3%A8sE.Z.KeungT.W.ChenC.M.SunJ.CalderaroY.-M.JengL.P.HsiaoL.LacroixA.Bougo%C3%BCinB+cells+are+associated+with+survival+and+immunotherapy+response+in+sarcomaNature5772020556560" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref30" href="#" role="doc-biblioref" data-xml-rid="bib30" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref30" aria-controls="sref30">Helmink et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref30"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">30.</div><div>Helmink, B.A. ∙ Reddy, S.M. ∙ Gao, J. ...</div><div><strong>B cells and tertiary lymphoid structures promote immunotherapy response</strong></div><div><em>Nature.</em> 2020; <strong>577</strong>:549-555</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.A.HelminkS.M.ReddyJ.GaoS.ZhangR.BasarR.ThakurK.YizhakM.Sade-FeldmanJ.BlandoG.HanB+cells+and+tertiary+lymphoid+structures+promote+immunotherapy+responseNature5772020549555" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref13" href="#" role="doc-biblioref" data-xml-rid="bib13" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref13" aria-controls="sref13">Cabrita et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref13"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">13.</div><div>Cabrita, R. ∙ Lauss, M. ∙ Sanna, A. ...</div><div><strong>Tertiary lymphoid structures improve immunotherapy and survival in melanoma</strong></div><div><em>Nature.</em> 2020; <strong>577</strong>:561-565</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.CabritaM.LaussA.SannaM.DoniaM.S.Skaarup+LarsenS.MitraI.JohanssonB.PhungK.HarbstJ.Vallon-ChristerssonTertiary+lymphoid+structures+improve+immunotherapy+and+survival+in+melanomaNature5772020561565" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref48-1" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48-1" aria-controls="sref48-1">Nelson, 2010</a><div class="dropBlock__holder" data-db-target-of="sref48-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">48.</div><div>Nelson, B.H.</div><div><strong>CD20+ B cells: the other tumor-infiltrating lymphocytes</strong></div><div><em>J.&nbsp;Immunol.</em> 2010; <strong>185</strong>:4977-4982</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.H.NelsonCD20%2B+B+cells%3A+the+other+tumor-infiltrating+lymphocytesJ.%C2%A0Immunol.185201049774982" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref36-1" href="#" role="doc-biblioref" data-xml-rid="bib36" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref36-1" aria-controls="sref36-1">Kroeger et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref36-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">36.</div><div>Kroeger, D.R. ∙ Milne, K. ∙ Nelson, B.H.</div><div><strong>Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer</strong></div><div><em>Clin. Cancer Res.</em> 2016; <strong>22</strong>:3005-3015</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.R.KroegerK.MilneB.H.NelsonTumor-infiltrating+plasma+cells+are+associated+with+tertiary+lymphoid+structures%2C+cytolytic+T-cell+responses%2C+and+superior+prognosis+in+ovarian+cancerClin.+Cancer+Res.22201630053015" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref54" href="#" role="doc-biblioref" data-xml-rid="bib54" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref54" aria-controls="sref54">Pitzalis et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref54"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">54.</div><div>Pitzalis, C. ∙ Jones, G.W. ∙ Bombardieri, M. ...</div><div><strong>Ectopic lymphoid-like structures in infection, cancer and autoimmunity</strong></div><div><em>Nat. Rev. Immunol.</em> 2014; <strong>14</strong>:447-462</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.PitzalisG.W.JonesM.BombardieriS.A.JonesEctopic+lymphoid-like+structures+in+infection%2C+cancer+and+autoimmunityNat.+Rev.+Immunol.142014447462" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Intratumoral B cells can support an antitumor immune response through several mechanisms, including antigen presentation to T&nbsp;cells (<span class="dropBlock reference-citations"><a id="body-ref-sref18" href="#" role="doc-biblioref" data-xml-rid="bib18" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref18" aria-controls="sref18">Cui et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref18"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">18.</div><div>Cui, C. ∙ Wang, J. ∙ Fagerberg, E. ...</div><div><strong>Neoantigen-driven B cell and CD4&nbsp;T follicular helper cell collaboration promotes robust anti-tumor CD8 T&nbsp;cell responses</strong></div><div><em>Cell.</em> 2021; <strong>184</strong>:6101-6118.e13</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.CuiJ.WangE.FagerbergP.M.ChenK.A.ConnollyM.DamoJ.F.CheungT.MaoA.S.AskariS.ChenNeoantigen-driven+B+cell+and+CD4%C2%A0T+follicular+helper+cell+collaboration+promotes+robust+anti-tumor+CD8+T%C2%A0cell+responsesCell184202161016118.e1310.1016%2Fj.cell.2021.11.007" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and differentiation to ASCs that secrete self-reactive and tumor-specific antibodies (<span class="dropBlock reference-citations"><a id="body-ref-sref64-1" href="#" role="doc-biblioref" data-xml-rid="bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64-1" aria-controls="sref64-1">Sharonov et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref64-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Sharonov, G.V. ∙ Serebrovskaya, E.O. ∙ Yuzhakova, D.V. ...</div><div><strong>B cells, plasma cells and antibody repertoires in the tumour microenvironment</strong></div><div><em>Nat. Rev. Immunol.</em> 2020; <strong>20</strong>:294-307</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.V.SharonovE.O.SerebrovskayaD.V.YuzhakovaO.V.BritanovaD.M.ChudakovB+cells%2C+plasma+cells+and+antibody+repertoires+in+the+tumour+microenvironmentNat.+Rev.+Immunol.202020294307" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref78-1" href="#" role="doc-biblioref" data-xml-rid="bib78" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref78-1" aria-controls="sref78-1">Wieland et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref78-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">78.</div><div>Wieland, A. ∙ Patel, M.R. ∙ Cardenas, M.A. ...</div><div><strong>Defining HPV-specific B cell responses in patients with head and neck cancer</strong></div><div><em>Nature.</em> 2021; <strong>597</strong>:274-278</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.WielandM.R.PatelM.A.CardenasC.S.EberhardtW.H.HudsonR.C.ObengC.C.GriffithX.WangZ.G.ChenH.T.KissickDefining+HPV-specific+B+cell+responses+in+patients+with+head+and+neck+cancerNature597202127427810.1038%2Fs41586-020-2931-3" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Although many studies have characterized the B cell subtypes and ASCs that reside in various tumors (<span class="dropBlock reference-citations"><a id="body-ref-sref40" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40" aria-controls="sref40">Maletzki et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref40"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Maletzki, C. ∙ Jahnke, A. ∙ Ostwald, C. ...</div><div><strong>Ex-vivo clonally expanded B lymphocytes infiltrating colorectal carcinoma are of mature immunophenotype and produce functional IgG</strong></div><div><em>PLoS One.</em> 2012; <strong>7</strong>:e32639</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.MaletzkiA.JahnkeC.OstwaldE.KlarF.PrallM.LinnebacherEx-vivo+clonally+expanded+B+lymphocytes+infiltrating+colorectal+carcinoma+are+of+mature+immunophenotype+and+produce+functional+IgGPLoS+One72012e32639" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref36-2" href="#" role="doc-biblioref" data-xml-rid="bib36" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref36-2" aria-controls="sref36-2">Kroeger et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref36-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">36.</div><div>Kroeger, D.R. ∙ Milne, K. ∙ Nelson, B.H.</div><div><strong>Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer</strong></div><div><em>Clin. Cancer Res.</em> 2016; <strong>22</strong>:3005-3015</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.R.KroegerK.MilneB.H.NelsonTumor-infiltrating+plasma+cells+are+associated+with+tertiary+lymphoid+structures%2C+cytolytic+T-cell+responses%2C+and+superior+prognosis+in+ovarian+cancerClin.+Cancer+Res.22201630053015" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref11" href="#" role="doc-biblioref" data-xml-rid="bib11" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref11" aria-controls="sref11">Bolotin et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">11.</div><div>Bolotin, D.A. ∙ Poslavsky, S. ∙ Davydov, A.N. ...</div><div><strong>Antigen receptor repertoire profiling from RNA-Seq data</strong></div><div><em>Nat. Biotechnol.</em> 2017; <strong>35</strong>:908-911</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.A.BolotinS.PoslavskyA.N.DavydovF.E.FrenkelL.FanchiO.I.ZolotarevaS.HemmersE.V.PutintsevaA.S.ObraztsovaM.ShugayAntigen+receptor+repertoire+profiling+from+RNA-Seq+dataNat.+Biotechnol.352017908911" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref61" href="#" role="doc-biblioref" data-xml-rid="bib61" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref61" aria-controls="sref61">Saul et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref61"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Saul, L. ∙ Ilieva, K.M. ∙ Bax, H.J. ...</div><div><strong>IgG subclass switching and clonal expansion in cutaneous melanoma and normal skin</strong></div><div><em>Sci. Rep.</em> 2016; <strong>6</strong>:29736</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.SaulK.M.IlievaH.J.BaxP.KaragiannisI.CorreaI.Rodriguez-HernandezD.H.JosephsI.TosiI.U.EgbuniweS.LombardiIgG+subclass+switching+and+clonal+expansion+in+cutaneous+melanoma+and+normal+skinSci.+Rep.6201629736" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref50" href="#" role="doc-biblioref" data-xml-rid="bib50" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref50" aria-controls="sref50">Nzula et&nbsp;al., 2003</a><div class="dropBlock__holder" data-db-target-of="sref50"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">50.</div><div>Nzula, S. ∙ Going, J.J. ∙ Stott, D.I.</div><div><strong>Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas</strong></div><div><em>Cancer Res.</em> 2003; <strong>63</strong>:3275-3280</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.NzulaJ.J.GoingD.I.StottAntigen-driven+clonal+proliferation%2C+somatic+hypermutation%2C+and+selection+of+B+lymphocytes+infiltrating+human+ductal+breast+carcinomasCancer+Res.63200332753280" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref46" href="#" role="doc-biblioref" data-xml-rid="bib46" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref46" aria-controls="sref46">Mose et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref46"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">46.</div><div>Mose, L.E. ∙ Selitsky, S.R. ∙ Bixby, L.M. ...</div><div><strong>Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V’DJer</strong></div><div><em>Bioinformatics.</em> 2016; <strong>32</strong>:3729-3734</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.E.MoseS.R.SelitskyL.M.BixbyD.L.MarronM.D.IglesiaJ.S.SerodyC.M.PerouB.G.VincentJ.S.ParkerAssembly-based+inference+of+B-cell+receptor+repertoires+from+short+read+RNA+sequencing+data+with+V%E2%80%99DJerBioinformatics32201637293734" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref45-1" href="#" role="doc-biblioref" data-xml-rid="bib45" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref45-1" aria-controls="sref45-1">Montfort et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref45-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">45.</div><div>Montfort, A. ∙ Pearce, O. ∙ Maniati, E. ...</div><div><strong>A strong B-cell response is part of the immune landscape in human high-grade serous ovarian metastases</strong></div><div><em>Clin. Cancer Res.</em> 2017; <strong>23</strong>:250-262</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.MontfortO.PearceE.ManiatiB.G.VincentL.BixbyS.B%C3%B6hmT.DoweE.H.WilkesP.ChakravartyR.ThompsonA+strong+B-cell+response+is+part+of+the+immune+landscape+in+human+high-grade+serous+ovarian+metastasesClin.+Cancer+Res.232017250262" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), the generation of monoclonal antibodies and comprehensive analysis of their origin, specificity, and function remains a challenge in cancers that lack defined surface immunogens (<span class="dropBlock reference-citations"><a id="body-ref-sref78-2" href="#" role="doc-biblioref" data-xml-rid="bib78" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref78-2" aria-controls="sref78-2">Wieland et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref78-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">78.</div><div>Wieland, A. ∙ Patel, M.R. ∙ Cardenas, M.A. ...</div><div><strong>Defining HPV-specific B cell responses in patients with head and neck cancer</strong></div><div><em>Nature.</em> 2021; <strong>597</strong>:274-278</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.WielandM.R.PatelM.A.CardenasC.S.EberhardtW.H.HudsonR.C.ObengC.C.GriffithX.WangZ.G.ChenH.T.KissickDefining+HPV-specific+B+cell+responses+in+patients+with+head+and+neck+cancerNature597202127427810.1038%2Fs41586-020-2931-3" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0055" role="paragraph">Intratumoral B cells and ASCs are frequently observed in ovarian tumors (<span class="dropBlock reference-citations"><a id="body-ref-sref48-2" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48-2" aria-controls="sref48-2">Nelson, 2010</a><div class="dropBlock__holder" data-db-target-of="sref48-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">48.</div><div>Nelson, B.H.</div><div><strong>CD20+ B cells: the other tumor-infiltrating lymphocytes</strong></div><div><em>J.&nbsp;Immunol.</em> 2010; <strong>185</strong>:4977-4982</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.H.NelsonCD20%2B+B+cells%3A+the+other+tumor-infiltrating+lymphocytesJ.%C2%A0Immunol.185201049774982" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref45-2" href="#" role="doc-biblioref" data-xml-rid="bib45" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref45-2" aria-controls="sref45-2">Montfort et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref45-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">45.</div><div>Montfort, A. ∙ Pearce, O. ∙ Maniati, E. ...</div><div><strong>A strong B-cell response is part of the immune landscape in human high-grade serous ovarian metastases</strong></div><div><em>Clin. Cancer Res.</em> 2017; <strong>23</strong>:250-262</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.MontfortO.PearceE.ManiatiB.G.VincentL.BixbyS.B%C3%B6hmT.DoweE.H.WilkesP.ChakravartyR.ThompsonA+strong+B-cell+response+is+part+of+the+immune+landscape+in+human+high-grade+serous+ovarian+metastasesClin.+Cancer+Res.232017250262" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In this desmoplastic cancer, the tumor mass, its highly fibrotic microenvironment, and metastatic cells are constantly in contact with ascites fluids that accumulate antibodies that are produced by ASCs in the tumor microenvironment (<span class="dropBlock reference-citations"><a id="body-ref-sref58-1" href="#" role="doc-biblioref" data-xml-rid="bib58" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref58-1" aria-controls="sref58-1">Rao and Hanjani, 1988</a><div class="dropBlock__holder" data-db-target-of="sref58-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">58.</div><div>Rao, G.S. ∙ Hanjani, P.</div><div><strong>Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid</strong></div><div><em>Am. J. Obstet. Gynecol.</em> 1988; <strong>159</strong>:94-98</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.S.RaoP.HanjaniDetection+of+human+ovarian+tumor-associated+antigens+by+antibodies+isolated+from+ovarian+carcinoma+ascitic+fluidAm.+J.+Obstet.+Gynecol.1591988949810.1016%2F0002-9378%2888%2990500-5" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref65-1" href="#" role="doc-biblioref" data-xml-rid="bib65" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref65-1" aria-controls="sref65-1">Silburn et&nbsp;al., 1984</a><div class="dropBlock__holder" data-db-target-of="sref65-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">65.</div><div>Silburn, P.A. ∙ Khoo, S.K. ∙ Hill, R. ...</div><div><strong>Demonstration of tumor-associated immunoglobulin G isolated from immune complexes in ascitic fluid of ovarian cancer</strong></div><div><em>Diagn. Immunol.</em> 1984; <strong>2</strong>:30-35</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.A.SilburnS.K.KhooR.HillB.DaunterE.V.MackayDemonstration+of+tumor-associated+immunoglobulin+G+isolated+from+immune+complexes+in+ascitic+fluid+of+ovarian+cancerDiagn.+Immunol.219843035" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Since these tumor-associated fluids are very accessible, this type of cancer is ideal for the analysis of the antitumor humoral immune response (<span class="dropBlock reference-citations"><a id="body-ref-sref58-2" href="#" role="doc-biblioref" data-xml-rid="bib58" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref58-2" aria-controls="sref58-2">Rao and Hanjani, 1988</a><div class="dropBlock__holder" data-db-target-of="sref58-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">58.</div><div>Rao, G.S. ∙ Hanjani, P.</div><div><strong>Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid</strong></div><div><em>Am. J. Obstet. Gynecol.</em> 1988; <strong>159</strong>:94-98</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.S.RaoP.HanjaniDetection+of+human+ovarian+tumor-associated+antigens+by+antibodies+isolated+from+ovarian+carcinoma+ascitic+fluidAm.+J.+Obstet.+Gynecol.1591988949810.1016%2F0002-9378%2888%2990500-5" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref65-2" href="#" role="doc-biblioref" data-xml-rid="bib65" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref65-2" aria-controls="sref65-2">Silburn et&nbsp;al., 1984</a><div class="dropBlock__holder" data-db-target-of="sref65-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">65.</div><div>Silburn, P.A. ∙ Khoo, S.K. ∙ Hill, R. ...</div><div><strong>Demonstration of tumor-associated immunoglobulin G isolated from immune complexes in ascitic fluid of ovarian cancer</strong></div><div><em>Diagn. Immunol.</em> 1984; <strong>2</strong>:30-35</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.A.SilburnS.K.KhooR.HillB.DaunterE.V.MackayDemonstration+of+tumor-associated+immunoglobulin+G+isolated+from+immune+complexes+in+ascitic+fluid+of+ovarian+cancerDiagn.+Immunol.219843035" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). High-grade serous ovarian carcinoma (HGSOC) is the most prevalent subtype of ovarian cancer (<span class="dropBlock reference-citations"><a id="body-ref-sref12-1" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12-1" aria-controls="sref12-1">Bowtell, 2010</a><div class="dropBlock__holder" data-db-target-of="sref12-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Bowtell, D.D.L.</div><div><strong>The genesis and evolution of high-grade serous ovarian cancer</strong></div><div><em>Nat. Rev. Cancer.</em> 2010; <strong>10</strong>:803-808</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.D.L.BowtellThe+genesis+and+evolution+of+high-grade+serous+ovarian+cancerNat.+Rev.+Cancer102010803808" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref56" href="#" role="doc-biblioref" data-xml-rid="bib56" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref56" aria-controls="sref56">Ramalingam, 2016</a><div class="dropBlock__holder" data-db-target-of="sref56"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">56.</div><div>Ramalingam, P.</div><div><strong>Morphologic, immunophenotypic, and molecular features of epithelial ovarian cancer</strong></div><div><em>Oncology (Williston Park).</em> 2016; <strong>30</strong>:166-176</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.RamalingamMorphologic%2C+immunophenotypic%2C+and+molecular+features+of+epithelial+ovarian+cancerOncology+%28Williston+Park%29302016166176" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref32" href="#" role="doc-biblioref" data-xml-rid="bib32" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref32" aria-controls="sref32">Jayson et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref32"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">32.</div><div>Jayson, G.C. ∙ Kohn, E.C. ∙ Kitchener, H.C. ...</div><div><strong>Ovarian cancer</strong></div><div><em>Lancet.</em> 2014; <strong>384</strong>:1376-1388</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.C.JaysonE.C.KohnH.C.KitchenerJ.A.LedermannOvarian+cancerLancet384201413761388" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and its treatment generally includes a combination of chemotherapy and surgery, whereas biological treatment alternatives are scarce and include primarily anti-VEGF therapy and poly ADP-ribose polymerase (PARP) inhibitors (<span class="dropBlock reference-citations"><a id="body-ref-sref39" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39" aria-controls="sref39">Mahmood et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref39"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Mahmood, R.D. ∙ Morgan, R.D. ∙ Edmondson, R.J. ...</div><div><strong>First-line management of advanced high-grade serous ovarian cancer</strong></div><div><em>Curr. Oncol. Rep.</em> 2020; <strong>22</strong>:64</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.D.MahmoodR.D.MorganR.J.EdmondsonA.R.ClampG.C.JaysonFirst-line+management+of+advanced+high-grade+serous+ovarian+cancerCurr.+Oncol.+Rep.22202064" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Specifically, the manipulation of the immune response through the administration of checkpoint inhibitors has not shown strong beneficial effects to date (<span class="dropBlock reference-citations"><a id="body-ref-sref24" href="#" role="doc-biblioref" data-xml-rid="bib24" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref24" aria-controls="sref24">Doo et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref24"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Doo, D.W. ∙ Norian, L.A. ∙ Arend, R.C.</div><div><strong>Checkpoint inhibitors in ovarian cancer: a review of preclinical data</strong></div><div><em>Gynecol. Oncol. Rep.</em> 2019; <strong>29</strong>:48-54</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.W.DooL.A.NorianR.C.ArendCheckpoint+inhibitors+in+ovarian+cancer%3A+a+review+of+preclinical+dataGynecol.+Oncol.+Rep.2920194854" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref10" href="#" role="doc-biblioref" data-xml-rid="bib10" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref10" aria-controls="sref10">Boland et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">10.</div><div>Boland, J.L. ∙ Zhou, Q. ∙ Martin, M. ...</div><div><strong>Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade</strong></div><div><em>Gynecol. Oncol.</em> 2019; <strong>152</strong>:251-258</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.L.BolandQ.ZhouM.MartinM.K.CallahanJ.KonnerR.E.O%E2%80%99CearbhaillC.F.FriedmanW.TewV.MakkerR.N.GrishamEarly+disease+progression+and+treatment+discontinuation+in+patients+with+advanced+ovarian+cancer+receiving+immune+checkpoint+blockadeGynecol.+Oncol.1522019251258" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), emphasizing the need for a deeper understanding of the immune response against this specific tumor.</div><div id="p0060" role="paragraph">In HGSOC patients, the tumor’s extracellular matrix (ECM) plays a pivotal role in promoting malignancy, as it supports cell growth and invasiveness (<span class="dropBlock reference-citations"><a id="body-ref-sref15" href="#" role="doc-biblioref" data-xml-rid="bib15" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref15" aria-controls="sref15">Cho et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref15"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">15.</div><div>Cho, A. ∙ Howell, V.M. ∙ Colvin, E.K.</div><div><strong>The extracellular matrix in epithelial ovarian cancer - A piece of a puzzle</strong></div><div><em>Front. Oncol.</em> 2015; <strong>5</strong>:245</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.ChoV.M.HowellE.K.ColvinThe+extracellular+matrix+in+epithelial+ovarian+cancer+-+A+piece+of+a+puzzleFront.+Oncol.52015245" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The malignant ECM is often highly fibrotic and constantly modulated by ECM-remodeling enzymes such as matrix metalloproteinases (MMPs), including MMP14 (MT1-MMP), which is highly expressed on the HGSOC cell surface (<span class="dropBlock reference-citations"><a id="body-ref-sref35-1" href="#" role="doc-biblioref" data-xml-rid="bib35" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref35-1" aria-controls="sref35-1">Kamel et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref35-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">35.</div><div>Kamel, H. ∙ Abdelazim, I. ∙ Habib, S.M. ...</div><div><strong>Immunoexpression of matrix metalloproteinase-2 (MMP-2) in malignant ovarian epithelial tumours</strong></div><div><em>J.&nbsp;Obstet. Gynaecol. Can.</em> 2010; <strong>32</strong>:580-586</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.KamelI.AbdelazimS.M.HabibM.A.A.El+ShourbagyN.S.AhmedImmunoexpression+of+matrix+metalloproteinase-2+%28MMP-2%29+in+malignant+ovarian+epithelial+tumoursJ.%C2%A0Obstet.+Gynaecol.+Can.32201058058610.1016%2FS1701-2163%2816%2934527-3" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref14-1" href="#" role="doc-biblioref" data-xml-rid="bib14" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref14-1" aria-controls="sref14-1">Cathcart et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref14-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Cathcart, J.M. ∙ Banach, A. ∙ Liu, A. ...</div><div><strong>Interleukin-6 increases matrix metalloproteinase-14 (MMP-14) levels via down-regulation of p53 to drive cancer progression</strong></div><div><em>Oncotarget.</em> 2016; <strong>7</strong>:61107-61120</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.M.CathcartA.BanachA.LiuJ.ChenM.GoligorskyJ.CaoInterleukin-6+increases+matrix+metalloproteinase-14+%28MMP-14%29+levels+via+down-regulation+of+p53+to+drive+cancer+progressionOncotarget720166110761120" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref73-1" href="#" role="doc-biblioref" data-xml-rid="bib73" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref73-1" aria-controls="sref73-1">Vos et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref73-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">73.</div><div>Vos, M.C. ∙ Hollemans, E. ∙ Ezendam, N. ...</div><div><strong>MMP-14 and CD44 in epithelial-to-mesenchymal transition (EMT) in ovarian cancer</strong></div><div><em>J.&nbsp;Ovarian Res.</em> 2016; <strong>9</strong>:53</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.C.VosE.HollemansN.EzendamH.FeijenD.BollB.PijlmanH.van+der+PuttenP.KlinkhamerT.H.van+KuppeveltA.A.van+der+WurffL.F.MassugerMMP-14+and+CD44+in+epithelial-to-mesenchymal+transition+%28EMT%29+in+ovarian+cancerJ.%C2%A0Ovarian+Res.9201653" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref59-1" href="#" role="doc-biblioref" data-xml-rid="bib59" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref59-1" aria-controls="sref59-1">Sakata et&nbsp;al., 2000</a><div class="dropBlock__holder" data-db-target-of="sref59-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">59.</div><div>Sakata, K. ∙ Shigemasa, K. ∙ Nagai, N. ...</div><div><strong>Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary</strong></div><div><em>Int. J. Oncol.</em> 2000; <strong>17</strong>:673-681</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=K.SakataK.ShigemasaN.NagaiK.OhamaExpression+of+matrix+metalloproteinases+%28MMP-2%2C+MMP-9%2C+MT1-MMP%29+and+their+inhibitors+%28TIMP-1%2C+TIMP-2%29+in+common+epithelial+tumors+of+the+ovaryInt.+J.+Oncol.17200067368110.3892%2Fijo.17.4.673" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref72-1" href="#" role="doc-biblioref" data-xml-rid="bib72" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref72-1" aria-controls="sref72-1">Vos et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref72-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">72.</div><div>Vos, M.C. ∙ van der Wurff, A.A.M. ∙ van Kuppevelt, T.H. ...</div><div><strong>The role of MMP-14 in ovarian cancer: a systematic review</strong></div><div><em>J.&nbsp;Ovarian Res.</em> 2021; <strong>14</strong>:1-13</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.C.VosA.A.M.van+der+WurffT.H.van+KuppeveltL.A.F.G.MassugerThe+role+of+MMP-14+in+ovarian+cancer%3A+a+systematic+reviewJ.%C2%A0Ovarian+Res.142021113" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Overexpression of tumor self-proteins was suggested to drive autoantibody generation (<span class="dropBlock reference-citations"><a id="body-ref-sref83-2" href="#" role="doc-biblioref" data-xml-rid="bib83" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref83-2" aria-controls="sref83-2">Zaenker et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref83-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">83.</div><div>Zaenker, P. ∙ Gray, E.S. ∙ Ziman, M.R.</div><div><strong>Autoantibody production in cancer—the humoral immune response toward autologous antigens in cancer patients</strong></div><div><em>Autoimmun. Rev.</em> 2016; <strong>15</strong>:477-483</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.ZaenkerE.S.GrayM.R.ZimanAutoantibody+production+in+cancer%E2%80%94the+humoral+immune+response+toward+autologous+antigens+in+cancer+patientsAutoimmun.+Rev.152016477483" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref43" href="#" role="doc-biblioref" data-xml-rid="bib43" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref43" aria-controls="sref43">Milne et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref43"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">43.</div><div>Milne, K. ∙ Barnes, R.O. ∙ Girardin, A. ...</div><div><strong>Tumor-infiltrating T&nbsp;cells correlate with NY-ESO-1-Specific autoantibodies in ovarian cancer</strong></div><div><em>PLoS One.</em> 2008; <strong>3</strong>:e3409</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=K.MilneR.O.BarnesA.GirardinM.A.MawerN.J.NesslingerA.NgJ.S.NielsenR.SahotaE.TranJ.R.WebbTumor-infiltrating+T%C2%A0cells+correlate+with+NY-ESO-1-Specific+autoantibodies+in+ovarian+cancerPLoS+One32008e3409" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref38" href="#" role="doc-biblioref" data-xml-rid="bib38" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref38" aria-controls="sref38">Ma et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref38"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">38.</div><div>Ma, Y. ∙ Wang, X. ∙ Qiu, C. ...</div><div><strong>Using protein microarray to identify and evaluate autoantibodies to tumor-associated antigens in ovarian cancer</strong></div><div><em>Cancer Sci.</em> 2020; <strong>112</strong>:537-549</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.MaX.WangC.QiuJ.QinK.WangG.SunD.JiangJ.LiL.WangJ.ShiUsing+protein+microarray+to+identify+and+evaluate+autoantibodies+to+tumor-associated+antigens+in+ovarian+cancerCancer+Sci.112202053754910.1111%2Fcas.14732" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and it was shown that antibodies directed against MMPs emerge under different pathological conditions, suggesting that this enzyme family may trigger an immune response in cancer (<span class="dropBlock reference-citations"><a id="body-ref-sref17-1" href="#" role="doc-biblioref" data-xml-rid="bib17" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref17-1" aria-controls="sref17-1">Crowley et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref17-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">17.</div><div>Crowley, J.T. ∙ Strle, K. ∙ Drouin, E.E. ...</div><div><strong>Matrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory lyme arthritis</strong></div><div><em>J.&nbsp;Autoimmun.</em> 2016; <strong>69</strong>:24-37</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.T.CrowleyK.StrleE.E.DrouinA.PiantaS.L.ArvikarQ.WangC.E.CostelloA.C.SteereMatrix+metalloproteinase-10+is+a+target+of+T+and+B+cell+responses+that+correlate+with+synovial+pathology+in+patients+with+antibiotic-refractory+lyme+arthritisJ.%C2%A0Autoimmun.6920162437" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref60-1" href="#" role="doc-biblioref" data-xml-rid="bib60" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref60-1" aria-controls="sref60-1">Sato et&nbsp;al., 2003</a><div class="dropBlock__holder" data-db-target-of="sref60-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">60.</div><div>Sato, S. ∙ Hayakawa, I. ∙ Hasegawa, M. ...</div><div><strong>Function blocking autoantibodies Against matrix metalloproteinase-1 in patients with systemic sclerosis</strong></div><div><em>J.&nbsp;Invest. Dermatol.</em> 2003; <strong>120</strong>:542-547</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.SatoI.HayakawaM.HasegawaM.FujimotoK.TakeharaFunction+blocking+autoantibodies+Against+matrix+metalloproteinase-1+in+patients+with+systemic+sclerosisJ.%C2%A0Invest.+Dermatol.120200354254710.1046%2Fj.1523-1747.2003.12097.x" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref49-1" href="#" role="doc-biblioref" data-xml-rid="bib49" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref49-1" aria-controls="sref49-1">Nishijima et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref49-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Nishijima, C. ∙ Hayakawa, I. ∙ Matsushita, T. ...</div><div><strong>Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis</strong></div><div><em>Clin. Exp. Immunol.</em> 2004; <strong>138</strong>:357-363</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.NishijimaI.HayakawaT.MatsushitaK.KomuraM.HasegawaK.TakeharaS.SatoAutoantibody+against+matrix+metalloproteinase-3+in+patients+with+systemic+sclerosisClin.+Exp.+Immunol.138200435736310.1111%2Fj.1365-2249.2004.02615.x" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref74-1" href="#" role="doc-biblioref" data-xml-rid="bib74" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref74-1" aria-controls="sref74-1">Wang et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref74-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Wang, E.Y. ∙ Mao, T. ∙ Klein, J. ...</div><div><strong>Diverse functional autoantibodies in patients with COVID-19</strong></div><div><em>medRxiv.</em> 2021;</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=E.Y.WangT.MaoJ.KleinYileDaiJ.D.HuckFeimeiLiuN.S.ZhengT.ZhouB.IsraelowP.WongDiverse+functional+autoantibodies+in+patients+with+COVID-19medRxiv202110.1101%2F2020.12.10.20247205" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref28" href="#" role="doc-biblioref" data-xml-rid="bib28" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref28" aria-controls="sref28">Gnjatic et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref28"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">28.</div><div>Gnjatic, S. ∙ Ritter, E. ∙ Büchler, M.W. ...</div><div><strong>Seromic profiling of ovarian and pancreatic cancer</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2010; <strong>107</strong>:5088-5093</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.GnjaticE.RitterM.W.B%C3%BCchlerN.A.GieseB.BrorsC.FreiA.MurrayN.HalamaI.Z%C3%B6rnigY.T.ChenSeromic+profiling+of+ovarian+and+pancreatic+cancerProc.+Natl.+Acad.+Sci.+USA107201050885093" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0065" role="paragraph">Here, using large-scale tumor section imaging, patient-derived monoclonal antibodies, and tumor target identification, we demonstrate that somatic hypermutations (SHMs) promote antibody reactivity to surface antigens in HGSOC patients in parallel to germline-encoded tumor-binding immunoglobulins.</div></section><section id="sec-2"><h2>Results</h2><section id="sec-2-1"><h3>The tumor cell surface is targeted by endogenous antibodies in cancer patients</h3><div id="p0070" role="paragraph">IgG autoantibodies that primarily bind intracellular targets were described in HGSOC and other types of cancer (<span class="dropBlock reference-citations"><a id="body-ref-sref31-1" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-1" aria-controls="sref31-1">Hu et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref31-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Hu, X. ∙ Zhang, J. ∙ Wang, J. ...</div><div><strong>Landscape of B cell immunity and related immune evasion in human cancers</strong></div><div><em>Nat. Genet.</em> 2019; <strong>51</strong>:560-567</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=X.HuJ.ZhangJ.WangJ.FuT.LiX.ZhengB.WangS.GuP.JiangJ.FanLandscape+of+B+cell+immunity+and+related+immune+evasion+in+human+cancersNat.+Genet.512019560567" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref64-2" href="#" role="doc-biblioref" data-xml-rid="bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64-2" aria-controls="sref64-2">Sharonov et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref64-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Sharonov, G.V. ∙ Serebrovskaya, E.O. ∙ Yuzhakova, D.V. ...</div><div><strong>B cells, plasma cells and antibody repertoires in the tumour microenvironment</strong></div><div><em>Nat. Rev. Immunol.</em> 2020; <strong>20</strong>:294-307</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.V.SharonovE.O.SerebrovskayaD.V.YuzhakovaO.V.BritanovaD.M.ChudakovB+cells%2C+plasma+cells+and+antibody+repertoires+in+the+tumour+microenvironmentNat.+Rev.+Immunol.202020294307" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref57" href="#" role="doc-biblioref" data-xml-rid="bib57" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref57" aria-controls="sref57">Ran et&nbsp;al., 1976</a><div class="dropBlock__holder" data-db-target-of="sref57"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">57.</div><div>Ran, M. ∙ Klein, G. ∙ Witz, I.P.</div><div><strong>Tumor-bound immunoglobulins. Evidence for the in&nbsp;vivo coating of tumor cells by potentially cytotoxic anti-tumour antibodies</strong></div><div><em>Int. J. Cancer.</em> 1976; <strong>17</strong>:90-97</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.RanG.KleinI.P.WitzTumor-bound+immunoglobulins.+Evidence+for+the+in%C2%A0vivo+coating+of+tumor+cells+by+potentially+cytotoxic+anti-tumour+antibodiesInt.+J.+Cancer1719769097" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref79" href="#" role="doc-biblioref" data-xml-rid="bib79" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref79" aria-controls="sref79">Witz, 1977</a><div class="dropBlock__holder" data-db-target-of="sref79"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">79.</div><div>Witz, I.P.</div><div><strong>Tumor-bound immunoglobulins: in&nbsp;situ expressions of humoral immunity</strong></div><div><em>Adv. Cancer Res.</em> 1977; <strong>25</strong>:95-148</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=I.P.WitzTumor-bound+immunoglobulins%3A+in%C2%A0situ+expressions+of+humoral+immunityAdv.+Cancer+Res.25197795148" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), but whether endogenous antibodies can directly bind tumor surfaces <i>in situ</i> was never systematically examined in a large patient cohort. To this end, we examined 34 tumor samples collected from HGSOC patients who had not yet received neoadjuvant chemotherapy and 17 healthy ovary and fallopian tube tissue samples. Formalin-fixed paraffin-embedded (FFPE) specimens were stained with H&amp;E and reviewed in a blinded manner by a certified pathologist specializing in gynecologic pathology to assure adequate sample quantity and quality (<a id="crosref0475" href="#fig1">Figure&nbsp;1</a>A; <a id="crosref0480" href="#mmc1">Table S1</a>). Healthy samples from the female reproductive tract were histologically validated after being obtained from non-diseased contralateral adnexa of patients undergoing surgery as well as from 9 patients in the cohort whose final pathological diagnosis ruled out HGSOC. In order to visualize the maximal area in tumor sections and avoid topological biases, we systematically imaged large sections of tumors (1.1–5.12&nbsp;cm<sup>2</sup>) that were stained with anti-IgG fluorescent antibodies using a slide scanner (<a id="crosref0485" href="#figs1">Figure&nbsp;S1</a>A). In the majority of the patient samples, IgG-positive tumor cells were primarily located in proximity to the vascular stroma as well as the papillary areas of the tumor (<a id="crosref0490" href="#fig1">Figure&nbsp;1</a>A). To precisely quantify the frequency of IgG-bound epithelial cells, we used a machine learning approach, QuPath (<span class="dropBlock reference-citations"><a id="body-ref-sref7" href="#" role="doc-biblioref" data-xml-rid="bib7" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref7" aria-controls="sref7">Bankhead et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">7.</div><div>Bankhead, P. ∙ Loughrey, M.B. ∙ Fernández, J.A. ...</div><div><strong>QuPath: open source software for digital pathology image analysis</strong></div><div><em>Sci. Rep.</em> 2017; <strong>7</strong>:16878</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.BankheadM.B.LoughreyJ.A.Fern%C3%A1ndezY.DombrowskiD.G.McArtP.D.DunneS.McQuaidR.T.GrayL.J.MurrayH.G.ColemanQuPath%3A+open+source+software+for+digital+pathology+image+analysisSci.+Rep.7201716878" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), to differentiate between stromal, epithelial, and immune cells based on multiple histological features, including nuclear shape, size, and chromatin density. This technique allowed us to quantify the number of IgG-coated cells per slide and determine their frequency in the sample. The malignant epithelial cells are thought to arise from either the fallopian tube epithelium (<span class="dropBlock reference-citations"><a id="body-ref-sref12-2" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12-2" aria-controls="sref12-2">Bowtell, 2010</a><div class="dropBlock__holder" data-db-target-of="sref12-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Bowtell, D.D.L.</div><div><strong>The genesis and evolution of high-grade serous ovarian cancer</strong></div><div><em>Nat. Rev. Cancer.</em> 2010; <strong>10</strong>:803-808</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.D.L.BowtellThe+genesis+and+evolution+of+high-grade+serous+ovarian+cancerNat.+Rev.+Cancer102010803808" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref37" href="#" role="doc-biblioref" data-xml-rid="bib37" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref37" aria-controls="sref37">Labidi-Galy et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref37"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">37.</div><div>Labidi-Galy, S.I. ∙ Papp, E. ∙ Hallberg, D. ...</div><div><strong>High grade serous ovarian carcinomas originate in the fallopian tube</strong></div><div><em>Nat. Commun.</em> 2017; <strong>8</strong>:1093</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.I.Labidi-GalyE.PappD.HallbergN.NiknafsV.AdleffM.NoeR.BhattacharyaM.NovakS.JonesJ.PhallenHigh+grade+serous+ovarian+carcinomas+originate+in+the+fallopian+tubeNat.+Commun.820171093" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref21" href="#" role="doc-biblioref" data-xml-rid="bib21" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref21" aria-controls="sref21">DeWeerdt, 2021</a><div class="dropBlock__holder" data-db-target-of="sref21"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">21.</div><div>DeWeerdt, S.</div><div><strong>The origins of ovarian cancer</strong></div><div><em>Nature.</em> 2021; <strong>600</strong>:S42-S44</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.DeWeerdtThe+origins+of+ovarian+cancerNature6002021S42S44" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) or the ovarian surface epithelium (<span class="dropBlock reference-citations"><a id="body-ref-sref5" href="#" role="doc-biblioref" data-xml-rid="bib5" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref5" aria-controls="sref5">Auersperg, 2013</a><div class="dropBlock__holder" data-db-target-of="sref5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">5.</div><div>Auersperg, N.</div><div><strong>Ovarian surface epithelium as a source of ovarian cancers: unwarranted speculation or evidence-based hypothesis?</strong></div><div><em>Gynecol. Oncol.</em> 2013; <strong>130</strong>:246-251</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.AuerspergOvarian+surface+epithelium+as+a+source+of+ovarian+cancers%3A+unwarranted+speculation+or+evidence-based+hypothesis%3FGynecol.+Oncol.1302013246251" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Therefore, we used both fallopian tube and ovarian surface epithelial cells as healthy control tissues. (<a id="crosref0520" href="#fig1">Figures 1</a>A and <a id="crosref0525" href="#figs1">S1</a>A). The percentages of IgG-coated cells out of the total epithelial cells in the sample for each patient or healthy control are shown in <a id="crosref0530" href="#fig1">Figure&nbsp;1</a>B. The majority (61%) of the analyzed HGSOC primary tumor specimens showed epithelial cell antibody coating above the background levels observed in healthy fallopian tube and ovarian surface epithelium (<a id="crosref0535" href="#fig1">Figures 1</a>A and 1B). Analysis of metastases recovered from the omentum of patients revealed IgG-positive cell clusters, suggesting that antibodies target tumor cells during the process of cancer dissemination as well (<a id="crosref0540" href="#figs1">Figure&nbsp;S1</a>B). Overall, this large-scale analysis demonstrates that malignant epithelial cells are targeted by endogenous IgG antibodies in HGSOC patients.</div><div class="figure-wrap"><figure id="fig1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.02.012/asset/c00807e2-2dec-4359-9ebb-b5632f0e86ae/main.assets/gr1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr1" src="/cms/10.1016/j.cell.2022.02.012/asset/3ca36bca-33aa-4bbb-afd5-6e32ca183739/main.assets/gr1.jpg" height="940" width="625" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/c00807e2-2dec-4359-9ebb-b5632f0e86ae/main.assets/gr1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;1</span> <span class="figure__title__text">Tumor-reactive antibodies and IgG<sup>+</sup> ASCs are frequently detected in solid tumors</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0015" role="paragraph">(A and B) H&amp;E and anti-human IgG staining (A) and quantification (B) of archival FFPE samples derived from chemo-naive HGSOC patients (<a id="crosref1245" href="#mmc1">Table S1</a>) and healthy tissues of the female reproductive tract. IgG<sup>+</sup> and IgG<sup>−</sup> tumor cells are represented in red and purple, respectively. IgG<sup>+</sup> and IgG<sup>−</sup> stromal cells are shown in light and dark green, respectively. Scale bars, 100&nbsp;μm.</div><div id="fspara0020" role="paragraph">(C) Quantification of IgG coating on 24 human cancer types. Red lines represent the median values; black lines represent the interquartile range. Below, representative examples of four tumors. Scale bars, 100&nbsp;μm.</div><div id="fspara0025" role="paragraph">(D) Flow cytometric analysis of fresh tumor cells retrieved from stage III–IV chemo-naive HGSOC patients and stained with anti-IgG. OVCAR3 cell line cells were used as a negative control. Each dot represents the fraction of IgG<sup>+</sup> tumor cells in an individual patient.</div><div id="fspara0030" role="paragraph">(E) Immunofluorescence staining of OVCAR3 cells using purified IgGs (500&nbsp;nM) from ascites fluids and sera of HGSOC patients and healthy controls (<a id="crosref1250" href="#mmc1">Table S2</a>). Quantification of fluorescence normalized to DAPI staining is shown. Scale bars, 40&nbsp;μm. Each dot represents IgGs from individual patients.</div><div id="fspara0035" role="paragraph">(F) CD20, CD138, IgG, and DAPI staining of HGSOC tumor slides. Lower left image scale bars, 50&nbsp;μm; lower right image scale bars, 20&nbsp;μm. The percentage of IgG<sup>+</sup> PCs per patient is shown in the graph.</div><div id="fspara0040" role="paragraph">(G) Flow cytometric analysis of HGSOC intratumoral IgG1<sup>+</sup> B cells and ASCs.</div><div id="fspara0045" role="paragraph">(H and I) Association between the presence of IgG<sup>+</sup> ASC (H) and tumor-reactive IgG (I) with progression-free and overall survival in HGSOC patients (<a id="crosref1350" href="#mmc1">Table S1</a>). Quantification of ASCs was averaged from 3 different high power fields. In (B), p values were determined by two-tailed Student’s t test. In (D), statistical significance was determined by one-way analysis of variance (ANOVA) followed by Dunnett’s post-hoc test. In (E), the Kruskal-Wallis test was used followed by Dunn’s post-hoc test. In (G), p values were determined by two-tailed Student’s paired t test. In (H) and (I), statistical significance between curves was determined using the log-rank (Mantel-Cox) test.</div><div id="fspara0050" role="paragraph">See also <a id="crosref1255" href="#figs1">Figure&nbsp;S1</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.02.012/asset/4a51e9d0-c767-4520-bdd1-dbc11b98e989/main.assets/figs1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs1" src="/cms/10.1016/j.cell.2022.02.012/asset/abc4e542-8e25-4a72-9910-d7644aa2dac1/main.assets/figs1.jpg" height="899" width="356" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/4a51e9d0-c767-4520-bdd1-dbc11b98e989/main.assets/figs1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S1</span> <span class="figure__title__text">Machine learning methodology for the identification of different cellular populations and measurement of IgG coating in large tumor specimens, related to <a id="crosref1280" href="#fig1">Figure&nbsp;1</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0220" role="paragraph">(A) The top panel depicts a typical tumor specimen at low (top) and high (bottom) magnifications. Corresponding scale bars represent 2&nbsp;mm and 100&nbsp;μm, respectively. Tumor and healthy control slides stained with anti-IgG and DAPI were scanned and analyzed using the QuPath v0.2.0-m9 software. Nuclei in the specimens were detected on the basis of the DAPI data, and the cellular border was extrapolated at a distance of 2&nbsp;μm from the nuclear border. An object classifier was trained to identify tumor cells versus non-transformed cells on the basis of multiple morphologic features. Following annotation, the IgG mean fluorescence intensity was measured for each individual cell in the area surrounding the nucleus. IgG<sup>+</sup> and IgG<sup>−</sup> tumor cells are annotated in red and purple, respectively, IgG<sup>+</sup> and IgG<sup>−</sup> non-tumor cells are annotated in dark green and light green, respectively, and the frequency of IgG-positive tumor cells or healthy epithelial counterparts is quantified for each specimen. The bottom panel demonstrates an example of the method described above (scale bars, 4&nbsp;μm) at the single-cell level. Note that while stromal and immune cells may stain positive for IgG, they were excluded from the tumor cell quantification based on their distinct morphological characteristics.</div><div id="fspara0225" role="paragraph">(B) Heterogeneous IgG staining in two adjacent tumor nests derived from an HGSOC omental metastasis from a single patient. Scale bars, 100&nbsp;μm.</div></div></div></div></figcaption></figure></div><div id="p0075" role="paragraph">We next examined whether IgG targeting of tumor cell surfaces occurs in other types of cancer. For this purpose, we examined 345 tumor specimens originating from 24 different human cancers derived from different organs. Quantification of IgG-coated cells using our computational analysis revealed that renal and urothelial carcinoma showed high levels of antibody coating, whereas fibrosarcoma showed nearly no fluorescence signal. B cell lymphomas were used as positive controls since they commonly express class-switched antibodies on their surface (<a id="crosref0545" href="#fig1">Figure&nbsp;1</a>C). We conclude that the targeting of solid tumors by IgG indicates a general phenomenon, which frequently occurs in multiple cancers. Thus, in analogy to the classification of tumors as “hot” and “cold” based on immune cell infiltrates, tumors can be classified as “antibody reactive” or “antibody non-reactive.”</div><div id="p0080" role="paragraph">To examine if the observed antibodies physically interact with the tumor cell surface in fresh samples, the extent of IgG coating was measured by flow cytometric analysis of live tumor cells. For this purpose, fresh samples, including primary tumors, omental metastases, and cells from ascites fluids were retrieved from surgical specimens removed from 10 stage III–IV chemo-naive HGSOC patients, which was followed by the removal of lymphocytes and fibroblasts. The cells were incubated with fluorescent anti-IgG antibodies, and the frequency of IgG-positive tumor cells was quantified. About ∼50% of the epithelial cells, including metastatic cells, were coated by IgGs on their surface, whereas the cultured control HGSOC cell line, OVCAR3, was IgG negative (<a id="crosref0550" href="#fig1">Figure&nbsp;1</a>D). To further assess the tumor reactivity of the patient-derived antibodies, we purified IgGs from ascites fluids and compared their tumor binding capacity to that of IgGs purified from patient sera and age-matched healthy subjects by immunofluorescence analysis (<a id="crosref0555" href="#mmc1">Table S2</a>). In this assay, 72% (18/25) of the ascites IgG samples showed tumor reactivity above the average tumor reactivity of the controls (<a id="crosref0560" href="#fig1">Figure&nbsp;1</a>E). These results, together with the immunohistochemistry analysis, demonstrate that the surface of tumor cells is targeted by endogenous IgGs in HGSOC patients.</div><div id="p0085" role="paragraph">Next, we examined whether the tumor-reactive IgGs are produced by intratumoral ASCs. Immunohistochemistry analysis of tumor samples revealed that CD20<sup>+</sup> B cells form TLS-like clusters enveloped by CD138<sup>+</sup> plasma cells (PCs) scattered in the stromal tissue adjacent to the tumor cells. An average of 50% of these cells were IgG-positive ASCs (<a id="crosref0565" href="#fig1">Figure&nbsp;1</a>F). Flow cytometry analysis revealed that 40%–96.6% of intratumoral ASCs expressed IgG1 in different patients while the frequency of IgG1<sup>+</sup> B cells was significantly lower (<a id="crosref0570" href="#fig1">Figure&nbsp;1</a>G). This result demonstrates that the total B cell compartment does not represent the antibody-producing cell population. Finally, we examined whether the presence of IgG<sup>+</sup> ASCs or tumor-binding antibodies correlates with positive patient outcomes. This analysis revealed that the presence of IgG-positive ASCs as well as IgG-tumor coating within the cancer tissues are associated with superior progression-free and overall survival in HGSOC patients (<a id="crosref0575" href="#fig1">Figures 1</a>H and 1I). Collectively, our observations indicate that IgG1 is a major isotype of antibodies expressed by intratumoral ASCs with the capacity to target tumor cell surfaces.</div></section><section id="sec-2-2"><h3>Intratumoral antibody-secreting cells show characteristic features of antigen-driven selection</h3><div id="p0090" role="paragraph">Antigen-driven positive selection and clonal expansion of B cells take place in GCs in response to immune challenge. We next examined whether the intratumoral ASCs in HGSOC are clonally related and emerge from the antibody affinity maturation process. For this purpose, we obtained fresh tumor samples from four stage III–IV HGSOC patients who did not receive neoadjuvant chemotherapy (<a id="crosref0580" href="#mmc1">Table S3</a>). Single IgG1<sup>+</sup> ASCs with unknown specificity were sorted from processed tumors, and their heavy (<i>Ighg1</i>) and light chain mRNAs (<i>Igk</i> and <i>Igλ</i>) were sequenced by single-cell immunoglobulin sequencing (<span class="dropBlock reference-citations"><a id="body-ref-sref66-1" href="#" role="doc-biblioref" data-xml-rid="bib66" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref66-1" aria-controls="sref66-1">Tiller et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref66-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">66.</div><div>Tiller, T. ∙ Meffre, E. ∙ Yurasov, S. ...</div><div><strong>Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expressionvector cloning</strong></div><div><em>J.&nbsp;Immunol. Methods.</em> 2008; <strong>329</strong>:112-124</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=T.TillerE.MeffreS.YurasovM.TsuijiM.C.NussenzweigH.WardemannEfficient+generation+of+monoclonal+antibodies+from+single+human+B+cells+by+single+cell+RT-PCR+and+expressionvector+cloningJ.%C2%A0Immunol.+Methods3292008112124" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (<a id="crosref0590" href="#figs2">Figure&nbsp;S2</a>A). Immunoglobulin gene analysis showed that Vh3 was the most frequent variable region in intratumoral ASCs, whereas the frequency of other specific light chain genes was more varied (<a id="crosref0595" href="#fig2">Figure&nbsp;2</a>A). Furthermore, recurrent pairings of specific heavy and light chains were observed in individual patients but not shared among the four patients, indicating that common public clones did not emerge in this group of patients (<a id="crosref0600" href="#figs2">Figure&nbsp;S2</a>B). Immunoglobulin clustering based on either heavy chain or light chain sequences revealed that in each of the four patients, at least 44.4% of the sequences were recovered more than once, suggesting that ASCs in tumors were clonally expanded. Heavy chain analysis revealed 11–36 expanded clonotypes per patient, comprising 44.4%–78.38% of the ASCs obtained from each of the four patients, including a single dominant clone, with a frequency ranging between 5.85% and 18% of the total sequences (<a id="crosref0605" href="#fig2">Figures 2</a>B and 2C). Similar results were obtained following a more precise analysis using coupled heavy and light chain sequences for the definition of a clone (<a id="crosref0610" href="#fig2">Figure&nbsp;2</a>C). The ASC immunoglobulin genes displayed a level of SHMs that is typical of circulating memory cells, with averages ranging between 17.29 and 21.69 mutations per heavy chain and between 10.3 and 16.46 mutations per light chain (<a id="crosref0615" href="#fig2">Figure&nbsp;2</a>D). These paired measurements correlated closely on a single-cell basis for all of the patients and accordingly validate our immunoglobulin sequence analyses (<a id="crosref0620" href="#figs2">Figure&nbsp;S2</a>C). To examine whether the intratumoral ASC clonal members were produced through clonal diversification, we reconstructed lineage trees of clones recovered from tumors using PHYLIP and Alakazam (<span class="dropBlock reference-citations"><a id="body-ref-sref26-1" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26-1" aria-controls="sref26-1">Felsenstein, 2005</a><div class="dropBlock__holder" data-db-target-of="sref26-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">26.</div><div>Felsenstein, J.</div><div><strong>PHYLIP (phylogeny Inference Package)</strong></div><div>2005</div><div>Distributed by the Author (Department of Genome Sciences, University of Washington). <a id="interref0010" href="http://evolution.genetics.washington.edu/phylip.html" target="_blank">http://evolution.genetics.washington.edu/phylip.html</a></div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.FelsensteinPHYLIP+%28phylogeny+Inference+Package%29version+3.62005Distributed+by+the+Author+%28Department+of+Genome+Sciences%2C+University+of+Washington%29.+http%3A%2F%2Fevolution.genetics.washington.edu%2Fphylip.html" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref29-1" href="#" role="doc-biblioref" data-xml-rid="bib29" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref29-1" aria-controls="sref29-1">Gupta et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref29-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Gupta, N.T. ∙ Vander Heiden, J.A. ∙ Uduman, M. ...</div><div><strong>Change-O: A toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data</strong></div><div><em>Bioinformatics.</em> 2015; <strong>31</strong>:3356-3358</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.T.GuptaJ.A.Vander+HeidenM.UdumanD.Gadala-MariaG.YaariS.H.KleinsteinChange-O%3A+A+toolkit+for+analyzing+large-scale+B+cell+immunoglobulin+repertoire+sequencing+dataBioinformatics31201533563358" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We found several families of clones that exhibited clonal diversification by progressive SHM accumulation, indicating that these cells are the product of stepwise positive selection (<a id="crosref0635" href="#fig2">Figures 2</a>E and <a id="crosref0640" href="#figs3">S3</a>). We conclude that significant numbers of ASCs in the tumor microenvironment were diversified by SHMs from a common ancestor, suggesting that their clonal expansion was driven by specific antigens as part of a T&nbsp;cell-dependent immune response.</div><div class="figure-wrap"><figure id="fig2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.02.012/asset/8cf0dce4-e01e-4911-8444-23084c758357/main.assets/gr2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr2" src="/cms/10.1016/j.cell.2022.02.012/asset/3d818ee0-cfee-4544-8e86-cdc4b9661ca3/main.assets/gr2.jpg" height="622" width="656" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/8cf0dce4-e01e-4911-8444-23084c758357/main.assets/gr2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;2</span> <span class="figure__title__text">Antibody-secreting cells in the tumor microenvironment are clonally related</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0060" role="paragraph">(A) Immunoglobulin analysis of intratumoral CD38<sup>++</sup> IgG1<sup>+</sup> ASCs derived from the primary tumors of four HGSOC patients. Pie charts depicting the relative abundance of V (variable) genes.</div><div id="fspara0065" role="paragraph">(B) The fraction of expanded clones out of total immunoglobulin sequences.</div><div id="fspara0070" role="paragraph">(C) The frequency of clonal families out of the total sequenced clonotypes of <i>Ighg1</i> or <i>Ighg1</i> and light chain sequences. Each colored slice represents a unique ASC clone. White slices represent unique clonotypes. The total number of analyzed immunoglobulins is shown in the center.</div><div id="fspara0075" role="paragraph">(D) The number of mutations per antibody chain (V and J segments).</div><div id="fspara0080" role="paragraph">(E) Examples of phylogenies of expanded intratumoral ASC clones based on paired sequences. Gray circles represent the hypothetical germline configuration. White circles represent hypothetical ancestors. Pale colored circles represent immunoglobulins identified by heavy chain sequences only. Bold colored circles represent immunoglobulins identified by both heavy and light chain sequences. Dotted arrows represent a Hamming distance of &gt;15 nucleotides. Numbers appearing above arrows represent the number of distinct heavy chain mutations accumulated between clonal members. Each color represents an individual patient.</div><div id="fspara0085" role="paragraph">See also <a id="crosref1260" href="#figs2">Figures S2</a> and <a id="crosref1265" href="#figs3">S3</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.02.012/asset/701c3a02-6e9f-43a7-bd9f-3949e96dad55/main.assets/figs2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs2" src="/cms/10.1016/j.cell.2022.02.012/asset/da5fc878-5642-4571-9313-f211370aae96/main.assets/figs2.jpg" height="842" width="656" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/701c3a02-6e9f-43a7-bd9f-3949e96dad55/main.assets/figs2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S2</span> <span class="figure__title__text">Light and heavy chain pairing analyses, related to <a id="crosref1285" href="#fig2">Figure&nbsp;2</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0235" role="paragraph">(A) Schematic representation of single-cell ASC sorting, immunoglobulin sequencing, cloning, and antibody expression pipeline.</div><div id="fspara0240" role="paragraph">(B) Circos plots linking coupled heavy and light chain sequences in all four patients according to their V alleles. The left plot represents paired expanded clonotypes in all four patients. The right plots represent all paired clonotypes in each patient. Bandwidths represent the incidence of a given paired combination.</div><div id="fspara0245" role="paragraph">(C) Correlation between the mutational load in the heavy and light immunoglobulin chains per patient. The degree of correlation was calculated using Pearson’s correlation coefficient. The line represents a linear regression model; dotted lines represent the error range.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-3"><h3>MMP14 is a major antibody target in HGSOC patients</h3><div id="p0095" role="paragraph">To further study the nature of the humoral immune response in HGSOC patients, we cloned the immunoglobulins that we isolated and expressed them as monoclonal antibodies (<a id="crosref0645" href="#mmc2">Table S4</a>). To this end, immunoglobulins representing expanded clones were primarily selected for antibody production and within each clonal family, either immunoglobulin sequences that represent multiple clonal members or clones with the highest SHM load were chosen (<a id="crosref0650" href="#figs3">Figure&nbsp;S3</a>). In order to examine whether the monoclonal antibodies bind the patient-derived tumor cells, we established HGSOC primary cultures originating from the primary tumor, omental metastasis, and ascites-derived tumor cells of three different patients. To remove cell-bound antibodies, as well as fibroblasts and immune cells, the tumor cells were isolated, cultured, and maintained for 2–3 passages. Flow cytometry analysis showed that all of the cultured cells were EpCAM positive (<a id="crosref0655" href="#figs4">Figure&nbsp;S4</a>A). Monoclonal and secondary antibodies were incubated with monolayers of primary tumor cultures or with the OVCAR3 cell line followed by measurement of the fluorescence signal. To avoid biases that can potentially arise from the different numbers of cells per sample, we also stained the monolayers with DAPI, which allowed us to normalize the fluorescence signal to the number of cells in each replicate. This analysis revealed that all the patients produced tumor-binding antibodies. Out of 27 monoclonal antibodies, 15 bound the primary and ascites-derived tumor cultures, and 17 of the monoclonal antibodies interacted with the cells that were generated from the omental metastasis tumor cells (<a id="crosref0660" href="#fig3">Figure&nbsp;3</a>A). To provide direct evidence for tumor cell binding by monoclonal antibodies, we stained OVCAR3 monolayers and measured antibody binding on the single-cell level by fluorescence microscopy and QuPath analysis (<a id="crosref0665" href="#figs1">Figure&nbsp;S1</a>). This approach revealed that most of the antibodies bound directly to the tumor cell lines (<a id="crosref0670" href="#fig3">Figure&nbsp;3</a>B). Furthermore, the monoclonal antibodies primarily interacted with ovarian carcinoma cell lines (OVCAR3 and 4) and a pancreatic cancer cell line (PANC1) and interacted to a lesser extent with the cells derived from other organs, suggesting specificity to both ovarian and pancreatic tumors, presumably through shared surface target antigens (<a id="crosref0675" href="#figs4">Figure&nbsp;S4</a>B). Thus, the ASCs located within the tumor microenvironment produce tumor-targeting antibodies.</div><div class="figure-wrap"><figure id="fig3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.02.012/asset/72039b34-3391-4bf5-b7dc-36aecae84363/main.assets/gr3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr3" src="/cms/10.1016/j.cell.2022.02.012/asset/1cff7633-e4d8-4fb8-9cde-ab0a1bd5d104/main.assets/gr3.jpg" height="854" width="656" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/72039b34-3391-4bf5-b7dc-36aecae84363/main.assets/gr3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;3</span> <span class="figure__title__text">Tumor-reactive MMP14 autoantibodies are generated in HGSOC patients</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0095" role="paragraph">(A) Representative images and quantification of normalized MFI of primary cultured tumors or OVCAR3 cells stained with monoclonal antibodies (500&nbsp;nM) and DAPI. The IgG fluorescent signal was normalized to DAPI to account for potential variability in cellular density between replicates. Each color represents an individual patient. Bars represent mean values of 2–3 replicates; whiskers represent standard deviations.</div><div id="fspara0100" role="paragraph">(B) Representative images and quantification of the mean fluorescence intensity of OVCAR3 cells stained with different monoclonal antibodies (500&nbsp;nM). Quantification of MFI was performed on each cell separately using QuPath v0.2.0-m9. Boxes are divided by the median value and represent the interquartile range; whiskers represent the 10–90 percentiles. The dashed line represents mean background fluorescence. Scale bars, 50&nbsp;μm. Each color represents an individual patient.</div><div id="fspara0105" role="paragraph">(C and D) Analysis of patient-derived polyclonal (C) and monoclonal (D) antibody binding to the indicated targets by ELISA. The heatmap depicts the mean optical density data from two independent ELISA. All antibodies were screened at a concentration of 100&nbsp;nM.</div><div id="fspara0110" role="paragraph">(E) ELISA showing dose-dependent binding of monoclonal antibodies to MMP14.</div><div id="fspara0115" role="paragraph">(F) ELISA of monoclonal antibodies against structurally distinct targets and the HEp-2 cell line lysate. ED38 was used as a positive control and the GD01 antibody as a negative control. In (A), comparison between the test antibodies and the isotype control was performed using one-way ANOVA followed by Dunnett’s post-hoc test. In (B), comparison to the isotype control was performed using the Kruskal-Wallis test followed by Dunn’s post-hoc test.</div><div id="fspara0120" role="paragraph">See also <a id="crosref0010a" href="#figs4">Figures S4</a>, <a id="crosref0010b" href="#figs5">S5</a>, and <a id="crosref0010c" href="#figs6">S6</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.02.012/asset/fe87081a-7096-49d6-84b4-d16aae5f40ae/main.assets/figs3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs3" src="/cms/10.1016/j.cell.2022.02.012/asset/93376182-23c7-4a3d-a9a8-2d1a79a2ee49/main.assets/figs3.jpg" height="839" width="656" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/fe87081a-7096-49d6-84b4-d16aae5f40ae/main.assets/figs3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S3</span> <span class="figure__title__text">Schematic representations of expanded intratumoral ASC clones, related to <a id="crosref1290" href="#fig2">Figure&nbsp;2</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0255" role="paragraph">Additional examples of phylogenies of expanded intratumoral ASC clones based on paired sequences. Gray circles represent the hypothetical germline configuration. White circles represent hypothetical ancestors. Pale colored circles represent immunoglobulins identified by heavy chain sequences only. Bold colored circles represent immunoglobulins identified by both heavy and light chains. Dotted arrows represent a Hamming distance of &gt;15 nucleotides. Numbers appearing above the arrows represent the number of distinct heavy chain mutations accumulated between clonal members. Annotated circles represent monoclonal antibodies which were cloned and expressed</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.02.012/asset/d542b641-7020-4a5f-ac1f-16c7150d891d/main.assets/figs4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs4" src="/cms/10.1016/j.cell.2022.02.012/asset/39fdaa23-36b8-4b7d-9f91-d5c0d7ee2d0e/main.assets/figs4.jpg" height="451" width="656" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/d542b641-7020-4a5f-ac1f-16c7150d891d/main.assets/figs4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S4</span> <span class="figure__title__text">Tumor-derived antibodies interact preferentially with ovarian carcinoma cell lines, related to <a id="crosref1360" href="#fig3">Figures 3</a> and <a id="crosref1355" href="#fig4">4</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0265" role="paragraph">(A) Flow cytometric analysis confirming the expression of the epithelial cell marker EpCAM in three primary cultures derived from primary tumor, omental metastasis, and ascites fluids of three different HGSOC patients, as well as in the OVCAR3 cell line as a positive control and PBMCs as a negative control.</div><div id="fspara0270" role="paragraph">(B) Fluorescence analysis for the binding of monoclonal antibodies to various cell lines. The fluorescence intensity was normalized to DAPI staining. GD01 was used as a negative control.</div><div id="fspara0275" role="paragraph">(C) Flow cytometric analysis confirming the successful transfection of K562 cells with the <i>mmp14:</i>mCherry construct.</div></div></div></div></figcaption></figure></div><div id="p0100" role="paragraph">Ovarian and pancreatic cancers are highly desmoplastic (fibrotic) and are constantly subjected to remodeling of their microenvironments by matrix proteases (<span class="dropBlock reference-citations"><a id="body-ref-sref35-2" href="#" role="doc-biblioref" data-xml-rid="bib35" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref35-2" aria-controls="sref35-2">Kamel et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref35-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">35.</div><div>Kamel, H. ∙ Abdelazim, I. ∙ Habib, S.M. ...</div><div><strong>Immunoexpression of matrix metalloproteinase-2 (MMP-2) in malignant ovarian epithelial tumours</strong></div><div><em>J.&nbsp;Obstet. Gynaecol. Can.</em> 2010; <strong>32</strong>:580-586</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.KamelI.AbdelazimS.M.HabibM.A.A.El+ShourbagyN.S.AhmedImmunoexpression+of+matrix+metalloproteinase-2+%28MMP-2%29+in+malignant+ovarian+epithelial+tumoursJ.%C2%A0Obstet.+Gynaecol.+Can.32201058058610.1016%2FS1701-2163%2816%2934527-3" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref14-2" href="#" role="doc-biblioref" data-xml-rid="bib14" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref14-2" aria-controls="sref14-2">Cathcart et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref14-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Cathcart, J.M. ∙ Banach, A. ∙ Liu, A. ...</div><div><strong>Interleukin-6 increases matrix metalloproteinase-14 (MMP-14) levels via down-regulation of p53 to drive cancer progression</strong></div><div><em>Oncotarget.</em> 2016; <strong>7</strong>:61107-61120</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.M.CathcartA.BanachA.LiuJ.ChenM.GoligorskyJ.CaoInterleukin-6+increases+matrix+metalloproteinase-14+%28MMP-14%29+levels+via+down-regulation+of+p53+to+drive+cancer+progressionOncotarget720166110761120" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref73-2" href="#" role="doc-biblioref" data-xml-rid="bib73" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref73-2" aria-controls="sref73-2">Vos et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref73-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">73.</div><div>Vos, M.C. ∙ Hollemans, E. ∙ Ezendam, N. ...</div><div><strong>MMP-14 and CD44 in epithelial-to-mesenchymal transition (EMT) in ovarian cancer</strong></div><div><em>J.&nbsp;Ovarian Res.</em> 2016; <strong>9</strong>:53</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.C.VosE.HollemansN.EzendamH.FeijenD.BollB.PijlmanH.van+der+PuttenP.KlinkhamerT.H.van+KuppeveltA.A.van+der+WurffL.F.MassugerMMP-14+and+CD44+in+epithelial-to-mesenchymal+transition+%28EMT%29+in+ovarian+cancerJ.%C2%A0Ovarian+Res.9201653" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref59-2" href="#" role="doc-biblioref" data-xml-rid="bib59" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref59-2" aria-controls="sref59-2">Sakata et&nbsp;al., 2000</a><div class="dropBlock__holder" data-db-target-of="sref59-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">59.</div><div>Sakata, K. ∙ Shigemasa, K. ∙ Nagai, N. ...</div><div><strong>Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary</strong></div><div><em>Int. J. Oncol.</em> 2000; <strong>17</strong>:673-681</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=K.SakataK.ShigemasaN.NagaiK.OhamaExpression+of+matrix+metalloproteinases+%28MMP-2%2C+MMP-9%2C+MT1-MMP%29+and+their+inhibitors+%28TIMP-1%2C+TIMP-2%29+in+common+epithelial+tumors+of+the+ovaryInt.+J.+Oncol.17200067368110.3892%2Fijo.17.4.673" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The ECM-remodeling enzymes, MMPs, were previously demonstrated to trigger the generation of autoreactive antibodies in autoimmune diseases and viral infection, suggesting that they may also provoke an immune response in cancer (<span class="dropBlock reference-citations"><a id="body-ref-sref17-2" href="#" role="doc-biblioref" data-xml-rid="bib17" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref17-2" aria-controls="sref17-2">Crowley et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref17-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">17.</div><div>Crowley, J.T. ∙ Strle, K. ∙ Drouin, E.E. ...</div><div><strong>Matrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory lyme arthritis</strong></div><div><em>J.&nbsp;Autoimmun.</em> 2016; <strong>69</strong>:24-37</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.T.CrowleyK.StrleE.E.DrouinA.PiantaS.L.ArvikarQ.WangC.E.CostelloA.C.SteereMatrix+metalloproteinase-10+is+a+target+of+T+and+B+cell+responses+that+correlate+with+synovial+pathology+in+patients+with+antibiotic-refractory+lyme+arthritisJ.%C2%A0Autoimmun.6920162437" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref49-2" href="#" role="doc-biblioref" data-xml-rid="bib49" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref49-2" aria-controls="sref49-2">Nishijima et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref49-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Nishijima, C. ∙ Hayakawa, I. ∙ Matsushita, T. ...</div><div><strong>Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis</strong></div><div><em>Clin. Exp. Immunol.</em> 2004; <strong>138</strong>:357-363</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.NishijimaI.HayakawaT.MatsushitaK.KomuraM.HasegawaK.TakeharaS.SatoAutoantibody+against+matrix+metalloproteinase-3+in+patients+with+systemic+sclerosisClin.+Exp.+Immunol.138200435736310.1111%2Fj.1365-2249.2004.02615.x" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref60-2" href="#" role="doc-biblioref" data-xml-rid="bib60" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref60-2" aria-controls="sref60-2">Sato et&nbsp;al., 2003</a><div class="dropBlock__holder" data-db-target-of="sref60-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">60.</div><div>Sato, S. ∙ Hayakawa, I. ∙ Hasegawa, M. ...</div><div><strong>Function blocking autoantibodies Against matrix metalloproteinase-1 in patients with systemic sclerosis</strong></div><div><em>J.&nbsp;Invest. Dermatol.</em> 2003; <strong>120</strong>:542-547</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.SatoI.HayakawaM.HasegawaM.FujimotoK.TakeharaFunction+blocking+autoantibodies+Against+matrix+metalloproteinase-1+in+patients+with+systemic+sclerosisJ.%C2%A0Invest.+Dermatol.120200354254710.1046%2Fj.1523-1747.2003.12097.x" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref74-2" href="#" role="doc-biblioref" data-xml-rid="bib74" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref74-2" aria-controls="sref74-2">Wang et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref74-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Wang, E.Y. ∙ Mao, T. ∙ Klein, J. ...</div><div><strong>Diverse functional autoantibodies in patients with COVID-19</strong></div><div><em>medRxiv.</em> 2021;</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=E.Y.WangT.MaoJ.KleinYileDaiJ.D.HuckFeimeiLiuN.S.ZhengT.ZhouB.IsraelowP.WongDiverse+functional+autoantibodies+in+patients+with+COVID-19medRxiv202110.1101%2F2020.12.10.20247205" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Furthermore, it was suggested that high levels of antigen can lead to a break of tolerance and generation of autoantibodies in cancer (<span class="dropBlock reference-citations"><a id="body-ref-sref35-3" href="#" role="doc-biblioref" data-xml-rid="bib35" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref35-3" aria-controls="sref35-3">Kamel et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref35-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">35.</div><div>Kamel, H. ∙ Abdelazim, I. ∙ Habib, S.M. ...</div><div><strong>Immunoexpression of matrix metalloproteinase-2 (MMP-2) in malignant ovarian epithelial tumours</strong></div><div><em>J.&nbsp;Obstet. Gynaecol. Can.</em> 2010; <strong>32</strong>:580-586</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.KamelI.AbdelazimS.M.HabibM.A.A.El+ShourbagyN.S.AhmedImmunoexpression+of+matrix+metalloproteinase-2+%28MMP-2%29+in+malignant+ovarian+epithelial+tumoursJ.%C2%A0Obstet.+Gynaecol.+Can.32201058058610.1016%2FS1701-2163%2816%2934527-3" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref14-3" href="#" role="doc-biblioref" data-xml-rid="bib14" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref14-3" aria-controls="sref14-3">Cathcart et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref14-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Cathcart, J.M. ∙ Banach, A. ∙ Liu, A. ...</div><div><strong>Interleukin-6 increases matrix metalloproteinase-14 (MMP-14) levels via down-regulation of p53 to drive cancer progression</strong></div><div><em>Oncotarget.</em> 2016; <strong>7</strong>:61107-61120</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.M.CathcartA.BanachA.LiuJ.ChenM.GoligorskyJ.CaoInterleukin-6+increases+matrix+metalloproteinase-14+%28MMP-14%29+levels+via+down-regulation+of+p53+to+drive+cancer+progressionOncotarget720166110761120" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref73-3" href="#" role="doc-biblioref" data-xml-rid="bib73" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref73-3" aria-controls="sref73-3">Vos et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref73-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">73.</div><div>Vos, M.C. ∙ Hollemans, E. ∙ Ezendam, N. ...</div><div><strong>MMP-14 and CD44 in epithelial-to-mesenchymal transition (EMT) in ovarian cancer</strong></div><div><em>J.&nbsp;Ovarian Res.</em> 2016; <strong>9</strong>:53</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.C.VosE.HollemansN.EzendamH.FeijenD.BollB.PijlmanH.van+der+PuttenP.KlinkhamerT.H.van+KuppeveltA.A.van+der+WurffL.F.MassugerMMP-14+and+CD44+in+epithelial-to-mesenchymal+transition+%28EMT%29+in+ovarian+cancerJ.%C2%A0Ovarian+Res.9201653" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref59-3" href="#" role="doc-biblioref" data-xml-rid="bib59" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref59-3" aria-controls="sref59-3">Sakata et&nbsp;al., 2000</a><div class="dropBlock__holder" data-db-target-of="sref59-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">59.</div><div>Sakata, K. ∙ Shigemasa, K. ∙ Nagai, N. ...</div><div><strong>Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary</strong></div><div><em>Int. J. Oncol.</em> 2000; <strong>17</strong>:673-681</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=K.SakataK.ShigemasaN.NagaiK.OhamaExpression+of+matrix+metalloproteinases+%28MMP-2%2C+MMP-9%2C+MT1-MMP%29+and+their+inhibitors+%28TIMP-1%2C+TIMP-2%29+in+common+epithelial+tumors+of+the+ovaryInt.+J.+Oncol.17200067368110.3892%2Fijo.17.4.673" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Therefore, we evaluated the binding capacity of polyclonal IgGs derived from the ascites fluids from 25 patients (<a id="crosref0740" href="#mmc1">Table S2</a>) to 6 recombinant MMPs and 3 additional ECM-associated targets. In this setting, BSA was used as a negative control antigen, and p53, which elicits an antibody response in HGSOC (<span class="dropBlock reference-citations"><a id="body-ref-sref1" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1" aria-controls="sref1">Anderson et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Anderson, K.S. ∙ Cramer, D.W. ∙ Sibani, S. ...</div><div><strong>Autoantibody signature for the serologic detection of ovarian cancer</strong></div><div><em>J.&nbsp;Proteome Res.</em> 2015; <strong>14</strong>:578-586</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=K.S.AndersonD.W.CramerS.SibaniG.WallstromJ.WongJ.ParkJ.QiuA.VitonisJ.LaBaerAutoantibody+signature+for+the+serologic+detection+of+ovarian+cancerJ.%C2%A0Proteome+Res.14201557858610.1021%2Fpr500908n" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), was used as a positive control target. ELISA revealed strong and reproducible antibody reactivity against MMP14 in all of the patients. Although reactivity to other MMPs was also evident, it was to a lesser extent (<a id="crosref0750" href="#fig3">Figure&nbsp;3</a>C). Accordingly, analysis of HGSOC RNA-seq datasets showed a high expression of MMP14 compared with other expressed genes, as well as in comparison with healthy control tissues (<a id="crosref0755" href="#figs5">Figures S5</a>A and S5B). Immunohistochemistry analyses revealed a strong expression of MMP14 on cancer cells, whereas adjacent healthy tissues showed lower expression levels (<a id="crosref0760" href="#figs5">Figure&nbsp;S5</a>C). Furthermore, using western blot analysis, MMP14 protein expression was also detected in tumor cell lines as well as in the patient-derived tumors (<a id="crosref0765" href="#figs5">Figure&nbsp;S5</a>D). Thus, since MMP14 is highly expressed on tumors and ascites-derived antibodies show high reactivity with this enzyme, we reasoned that this is a highly relevant target in HGSOC patients for further testing of patient-derived monoclonal antibodies.</div><div class="figure-wrap"><figure id="figs5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.02.012/asset/3d3b63d9-11b2-4210-9a66-ccf13a2c332f/main.assets/figs5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs5" src="/cms/10.1016/j.cell.2022.02.012/asset/d7425a97-e5b9-46f9-8ba0-11eb80fbe237/main.assets/figs5.jpg" height="896" width="656" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/3d3b63d9-11b2-4210-9a66-ccf13a2c332f/main.assets/figs5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S5</span> <span class="figure__title__text">MMP14 is highly expressed in HGSOC, related to <a id="crosref1300" href="#fig3">Figure&nbsp;3</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0285" role="paragraph">(A) Correlation matrix depicting the mean expression level of genes derived from published RNA sequencing datasets of 85 HGSOC primary tumors (Database: GEO: <a id="interref365" href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE102094" target="_blank">GSE102094</a>) and 35 HGSOC omental metastases (Database: GEO: <a id="interref360" href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE71340" target="_blank">GSE71340</a>). Each dot represents a mean Log<sub>2</sub>CPM value. Specific gene families are highlighted—MMPs in red, ADAMs in purple, LOXs in green, Kallikreins in yellow, and house-keeping genes in blue. The yellow, orange, and pink backgrounds represent RNA corresponding to the top 10%, 5%, and 1% genes, respectively. The dashed circle represents the most highly expressed matrix degrading enzymes in both the primary tumor and metastasis.</div><div id="fspara0290" role="paragraph">(B) Normalized MMP14 expression levels and standard deviations in a published RNA sequencing dataset of 85 HGSOC primary tumors and pools of normal ovary and fallopian tube tissues (Database: GEO: <a id="interref370" href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE102094" target="_blank">GSE102094</a>).</div><div id="fspara0295" role="paragraph">(C) MMP14 immunofluorescence staining and quantification originating from 32 FFPE specimens derived from 26 HGSOC primary tumors and 6 metastases adjacent to healthy marginal tissues. MMP14 staining intensity was measured on the single-cell level in various diseased and healthy cellular compartments and quantified using the QuPath v0.2.0-m9 software. Scale bars, 50&nbsp;μm. In each graph, tumor cells to an adjacent normal tissue are compared.</div><div id="fspara0300" role="paragraph">(D) Western blot analysis for MMP14, which was performed on lysates from different cell lines and patient tumor samples. In (A), the degree of correlation was calculated using Pearson’s correlation coefficient. The black line represents a linear regression model. In (B), p values were calculated by DESeq2. In (C), p values were determined by two-tailed Student’s paired t test for matched samples.</div></div></div></div></figcaption></figure></div><div id="p0105" role="paragraph">Evaluation of monoclonal antibody binding to MMPs by ELISA revealed several immunoglobulins that reproducibly bound to MMP14, with a mild to moderate cross-reactivity with other MMP enzymes (<a id="crosref0770" href="#fig3">Figure&nbsp;3</a>D). Strikingly, in all 4 of the patients, monoclonal antibodies that bound MMP14 with various degrees of efficacy and specificity were detected, confirming our analyses using polyclonal patient-derived antibodies. To strengthen our findings, we tested the binding of monoclonal antibodies to MMP14 at different dilutions by ELISA and found a dose-dependent response (<a id="crosref0775" href="#fig3">Figure&nbsp;3</a>E). To examine if these antibodies are reactive with many types of antigens (polyreactive), we tested their binding to a panel of structurally unrelated, biologically relevant antigens, including insulin, double-stranded DNA, and lipopolysaccharide, by ELISA. Typically, antibodies that bind at least two members of this defined set of antigens are considered polyreactive (<span class="dropBlock reference-citations"><a id="body-ref-sref75-1" href="#" role="doc-biblioref" data-xml-rid="bib75" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref75-1" aria-controls="sref75-1">Wardemann et&nbsp;al., 2003</a><div class="dropBlock__holder" data-db-target-of="sref75-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">75.</div><div>Wardemann, H. ∙ Yurasov, S. ∙ Schaefer, A. ...</div><div><strong>Predominant autoantibody production by early human B cell precursors</strong></div><div><em>Science.</em> 2003; <strong>301</strong>:1374-1377</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.WardemannS.YurasovA.SchaeferJ.W.YoungE.MeffreM.C.NussenzweigPredominant+autoantibody+production+by+early+human+B+cell+precursorsScience301200313741377" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). ED38, a well-characterized polyreactive antibody, was used as a positive control, and GD01, an antibody that binds an unrelated target (Junin virus GP1), was used as a negative control. Minimal binding of the monoclonal antibodies to the unrelated targets was detected even at high antibody concentrations, whereas the polyreactive ED38 was strongly positive in this assay (<a id="crosref0785" href="#fig3">Figure&nbsp;3</a>F). Similar results were obtained from testing the binding to human epithelial type 2 (HEp-2) cell lysates, a commonly used assay to determine antibody polyreactivity (<a id="crosref0790" href="#fig3">Figure&nbsp;3</a>F). We conclude that the monoclonal antibodies that we isolated are not polyreactive and show strong binding to MMPs, particularly to MMP14, which is abundantly expressed on the surface of HGSOC tumor cells.</div><div id="p0110" role="paragraph">Our findings indicate that self-reactive antibodies are formed in cancer patients with the potential to bind healthy tissues in addition to tumor cells. To examine this possibility, we purified IgGs from serum and ascites of individual patients and examined their binding capacity to several normal tissues, including fallopian tube, uterus, pancreas, and colon tissues, all of which are known to express MMP14. Staining with LEM 2/15, highly specific and well-characterized mouse antibody that binds MMP14 (<span class="dropBlock reference-citations"><a id="body-ref-sref68-1" href="#" role="doc-biblioref" data-xml-rid="bib68" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref68-1" aria-controls="sref68-1">Udi et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref68-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">68.</div><div>Udi, Y. ∙ Fragai, M. ∙ Grossman, M. ...</div><div><strong>Unraveling hidden allosteric regulatory sites in structurally homologues metalloproteases</strong></div><div><em>J.&nbsp;Mol. Biol.</em> 2013; <strong>425</strong>:2330-2346</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.UdiM.FragaiM.GrossmanS.MitternachtR.Arad-YellinV.CalderoneM.MelikianM.ToccafondiI.N.BerezovskyC.LauchinatI.SagoUnraveling+hidden+allosteric+regulatory+sites+in+structurally+homologues+metalloproteasesJ.%C2%A0Mol.+Biol.42520132330234610.1016%2Fj.jmb.2013.04.009" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), confirmed MMP14 expression on various cell types within the healthy tissues (<a id="crosref0800" href="#figs6">Figure&nbsp;S6</a>A). This analysis revealed that antibodies derived from patient serum can bind healthy tissues, although significantly less effectively than ascites-derived antibodies. To evaluate whether self-reactive antibodies persist during cancer remission, we collected blood from eight patients who completed their adjuvant treatment. All the evaluated patients exhibited CA125 values within the normal range, and no evidence of disease was observed by PET-CT (<a id="crosref0805" href="#mmc1">Table S5</a>). ELISA revealed a weak signal in this cohort, which was above the background that was detected in healthy controls, and only one out of the eight patients had high levels of anti-MMP14 antibodies in her serum (<a id="crosref0810" href="#figs6">Figures S6</a>B and S6C).</div><div class="figure-wrap"><figure id="figs6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.02.012/asset/e88e8096-3255-49e4-94f3-9f3b2a487403/main.assets/figs6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs6" src="/cms/10.1016/j.cell.2022.02.012/asset/e6a15bc8-21df-41d0-b177-a31551d89397/main.assets/figs6.jpg" height="907" width="656" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/e88e8096-3255-49e4-94f3-9f3b2a487403/main.assets/figs6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S6</span> <span class="figure__title__text">Serum-derived antibodies in HGSOC patients are reactive with healthy MMP14 expressing tissues, related to <a id="crosref1305" href="#fig3">Figure&nbsp;3</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0310" role="paragraph">(A) Upper panel: dual immunofluorescence staining of consecutive tissue sections derived from a healthy fallopian tube. Staining was performed with the commercial anti-MMP14 antibody LEM-2/15.8 and polyclonal antibodies (500&nbsp;nM) derived from patients or healthy control individuals. Polyclonal IgGs originated from 3 healthy controls as well as from matched sera and ascites samples acquired from 7 HGSOC patients. The ascites fluids and serum samples were taken from the patients at the same time. Lower panel: quantification of ascites or sera IgG staining of MMP14 expressing epithelial compartments on various healthy tissues. Healthy tissues that were evaluated include the fallopian tube, endometrial uterine lining, pancreas, and colon tissues. In these specimens, MMP14-expressing epithelial compartments were defined using QuPath v0.2.0-m9 on the basis of LEM-2/15.8 staining. IgG staining was quantified per cell and normalized to the background signal. Scale bars, 20&nbsp;μm.</div><div id="fspara0315" role="paragraph">(B) ELISA comparing the MMP14 reactivity of control sera with that of ascites-derived polyclonal and anti-MMP14 monoclonal antibodies.</div><div id="fspara0320" role="paragraph">(C) ELISA comparing the MMP14 reactivity of sera from HGSOC patients in remission with that of an anti-MMP14 monoclonal antibody.</div><div id="fspara0325" role="paragraph">(D) Annual incidence rate of autoimmunity among women who were previously diagnosed with ovarian cancer compared with female controls following adjustment to age and calendar year. Bars represent the annual incidence rate of autoimmunity per 100,000 women. Whiskers represent the confidence interval. Colors represent the follow-up time following diagnosis of HGSOC. In (A), p values were determined by two-tailed Student’s paired t test for matched samples. In (C), p values were determined by two-tailed Student’s t test.</div></div></div></div></figcaption></figure></div><div id="p0115" role="paragraph">Finally, a large-scale retrospective analysis of 870,356 women (including 3,353 ovarian cancer patients) over a follow-up period of up to 15 years was performed based on the electronic health record (EHR) database from Clalit Healthcare Services (<span class="dropBlock reference-citations"><a id="body-ref-sref6-1" href="#" role="doc-biblioref" data-xml-rid="bib6" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref6-1" aria-controls="sref6-1">Balicer and Afek, 2017</a><div class="dropBlock__holder" data-db-target-of="sref6-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">6.</div><div>Balicer, R.D. ∙ Afek, A.</div><div><strong>Digital health nation: Israel’s global big data innovation hub</strong></div><div><em>Lancet.</em> 2017; <strong>389</strong>:2451-2453</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.D.BalicerA.AfekDigital+health+nation%3A+Israel%E2%80%99s+global+big+data+innovation+hubLancet389201724512453" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). This analysis did not reveal an increased incidence of autoimmune diseases among the patients previously diagnosed with ovarian cancer (<a id="crosref0820" href="#figs6">Figure&nbsp;S6</a>D). Collectively, although we did find autoantibodies in sera of HGSOC patients, no signs of autoimmune diseases were detected in the patients. Of note, the recovered patients were subjected to various treatments, including chemotherapy, which may affect their ability to produce antibodies.</div></section><section id="sec-2-4"><h3>Characterization of a patient-derived monoclonal antibody that binds MMP14</h3><div id="p0120" role="paragraph">To provide additional evidence for MMP14 binding by patient-derived antibodies, we further characterized one such clone, T13, an antibody that showed effective binding to MMP14 by ELISA in multiple antigen binding assays. Using the Octet QKe platform, we found that the K<sub>D</sub> value of T13 was 410 ± 45&nbsp;nM (R<sup>2</sup>&nbsp;= 99.34%) (<a id="crosref0825" href="#fig4">Figure&nbsp;4</a>A). To examine whether T13 binds a linear epitope or a complex protein conformation, we performed a western blot analysis on 14 different cell lines of epithelial, mesenchymal, and neural crest origin, representing a wide variety of cell types and organs. Bands of approximately 63&nbsp;kDa were detected in this assay, compatible with the size of MMP14, and an additional ∼35&nbsp;kDa band appeared as well, which coincides with a known degradation product of MMP14 (<a id="crosref0830" href="#fig4">Figure&nbsp;4</a>B). Notably, OVCAR3 and HT1080, which express high levels of MMP14, showed the strongest signals, and very few additional bands were detected. To verify that the antibody binds native MMP14, we expressed MMP14 together with mCherry in K562 cells. Although the antibody did not show binding to mCherry-negative cells, mCherry-positive cells showed clear antibody binding by flow cytometric analysis (<a id="crosref0835" href="#fig4">Figures 4</a>C and <a id="crosref0840" href="#figs4">S4</a>C). To further examine cross-reactivity and identify additional potential surface targets, we tested the binding of T13 as well as an antibody that did not bind OVCAR3 as a control (T15) to a microarray that included 9,400 recombinant human proteins (either full length or fragments). Although several membrane proteins showed reactivity with T13, the manual inspection of their sequences and validation by traditional ELISA did not reveal additional surface molecules that could serve as a target for the monoclonal antibodies on tumor cells (<a id="crosref0845" href="#figs7">Figures S7</a>A and S7B;<a id="crosref0850" href="#mmc3">Table S6</a>). Other antibodies that were tested in this assay did not reveal cell surface or tumor-associated targets that are relevant to HGSOC. Overall, these results demonstrate that a linear epitope on MMP14 is a major target for the T13 monoclonal antibody.</div><div class="figure-wrap"><figure id="fig4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.02.012/asset/cf4befcd-ea6f-460d-9c9d-d90a09579606/main.assets/gr4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr4" src="/cms/10.1016/j.cell.2022.02.012/asset/f9cd5f0a-12e8-40c5-b327-1083226a2c05/main.assets/gr4.jpg" height="555" width="656" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/cf4befcd-ea6f-460d-9c9d-d90a09579606/main.assets/gr4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;4</span> <span class="figure__title__text">T13 monoclonal antibody binds a linear epitope on MMP14</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0130" role="paragraph">(A) Measurement of the kinetic constants governing the binding of the T13 mAb to MMP14 by biolayer interferometry analysis using the Octet Qke platform.</div><div id="fspara0135" role="paragraph">(B) Western blot analysis of T13 binding to various cell line lysates.</div><div id="fspara0140" role="paragraph">(C) Analysis of T13 binding to K562 cells over-expressing MMP14:mCherry. Fluorescence intensity values from three independent experiments are shown.</div><div id="fspara0145" role="paragraph">(D) Phage display data depicting the epitope sequence of mAb T13 in the catalytic domain of MMP14. The x axis represents the amino acid sequence (108–293) of MMP14 catalytic domain. The bars represent the number of NGS reads of different peptides that were aligned to a given amino acid sequence. Bar colors are coded to the top 25 enriched peptides whose relative abundance is depicted in the pie chart. The number of NGS reads per peptide represents the average of three replicates.</div><div id="fspara0150" role="paragraph">(E) ELISA using the putative epitope of T13 and a control peptide and mAbs T13 and T12. The dashed line represents an FMO control.</div><div id="fspara0155" role="paragraph">(F) <i>In silico</i> structural representation of T13-V<sub>H</sub>V<sub>L</sub> antibody targeting the predicted binding epitope on MMP14. The antibody framework appears in light purple, CDRs in cyan, and MMP14 in green with the phage display epitope in blue. In (C), one-way ANOVA was used, followed by Dunnett’s post-hoc test.</div><div id="fspara0160" role="paragraph">See also <a id="crosref1270" href="#figs7">Figure&nbsp;S7</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.02.012/asset/daffeab7-3300-4576-9d92-0c828adc4c61/main.assets/figs7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs7" src="/cms/10.1016/j.cell.2022.02.012/asset/26eb6dbf-6689-4ad2-bb32-a2dba8ac915b/main.assets/figs7.jpg" height="669" width="656" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/daffeab7-3300-4576-9d92-0c828adc4c61/main.assets/figs7_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs7-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S7</span> <span class="figure__title__text">Protein microarray analyses and immunofluorescence staining of intratumoral NK cells in HGSOC, related to <a id="crosref1310" href="#fig4">Figures 4</a> and <a id="crosref1315" href="#fig6">6</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs7-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0335" role="paragraph">(A) Protein microarray reactivity analyses of mAb T13, which binds MMP14, and four additional mAbs (T2, T4, T7, and T15) that are not reactive to MMP14. Top 1% hits are presented. Normalized median signal intensities depleted of the background signal (F532 – B532) are plotted against relative fluorescence units (RFUs) in Log<sub>10</sub> scale. RFU reflects the amount of protein for each target on the array surface. Proteins that contain human IgG Fc domain were disregarded.</div><div id="fspara0340" role="paragraph">(B) ELISA comparing the reactivity of T13 with MMP14, BSA, and ACVR1B—a top membrane-bound hit identified by the protein microarray for T13. Binding to ACVR1B was not detected by ELISA.</div><div id="fspara0345" role="paragraph">(C) Immunofluorescence staining for CD56, CD3, and DAPI in HGSOC tumors. Representative examples from six patients. In some patients, CD56 expression was detected on tumor cells (patient #31). This phenomenon was previously described, and this type of signal was used as a positive control when no CD56 expressing cells were detected in the tumors. Scale bars, 20&nbsp;μm.</div></div></div></div></figcaption></figure></div><div id="p0125" role="paragraph">To identify the binding site of T13 on MMP14, we used a phage display assay to analyze binding to random peptides (<span class="dropBlock reference-citations"><a id="body-ref-sref4" href="#" role="doc-biblioref" data-xml-rid="bib4" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref4" aria-controls="sref4">Ashkenazy et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Ashkenazy, H. ∙ Avram, O. ∙ Ryvkin, A. ...</div><div><strong>Motifier: an IgOme profiler based on peptide motifs using machine learning</strong></div><div><em>J.&nbsp;Mol. Biol.</em> 2021; <strong>433</strong>:167071</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.AshkenazyO.AvramA.RyvkinA.Roitburd-BermanY.Weiss-OttolenghiS.Hada-NeemanJ.M.GershoniT.PupkoMotifier%3A+an+IgOme+profiler+based+on+peptide+motifs+using+machine+learningJ.%C2%A0Mol.+Biol.433202116707110.1016%2Fj.jmb.2021.167071" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref27-1" href="#" role="doc-biblioref" data-xml-rid="bib27" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref27-1" aria-controls="sref27-1">Freund et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref27-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">27.</div><div>Freund ∙ Tarnovitski, N. ∙ Enshell-Seijffers, D. ...</div><div><strong>Phage display selection, analysis, and prediction of B cell epitopes</strong></div><div><em>Curr. Protoc. Immunol.</em> 2009; <strong>9</strong>:8</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=FreundN.TarnovitskiD.Enshell-SeijffersJ.M.GershoniPhage+display+selection%2C+analysis%2C+and+prediction+of+B+cell+epitopesCurr.+Protoc.+Immunol.920098" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Although an antibody that did not show tumor reactivity (T15) interacted with only 10,222 peptides, T13 interacted with 529,495 peptides, and 85.1% of these showed a strong homology to a sequence found in the MMP14 catalytic site (<a id="crosref0865" href="#fig4">Figure&nbsp;4</a>D). ELISA confirmed the binding of T13 and of T12, an additional clonal member with similar specificity, to the homologous sequence found on MMP14 but not to a control peptide derived from a non-binding region (<a id="crosref0870" href="#fig4">Figure&nbsp;4</a>E). Further to this analysis, the molecular structure of the T13 antibody was modeled using the AlphaFold framework (<span class="dropBlock reference-citations"><a id="body-ref-sref44" href="#" role="doc-biblioref" data-xml-rid="bib44" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref44" aria-controls="sref44">Mirdita et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref44"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">44.</div><div>Mirdita, Milot ∙ Schütze, K. ∙ Moriwaki, Y. ...</div><div><strong>ColabFold - making protein folding accessible to all</strong></div><div><em>Biorxiv.</em> 2021;</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=MilotMirditaK.Sch%C3%BCtzeY.MoriwakiL.HeoS.OvchinnikovM.SteineggerColabFold+-+making+protein+folding+accessible+to+allBiorxiv202110.21203%2Frs.3.rs-1032816%2Fv1" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref33-1" href="#" role="doc-biblioref" data-xml-rid="bib33" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref33-1" aria-controls="sref33-1">Jumper et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref33-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">33.</div><div>Jumper, J. ∙ Evans, R. ∙ Pritzel, A. ...</div><div><strong>Highly accurate protein structure prediction with AlphaFold</strong></div><div><em>Nature.</em> 2021; <strong>596</strong>:583-589</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.JumperR.EvansA.PritzelT.GreenM.FigurnovO.RonnebergerK.TunyasuvunakoolR.BatesA.%C5%BD%C3%ADdekA.PotapenkoHighly+accurate+protein+structure+prediction+with+AlphaFoldNature5962021583589" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) followed by the Global Docking computation of the MMP14-T13 atomic model complex. The PatchDock algorithm was used to dock the MMP14 (PDB <a id="intref0010" href="http://firstglance.jmol.org/fg.htm?mol5H0U" target="_blank">5H0U</a>) atomic model to the predicted T13 model using the protein-protein refinement stage on the FireDock server (<span class="dropBlock reference-citations"><a id="body-ref-sref25" href="#" role="doc-biblioref" data-xml-rid="bib25" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref25" aria-controls="sref25">Duhovny et&nbsp;al., 2002</a><div class="dropBlock__holder" data-db-target-of="sref25"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Duhovny, D. ∙ Nussinov, R. ∙ Wolfson, H.</div><div><strong>Efficient unbound docking of rigid molecules</strong></div><div><div>Guigó, R. ∙ Gusfield, D. (Editors)</div></div><div><strong>Proceedings of the 2’nd Workshop on Algorithms in Bioinformatics (WABI) Rome, Italy, Lecture Notes in Computer Science 2452</strong></div><div>2002</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.DuhovnyR.NussinovH.WolfsonEfficient+unbound+docking+of+rigid+moleculesR.Guig%C3%B3D.GusfieldProceedings+of+the+2%E2%80%99nd+Workshop+on+Algorithms+in+Bioinformatics+%28WABI%29+Rome%2C+Italy%2C+Lecture+Notes+in+Computer+Science+24522002" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref62-1" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-1" aria-controls="sref62-1">Schneidman-Duhovny et&nbsp;al., 2005</a><div class="dropBlock__holder" data-db-target-of="sref62-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Schneidman-Duhovny, D. ∙ Inbar, Y. ∙ Nussinov, R. ...</div><div><strong>PatchDock and SymmDock: servers for rigid and symmetric docking</strong></div><div><em>Nucleic Acids Res.</em> 2005; <strong>33</strong>:W363-W367</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.Schneidman-DuhovnyY.InbarR.NussinovH.J.WolfsonPatchDock+and+SymmDock%3A+servers+for+rigid+and+symmetric+dockingNucleic+Acids+Res.332005W363W367" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref3" href="#" role="doc-biblioref" data-xml-rid="bib3" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref3" aria-controls="sref3">Andrusier et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">3.</div><div>Andrusier, N. ∙ Nussinov, R. ∙ Wolfson, H.J.</div><div><strong>FireDock: fast interaction refinement in molecular docking</strong></div><div><em>Proteins.</em> 2007; <strong>69</strong>:139-159</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.AndrusierR.NussinovH.J.WolfsonFireDock%3A+fast+interaction+refinement+in+molecular+dockingProteins692007139159" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref41-1" href="#" role="doc-biblioref" data-xml-rid="bib41" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref41-1" aria-controls="sref41-1">Mashiach et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref41-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">41.</div><div>Mashiach, E. ∙ Schneidman-Duhovny, D. ∙ Andrusier, N. ...</div><div><strong>FireDock: A web server for fast interaction refinement in molecular docking</strong></div><div><em>Nucleic Acids Res.</em> 2008; <strong>36</strong>:W229-W232</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=E.MashiachD.Schneidman-DuhovnyN.AndrusierR.NussinovH.J.WolfsonFireDock%3A+A+web+server+for+fast+interaction+refinement+in+molecular+dockingNucleic+Acids+Res.362008W229W232" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). This analysis resulted in a “top hit” comprising the peptide sequence found in our phage display assay and identified by ELISA (<a id="crosref1330" href="#fig4">Figure 4</a>F). Collectively, these data predict the binding epitope of one of the patient-derived antibodies on MMP14.</div></section><section id="sec-2-5"><h3>Acquisition of somatic hypermutations contributes to antibody tumor-reactivity</h3><div id="p0130" role="paragraph">B cell central tolerance is established during the development of mature B cells in the bone marrow (BM) where autoreactive clones are eliminated. Nonetheless, it has been estimated that 5% of the B cells that emerge from this process are autoreactive but typically do not cause an apparent autoimmune disease (<span class="dropBlock reference-citations"><a id="body-ref-sref75-2" href="#" role="doc-biblioref" data-xml-rid="bib75" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref75-2" aria-controls="sref75-2">Wardemann et&nbsp;al., 2003</a><div class="dropBlock__holder" data-db-target-of="sref75-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">75.</div><div>Wardemann, H. ∙ Yurasov, S. ∙ Schaefer, A. ...</div><div><strong>Predominant autoantibody production by early human B cell precursors</strong></div><div><em>Science.</em> 2003; <strong>301</strong>:1374-1377</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.WardemannS.YurasovA.SchaeferJ.W.YoungE.MeffreM.C.NussenzweigPredominant+autoantibody+production+by+early+human+B+cell+precursorsScience301200313741377" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). An additional pathway for the generation of autoreactive antibodies is through the insertion of SHMs into the immunoglobulin genes of antibodies that do not bind a self-target in their original germline version (<span class="dropBlock reference-citations"><a id="body-ref-sref53" href="#" role="doc-biblioref" data-xml-rid="bib53" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53" aria-controls="sref53">Piccoli et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref53"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Piccoli, L. ∙ Campo, I. ∙ Fregni, C.S. ...</div><div><strong>Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis</strong></div><div><em>Nat. Commun.</em> 2015; <strong>6</strong>:7375</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.PiccoliI.CampoC.S.FregniB.M.RodriguezA.MinolaF.SallustoM.LuisettiD.CortiA.LanzavecchiaNeutralization+and+clearance+of+GM-CSF+by+autoantibodies+in+pulmonary+alveolar+proteinosisNat.+Commun.620157375" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref22" href="#" role="doc-biblioref" data-xml-rid="bib22" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref22" aria-controls="sref22">Di Zenzo et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref22"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Di Zenzo, G. ∙ Di Lullo, G. ∙ Corti, D. ...</div><div><strong>Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2012; <strong>122</strong>:3781-3790</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.Di+ZenzoG.Di+LulloD.CortiV.CalabresiA.SinistroF.VanzettaB.DidonaG.CianchiniM.HertlR.EmingPemphigus+autoantibodies+generated+through+somatic+mutations+target+the+desmoglein-3+cis-interfaceJ.%C2%A0Clin.+Invest.122201237813790" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref42" href="#" role="doc-biblioref" data-xml-rid="bib42" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref42" aria-controls="sref42">Mietzner et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref42"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">42.</div><div>Mietzner, B. ∙ Tsuiji, M. ∙ Scheid, J. ...</div><div><strong>Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2008; <strong>105</strong>:9727-9732</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.MietznerM.TsuijiJ.ScheidK.VelinzonT.TillerK.AbrahamJ.B.GonzalezV.PascualD.StichwehH.WardemannM.C.NussenzweigAutoreactive+IgG+memory+antibodies+in+patients+with+systemic+lupus+erythematosus+arise+from+nonreactive+and+polyreactive+precursorsProc.+Natl.+Acad.+Sci.+USA105200897279732" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref63" href="#" role="doc-biblioref" data-xml-rid="bib63" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref63" aria-controls="sref63">Schroeder et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref63"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Schroeder, K. ∙ Herrmann, M. ∙ Winkler, T.H.</div><div><strong>The role of somatic hypermutation in the generation of pathogenic antibodies in SLE</strong></div><div><em>Autoimmunity.</em> 2013; <strong>46</strong>:121-127</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=K.SchroederM.HerrmannT.H.WinklerThe+role+of+somatic+hypermutation+in+the+generation+of+pathogenic+antibodies+in+SLEAutoimmunity462013121127" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref67" href="#" role="doc-biblioref" data-xml-rid="bib67" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref67" aria-controls="sref67">Tiller et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref67"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">67.</div><div>Tiller, T. ∙ Tsuiji, M. ∙ Yurasov, S. ...</div><div><strong>Autoreactivity in human IgG+ memory B cells</strong></div><div><em>Immunity.</em> 2007; <strong>26</strong>:205-213</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=T.TillerM.TsuijiS.YurasovK.VelinzonM.C.NussenzweigH.WardemannAutoreactivity+in+human+IgG%2B+memory+B+cellsImmunity262007205213" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). To examine whether the binding of patient-derived monoclonal antibodies depended on SHMs for tumor binding, we generated parental immunoglobulin configurations by reverting their sequence to their germline versions and tested their binding capacity to OVCAR3 using fluorescence microscopy and QuPath analysis. For this purpose, we used antibodies that showed a significant or moderate tumor binding by the immunofluorescence assay (<a id="crosref1335" href="#fig3">Figure 3</a>A). This assay revealed eleven patient-derived monoclonal antibodies that lost tumor binding after removal of SHMs and an additional twelve antibodies that did not show a significant decrease in tumor binding in their germline form (<a id="crosref0940" href="#fig5">Figure&nbsp;5</a>A). Interestingly, two antibodies gained binding to the tumor cell line after removal of the SHMs (<a id="crosref0945" href="#fig5">Figure&nbsp;5</a>A). We conclude that two types of tumor-reactive antibodies exist in the patients: one that depends on SHMs for tumor binding (class I) and another type that binds the tumor in their germline form (class II).</div><div class="figure-wrap"><figure id="fig5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.02.012/asset/9807afa2-990b-4a2e-8144-3a9990a45f9d/main.assets/gr5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr5" src="/cms/10.1016/j.cell.2022.02.012/asset/e57ccc3f-3dfc-47cd-816f-98f06dc80542/main.assets/gr5.jpg" height="698" width="759" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/9807afa2-990b-4a2e-8144-3a9990a45f9d/main.assets/gr5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;5</span> <span class="figure__title__text">Tumor-reactive antibodies arise from autoreactive and non-binding precursors</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0170" role="paragraph">(A) Quantification of OVCAR3 binding by mutated and non-mutated antibodies (500&nbsp;nM) as measured by fluorescence microscopy. Quantification of mean fluorescence intensity was performed on each cell separately using QuPath v0.2.0-m9. Boxes are divided by the median value and represent the interquartile range; whiskers represent the 10–90 percentiles. Fold change in median fluorescence of the mutated antibody compared with the non-mutated putative ancestor is indicated.</div><div id="fspara0175" role="paragraph">(B) ELISA for MMP14 binding using mutated and non-mutated monoclonal antibodies.</div><div id="fspara0180" role="paragraph">(C) ELISA for MMP14 using T3, T17, their inferred ancestors, and their germline configurations. In (A), a comparison between the mutated version and germline configuration of each antibody was performed using the Mann-Whitney <i>U</i> test. A difference in medians was found to be statistically significant in all panels with a p&nbsp;&lt; 0.0001, except mAb T18 (p&nbsp;&lt; 0.01) and mAb T23 (ns).</div></div></div></div></figcaption></figure></div><div id="p0135" role="paragraph">To strengthen our antibody classification, we tested the binding of germline antibodies to MMP14 using ELISA. Similar to the previous experiment, this analysis revealed two groups of antibodies: one that depends on SHMs for MMP14 binding and one whose members bind MMP14 in their germline configurations (<a id="crosref0950" href="#fig5">Figure&nbsp;5</a>B). These data suggest that antitumor antibodies can form before the introduction of an antigen in a germline version and also develop through the acquisition of SHMs.</div><div id="p0140" role="paragraph">To gain more insights regarding the role of SHMs in affinity maturation, in addition to the germline configuration, we generated inferred ancestors based on shared and non-shared SHMs among sequences within clonal families. For this purpose, sequences that contain only shared mutations in their downstream diversified progenies were used for the generation of monoclonal antibodies. ELISA demonstrated that T13 shows effective binding to MMP14, whereas its inferred ancestor exhibited decreased binding when the non-shared mutations were removed in a stepwise manner (<a id="crosref0955" href="#fig5">Figure&nbsp;5</a>C). Similar results were obtained from the analysis of the inferred ancestors of T17 (<a id="crosref0960" href="#fig5">Figure&nbsp;5</a>C). These two examples indicate that a stepwise increase in the affinity against MMP14 may occur in HGSOC patients.</div></section><section id="sec-2-6"><h3>Patient-derived autoantibodies support antibody-mediated effector functions</h3><div id="p0145" role="paragraph">To examine whether the two antibody classes exhibit potential antitumor effector activity, we examined their Fc-mediated functions. Antibodies can support antibody-dependent cellular phagocytic (ADCP) activity through interaction with Fc receptors expressed on phagocytic cells (<span class="dropBlock reference-citations"><a id="body-ref-sref77" href="#" role="doc-biblioref" data-xml-rid="bib77" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref77" aria-controls="sref77">Wieland and Ahmed, 2019</a><div class="dropBlock__holder" data-db-target-of="sref77"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">77.</div><div>Wieland, A. ∙ Ahmed, R.</div><div><strong>Fc receptors in antimicrobial protection</strong></div><div><em>Curr. Top. Microbiol. Immunol.</em> 2019; <strong>423</strong>:119-150</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.WielandR.AhmedFc+receptors+in+antimicrobial+protectionCurr.+Top.+Microbiol.+Immunol.4232019119150" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref23" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23" aria-controls="sref23">DiLillo and Ravetch, 2015</a><div class="dropBlock__holder" data-db-target-of="sref23"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">23.</div><div>DiLillo, D.J. ∙ Ravetch, J.V.</div><div><strong>Fc-receptor interactions regulate both cytotoxic and immunomodulatory therapeutic antibody effector functions</strong></div><div><em>Cancer Immunol. Res.</em> 2015; <strong>3</strong>:704-713</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.J.DiLilloJ.V.RavetchFc-receptor+interactions+regulate+both+cytotoxic+and+immunomodulatory+therapeutic+antibody+effector+functionsCancer+Immunol.+Res.3201570471310.1158%2F2326-6066.CIR-15-0120" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref76-1" href="#" role="doc-biblioref" data-xml-rid="bib76" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref76-1" aria-controls="sref76-1">Webb et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref76-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">76.</div><div>Webb, N.E. ∙ Bernshtein, B. ∙ Alter, G.</div><div><strong>Tissues: the unexplored frontier of antibody mediated immunity</strong></div><div><em>Curr. Opin. Virol.</em> 2021; <strong>47</strong>:52-67</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.E.WebbB.BernshteinG.AlterTissues%3A+the+unexplored+frontier+of+antibody+mediated+immunityCurr.+Opin.+Virol.4720215267" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Incubation of THP-1 monocytes with 25 patient-derived polyclonal antibodies (<a id="crosref0980" href="#mmc1">Table S2</a>) and MMP14-coated beads induced their effective uptake by the cells (<a id="crosref0985" href="#fig6">Figure&nbsp;6</a>A). Furthermore, incubation of patient-derived polyclonal antibodies with OVCAR3 cells induced antibody-dependent cell cytotoxicity (ADCC) by NK cells (<a id="crosref0990" href="#fig6">Figure&nbsp;6</a>B). Of note, these antibodies carry post-translational modifications which were introduced naturally within the patients. By contrast, only some of the monoclonal antibodies were effective in inducing effective ADCP and ADCC (<a id="crosref0995" href="#fig6">Figures 6</a>C and 6D), suggesting that different affinities and targeted epitopes affect the functions of specific antibodies. These results demonstrate that all ovarian cancer patients have antibodies with effector function potential, but not all of the antibodies can trigger antitumor activity by effector cells. Nonetheless, although clusters of T&nbsp;cells were detected in the stromal compartment of most of the HGSOC tumors, NK cells were very rare (<a id="crosref1000" href="#figs7">Figure&nbsp;S7</a>C). Collectively, these findings indicate that tumor-reactive antibodies in HGSOC have functional potential. Yet, ineffective recruitment of effector cells, such as NK cells, into the tumors or dysfunction of other cell types (<span class="dropBlock reference-citations"><a id="body-ref-sref20-1" href="#" role="doc-biblioref" data-xml-rid="bib20" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref20-1" aria-controls="sref20-1">DeNardo and Ruffell, 2019</a><div class="dropBlock__holder" data-db-target-of="sref20-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">20.</div><div>DeNardo, D.G. ∙ Ruffell, B.</div><div><strong>Macrophages as regulators of tumour immunity and immunotherapy</strong></div><div><em>Nat. Rev. Immunol.</em> 2019; <strong>19</strong>:369-382</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.G.DeNardoB.RuffellMacrophages+as+regulators+of+tumour+immunity+and+immunotherapyNat.+Rev.+Immunol.192019369382" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) may preclude effective activation of cell-mediated antibody-effector functions.</div><div class="figure-wrap"><figure id="fig6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.02.012/asset/7eeb36ce-a292-4072-9aff-b88697a28c2b/main.assets/gr6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr6" src="/cms/10.1016/j.cell.2022.02.012/asset/a36e83af-a86c-41e8-8e98-4be76e080ec7/main.assets/gr6.jpg" height="332" width="656" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/7eeb36ce-a292-4072-9aff-b88697a28c2b/main.assets/gr6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;6</span> <span class="figure__title__text">Patient-derived and monoclonal antibodies support effector functions</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0190" role="paragraph">(A) Flow cytometric quantification of patient-derived polyclonal antibody-mediated phagocytosis of MMP14-coated beads by THP-1 monocytes. Polyclonal antibodies were introduced at a concentration of 1&nbsp;μM.</div><div id="fspara0195" role="paragraph">(B) Longitudinal quantification of antibody-dependent cell-mediated cytotoxicity (ADCC) targeting OVCAR3 cells in the presence of NK cells alone and together with patient-derived polyclonal antibodies (500&nbsp;nM). A commercial anti-EGFR antibody (cetuximab) was used as a positive control. The left graph represents mean ± SD. The right graph shows dead tumor cell quantification at the time point marked by the dotted line in the left graph.</div><div id="fspara0200" role="paragraph">(C) Phagocytosis analysis as in (A) using monoclonal antibodies (500&nbsp;nM). GD01 was used as a negative control.</div><div id="fspara0205" role="paragraph">(D) OVCAR3 killing by NK cells in the presence of monoclonal antibodies (500&nbsp;nM). An average of four reactions ±SEM is shown. The right graph shows dead tumor cell quantification at the time point marked by the dotted line in the left graph. In (A–D), statistical significance was determined by one-way ANOVA followed by Dunnett’s post-hoc test.</div><div id="fspara0210" role="paragraph">See also <a id="crosref1275" href="#figs7">Figure&nbsp;S7</a>.</div></div></div></div></figcaption></figure></div></section></section><section id="sec-3"><h2>Discussion</h2><div id="p0150" role="paragraph">The presence of B cells in tumors was associated with a positive prognosis in some cancers, yet it remains unknown how tumor-binding antibodies evolve. Using large-scale imaging approaches, we demonstrate that the surfaces of HGSOC and many other tumors are frequently coated with endogenous IgG antibodies. Through bait-free single-cell sequencing and antibody cloning, we found that SHMs support endogenous antibody-mediated immune response in HGSOC patients in parallel to pre-existing antibody autoreactivity. Conceptually, our results describe the evolution of the serological immune response in cancer patients and show that the antibodies that bind the tumor cells can emerge from non-reactive precursors through antigen-driven positive selection (class I). In parallel, pre-existing autoreactive B cells that escape deletion during negative selection in the BM are also recruited to the tumor and contribute to the overall humoral immune response (class II). As opposed to autoantibodies in deleterious autoimmune diseases, both antibody classes have the potential for beneficial functions in cancer patients; however, additional players are required for effective tumor eradication, such as the infiltration of effector cells.</div><div id="p0155" role="paragraph">It was shown that a humoral immune response against foreign viral proteins can form in HPV-driven head and neck cancer (<span class="dropBlock reference-citations"><a id="body-ref-sref78-3" href="#" role="doc-biblioref" data-xml-rid="bib78" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref78-3" aria-controls="sref78-3">Wieland et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref78-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">78.</div><div>Wieland, A. ∙ Patel, M.R. ∙ Cardenas, M.A. ...</div><div><strong>Defining HPV-specific B cell responses in patients with head and neck cancer</strong></div><div><em>Nature.</em> 2021; <strong>597</strong>:274-278</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.WielandM.R.PatelM.A.CardenasC.S.EberhardtW.H.HudsonR.C.ObengC.C.GriffithX.WangZ.G.ChenH.T.KissickDefining+HPV-specific+B+cell+responses+in+patients+with+head+and+neck+cancerNature597202127427810.1038%2Fs41586-020-2931-3" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We demonstrate that autoantibodies against self-antigens are formed in HGSOC patients, but in contrast to the immune response elicited against foreign antigens, this process must involve a break in immune tolerance. It is most likely that the unusually high levels of antigens, such as MMP14, activate rare autoreactive B cells with the capacity to generate autoantibodies (<span class="dropBlock reference-citations"><a id="body-ref-sref34-1" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-1" aria-controls="sref34-1">Kaimal et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref34-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Kaimal, R. ∙ Aljumaily, R. ∙ Tressel, S.L. ...</div><div><strong>Selective blockade of matrix Metalloprotease-14 with a monoclonal antibody abrogates invasion, angiogenesis, and tumor growth in ovarian cancer</strong></div><div><em>Cancer Res.</em> 2013; <strong>73</strong>:2457-2467</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.KaimalR.AljumailyS.L.TresselR.V.PradhanL.CovicA.KuliopulosC.ZarwanY.B.KimS.SharifiA.AgarwalSelective+blockade+of+matrix+Metalloprotease-14+with+a+monoclonal+antibody+abrogates+invasion%2C+angiogenesis%2C+and+tumor+growth+in+ovarian+cancerCancer+Res.73201324572467" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref83-3" href="#" role="doc-biblioref" data-xml-rid="bib83" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref83-3" aria-controls="sref83-3">Zaenker et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref83-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">83.</div><div>Zaenker, P. ∙ Gray, E.S. ∙ Ziman, M.R.</div><div><strong>Autoantibody production in cancer—the humoral immune response toward autologous antigens in cancer patients</strong></div><div><em>Autoimmun. Rev.</em> 2016; <strong>15</strong>:477-483</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.ZaenkerE.S.GrayM.R.ZimanAutoantibody+production+in+cancer%E2%80%94the+humoral+immune+response+toward+autologous+antigens+in+cancer+patientsAutoimmun.+Rev.152016477483" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). This hypothesis is difficult to test in human patients because the antibodies represent the end product of the immune response when the break in tolerance already occurred. We suggest that the chronic nature of the cancer and high antigenic load have the potential to drive the accumulation of SHMs over time and generate endogenous antibodies with a tumor binding capacity.</div><div id="p0160" role="paragraph">MMP14 is highly expressed in HGSOC, and the activity of this enzyme is essential for tumor progression and metastatic dissemination (<span class="dropBlock reference-citations"><a id="body-ref-sref34-2" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-2" aria-controls="sref34-2">Kaimal et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref34-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Kaimal, R. ∙ Aljumaily, R. ∙ Tressel, S.L. ...</div><div><strong>Selective blockade of matrix Metalloprotease-14 with a monoclonal antibody abrogates invasion, angiogenesis, and tumor growth in ovarian cancer</strong></div><div><em>Cancer Res.</em> 2013; <strong>73</strong>:2457-2467</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.KaimalR.AljumailyS.L.TresselR.V.PradhanL.CovicA.KuliopulosC.ZarwanY.B.KimS.SharifiA.AgarwalSelective+blockade+of+matrix+Metalloprotease-14+with+a+monoclonal+antibody+abrogates+invasion%2C+angiogenesis%2C+and+tumor+growth+in+ovarian+cancerCancer+Res.73201324572467" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref72-2" href="#" role="doc-biblioref" data-xml-rid="bib72" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref72-2" aria-controls="sref72-2">Vos et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref72-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">72.</div><div>Vos, M.C. ∙ van der Wurff, A.A.M. ∙ van Kuppevelt, T.H. ...</div><div><strong>The role of MMP-14 in ovarian cancer: a systematic review</strong></div><div><em>J.&nbsp;Ovarian Res.</em> 2021; <strong>14</strong>:1-13</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.C.VosA.A.M.van+der+WurffT.H.van+KuppeveltL.A.F.G.MassugerThe+role+of+MMP-14+in+ovarian+cancer%3A+a+systematic+reviewJ.%C2%A0Ovarian+Res.142021113" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref47" href="#" role="doc-biblioref" data-xml-rid="bib47" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref47" aria-controls="sref47">Moss et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref47"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">47.</div><div>Moss, N.M. ∙ Barbolina, M.V. ∙ Liu, Y. ...</div><div><strong>Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination</strong></div><div><em>Cancer Res.</em> 2009; <strong>69</strong>:7121-7129</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.M.MossM.V.BarbolinaY.LiuL.SunH.G.MunshiM.S.StackOvarian+cancer+cell+detachment+and+multicellular+aggregate+formation+are+regulated+by+membrane+type+1+matrix+metalloproteinase%3A+a+potential+role+in+I.p.+metastatic+disseminationCancer+Res.69200971217129" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We recovered several tumor-binding antibodies, of which 9 showed reactivity with MMP14 as well as milder cross-reactivity with other similar enzymes but not with other protein and non-protein targets that were tested. Since MMP14 is a surface-bound enzyme and expressed in unusually high levels on the tumor surface, we suggest that this is the most relevant self-target of our cloned antibodies in HGSOC. Nonetheless, we cannot rule out the possibility that other antigens are targeted by MMP14-reactive antibodies as well.</div><div id="p0165" role="paragraph">The presence of SHMs and gradual increase in antibody affinity from the germline configuration to the final mutated form indicate that an antigen-driven process took place in the patients. Acquisition of SHMs typically takes place in GCs that can be located either in the tumor within TLS or in tumor-draining lymph nodes (<span class="dropBlock reference-citations"><a id="body-ref-sref36-3" href="#" role="doc-biblioref" data-xml-rid="bib36" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref36-3" aria-controls="sref36-3">Kroeger et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref36-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">36.</div><div>Kroeger, D.R. ∙ Milne, K. ∙ Nelson, B.H.</div><div><strong>Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer</strong></div><div><em>Clin. Cancer Res.</em> 2016; <strong>22</strong>:3005-3015</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.R.KroegerK.MilneB.H.NelsonTumor-infiltrating+plasma+cells+are+associated+with+tertiary+lymphoid+structures%2C+cytolytic+T-cell+responses%2C+and+superior+prognosis+in+ovarian+cancerClin.+Cancer+Res.22201630053015" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Of note, the size of excised ovarian tumors is large, typically ranging from 5&nbsp;cm to more than 30&nbsp;cm in their largest dimension. In order to extract and sequence antibody-secreting cells, we used a very small fragment of the tumor (less than 1 cubic cm). If cells clonally expand at a distant site and then home to the tumor through the circulation, the chances of detection of clonally related ASCs without a bait is extremely small, as they would be expected to spread throughout the tumor tissue and other organs such as the BM and mix with other non-related clones. Yet, the possibility that the mutated cells originated from draining lymph nodes cannot be excluded, and further studies are needed to address this question.</div><div id="p0170" role="paragraph">Affinity-based selection is a highly regulated process that involves well-defined cellular and molecular interactions (<span class="dropBlock reference-citations"><a id="body-ref-sref8" href="#" role="doc-biblioref" data-xml-rid="bib8" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref8" aria-controls="sref8">Biram et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Biram, A. ∙ Davidzohn, N. ∙ Shulman, Z.</div><div><strong>T cell interactions with B cells during germinal center formation, a three-step model</strong></div><div><em>Immunol. Rev.</em> 2019; <strong>288</strong>:37-48</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.BiramN.DavidzohnZ.ShulmanT+cell+interactions+with+B+cells+during+germinal+center+formation%2C+a+three-step+modelImmunol.+Rev.28820193748" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Nonetheless, it remains possible that the response started as a “bystander” reaction and drifted toward MMP14 specificity as a result of the abundant antigen or a different break-of-tolerance driver. Indeed, few autoreactive cells have the potential to generate new self-reactive antibodies through epitope spreading and thereby enhance the overall autoreactivity against the tumor (<span class="dropBlock reference-citations"><a id="body-ref-sref19" href="#" role="doc-biblioref" data-xml-rid="bib19" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref19" aria-controls="sref19">Degn et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref19"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Degn, S.E. ∙ van der Poel, C.E. ∙ Firl, D.J. ...</div><div><strong>Clonal evolution of autoreactive germinal centers</strong></div><div><em>Cell.</em> 2017; <strong>170</strong>:913-926.e19</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.E.DegnC.E.van+der+PoelD.J.FirlB.AyogluF.A.Al+QureshahG.BajicL.MesinC.A.ReynaudJ.C.WeillP.J.UtzClonal+evolution+of+autoreactive+germinal+centersCell1702017913926.e19" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref71" href="#" role="doc-biblioref" data-xml-rid="bib71" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref71" aria-controls="sref71">Vinuesa et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref71"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">71.</div><div>Vinuesa, C.G. ∙ Sanz, I. ∙ Cook, M.C.</div><div><strong>Dysregulation of germinal centres in autoimmune disease</strong></div><div><em>Nat. Rev. Immunol.</em> 2009; <strong>9</strong>:845-857</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.G.VinuesaI.SanzM.C.CookDysregulation+of+germinal+centres+in+autoimmune+diseaseNat.+Rev.+Immunol.92009845857" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref16" href="#" role="doc-biblioref" data-xml-rid="bib16" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref16" aria-controls="sref16">Cornaby et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref16"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">16.</div><div>Cornaby, C. ∙ Gibbons, L. ∙ Mayhew, V. ...</div><div><strong>B cell epitope spreading: mechanisms and contribution to autoimmune diseases</strong></div><div><em>Immunol. Lett.</em> 2015; <strong>163</strong>:56-68</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.CornabyL.GibbonsV.MayhewC.S.SloanA.WellingB.D.PooleB+cell+epitope+spreading%3A+mechanisms+and+contribution+to+autoimmune+diseasesImmunol.+Lett.16320155668" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). An additional possible source of class I antibodies are mutated memory cells that evolved in response to foreign stimuli and acquire cross-reactivity with tumor antigens, as demonstrated in some infectious diseases (<span class="dropBlock reference-citations"><a id="body-ref-sref81" href="#" role="doc-biblioref" data-xml-rid="bib81" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref81" aria-controls="sref81">Yang et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref81"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">81.</div><div>Yang, F. ∙ Nielsen, S.C.A. ∙ Hoh, R.A. ...</div><div><strong>Shared B cell memory to coronaviruses and other pathogens varies in human age groups and tissues</strong></div><div><em>Science.</em> 2021; <strong>372</strong>:738-741</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=F.YangS.C.A.NielsenR.A.HohK.R%C3%B6ltgenO.F.WirzE.HaraguchiG.H.JeanJ.Y.LeeT.D.PhamK.J.L.JacksonShared+B+cell+memory+to+coronaviruses+and+other+pathogens+varies+in+human+age+groups+and+tissuesScience372202173874110.1126%2Fscience.abf6648" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). As opposed to class I, class II antibodies are tumor reactive, and yet, SHMs did not contribute to their tumor binding capacity, which might suggest that they were elicited against a different antigen, while retaining their original reactivity toward MMP14. Thus, it is most likely that class II antibodies emerged in a bystander response, which was further amplified in response to the tumor cells. Furthermore, since the B cell response is ongoing within the patients, class II antibodies can potentially convert to class I upon the acquisition of additional SHMs.</div><div id="p0175" role="paragraph">Our work demonstrates that, in contrast to cell-mediated immune responses, the humoral response against the tumor in HGSOC is largely intact and has the potential to trigger Fc-mediated antitumor effector functions (<span class="dropBlock reference-citations"><a id="body-ref-sref76-2" href="#" role="doc-biblioref" data-xml-rid="bib76" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref76-2" aria-controls="sref76-2">Webb et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref76-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">76.</div><div>Webb, N.E. ∙ Bernshtein, B. ∙ Alter, G.</div><div><strong>Tissues: the unexplored frontier of antibody mediated immunity</strong></div><div><em>Curr. Opin. Virol.</em> 2021; <strong>47</strong>:52-67</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.E.WebbB.BernshteinG.AlterTissues%3A+the+unexplored+frontier+of+antibody+mediated+immunityCurr.+Opin.+Virol.4720215267" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Yet, it was shown that antibodies can interact with Fcγ receptors on tumor-associated macrophages, promoting angiogenesis and tumor progression (<span class="dropBlock reference-citations"><a id="body-ref-sref2" href="#" role="doc-biblioref" data-xml-rid="bib2" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref2" aria-controls="sref2">Andreu et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Andreu, P. ∙ Johansson, M. ∙ Affara, N.I. ...</div><div><strong>FcRgamma activation regulates inflammation-associated squamous carcinogenesis</strong></div><div><em>Cancer Cell.</em> 2010; <strong>17</strong>:121-134</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.AndreuM.JohanssonN.I.AffaraF.PucciT.TanS.JunankarL.KoretsJ.LamD.TawfikD.G.DeNardoFcRgamma+activation+regulates+inflammation-associated+squamous+carcinogenesisCancer+Cell172010121134" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref20-2" href="#" role="doc-biblioref" data-xml-rid="bib20" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref20-2" aria-controls="sref20-2">DeNardo and Ruffell, 2019</a><div class="dropBlock__holder" data-db-target-of="sref20-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">20.</div><div>DeNardo, D.G. ∙ Ruffell, B.</div><div><strong>Macrophages as regulators of tumour immunity and immunotherapy</strong></div><div><em>Nat. Rev. Immunol.</em> 2019; <strong>19</strong>:369-382</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.G.DeNardoB.RuffellMacrophages+as+regulators+of+tumour+immunity+and+immunotherapyNat.+Rev.+Immunol.192019369382" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Furthermore, in this context, it was demonstrated that the inhibition of Fcγ receptor signaling can reverse the T&nbsp;cell dysfunctional state in tumors, suggesting that macrophage engagement with antibodies could have an immunosuppressive effect on the antitumor immune response (<span class="dropBlock reference-citations"><a id="body-ref-sref20-3" href="#" role="doc-biblioref" data-xml-rid="bib20" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref20-3" aria-controls="sref20-3">DeNardo and Ruffell, 2019</a><div class="dropBlock__holder" data-db-target-of="sref20-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">20.</div><div>DeNardo, D.G. ∙ Ruffell, B.</div><div><strong>Macrophages as regulators of tumour immunity and immunotherapy</strong></div><div><em>Nat. Rev. Immunol.</em> 2019; <strong>19</strong>:369-382</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.G.DeNardoB.RuffellMacrophages+as+regulators+of+tumour+immunity+and+immunotherapyNat.+Rev.+Immunol.192019369382" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). It is most likely that dysfunctional phagocytic cells and insufficient recruitment of effector cells such as NK cells preclude adequate antibody-mediated effector functions such as ADCP and ADCC (<span class="dropBlock reference-citations"><a id="body-ref-sref69" href="#" role="doc-biblioref" data-xml-rid="bib69" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref69" aria-controls="sref69">Uppendahl et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref69"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">69.</div><div>Uppendahl, L.D. ∙ Dahl, C.M. ∙ Miller, J.S. ...</div><div><strong>Natural killer cell-based immunotherapy in gynecologic malignancy: a review</strong></div><div><em>Front. Immunol.</em> 2017; <strong>8</strong>:1825</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.D.UppendahlC.M.DahlJ.S.MillerM.FelicesM.A.GellerNatural+killer+cell-based+immunotherapy+in+gynecologic+malignancy%3A+a+reviewFront.+Immunol.820171825" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Nonetheless, the presence of IgGs and other isotypes in the tumor correlated with disease-free progression and patient survival, suggesting that antibodies in patients have overall beneficial functions (<span class="dropBlock reference-citations"><a id="body-ref-sref9" href="#" role="doc-biblioref" data-xml-rid="bib9" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref9" aria-controls="sref9">Biswas et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">9.</div><div>Biswas, S. ∙ Mandal, G. ∙ Payne, K.K. ...</div><div><strong>IgA transcytosis and antigen recognition govern ovarian cancer immunity</strong></div><div><em>Nature.</em> 2021; <strong>591</strong>:464-470</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.BiswasG.MandalK.K.PayneC.M.AnadonC.D.GatenbeeR.A.ChaurioT.L.CostichC.MoranC.M.HarroK.E.RigolizzoIgA+transcytosis+and+antigen+recognition+govern+ovarian+cancer+immunityNature5912021464470" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref31-2" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-2" aria-controls="sref31-2">Hu et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref31-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Hu, X. ∙ Zhang, J. ∙ Wang, J. ...</div><div><strong>Landscape of B cell immunity and related immune evasion in human cancers</strong></div><div><em>Nat. Genet.</em> 2019; <strong>51</strong>:560-567</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=X.HuJ.ZhangJ.WangJ.FuT.LiX.ZhengB.WangS.GuP.JiangJ.FanLandscape+of+B+cell+immunity+and+related+immune+evasion+in+human+cancersNat.+Genet.512019560567" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0180" role="paragraph">Collectively, our study describes a target for antibodies in HGSOC and demonstrates that the responding antibodies are divided into two classes based on their origin. Patient-derived monoclonal antibodies are potentially useful for chemoattractants or drug delivery to tumors and for cell-mediated therapeutic approaches, such as in CAR-T cell therapy.</div><section id="sec-3-1"><h3>Limitations of the study</h3><div id="p0185" role="paragraph">Since we examined samples from human patients rather than a mouse lab model, we were unable to explore the mechanism through which the break of tolerance occurred in the patients, and further studies should address this point. Furthermore, although we found that several of the monoclonal antibodies bind MMP14, we cannot exclude additional targets. Lastly, since we examined antibody-forming cells isolated from the tumors, we were unable to determine whether they originated from the tumor mass or migrated from tumor-draining lymph nodes.</div></section></section><section id="sec-4"><h2>STAR★Methods</h2><section id="sec-4-1"><h3>Key resources table</h3><div id="p0190" role="paragraph"><div class="figure-wrap"><figure id="undtbl1" class="table" data-figureviewer-ignore="true"><div class="table-wrap"><table data-figureviewer-ignore="true" tabindex="0"><thead><tr class="rowsep"><th>REAGENT or RESOURCE</th><th>SOURCE</th><th>IDENTIFIER</th></tr></thead><tbody><tr class="rowsep"><td colspan="3"><b>Antibodies</b></td></tr><tr><td>CD138/Syndecan-1 Polyclonal antibody</td><td>Proteintech</td><td>Cat# 10593-1-AP; RRID: <a id="interref270" href="https://antibodyregistry.org/AB_2182736" target="_blank">AB_2182736</a></td></tr><tr><td>Monoclonal mouse anti Human CD20 antibody</td><td>Dako</td><td>Cat# M0755; RRID: <a id="interref275" href="https://antibodyregistry.org/AB_2282030" target="_blank">AB_2282030</a></td></tr><tr><td>CD3e Monoclonal Antibody (SP7)</td><td>Thermo Fisher Scientific</td><td>Cat# MA1-90582; RRID: <a id="interref280" href="https://antibodyregistry.org/AB_1956722" target="_blank">AB_1956722</a></td></tr><tr><td>Human/Mouse NCAM-1/CD56 Antibody</td><td>R&amp;D Systems</td><td>Cat# AF2408; RRID: <a id="interref285" href="https://antibodyregistry.org/AB_442152" target="_blank">AB_442152</a></td></tr><tr><td>Monoclonal mouse antiMMP14 (clone: LEM-2/15.8)</td><td>Prof. Irit Sagi lab</td><td>Cat# MAB3328; RRID: <a id="interref290" href="https://antibodyregistry.org/AB_570599" target="_blank">AB_570599</a></td></tr><tr><td>PE anti-human CD326 (Ep-CAM)</td><td>Biolegend</td><td>Cat# 324207; RRID: <a id="interref295" href="https://antibodyregistry.org/AB_756081" target="_blank">AB_756081</a></td></tr><tr><td>Alexa Fluor 700 anti-human CD19</td><td>Biolegend</td><td>Cat# 302225; RRID: <a id="interref300" href="https://antibodyregistry.org/AB_493750" target="_blank">AB_493750</a></td></tr><tr><td>Brilliant Violet 605 anti-human CD19</td><td>Biolegend</td><td>Cat# 302243; RRID: <a id="interref305" href="https://antibodyregistry.org/AB_2562014" target="_blank">AB_2562014</a></td></tr><tr><td>Anti-IgG1-APC</td><td>Miltenyi Biotec</td><td>Cat# 130-099-208; RRID: <a id="interref310" href="https://antibodyregistry.org/AB_2661458" target="_blank">AB_2661458</a></td></tr><tr><td>PerCP/Cy5.5 conjugated anti-human CD38</td><td>Biolegend</td><td>Cat# 303521; RRID: <a id="interref315" href="https://antibodyregistry.org/AB_893316" target="_blank">AB_893316</a></td></tr><tr><td>PE anti-human IgM Antibody</td><td>Biolegend</td><td>Cat# 305211; RRID: <a id="interref320" href="https://antibodyregistry.org/AB_314507" target="_blank">AB_314507</a></td></tr><tr><td>Alexa Fluor® 488 AffiniPure Donkey Anti-Human IgG (H+L)</td><td>Jackson Immunoresearch</td><td>Cat# 709-545-149; RRID: <a id="interref325" href="https://antibodyregistry.org/AB_2340566" target="_blank">AB_2340566</a></td></tr><tr><td>Alexa Fluor® 594 AffiniPure Mouse Anti-Human IgG (H+L)</td><td>Jackson Immunoresearch</td><td>Cat# 209-585-082; RRID: <a id="interref330" href="https://antibodyregistry.org/AB_2339138" target="_blank">AB_2339138</a></td></tr><tr><td>Alexa Fluor® 488 AffiniPure Goat Anti-Rabbit IgG (H+L)</td><td>Jackson Immunoresearch</td><td>Cat# 111-545-045; RRID: <a id="interref335" href="https://antibodyregistry.org/AB_2338049" target="_blank">AB_2338049</a></td></tr><tr><td>Alexa Fluor® 647 AffiniPure Donkey Anti-Mouse IgG (H+L)</td><td>Jackson Immunoresearch</td><td>Cat# 715-605-150; RRID: <a id="interref340" href="https://antibodyregistry.org/AB_2340862" target="_blank">AB_2340862</a></td></tr><tr><td>Cy™3 AffiniPure Goat Anti-Human IgG (H+L)</td><td>Jackson Immunoresearch</td><td>Cat# 109-165-003; RRID: <a id="interref345" href="https://antibodyregistry.org/AB_2337718" target="_blank">AB_2337718</a></td></tr><tr><td>Peroxidase AffiniPure Donkey Anti-Human IgG (H+L)</td><td>Jackson Immunoresearch</td><td>Cat# 709-035-149; RRID: <a id="interref350" href="https://antibodyregistry.org/AB_2340495" target="_blank">AB_2340495</a></td></tr><tr><td>Peroxidase AffiniPure Donkey Anti-Mouse IgG (H+L)</td><td>Jackson Immunoresearch</td><td>Cat# 715-035-150; RRID: <a id="interref355" href="https://antibodyregistry.org/AB_2340770" target="_blank">AB_2340770</a></td></tr><tr><td>HRP Streptavidin</td><td>Biolegend</td><td>Cat# 405210</td></tr><tr><td>Monoclonal antibodies T1-T30</td><td>This paper</td><td>N/A</td></tr><tr><td>Ascites derived polyclonal antibodies (X25)</td><td>This paper</td><td>N/A</td></tr><tr><td>mAb GD01</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td>mAb ED38</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Bacterial and virus strains</b></td></tr><tr class="rowsep"><td>HIT™-DH5a High 10<sup>8</sup></td><td>Real Biotech</td><td>RBC-RH618</td></tr><tr class="rowsep"><td colspan="3"><b>Biological samples</b></td></tr><tr><td>Tissue microarray</td><td>US Biomax</td><td>MC5004</td></tr><tr><td>HGSOC containing FFPE blocks (X29)</td><td>Rabin Medical Center, department of pathology</td><td><a id="intref0015" href="https://hospitals.clalit.co.il/rabin/en/departments/pathology/Pages/default.aspx" target="_blank">https://hospitals.clalit.co.il/rabin/en/departments/pathology/Pages/default.aspx</a></td></tr><tr><td>HGSOC containing FFPE blocks (X8)</td><td>Sheba Medical Center Biobank</td><td><a id="intref0020" href="https://eng.sheba.co.il/156088" target="_blank">https://eng.sheba.co.il/156088</a></td></tr><tr><td>Frozen ascites samples (X18)</td><td>Sheba Medical Center Biobank</td><td><a id="intref0025" href="https://eng.sheba.co.il/156088" target="_blank">https://eng.sheba.co.il/156088</a></td></tr><tr><td>Fresh ascites samples (X7)</td><td>Rabin Medical Center, division of Gynecological Oncology</td><td><a id="intref0030" href="https://hospitals.clalit.co.il/rabin/en/departments/womens_hospital/Pages/womens_hospital_beilinson_and_hasharon.aspx" target="_blank">https://hospitals.clalit.co.il/rabin/en/departments/womens_hospital/Pages/womens_hospital_beilinson_and_hasharon.aspx</a></td></tr><tr><td>Fresh HGSOC primary tumors, metastases, sera and healthy marginal tissues (X19 patients)</td><td>Rabin Medical Center, division of Gynecological Oncology</td><td><a id="intref0035" href="https://hospitals.clalit.co.il/rabin/en/departments/womens_hospital/Pages/womens_hospital_beilinson_and_hasharon.aspx" target="_blank">https://hospitals.clalit.co.il/rabin/en/departments/womens_hospital/Pages/womens_hospital_beilinson_and_hasharon.aspx</a></td></tr><tr><td>Sera from patients in remission (X8)</td><td>Rabin Medical Center, Davidoff cancer center</td><td><a id="intref0040" href="https://hospitals.clalit.co.il/rabin/en/departments/cancer_davidoff_center/Pages/default.aspx" target="_blank">https://hospitals.clalit.co.il/rabin/en/departments/cancer_davidoff_center/Pages/default.aspx</a></td></tr><tr><td>Healthy donor sera</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td>Healthy donor Natural Killer cells</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Chemicals, peptides, and recombinant proteins</b></td></tr><tr><td>IgG elution buffer</td><td>Thermo Fisher</td><td>21004</td></tr><tr><td>DMEM 1X</td><td>Gibco</td><td>41965-039</td></tr><tr><td>Pen/Strep Solution</td><td>Biological Industries</td><td>03-031-1B</td></tr><tr><td>L-Glutamine Solution</td><td>Biological Industries</td><td>03-020-1B</td></tr><tr><td>FCS</td><td>Biological Industries</td><td>04-007-1A</td></tr><tr><td>MEM Eagle Non-essential amino acids</td><td>Biological Industries</td><td>01-340-1B</td></tr><tr><td>Opti-MEM™ I Reduced Serum Medium</td><td>Gibco</td><td>31985-070</td></tr><tr><td>Dimethyl Sulfoxide (DMSO)</td><td>Sigma Aldrich</td><td>D2650-100ml</td></tr><tr><td>Paraformaldehyde solution 4% in PBS</td><td>ChemCruz</td><td>Sc-281692</td></tr><tr><td>Dulbecco’s Phosphate Buffered Saline (PBS)</td><td>Biological Industries</td><td>02-023-1A</td></tr><tr><td>Ficoll-paque™ plus</td><td>Cytiva</td><td>17144003</td></tr><tr><td>DAPI</td><td>Sigma Aldrich</td><td>D9542-10MG</td></tr><tr><td>Bovine serum albumin (BSA)</td><td>MPBio</td><td>160069</td></tr><tr><td>TWEEN® 20</td><td>Sigma Aldrich</td><td>P1379</td></tr><tr><td>TMB Soluble Reagent (High Sensitivity)</td><td>ScyTek Laboratories</td><td>TM4500</td></tr><tr><td>Biotinylated peptide 127-140: CIQNYTPKVGEYAT</td><td>Genscript</td><td>N/A</td></tr><tr><td>Biotinylated control peptide: ENFVLPDDDRRGIQ</td><td>Genscript</td><td>N/A</td></tr><tr><td>Human recombinant IL-2</td><td>PeproTech</td><td>200-02-50</td></tr><tr><td>Igepal CA-630</td><td>Sigma Aldrich</td><td>I8896-100ML</td></tr><tr><td>PEI MAX - Transfection Grade Linear Polyethylenimine Hydrochloride (MW 40,000)</td><td>Polysciences</td><td>24765-1</td></tr><tr><td>Lipopolysaccharides from Escherichia coli O55:B5</td><td>Sigma Aldrich</td><td>L4005-100MG</td></tr><tr><td>Human recombinant insulin</td><td>Gibco</td><td>12-585-014</td></tr><tr><td>Deoxyribonucleic acid (dsDNA), from calf thymus</td><td>Sigma Aldrich</td><td>D4522</td></tr><tr><td>MMP14</td><td>Prof. Irit Sagi lab</td><td>N/A</td></tr><tr><td>MMP1</td><td>Prof. Irit Sagi lab</td><td>N/A</td></tr><tr><td>MMP13</td><td>Prof. Irit Sagi lab</td><td>N/A</td></tr><tr><td>MMP7</td><td>Prof. Irit Sagi lab</td><td>N/A</td></tr><tr><td>MMP2</td><td>Prof. Irit Sagi lab</td><td>N/A</td></tr><tr><td>MMP9</td><td>Prof. Irit Sagi lab</td><td>N/A</td></tr><tr><td>TACE Pro Domain (TPD)</td><td>Prof. Irit Sagi lab</td><td>N/A</td></tr><tr><td>TACE</td><td>Prof. Irit Sagi lab</td><td>N/A</td></tr><tr><td>KLK4</td><td>Prof. Irit Sagi lab</td><td>N/A</td></tr><tr class="rowsep"><td>p53</td><td>Dr. Nir London lab</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Critical commercial assays</b></td></tr><tr><td>RNasin® Ribonuclease Inhibitor</td><td>Promega</td><td>N2615</td></tr><tr><td>Phusion High-Fidelity DNA Polymerase</td><td>NEB</td><td>M0530L</td></tr><tr><td>DpnI restriction enzyme</td><td>NEB</td><td>R0176L</td></tr><tr><td>SuperScript™ III Reverse Transcriptase</td><td>Invitrogen</td><td>18080-044</td></tr><tr><td>Plasmid Maxi Kit</td><td>QIAGEN</td><td>12163</td></tr><tr><td>TransIT-X2® Dynamic Delivery System</td><td>Mirus Bio</td><td>MIR 6004</td></tr><tr><td>EasySep™ Human NK Cell Isolation Kit</td><td>StemCell Technologies</td><td>#17955</td></tr><tr><td>Presto™ Mini Plasmid Kit</td><td>Geneaid</td><td>PDH100</td></tr><tr><td>Biotinylation Kit / Biotin Conjugation Kit (Fast, Type B) - Lightning-Link®</td><td>Abcam</td><td>ab201796</td></tr><tr class="rowsep"><td>Pierce™ BCA Protein Assay Kit</td><td>Thermo Scientific</td><td>23227</td></tr><tr class="rowsep"><td colspan="3"><b>Deposited data</b></td></tr><tr><td>Heavy chain sequences of cloned monoclonal antibodies</td><td>This paper</td><td>GenBank: OM628888-OM628942</td></tr><tr class="rowsep"><td>Light chain sequences of cloned monoclonal antibodies</td><td>This paper</td><td>GenBank: OM628943-OM628997</td></tr><tr class="rowsep"><td colspan="3"><b>Experimental models: Cell lines</b></td></tr><tr><td>ADR∖Res</td><td>Weizmann Institute of Science cell line repository</td><td><a id="intref0045" href="https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about" target="_blank">https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about</a></td></tr><tr><td>IGROV1</td><td>Weizmann Institute of Science cell line repository</td><td><a id="intref0050" href="https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about" target="_blank">https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about</a></td></tr><tr><td>ES2</td><td>Weizmann Institute of Science cell line repository</td><td><a id="intref0055" href="https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about" target="_blank">https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about</a></td></tr><tr><td>SKOV3</td><td>Weizmann Institute of Science cell line repository</td><td><a id="intref0060" href="https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about" target="_blank">https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about</a></td></tr><tr><td>OVCAR3</td><td>Weizmann Institute of Science cell line repository</td><td><a id="intref0065" href="https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about" target="_blank">https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about</a></td></tr><tr><td>OVCAR4</td><td>Weizmann Institute of Science cell line repository</td><td><a id="intref0070" href="https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about" target="_blank">https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about</a></td></tr><tr><td>OVCAR5</td><td>Weizmann Institute of Science cell line repository</td><td><a id="intref0075" href="https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about" target="_blank">https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about</a></td></tr><tr><td>OVCAR8</td><td>Weizmann Institute of Science cell line repository</td><td><a id="intref0080" href="https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about" target="_blank">https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about</a></td></tr><tr><td>ID8</td><td>Weizmann Institute of Science cell line repository</td><td><a id="intref0085" href="https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about" target="_blank">https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about</a></td></tr><tr><td>PANC1</td><td>Weizmann Institute of Science cell line repository</td><td><a id="intref0090" href="https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about" target="_blank">https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about</a></td></tr><tr><td>MCF7</td><td>Weizmann Institute of Science cell line repository</td><td><a id="intref0095" href="https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about" target="_blank">https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about</a></td></tr><tr><td>HT29</td><td>Weizmann Institute of Science cell line repository</td><td><a id="intref0100" href="https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about" target="_blank">https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about</a></td></tr><tr><td>MDAMB435</td><td>Weizmann Institute of Science cell line repository</td><td><a id="intref0105" href="https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about" target="_blank">https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about</a></td></tr><tr><td>HT1080</td><td>Weizmann Institute of Science cell line repository</td><td><a id="intref0110" href="https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about" target="_blank">https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about</a></td></tr><tr><td>THP-1</td><td>ATCC</td><td><a id="intref0115" href="https://www.atcc.org/products/tib-202" target="_blank">https://www.atcc.org/products/tib-202</a></td></tr><tr><td>Hep2</td><td>Weizmann Institute of Science cell line repository</td><td><a id="intref0120" href="https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about" target="_blank">https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about</a></td></tr><tr><td>HEK293t</td><td>Weizmann Institute of Science cell line repository</td><td><a id="intref0125" href="https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about" target="_blank">https://www.weizmann.ac.il/LS_CoreFacilities/stem-cells-advanced-cell-technologies/about</a></td></tr><tr><td>Primary tumor (test subject 16) primary culture</td><td>This paper</td><td>N/A</td></tr><tr><td>Omental metastasis (test subject 17) primary culture</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td>Ascites cells (test subject 22) primary culture</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Oligonucleotides</b></td></tr><tr><td>Random primers</td><td>Invitrogen</td><td>48190011</td></tr><tr class="rowsep"><td>Primers for single human B cell amplification and sequencing</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref66-2" href="#" role="doc-biblioref" data-xml-rid="bib66" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref66-2" aria-controls="sref66-2">Tiller et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref66-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">66.</div><div>Tiller, T. ∙ Meffre, E. ∙ Yurasov, S. ...</div><div><strong>Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expressionvector cloning</strong></div><div><em>J.&nbsp;Immunol. Methods.</em> 2008; <strong>329</strong>:112-124</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=T.TillerE.MeffreS.YurasovM.TsuijiM.C.NussenzweigH.WardemannEfficient+generation+of+monoclonal+antibodies+from+single+human+B+cells+by+single+cell+RT-PCR+and+expressionvector+cloningJ.%C2%A0Immunol.+Methods3292008112124" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><br>IDT</td><td><a id="intref0130" href="https://eu.idtdna.com/" target="_blank">https://eu.idtdna.com/</a></td></tr><tr class="rowsep"><td colspan="3"><b>Recombinant DNA</b></td></tr><tr><td>AbVec2.0-IGHG1</td><td>AddGene</td><td><a id="intref0135" href="http://www.addgene.org/" target="_blank">http://www.addgene.org/</a></td></tr><tr><td>AbVec1.1-IGKC</td><td>AddGene</td><td><a id="intref0140" href="http://www.addgene.org/" target="_blank">http://www.addgene.org/</a></td></tr><tr><td>AbVec1.1-IGLC2</td><td>AddGene</td><td><a id="intref0145" href="http://www.addgene.org/" target="_blank">http://www.addgene.org/</a></td></tr><tr><td>mCherry-MMP14 expression vector</td><td>Prof. Philippe Chavrier lab</td><td>N/A</td></tr><tr><td>Synthetic genes (gBlocks) of all monoclonal antibodies expressed, heavy&nbsp;+ light chains</td><td>IDT</td><td><a id="intref0150" href="https://eu.idtdna.com/" target="_blank">https://eu.idtdna.com/</a></td></tr><tr><td>Expression vector for mAb GD01</td><td>Dr. Ron Diskin lab</td><td>N/A</td></tr><tr class="rowsep"><td>Expression vector for mAb ED38</td><td>Prof. Michelle Nussenzweig lab</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Software and algorithms</b></td></tr><tr><td>QuPath v0.2.0-m9</td><td>QuPath</td><td><a id="intref0155" href="https://qupath.github.io/" target="_blank">https://qupath.github.io/</a></td></tr><tr><td>CaseViewer v2.2</td><td>3DHistech</td><td><a id="intref0160" href="https://www.3dhistech.com/" target="_blank">https://www.3dhistech.com/</a></td></tr><tr><td>FlowJo 10.5.3</td><td>FlowJo</td><td><a id="intref0165" href="https://www.flowjo.com/" target="_blank">https://www.flowjo.com/</a></td></tr><tr><td>Prism v9.3.1</td><td>Graphpad</td><td><a id="intref0170" href="https://www.graphpad.com" target="_blank">https://www.graphpad.com</a></td></tr><tr><td>IgBlast v1.14.0</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref82-1" href="#" role="doc-biblioref" data-xml-rid="bib82" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref82-1" aria-controls="sref82-1">Ye et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref82-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">82.</div><div>Ye, J. ∙ Ma, N. ∙ Madden, T.L. ...</div><div><strong>IgBLAST: an immunoglobulin variable domain sequence analysis tool</strong></div><div><em>Nucleic Acids Res.</em> 2013; <strong>41</strong>:W34-W40</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.YeN.MaT.L.MaddenJ.M.OstellIgBLAST%3A+an+immunoglobulin+variable+domain+sequence+analysis+toolNucleic+Acids+Res.412013W34W40" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0175" href="https://ncbi.github.io/igblast/" target="_blank">https://ncbi.github.io/igblast/</a></td></tr><tr><td>Change-O v0.4.6</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref29-2" href="#" role="doc-biblioref" data-xml-rid="bib29" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref29-2" aria-controls="sref29-2">Gupta et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref29-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Gupta, N.T. ∙ Vander Heiden, J.A. ∙ Uduman, M. ...</div><div><strong>Change-O: A toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data</strong></div><div><em>Bioinformatics.</em> 2015; <strong>31</strong>:3356-3358</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.T.GuptaJ.A.Vander+HeidenM.UdumanD.Gadala-MariaG.YaariS.H.KleinsteinChange-O%3A+A+toolkit+for+analyzing+large-scale+B+cell+immunoglobulin+repertoire+sequencing+dataBioinformatics31201533563358" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0180" href="https://changeo.readthedocs.io/en/stable/" target="_blank">https://changeo.readthedocs.io/en/stable/</a></td></tr><tr><td>Alakazam v0.3.0</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref29-3" href="#" role="doc-biblioref" data-xml-rid="bib29" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref29-3" aria-controls="sref29-3">Gupta et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref29-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Gupta, N.T. ∙ Vander Heiden, J.A. ∙ Uduman, M. ...</div><div><strong>Change-O: A toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data</strong></div><div><em>Bioinformatics.</em> 2015; <strong>31</strong>:3356-3358</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.T.GuptaJ.A.Vander+HeidenM.UdumanD.Gadala-MariaG.YaariS.H.KleinsteinChange-O%3A+A+toolkit+for+analyzing+large-scale+B+cell+immunoglobulin+repertoire+sequencing+dataBioinformatics31201533563358" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0185" href="https://alakazam.readthedocs.io/en/stable/" target="_blank">https://alakazam.readthedocs.io/en/stable/</a></td></tr><tr><td>BuildPhylipLineage v0.3.0</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref29-4" href="#" role="doc-biblioref" data-xml-rid="bib29" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref29-4" aria-controls="sref29-4">Gupta et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref29-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Gupta, N.T. ∙ Vander Heiden, J.A. ∙ Uduman, M. ...</div><div><strong>Change-O: A toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data</strong></div><div><em>Bioinformatics.</em> 2015; <strong>31</strong>:3356-3358</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.T.GuptaJ.A.Vander+HeidenM.UdumanD.Gadala-MariaG.YaariS.H.KleinsteinChange-O%3A+A+toolkit+for+analyzing+large-scale+B+cell+immunoglobulin+repertoire+sequencing+dataBioinformatics31201533563358" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0190" href="https://alakazam.readthedocs.io/en/stable/topics/buildPhylipLineage/" target="_blank">https://alakazam.readthedocs.io/en/stable/topics/buildPhylipLineage/</a></td></tr><tr><td>PHYLIP-3.69</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref29-5" href="#" role="doc-biblioref" data-xml-rid="bib29" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref29-5" aria-controls="sref29-5">Gupta et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref29-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Gupta, N.T. ∙ Vander Heiden, J.A. ∙ Uduman, M. ...</div><div><strong>Change-O: A toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data</strong></div><div><em>Bioinformatics.</em> 2015; <strong>31</strong>:3356-3358</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.T.GuptaJ.A.Vander+HeidenM.UdumanD.Gadala-MariaG.YaariS.H.KleinsteinChange-O%3A+A+toolkit+for+analyzing+large-scale+B+cell+immunoglobulin+repertoire+sequencing+dataBioinformatics31201533563358" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0195" href="https://alakazam.readthedocs.io/en/stable/vignettes/Lineage-Vignette/" target="_blank">https://alakazam.readthedocs.io/en/stable/vignettes/Lineage-Vignette/</a></td></tr><tr><td>SHazaM v0.2.3</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref29-6" href="#" role="doc-biblioref" data-xml-rid="bib29" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref29-6" aria-controls="sref29-6">Gupta et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref29-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Gupta, N.T. ∙ Vander Heiden, J.A. ∙ Uduman, M. ...</div><div><strong>Change-O: A toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data</strong></div><div><em>Bioinformatics.</em> 2015; <strong>31</strong>:3356-3358</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.T.GuptaJ.A.Vander+HeidenM.UdumanD.Gadala-MariaG.YaariS.H.KleinsteinChange-O%3A+A+toolkit+for+analyzing+large-scale+B+cell+immunoglobulin+repertoire+sequencing+dataBioinformatics31201533563358" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0200" href="https://shazam.readthedocs.io/en/stable/" target="_blank">https://shazam.readthedocs.io/en/stable/</a></td></tr><tr><td>BASELINe’s v0.2.3</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref80-1" href="#" role="doc-biblioref" data-xml-rid="bib80" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref80-1" aria-controls="sref80-1">Yaari et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref80-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">80.</div><div>Yaari, G. ∙ Uduman, M. ∙ Kleinstein, S.H.</div><div><strong>Quantifying selection in high-throughput immunoglobulin sequencing data sets</strong></div><div><em>Nucleic Acids Res.</em> 2012; <strong>40</strong>:e134</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.YaariM.UdumanS.H.KleinsteinQuantifying+selection+in+high-throughput+immunoglobulin+sequencing+data+setsNucleic+Acids+Res.402012e134" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0205" href="https://shazam.readthedocs.io/en/stable/topics/calcBaseline/" target="_blank">https://shazam.readthedocs.io/en/stable/topics/calcBaseline/</a></td></tr><tr><td>Pymol</td><td>Schrodinger</td><td><a id="intref0210" href="https://www.pymol.org/" target="_blank">https://www.pymol.org/</a></td></tr><tr><td>ColabFold "Advanced" notebook</td><td>Google Research</td><td><a id="intref0215" href="https://colab.research.google.com/github/sokrypton/ColabFold/blob/main/beta/AlphaFold2_advanced.ipynb" target="_blank">https://colab.research.google.com/github/sokrypton/ColabFold/blob/main/beta/AlphaFold2_advanced.ipynb</a></td></tr><tr><td>AlphaFold</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref33-2" href="#" role="doc-biblioref" data-xml-rid="bib33" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref33-2" aria-controls="sref33-2">Jumper et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref33-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">33.</div><div>Jumper, J. ∙ Evans, R. ∙ Pritzel, A. ...</div><div><strong>Highly accurate protein structure prediction with AlphaFold</strong></div><div><em>Nature.</em> 2021; <strong>596</strong>:583-589</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.JumperR.EvansA.PritzelT.GreenM.FigurnovO.RonnebergerK.TunyasuvunakoolR.BatesA.%C5%BD%C3%ADdekA.PotapenkoHighly+accurate+protein+structure+prediction+with+AlphaFoldNature5962021583589" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>PatchDock</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref62-2" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-2" aria-controls="sref62-2">Schneidman-Duhovny et&nbsp;al., 2005</a><div class="dropBlock__holder" data-db-target-of="sref62-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Schneidman-Duhovny, D. ∙ Inbar, Y. ∙ Nussinov, R. ...</div><div><strong>PatchDock and SymmDock: servers for rigid and symmetric docking</strong></div><div><em>Nucleic Acids Res.</em> 2005; <strong>33</strong>:W363-W367</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.Schneidman-DuhovnyY.InbarR.NussinovH.J.WolfsonPatchDock+and+SymmDock%3A+servers+for+rigid+and+symmetric+dockingNucleic+Acids+Res.332005W363W367" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0220" href="https://bioinfo3d.cs.tau.ac.il/PatchDock/" target="_blank">https://bioinfo3d.cs.tau.ac.il/PatchDock/</a></td></tr><tr class="rowsep"><td>FireDock</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref41-2" href="#" role="doc-biblioref" data-xml-rid="bib41" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref41-2" aria-controls="sref41-2">Mashiach et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref41-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">41.</div><div>Mashiach, E. ∙ Schneidman-Duhovny, D. ∙ Andrusier, N. ...</div><div><strong>FireDock: A web server for fast interaction refinement in molecular docking</strong></div><div><em>Nucleic Acids Res.</em> 2008; <strong>36</strong>:W229-W232</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=E.MashiachD.Schneidman-DuhovnyN.AndrusierR.NussinovH.J.WolfsonFireDock%3A+A+web+server+for+fast+interaction+refinement+in+molecular+dockingNucleic+Acids+Res.362008W229W232" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0225" href="https://bioinfo3d.cs.tau.ac.il/FireDock/" target="_blank">https://bioinfo3d.cs.tau.ac.il/FireDock/</a></td></tr><tr class="rowsep"><td colspan="3"><b>Other</b></td></tr><tr><td>Protein G Sepharose beads</td><td>Cytiva/GE</td><td>17-0618-05</td></tr><tr><td>Mini Bio-Spin Chromatography Columns</td><td>BioRad</td><td>7326207</td></tr><tr><td>Maxi GeBSflex-tube, 8&nbsp;kDa MWCO</td><td>Gebaflex</td><td>MAXI8-30</td></tr><tr><td>Streptavidin Coated Microspheres</td><td>Bangs Laboratories Inc.</td><td>CFFR004/CP01F</td></tr><tr><td>E-Plate 16 PET</td><td>Agilent</td><td>00300600890</td></tr><tr><td>ProtoArray® Human Protein Microarray v5.1</td><td>Invitrogen</td><td>PAH05251020</td></tr><tr><td>4–20% Mini-PROTEAN® TGX Stain-Free™ Protein Gels, 15 well, 15&nbsp;μl</td><td>BioRad</td><td>#4568096</td></tr><tr><td>Trans-Blot Turbo Midi 0.2&nbsp;μm Nitrocellulose Transfer Packs</td><td>BioRad</td><td>#1704159</td></tr><tr><td>Flat-bottom MaxiSorp™ 96-well plates</td><td>Invitrogen</td><td>44-2404-21</td></tr></tbody></table></div><figcaption><div class="core-table-tools"><ul><li><a class="core-table-show-action" href="/action/showFullTableHTML?isHtml=true&amp;tableId=undtbl1&amp;pii=S0092-8674%2822%2900192-1" target="_blank">Open table in a new tab</a></li></ul></div></figcaption></figure></div></div></section><section id="sec-4-2"><h3>Resource availability</h3><section id="sec-4-2-1"><h4>Lead contact</h4><div id="p0195" role="paragraph">Further information and requests for resources and reagents should be directed to the lead contact, Ziv Shulman (<a id="intref0230" href="mailto:ziv.shulman@weizmann.ac.il">ziv.shulman@weizmann.ac.il</a>).</div></section><section id="sec-4-2-2"><h4>Materials availability</h4><div id="p0200" role="paragraph">Primary cultures and monoclonal antibody expression vectors generated in this study will be distributed upon request.</div></section></section><section id="sec-4-3"><h3>Experimental model and subject details</h3><section id="sec-4-3-1"><h4>Human samples and cohorts</h4><div id="p0205" role="paragraph">The acquisition of human samples for the purpose of this study was approved by the Helsinki committee of the Rabin Medical Center under protocol 0450-16-RMC and by the Institutional Review Board of the Weizmann Institute of Science under protocol 71-1. Informed consent was obtained from all participants prior to their recruitment to the study. Throughout the study, data were collected based on human samples obtained from four patient cohorts as detailed below. The clinical characteristics of each of these cohorts appear in <a id="crosref1160" href="#mmc1">Tables S1–S3</a> and <a id="crosref1165" href="#mmc1">S5</a>.</div><section id="sec-4-3-1-1"><h5>Cohort 1 (FFPE samples)</h5><div id="p0210" role="paragraph">A total of 37 FFPE samples were collected from the surgical theatre and department of pathology at the Rabin medical center (29/37)&nbsp;and&nbsp;purchased from the Sheba medical center biobank (8/37). All FFPE specimens in this study were reviewed by a certified gyneco-pathologist to confirm the diagnosis of HGSOC and to ensure sufficient tumor quantity and quality. Moreover, all samples originate from chemonaive patients who underwent primary surgery (TAH/BSO) at the time of sample acquisition. 3 samples were removed from the cohort due to poor specimen quality - culminating in 34 FFPE samples; 81.1% of patients in this cohort had stage III-IV disease.</div></section><section id="sec-4-3-1-2"><h5>Cohort 2 (ascites samples)</h5><div id="p0215" role="paragraph">A total of 25 ascites samples were obtained from the surgical theatre and department of gynecologic oncology at the Rabin medical center (7/25) and purchased from the Sheba medical center biobank (18/25). When obtained fresh, fluids were separated to their liquid and cellular phases and cryopreserved accordingly. All cellular samples were preserved in 90% fetal calf serum plus 10% DMSO and stored in liquid nitrogen vapor phase conditions. Fluid samples were flash frozen and stored at -80C. 100% of these patients in this cohort had stage III-IV disease.</div></section><section id="sec-4-3-1-3"><h5>Cohort 3 (fresh samples)</h5><div id="p0220" role="paragraph">Fresh tissue samples were obtained from the surgical theatre at the Rabin medical center during the patients’ primary surgery (TAH/BSO). Specimens collected included samples of ovarian carcinoma primary tumors, metastases, ascites fluids (enlisted in cohort 2) and peripheral blood as well as samples of healthy ovaries and fallopian tubes from the contralateral non-diseased adnexa, when available. Acquired tissues and tumors were frozen as single cell suspensions and protein extracts, and were also preserved in formalin fixed paraffin embedded (FFPE) tissue blocks (enlisted in cohort 1). Protein extracts were flash frozen and stored at -80C. Samples from a total of 19 chemonaive patients were obtained. Of these, 10 patients received a pathological diagnosis of HGSOC and thus were included in this study. The remaining 9 patients were excluded from this cohort based on the following pathological diagnoses: fibrothecoma (2/9), borderline ovarian carcinoma (2/9), granulosa cell tumor (1/9), high grade ovarian leiomyosarcoma (1/9), Low grade endometrial carcinoma with ovarian involvement (1/9), Mucinous ovarian carcinoma (1/9), Primary peritoneal carcinoma (1/9). 100% of patients in this cohort had stage III-IV disease.</div></section><section id="sec-4-3-1-4"><h5>Cohort 4 (serum samples from patient is remission)</h5><div id="p0225" role="paragraph">A total of 8 blood samples of HGSOC patients in remission were obtained from the department of gynecological oncology at the Rabin medical center. All patients underwent TAH/BSO, completed their adjuvant therapy and exhibited CA125 values within normal range as well as no evidence of disease on PET/CT. Samples were collected during routine follow up visits with a mean remission duration of 7.3&nbsp;months (range: 2.3-17.9&nbsp;months). At the time of diagnosis, 75% of these patients had stage III-IV disease.</div></section><section id="sec-4-3-1-5"><h5>Additional tumor samples</h5><div id="p0230" role="paragraph">FFPE samples of multiple human tumor types were procured as a tissue microarray (MC5004) from US Biomax.</div></section></section><section id="sec-4-3-2"><h4>Study participants</h4><div id="p0235" role="paragraph">Information about study participants can be found in <a id="crosref1170" href="#mmc4">Table S7</a>.</div></section><section id="sec-4-3-3"><h4>Cell culture conditions</h4><div id="p0240" role="paragraph">Cell lines and primary cultures were maintained in DMEM media supplemented with 10% (v/v) foetal bovine serum, 1% (v/v) MEM-Eagle non essential amino acids, 1% (v/v) 2mM glutamine and 1% (v/v) Pen-Strep solution. Cells were cultured at 37 °C with 5% carbon dioxide.</div></section><section id="sec-4-3-4"><h4>Cell lines</h4><div id="p0245" role="paragraph">ADR/Res, IGROV1, SKOV3, OVCAR3, OVCAR4, OVCAR5, OVCAR8, PANC1, MCF7, HT29, MDAMB435, HEK293T, HEp-2 and K562 were obtained from the Weizmann Institute of Science cell repository. Cell lines originating from the Weizmann Institute of Science cell repository are pre-authenticated and confirmed to be mycoplasma free.</div></section><section id="sec-4-3-5"><h4>Primary cultures</h4><div id="p0250" role="paragraph">Fresh HGSOC primary tumor, omental metastases, and ascites samples were retrieved from the operating theatre. Primary cultures were established from these specimens as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref51" href="#" role="doc-biblioref" data-xml-rid="bib51" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref51" aria-controls="sref51">O Donnell et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref51"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">51.</div><div>O Donnell, R.L. ∙ McCormick, A. ∙ Mukhopadhyay, A. ...</div><div><strong>The use of ovarian cancer cells from patients undergoing surgery to generate primary cultures capable of undergoing functional analysis</strong></div><div><em>PLoS One.</em> 2014; <strong>9</strong>:e90604</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.L.O+DonnellA.McCormickA.MukhopadhyayL.C.WoodhouseM.MoatA.GrundyM.DixonA.KaufmanA.ElattarThe+use+of+ovarian+cancer+cells+from+patients+undergoing+surgery+to+generate+primary+cultures+capable+of+undergoing+functional+analysisPLoS+One92014e90604" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and used after 2-3 passages. Cell preparation included removing fibroblasts as well as all non-adherent cells from the culture. 100% of the cultured cells were EpCAM positive (324207, Biolegend, 1:200). For quantification of tumor IgG binding by flow cytometry, primary cultures were stained for IgG (709-545-149, Jackson Immunoresearch, 1:200) 24 hours following sample acquisition, and evaluated using a flow cytometer.</div></section></section><section id="sec-4-4"><h3>Method details</h3><section id="sec-4-4-1"><h4>Immunohistochemical and immunofluorescence staining of tissue sections</h4><div id="p0255" role="paragraph">The following commercial antibodies were used: IgG (709-545-149, Jackson Immunoresearch, 1:200), CD138 (10593-1-AP, Proteintech, 1:800), CD20 (M0755, Dako, 1:200), CD3 (SP7, Thermo, 1:25), CD56 (AF2408-SP, R&amp;D, 10μg/ml) and MMP14 (LEM-2/15.8, 1:100). Briefly, FFPE specimens were sectioned onto 4μm slides, stained with H&amp;E and evaluated by a certified gynco-pathologist, to assure adequate sample quantity and quality. Unstained slides were then deparaffinized, subjected to antigen retrieval in TE buffer, blocked using 1% bovine serum albumin for 90&nbsp;minutes, and stained with the appropriate primary and secondary antibodies, overnight at 4°C and for 2&nbsp;hrs at room temperature, respectively. Slides were then stained with DAPI (1:5000) and sealed using Immunomount.</div></section><section id="sec-4-4-2"><h4>Quantification of tumor binding by endogenous IgG typed antibodies in FFPE samples</h4><div id="p0260" role="paragraph">Stained slides were scanned using a 3D Histech Pannoramic SCAN II slide scanner. Post processing of the scanned raw data included identification of all nuclei in the sample using QuPath v0.2.0-m9 cell detection function. Threshold parameters were optimized to identify nuclei of all shapes and sizes, and IgG signal was quantified within a 2μm radius of the nuclear border. An object classifier based on the Random trees (RTrees) machine learning algorithm was trained to distinguish between tumor and non-tumor cell architectures. To negate potential bias, the training was performed on the basis of a multitude of parameters derived from the nuclear data layer (DAPI) only. The software could then distinguish between IgG positive and negative cells and calculate the percentage of IgG-positive cells within each compartment. Quantification of various populations of immune cells was performed in a similar manner using samples stained for CD138, CD20, IgG, DAPI or CD56 and CD3.</div></section><section id="sec-4-4-3"><h4>Purification of polyclonal IgG antibody fractions</h4><div id="p0265" role="paragraph">Polyclonal IgG fractions were isolated from ascites fluids and sera. Briefly, the fluids of interest were filtered through a 0.2μm filter and reacted with protein G Sepharose beads (17-0618-05, Cytiva/GE) on a tilt table, overnight in 4°C. Beads were then pulled down, washed in PBS and eluted using IgG elution buffer (21004, ThermoFisher) into 1M TRIS pH 9. The eluate was then dialyzed against PBS overnight.</div></section><section id="sec-4-4-4"><h4>Immunofluorescence staining of cell lines and primary cultures</h4><div id="p0270" role="paragraph">Cell lines or primary cultures of interest were grown on 96 well plates or chamber slides, fixed with 4% PFA, washed with PBS, blocked with 1% BSA for 90&nbsp;minutes, stained with the antibodies of interest at a concentration of 500nM overnight in 4°C, followed by staining with an Alexa Fluor 488 conjugated secondary antibody and DAPI (1:5000). For fluorescent analysis of monolayers, DAPI normalized Alexa Fluor 488 signal was used to quantify the staining per well using a Synergy HTX plate reader (Biotek). For quantification of immunofluorescence staining, slides were acquired using a Zeiss LSM 880 confocal microscope. The mean fluorescence signal was calculated per cell using QuPath v0.2.0-m9.</div></section><section id="sec-4-4-5"><h4>ELISA for antibody binding of recombinant proteins</h4><div id="p0275" role="paragraph">ELISA reactions were carried out using flat-bottom MaxiSorp™ 96-well plates (Invitrogen). Antigen coating was performed in PBS at 100μl per well and left overnight at 4°C. For standard dose response ELISA assays, antigens were plated at a concentration of 1&nbsp;μg/ml. The enzyme targets were expressed recombinantly, in house (<span class="dropBlock reference-citations"><a id="body-ref-sref68-2" href="#" role="doc-biblioref" data-xml-rid="bib68" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref68-2" aria-controls="sref68-2">Udi et&nbsp;al. 2013</a><div class="dropBlock__holder" data-db-target-of="sref68-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">68.</div><div>Udi, Y. ∙ Fragai, M. ∙ Grossman, M. ...</div><div><strong>Unraveling hidden allosteric regulatory sites in structurally homologues metalloproteases</strong></div><div><em>J.&nbsp;Mol. Biol.</em> 2013; <strong>425</strong>:2330-2346</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.UdiM.FragaiM.GrossmanS.MitternachtR.Arad-YellinV.CalderoneM.MelikianM.ToccafondiI.N.BerezovskyC.LauchinatI.SagoUnraveling+hidden+allosteric+regulatory+sites+in+structurally+homologues+metalloproteasesJ.%C2%A0Mol.+Biol.42520132330234610.1016%2Fj.jmb.2013.04.009" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). For comparative ELISA assays with multiple targets, antigens were plated at a constant molar concentration of 50nM. The plates were washed 5 times with a washing buffer (1× PBS, 0.05% Tween-20) and incubated with 100μl blocking buffer (1× PBS with 1% BSA) for 1h at room temperature. The blocking solution was subsequently replaced by serial dilutions of either mono- or polyclonal antibodies or serum samples for 2.5h at RT. For standard dose response ELISA assays, antibodies were introduced over a range of dilutions whereas for ELISA screens, antibodies were used at 100nM. Serum samples were assayed at a dilution of 1:100. Plates were washed 5 times with a washing buffer and then incubated with anti-human IgG secondary antibody conjugated to horseradish peroxidase (HRP) (Jackson Immuno Research) in PBS at a 1:5,000 dilution. After washing the plates for an additional 5 times, the plates were developed using TMB (Thermo Fisher) and absorbance was measured at 630nm with an ELISA microplate reader (Synergy HTX plate reader, Biotek). ELISA assays for evaluating antibody polyreactivity were performed as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref55" href="#" role="doc-biblioref" data-xml-rid="bib55" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref55" aria-controls="sref55">Prigent et&nbsp;al. 2016</a><div class="dropBlock__holder" data-db-target-of="sref55"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">55.</div><div>Prigent, J. ∙ Lorin, V. ∙ Kök, A. ...</div><div><strong>Scarcity of autoreactive human blood IgA+ memory B cells</strong></div><div><em>Eur. J. Immunol.</em> 2016; <strong>46</strong>:2340-2351</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.PrigentV.LorinA.K%C3%B6kT.HieuS.BourgeauH.MouquetScarcity+of+autoreactive+human+blood+IgA%2B+memory+B+cellsEur.+J.+Immunol.46201623402351" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). For peptide ELISA, the putative epitope sequence of mAb T13 was purchased as a biotinylated peptide from Genscript. Confirmation of peptide binding to mAbs T13 &amp; T12 was performed by coating Maxisorp plates with 5μg/ml of the desired antibody overnight at 4C followed by blocking, incubation with different peptide dilutions, washing (X5), exposure to HRP conjugated streptavidin (1:2000), washing (X5) and TMB development.</div></section><section id="sec-4-4-6"><h4>Flow cytometric analysis, single ASC sorting and immunoglobulin sequencing</h4><div id="p0280" role="paragraph">Fresh HGSOC primary tumors retrieved from the operating theatre were immediately dissociated to a single cell suspension in growth&nbsp;medium (DMEM, 10% (v/v) foetal bovine serum, 1% (v/v) MEM-Eagle non essential amino acids, 1% (v/v) 2mM glutamine and 1% (v/v) Pen-Strep solution.) and placed on ice. Cells were washed in PBS and stained with the following antibodies: Alexa fluor 700 conjugated anti-human CD19 (Biolegend, clone: HIB19), PerCP/Cy5.5 conjugated anti-human CD38 (Biolegend, Clone: HIT2), APC conjugated anti-human IgG1 FC region (RD Systems, Clone: #97924), PE conjugated anti-human IgM (Biolegend, Clone: MHM-88). Samples were stained on ice for 45&nbsp;minutes, washed and acquired using a Cytoflex flow cytometer and analysed using FlowJo 10.5.3. For immunoglobulin sequencing, tumor infiltrating CD19<sup>+</sup>, CD38<sup>++</sup>, IgM<sup>-</sup>, IgG1<sup>+</sup>, ASCs originating from the primary tumors of 4 HGSOC patients also underwent single cell sorting into 96 well PCR plates containing 4ul per well of mRNA preserving lysis buffer (in RNAse free water, 10% DTT 0.1M v/v, 5% PBS X10 v/v, 7.5% RNasin ribonuclease inhibitor v/v, cat: N2615). Sorted plates were immediately frozen to -80C to preserve mRNA integrity. Single cell sorted tumor infiltrating ACSs were reverse transcribed and underwent nested PCR amplification and sequencing of their heavy and light chain transcripts as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref66-3" href="#" role="doc-biblioref" data-xml-rid="bib66" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref66-3" aria-controls="sref66-3">Tiller et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref66-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">66.</div><div>Tiller, T. ∙ Meffre, E. ∙ Yurasov, S. ...</div><div><strong>Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expressionvector cloning</strong></div><div><em>J.&nbsp;Immunol. Methods.</em> 2008; <strong>329</strong>:112-124</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=T.TillerE.MeffreS.YurasovM.TsuijiM.C.NussenzweigH.WardemannEfficient+generation+of+monoclonal+antibodies+from+single+human+B+cells+by+single+cell+RT-PCR+and+expressionvector+cloningJ.%C2%A0Immunol.+Methods3292008112124" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-4-4-7"><h4>Data analysis of immunoglobulin sequences</h4><div id="p0285" role="paragraph">Ig Fasta sequences were aligned against the IMGT human heavy chain gene database (downloaded in Dec. 2019) and light chain gene database (downloaded in Feb. 2017) using NCBI IgBlast (version 1.14.0) (<span class="dropBlock reference-citations"><a id="body-ref-sref82-2" href="#" role="doc-biblioref" data-xml-rid="bib82" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref82-2" aria-controls="sref82-2">Ye et&nbsp;al. 2013</a><div class="dropBlock__holder" data-db-target-of="sref82-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">82.</div><div>Ye, J. ∙ Ma, N. ∙ Madden, T.L. ...</div><div><strong>IgBLAST: an immunoglobulin variable domain sequence analysis tool</strong></div><div><em>Nucleic Acids Res.</em> 2013; <strong>41</strong>:W34-W40</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.YeN.MaT.L.MaddenJ.M.OstellIgBLAST%3A+an+immunoglobulin+variable+domain+sequence+analysis+toolNucleic+Acids+Res.412013W34W40" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Post processing of IgBlast output and clonal clustering were performed using Change-O v0.4.6 (<a id="intref0235" href="https://changeo.readthedocs.io" target="_blank">https://changeo.readthedocs.io</a>) (<span class="dropBlock reference-citations"><a id="body-ref-sref29-7" href="#" role="doc-biblioref" data-xml-rid="bib29" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref29-7" aria-controls="sref29-7">Gupta et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref29-7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Gupta, N.T. ∙ Vander Heiden, J.A. ∙ Uduman, M. ...</div><div><strong>Change-O: A toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data</strong></div><div><em>Bioinformatics.</em> 2015; <strong>31</strong>:3356-3358</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.T.GuptaJ.A.Vander+HeidenM.UdumanD.Gadala-MariaG.YaariS.H.KleinsteinChange-O%3A+A+toolkit+for+analyzing+large-scale+B+cell+immunoglobulin+repertoire+sequencing+dataBioinformatics31201533563358" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), Alakazam v0.3.0 (<a id="intref0240" href="https://alakazam.readthedocs" target="_blank">https://alakazam.readthedocs</a>.), SHazaM v0.2.3 (<a id="intref0245" href="https://shazam.readthedocs.io" target="_blank">https://shazam.readthedocs.io</a>), and custom scripts within the R statistical computing environment, as follows. V(D)J sequences were assigned to clonal groups by partitioning sequences based on identity of IGHV gene annotations, IGHJ gene annotations, and junction region lengths. Within these groups, sequences differing from one another by more than 15 nucleotides between the V genes were defined as separate clones. Full-length germline sequences were reconstructed for each clone, with the D segment and nucleotide additions in the junction between the V-D and D-J segments) replaced with Ns. Lineage trees were constructed for each clone with at least two unique sequences using the Alakazam R package function, BuildPhylipLineage (<span class="dropBlock reference-citations"><a id="body-ref-sref29-8" href="#" role="doc-biblioref" data-xml-rid="bib29" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref29-8" aria-controls="sref29-8">Gupta et&nbsp;al. 2015</a><div class="dropBlock__holder" data-db-target-of="sref29-8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Gupta, N.T. ∙ Vander Heiden, J.A. ∙ Uduman, M. ...</div><div><strong>Change-O: A toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data</strong></div><div><em>Bioinformatics.</em> 2015; <strong>31</strong>:3356-3358</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.T.GuptaJ.A.Vander+HeidenM.UdumanD.Gadala-MariaG.YaariS.H.KleinsteinChange-O%3A+A+toolkit+for+analyzing+large-scale+B+cell+immunoglobulin+repertoire+sequencing+dataBioinformatics31201533563358" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), which utilizes PHYLIP (<span class="dropBlock reference-citations"><a id="body-ref-sref26-2" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26-2" aria-controls="sref26-2">Felsenstein 2005</a><div class="dropBlock__holder" data-db-target-of="sref26-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">26.</div><div>Felsenstein, J.</div><div><strong>PHYLIP (phylogeny Inference Package)</strong></div><div>2005</div><div>Distributed by the Author (Department of Genome Sciences, University of Washington). <a id="interref0010" href="http://evolution.genetics.washington.edu/phylip.html" target="_blank">http://evolution.genetics.washington.edu/phylip.html</a></div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.FelsensteinPHYLIP+%28phylogeny+Inference+Package%29version+3.62005Distributed+by+the+Author+%28Department+of+Genome+Sciences%2C+University+of+Washington%29.+http%3A%2F%2Fevolution.genetics.washington.edu%2Fphylip.html" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In brief, maximum parsimony is a character-based approach that infers a phylogenetic tree by minimizing the total number of steps. The BuildPhylipLineage Alakazam function constructs the immunoglobulin phylogenetic trees through maximum parsimony by an external call to the dnapars (DNA Parsimony Program) application of the PHYLIP package. The dnapars program carries out unrooted parsimony on DNA sequences. It assumes that each site evolves independently, that different lineages evolve independently, that the probability of a base substitution at a given site is small over the lengths of time involved in a branch of the phylogeny, and that the expected degree of change in different branches of the phylogeny do not vary by so much that two changes in a high-rate branch are more probable than one change in a low-rate branch. Finally, the expected amounts of change do not vary so much among sites, so that two changes at one site would be more probable than one change at another. Following lineage tree generation, the dnapars output is changed to allow input sequences to appear as internal nodes of the tree. Intermediate sequences inferred by dnapars are replaced by progeny within the tree having a Hamming distance of zero from their parent node. The distance calculation allows IUPAC ambiguous character matches, where an ambiguous character has distance zero to any character in the set of characters it represents. Distance calculation and movement of downstream nodes up the tree are repeated until all parent-progeny pairs have a distance greater than zero between them. The germline sequence (outgroup) is moved to the base of the tree and excluded from the node replacement processes, which permits the trunk of the tree to be the only edge with a distance of zero. Edge weights of the resultant tree are assigned as the distance between each sequence. In selected cases, in which V-J configurations and junction lengths are identical between different sequences for both the heavy and light chains, yet the V genes differed by more than 15 nucleotides, members were manually clustered into single clones, though a common ancestry could not be assumed. Such relations appear with a dashed connecting line in lineage trees. Additionally, multiple identical sequences are treated as a single expanded clone. Selection quantification was calculated using BASELINe’s local test (<span class="dropBlock reference-citations"><a id="body-ref-sref80-2" href="#" role="doc-biblioref" data-xml-rid="bib80" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref80-2" aria-controls="sref80-2">Yaari et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref80-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">80.</div><div>Yaari, G. ∙ Uduman, M. ∙ Kleinstein, S.H.</div><div><strong>Quantifying selection in high-throughput immunoglobulin sequencing data sets</strong></div><div><em>Nucleic Acids Res.</em> 2012; <strong>40</strong>:e134</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.YaariM.UdumanS.H.KleinsteinQuantifying+selection+in+high-throughput+immunoglobulin+sequencing+data+setsNucleic+Acids+Res.402012e134" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-4-4-8"><h4>Antibody expression</h4><div id="p0290" role="paragraph">ASC immunoglobulin transcripts were chosen for cloning and expression on the basis of several criteria. These included: relation of the candidate to an expanded clone, occurrence of multiple identical clonal members, and high load of somatic hypermutations. Following selection of antibody candidates, constructs containing the heavy and light chain variable regions were produced as gBlocks by IDT and cloned into human IgG1, IgK and IgL expression vectors via the restriction free method. Cloning was performed into human IgG1, IgK and IgL expression vectors (AddGene, AbVec2.0-IGHG1, AbVec1.1-IGKC, AbVec1.1-IGLC2) using Phusion High-Fidelity DNA Polymerase (NEB, cat: M0530L) according to the manufacturer’s instructions. The template plasmids were then selectively degraded using the DpnI restriction enzyme (NEB, cat: R0176L) for 16 hours at 37°C. Cloned vectors were transformed into DH5a competent bacteria (Real Biotech) according to the manufacturer's protocol. Plasmid containing bacteria were selected on the basis of vector-acquired ampicillin resistance. After plating, monoclonal bacterial colonies underwent PCR and sequencing validation of their transformed plasmids. Successfully transformed colonies were then expanded and harvested using Qiagen’s plasmid purification kit. Purified vectors were transfected into HEK293t cells in 150mm tissue culture plates (Corning) at 12.5ug/DNA per chain using linear 40kDa polyethyleneimine (at a DNA:PEI mass ratio of 1:2) and grown in serum free media for 5&nbsp;days. Supernatants were filtered through a 0.2μm strainer and reacted with protein G Sepharose beads (17-0618-05, Cytiva/GE) on a tilt table, overnight at 4°C. Beads were then pelleted by centrifugation, washed in PBS and eluted using IgG elution buffer (21004, ThermoFisher) into TRIS pH 9 1M. The eluate was then dialyzed against PBS overnight and its final concentration measured using Nanodrop.</div></section><section id="sec-4-4-9"><h4>Biolayer interferometry</h4><div id="p0295" role="paragraph">Analysis of the kinetic binding constants of mAb T13 to MMP14 was performed using the Octet QKe platform. Experiments were conducted at 30°C with shaking at 1,000&nbsp;rpm. Antibody loading of mAb T13 was performed at an optimized pre-calibrated concentration of 12.5nM for 5&nbsp;minutes in PBS. Loaded sensors were then exposed to TNC buffer (50mM Tris pH 8, 150mM NaCl, 5mM CaCl<sub>2</sub>) for 30 seconds and 1&nbsp;min in two adjacent wells. Next, MMP14 association was tested over a range of concentrations (30nM-2000nM), in TNC buffer for 30&nbsp;minutes. Finally, antigen dissociation was followed in TNC buffer for 30&nbsp;minutes. Data processing, construction of a response model and curve fitting was accomplished using the Fortebio Octet Data analysis software.</div></section><section id="sec-4-4-10"><h4>Western blot</h4><div id="p0300" role="paragraph">Cell lysates were made from cell lines and patient derived tumor specimens. Cell lines grown to confluence and minced tumor specimens were emulsified in 500ul of RIPA buffer (20mM Tris pH 7.4, 137mM NaCl, 10% glycerol, 0.1% SDS, 0.5% deoxycholate, 1% triton X-100, 2mM EDTA pH 8, 1mM PMSF, 20uM Leupeptin, in DDW) and protease inhibitor (1:100). Mixture was vortexed, agitated for 1 hour at 4°C and centrifuged. Supernatants were separated and flash frozen. Prior to the experiment, the protein concentration of the lysates was measured in triplicates using a BCA kit (Pierce™ BCA Protein Assay Kit). Samples containing 25μg of protein were mixed with sample buffer in the presence of DTT, heated to 95°C for 5&nbsp;minutes and introduced to 15-well gradient gels (Bio-Rad). The gel content was transferred to a nitrocellulose membrane using the rapid transfer method. Nitrocellulose membranes were incubated in blocking buffer (5% BSA, 0.1% tween in PBS) for 1 hour, at room temperature on a tilt table. The membranes were then exposed to the appropriate primary antibodies at 1&nbsp;μg/ml in 5% BSA in PBS, overnight at 4°C on a tilt table. The next day, membranes were washed 3 times in wash buffer (0.1% tween in PBS), exposed to the appropriate isotype targeting horseradish peroxidase (HRP) conjugated secondary antibodies (Jackson ImmunoResearch) at 1:5000 for 1 hour at room temperature, washed 3 times and developed using ECL. Antibody signals were acquired using the ChemiDoc imaging system (Bio-Rad). Images were analysed using the Image Lab 6.0.1 software (Bio-Rad).</div></section><section id="sec-4-4-11"><h4>MMP14 overexpression assay</h4><div id="p0305" role="paragraph">K562 cells were transfected with an <i>mmp14</i>:mCherry expression vector using the TransIT-X2 transfection reagent (Mirus Bio) according to the manufacturer’s protocol. Briefly, 0.5M K562 cells were plated in 6 well plates in 2.5ml of growth medium (DMEM, 10% (v/v) foetal bovine serum, 1% (v/v) MEM-Eagle non essential amino acids, 1% (v/v) 2mM glutamine and 1% (v/v) Pen-Strep solution) per well. For each condition, in a separate tube, 2.5μg of the <i>mmp14</i>:Cherry vector and 7.5μl of the TransIT-X2 transfection reagent were mixed in 250ul of Opti-MEM I reduced serum medium (Gibco) and incubated at room temperature for 30&nbsp;minutes. Following incubation, the mixture was added to the cells in a drop-wise manner. A mock transfection without the <i>mmp14</i>:mCherry construct was performed in parallel as a negative control. Following a 48&nbsp;hr incubation, the cells were stained with 500nM T13 antibody for 45&nbsp;minutes on ice, washed, stained with an Alexa fluor 488 conjugated anti human IgG secondary antibody (Jackson Immunoresearch) for 30&nbsp;minutes on ice, washed and analysed using a Cytoflex flow cytometer.</div></section><section id="sec-4-4-12"><h4>Phage display assay</h4><div id="p0310" role="paragraph">Biopanning was performed as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref27-2" href="#" role="doc-biblioref" data-xml-rid="bib27" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref27-2" aria-controls="sref27-2">Freund et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref27-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">27.</div><div>Freund ∙ Tarnovitski, N. ∙ Enshell-Seijffers, D. ...</div><div><strong>Phage display selection, analysis, and prediction of B cell epitopes</strong></div><div><em>Curr. Protoc. Immunol.</em> 2009; <strong>9</strong>:8</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=FreundN.TarnovitskiD.Enshell-SeijffersJ.M.GershoniPhage+display+selection%2C+analysis%2C+and+prediction+of+B+cell+epitopesCurr.+Protoc.+Immunol.920098" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Briefly, approximately 1x1010 phages of the random-peptide library were mixed with 2&nbsp;μg antibody in TBS x1 3% BSA solution (complete to 100μl) in 0.5&nbsp;mL vials (AXYGEN, PCR-05-C) and incubated for 1&nbsp;h on a rotating mixer at RT. Next, 30&nbsp;μL of protein G coated magnetic beads (Invitrogen, DynabeadsTM Protein G) were added and the mix was incubated for 30&nbsp;min on a rotating mixer at RT. The vials were then placed on a magnetic stand (Promega, MagneSphere® Technology Magnetic Separation Stands) for 2&nbsp;min and the supernatant was discarded. The magnetically bound beads were washed 3 times with 200&nbsp;μL wash buffer (TBS x1 0.5% Tween20), re-suspended in 100μl wash buffer, and transferred to a new vial. The vials were then placed on the magnetic stand and the supernatant was discarded. The bound phages were eluted twice with 105&nbsp;μL of elution buffer (0.1M HCl adjusted to pH 2.2 with glycine, 1&nbsp;mg/mL BSA) while rotating at RT for 10&nbsp;min and neutralized with 19&nbsp;μL of neutralizing buffer (1M Tris-HCl pH 9.1). Two additional rounds of amplification and biopanning were carried out for each screen. To confirm binding to affinity-selected phages, E.&nbsp;coli DH5αF+ were infected with the eluted affinity-selected phages and the bacteria were plated on LB with 20&nbsp;μg/ml of tetracycline. Single colonies were picked and grown as mini-cultures in U-bottom 96-well cell culture plates (Corning Inc. Life Sciences). The plates were centrifuged to pellet the bacteria and the supernatants were transferred to 96-well flat bottom plates (Greiner Bio-One) containing poly-ethylene glycol/NaCl solution (33% PEG 3.3M NaCl) to precipitate the phages followed by another centrifugation step to pellet the phages. The phages were re-suspended in TBS x1, quantified, and used in dot blot to validate binding by the appropriate antibody. To introduce each sample with its own sample-barcode and the Illumina adaptors, separate, parallel PCR reactions were conducted. 1&nbsp;μL of the eluted phages was mixed with 12.5&nbsp;μL high-fidelity DNA polymerase (Invitrogen, PlatinumTM SuperFiTM PCR Master Mix), 10 pmol forward and reverse primers and supplemented with ultra-pure H2O for a total reaction volume of 25&nbsp;μL. The thermal profile was as followed: 98°C for 2&nbsp;min, 15 cycles of 98°C for 10 sec and 72°C for 5 sec. PCR products were validated by 2% agarose gel, purified by AMPure XP&nbsp;– PCR Purification (Beckman Coulter) and the concentration was measured using Qubit fluorometer. The samples were then diluted to 10&nbsp;nM, merged, and sent for Illumina NGS sequencing.</div></section><section id="sec-4-4-13"><h4>Antibody-dependent cellular phagocytosis</h4><div id="p0315" role="paragraph">Biotinylated MMP14 (2μg) protein was used to saturate the binding sites of 0.5mg 1μm fluorescent NeutrAvidin beads (Invitrogen). Excess antigen was removed by washing the beads, which were then blocked with 1% BSA. Next, the beads were washed and incubated with antibodies at final concentrations of 0.5μM (for monoclonal antibodies) or 1μM (for polyclonal antibodies) for 2h at 37°C. Following opsonization, beads were washed, and unbound antibodies were removed. The beads were then either stained for IgG to confirm IgG coating or incubated with phagocytic cells. For the phagocytosis assay, THP-1 cells were added, and the cells were incubated for 1h at 37°C to allow phagocytosis, after which the extent of phagocytosis was measured via flow cytometry (CytoFLEX). For IgG staining, the beads were incubated with anti-human IgG secondary antibody (Jackson Immuno Research) in a blocking buffer at a 1:100 dilution for 30&nbsp;minutes on ice. The beads were then washed, and the IgG was measured using the CytoFLEX flow cytometer.</div></section><section id="sec-4-4-14"><h4>Antibody dependent cell-mediated cytotoxicity</h4><div id="p0320" role="paragraph">Antibody dependent cell-mediated cytotoxicity (ADCC) assays were performed using xCelligence RTCA DP platform. Briefly, RTCA DP plates were filled with media and measured for background values. Then, OVCAR3 cells were plated at an optimized quantity of 20 <sup>∗</sup> 10<sup>3</sup> cells per well on RTCA DP plates. OVCAR3 cell proliferation during the seeding phase was monitored via&nbsp;their cell index value. 24 hours after seeding, the cells were incubated withmonoclonal or polyclonal antibodies at 500nM for 1 hour in PBS, and mixed with lymphokine activated donor natural killer cells at various effector to target (E:T) ratios. Upon introduction of the effector cells, the viability of the OVCAR3 tumor cell population was monitored over a 24-72 hour period. Prior to the ADCC assay, NK cells were isolated from the peripheral blood of healthy donors using the EasySep human NK cell enrichment kit (STEMCELL), and activated by incubation in growth media in the presence of 500IU/ml human recombinant IL-2 overnight.</div></section><section id="sec-4-4-15"><h4>Analysis of previously published RNA expression data</h4><div id="p0325" role="paragraph">RNA-seq counts were obtained from Gene Expression Omnibus (Database: GEO: <a id="interref260" href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE102094" target="_blank">GSE102094</a>, Database: GEO: <a id="interref265" href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE71340" target="_blank">GSE71340</a>). Differential expression analysis between HGSOC patients and normal tissues was performed by using DESeq2 (Love et&nbsp;al, Genome Biology, 2014 / 25516281).</div></section><section id="sec-4-4-16"><h4>Retrospective estimation of the risk for autoimmunity among ovarian cancer patients</h4><div id="p0330" role="paragraph">Estimation of the risk for autoimmunity was performed based on data from the electronic health record (EHR) database from Clalit Healthcare Services (<span class="dropBlock reference-citations"><a id="body-ref-sref6-2" href="#" role="doc-biblioref" data-xml-rid="bib6" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref6-2" aria-controls="sref6-2">Balicer and Afek 2017</a><div class="dropBlock__holder" data-db-target-of="sref6-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">6.</div><div>Balicer, R.D. ∙ Afek, A.</div><div><strong>Digital health nation: Israel’s global big data innovation hub</strong></div><div><em>Lancet.</em> 2017; <strong>389</strong>:2451-2453</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.D.BalicerA.AfekDigital+health+nation%3A+Israel%E2%80%99s+global+big+data+innovation+hubLancet389201724512453" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In this analysis we evaluated women aged 40-80 years between 2005-2020. Two cohorts were defined: an autoimmune cohort and an ovarian cancer cohort. Female patients were included in the autoimmune cohort pending a previously documented ICD-9 code corresponding to the diagnosis of an autoimmune disease in their medical records. These included: systemic lupus erythematosus (710.0), rheumatoid arthritis (L88 / 714.5 / 714.2 / 714 / 714.0), systemic sclerosis and other forms of scleroderma (710.1 / 701.0), ankylosing spondylitis (720.0), dermatomyositis (710.3), polymyositis (710.4), Sjögren syndrome (710.2), psoriatic arthropathy (696.0), polyarteritis nodosa (446.0), chronic postrheumatic arthropathy (714.4), polymyalgia rheumatica (725), inflammatory polyarthropathy (714.9) and other rheumatic and connective tissue diseases (729 / 710 / 710.9 / 710.8 / 710.5). The onset of diagnosis was adjusted upon evidence of prior therapy for autoimmune diseases (methotrexate / hydroxychloroquine) or a diagnosis of palindromic rheumatism (719.3) in the three years preceding the diagnosis of autoimmunity. Female patients were included in the ovarian cancer cohort pending a previously documented ICD-9 code indicating a diagnosis of ovarian cancer in the patient’s medical records (ICD-9 codes: 183.9, 183.8, 183.2, 183.0, 183). The onset of ovarian cancer diagnosis was adjusted upon evidence of prior administration of chemotherapy (carboplatin / paclitaxel / topotecan) or traditional antiemetics (ondansetron, granisetron) in the five years preceding the diagnosis. Onset was also adjusted in case of the following ICD 9 diagnoses: malignant neoplasm of uterus, part unspecified (179), unspecified malignant neoplasm (D77/ W72) and excision or destruction of peritoneal tissue (Z54.4) in the five years preceding the diagnosis - or - abdominal or pelvic swelling, mass or lump (789.3), ascites (789.5) or unspecified ovarian cyst (620.2) in the two years preceding the diagnosis. Patients with previous diagnoses of other malignancies were excluded as well as patients who had a diagnosis of an autoimmune disease preceding their ovarian cancer diagnosis. Controls were sampled from the general population and consisted of females who were not diagnosed with ovarian cancer and who were matched to the ovarian cancer cohort patients based on age and calendar year. In the ovarian cancer cohort and controls, the number of patients diagnosed with an autoimmune disease was counted during the followup period. The binomial estimate for the probability to have an autoimmune disease in a single month was calculated by dividing the number of patients who were diagnosed with an autoimmune disease in a given cohort, by the cumulative number of patient-months available in a given follow up period. The ovarian cancer cohort included 3,353 patients contributing up to 179,555 patient months to the analysis, while the control included 43,589 matched controls contributing up to 2,549,627 patient months. Thus, an annual incidence rate was calculated per 100,000 patients as well as a confidence interval, for followup periods of 1, 5, 10 and 15 years.</div></section><section id="sec-4-4-17"><h4>Antigen microarray</h4><div id="p0335" role="paragraph">Human Protein Microarray (ProtoArray) was used to measure antibody binding against a panel of proteins absorbed on the surface (Cat #PAH05251020, Invitrogen). Microarrays were blocked for 1 hour at RT with 2% bovine serum albumin and incubated under a coverslip overnight at 4°C with 10&nbsp;μg patient purified antibodies in blocking buffer (2% BSA in TBS). The arrays were then washed (X3 with 0.05% Tween20) and incubated for 2 hour at RT with a goat anti-human IgG Cy3-conjugated antibody ((1:250), Jackson ImmunoResearch Laboratories Inc, CAT#109-165-003.). The arrays were then washed (X3 with 0.05% Tween20), dried and scanned using InnoScan 710 (INNOPSYS) at 532&nbsp;nm.</div></section><section id="sec-4-4-18"><h4>Antigen microarray data processing and background filtering</h4><div id="p0340" role="paragraph">For each spot, the intensity was defined as the mean fluorescence intensity minus the localized background intensity (denoted F532-B532). Then, the average of two technical replicates in each chip was normalized by its median reactivity to account for differences in total protein concentrations that affect the background intensity level. The amount of material deposited in each spot was provided by the manufacturer based on the measurement of the GST tag of the absorbed protein. Signal intensity for each spot was then normalized to the GST signal. Proteins that contained a region from human Fc region (as indicated by the manufacturer) which can be bound by secondary anti-human Fc were not included in the analysis.</div></section><section id="sec-4-4-19"><h4>Patient survival analysis</h4><div id="p0345" role="paragraph">The clinical data was collected from the medical records of 34 recruited HGSOC patients for whom FFPE specimens of their primary tumor were available. In order to minimize potential biases, the cohort of patients was designed to be as homogenous as possible in terms of disease progression and survival-influencing factors – such as disease stage at presentation, debulking status and adjuvant treatment. All the patients recruited underwent primary debulking surgery (total abdominal hysterectomy with bilateral salpingo-oophorectomy) without receiving prior neoadjuvant chemotherapy. Following surgery, all patients received taxane and platinum-based standard of care adjuvant chemotherapy. All patients were regularly followed up by their gyneco-oncologists. Of note, none of the patients recruited experienced intraoperative or perioperative complications or perished from aetiologies unrelated to their malignancy. Overall survival (OS) was calculated as the time interval between diagnosis and death, or last follow-up if the patient did not succumb to her disease. Progression free survival (PFS) was calculated as the time between primary surgery and the date in which the first objective evidence of recurrence was recorded, or last follow up if the patient did not experience disease recurrence. One patient was omitted from the PFS analysis due to inconclusive data relating to her date of disease recurrence. OS and PFS were correlated to data retrieved from immunofluorescence staining of the primary tumors, namely, the percentage of IgG coated tumor cells and the abundance of IgG<sup>+</sup> ASCs in the tumor microenvironment. Tumors which exhibited positive IgG staining in less than 10% of their cells were consideredIgG<sup>-</sup>, whereas staining equal to or greater than 10% was considered IgG<sup>+</sup>. For infiltration of IgG<sup>+</sup> ASCs, an average number of 100 IgG<sup>+</sup> ASCs per high power field (HPF) was established as the threshold value. This was determined following computational quantification of IgG<sup>+</sup> ASCs in three independent HPFs per patient. These data were used to construct Kaplan-Meier curves. Statistical significance between the curves was determined using the log-rank (Mantel-Cox) test.</div></section><section id="sec-4-4-20"><h4>Structure prediction and docking analysis</h4><div id="p0350" role="paragraph">The amino acid sequence of T13 antibody VDJ region</div><div id="p0355" role="paragraph">(VH:EVQLVESGGGLVQPGGSLRLSCAASGFIFSKHDMYWVRQRPGKGLEWVSRIGDAGDTYYAGSVKGRFTIFRENAKNTLYFQMNRLTDGDTAVYYCGRGMAVAGFPLDVWGRGTRVTVTS;</div><div id="p0360" role="paragraph">VL:EIVMTQSPATLSVSPGERATLSCRASQNIHINLAWYQQKPGQAPRLIIYAASTRAAGIPARFSASGSGTEFTLTISSLQSEDFAVYYCQQFNPWSPWTFGQGTKVEVK) was computed on the ”advanced” Google Colab cloud interface using the AlphaFold framework (<span class="dropBlock reference-citations"><a id="body-ref-sref33-3" href="#" role="doc-biblioref" data-xml-rid="bib33" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref33-3" aria-controls="sref33-3">Jumper et&nbsp;al. 2021</a><div class="dropBlock__holder" data-db-target-of="sref33-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">33.</div><div>Jumper, J. ∙ Evans, R. ∙ Pritzel, A. ...</div><div><strong>Highly accurate protein structure prediction with AlphaFold</strong></div><div><em>Nature.</em> 2021; <strong>596</strong>:583-589</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.JumperR.EvansA.PritzelT.GreenM.FigurnovO.RonnebergerK.TunyasuvunakoolR.BatesA.%C5%BD%C3%ADdekA.PotapenkoHighly+accurate+protein+structure+prediction+with+AlphaFoldNature5962021583589" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Multiple sequence alignments (MSAs) were generated using MMseqs2 and analysis resulted in five models that were sorted by their pLDDT score. The top-ranked model was then docked to MMP14 (PDB <a id="intref0250" href="http://firstglance.jmol.org/fg.htm?mol5H0U" target="_blank">5H0U</a>) via Global Docking analysis using the PatchDock algorithm (<span class="dropBlock reference-citations"><a id="body-ref-sref62-3" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-3" aria-controls="sref62-3">Schneidman-Duhovny et&nbsp;al. 2005</a><div class="dropBlock__holder" data-db-target-of="sref62-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Schneidman-Duhovny, D. ∙ Inbar, Y. ∙ Nussinov, R. ...</div><div><strong>PatchDock and SymmDock: servers for rigid and symmetric docking</strong></div><div><em>Nucleic Acids Res.</em> 2005; <strong>33</strong>:W363-W367</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.Schneidman-DuhovnyY.InbarR.NussinovH.J.WolfsonPatchDock+and+SymmDock%3A+servers+for+rigid+and+symmetric+dockingNucleic+Acids+Res.332005W363W367" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) followed by protein-protein refinement stage on the FireDock server (<span class="dropBlock reference-citations"><a id="body-ref-sref41-3" href="#" role="doc-biblioref" data-xml-rid="bib41" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref41-3" aria-controls="sref41-3">Mashiach et&nbsp;al. 2008</a><div class="dropBlock__holder" data-db-target-of="sref41-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">41.</div><div>Mashiach, E. ∙ Schneidman-Duhovny, D. ∙ Andrusier, N. ...</div><div><strong>FireDock: A web server for fast interaction refinement in molecular docking</strong></div><div><em>Nucleic Acids Res.</em> 2008; <strong>36</strong>:W229-W232</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=E.MashiachD.Schneidman-DuhovnyN.AndrusierR.NussinovH.J.WolfsonFireDock%3A+A+web+server+for+fast+interaction+refinement+in+molecular+dockingNucleic+Acids+Res.362008W229W232" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Final complexes were assessed for their binding site and cross-referenced with the phage display hits.</div></section></section><section id="sec-4-5"><h3>Statistical analysis</h3><div id="p0365" role="paragraph">The D'Agostino-Pearson and Shapiro-Wilk normality tests were employed to assess the normality of our data. Normally and near-normally distributed datasets were evaluated using parametric statistical tests such as one way ANOVA and student’s paired / unpaired t-test, as appropriate. Normality was assumed in datasets which were too small to be tested for normality. Non-normally distributed datasets were mainly of lognormal distribution. These datasets were tested using non-parametric tests such as the Kruskal-Wallis test and the Mann–Whitney U test. Post-hoc analyses were performed following each relevant test. For one way ANOVA, we used Dunnett’s post-hoc test and for Kruskal-Wallis test, we used Dunn’s post-hoc test. For survival analyses, we used the log-rank (Mantel-Cox) test to determine the difference between Kaplan Meier plots. Correlation between datasets composed of continuous variables was performed using Pearson’s correlation coefficient and fitting of a linear regression model. Differential gene expression analysis was performed using DESeq2.</div></section></section><section id="acknowledgments" role="doc-acknowledgments"><h2>Acknowledgments</h2><div id="p0370" role="paragraph">Z.S. is supported by the Morris Kahn Institute for Human Immunology, Human Frontiers of Science Program (CDA-00023/2016), Azrieli Foundation, Moross Integrated Cancer Center, Rising Tide Foundation, and Israel Science Foundation (1090/18). This study was also supported by RCDA (18-703-R) and Beverley Lubrach Abshez initiative for ovarian and female reproductive system cancers (Israel Cancer Research Fund). Z.S. is a member of the European Molecular Biology Organization (EMBO) Young Investigator Program. I.S. is an incumbent of the Maurizio Pontecorvo Professorial Chair and has received funding from the European Union’s Horizon 2020 research and innovation program (grant agreement no. 801126), European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement no. 695437), Israel Science Foundation (1800/19), and the Thompson Family Foundation. M.D.S. is supported by Marie Sklodowska-Curie individual fellowship (Horizon, 2020 grant no. GAP-845066).</div><section id="sec-5"><h3>Author contributions</h3><div id="p0375" role="paragraph">R.D.M. conceived the study, designed and conducted the experiments, performed data analysis, and wrote the manuscript. N.N. assisted in conducting multiple experiments, including antibody cloning and expression, and calibrated and performed the ADCP assay. A.G. performed the immunoglobulin repertoire and clonality analyses. L.S.-B. assisted in conducting multiple experiments, including intratumoral ASC sorting, and participated in formulating the figures for the manuscript. L.M. performed <i>in silico</i> docking analyses of mAb T13. I. Solomonov supervised biochemical analyses, A.H. generated and characterized recombinant proteins. Y.D. assisted in immunofluorescence staining. M.D.S. conducted the protein array antigen screens for the monoclonal antibodies. H.H. conducted bioinformatic analyses of gene expression databases. I.Z. assisted in conducting some of the BCR sequencing experiments. M.M. performed the phage display assays. O.G. helped developing the QuPath analysis for evaluating tumor cell coating by IgG-typed antibodies. G.S., A.J.-S., L.S., E.Y., and R.E. recruited HGSOC patients, performed the surgical procedures, and provided important clinical insights throughout the study. N.Y. and M.F. performed the pathological evaluation of the samples. D.T., I.E., and E.P. participated in recruiting patients, collecting samples, and establishing the clinical database. N.M.C. performed the large-scale data analyses based on the Clalit Healthcare Services EHR database. J.M.G., N.F., Y.M., and G.Y. provided critical feedback and advised throughout the study. I. Sagi supervised the study, designed experiments, and wrote the manuscript. Z.S. conceived the study, supervised the study, designed experiments, and wrote the manuscript. All authors discussed the results and contributed to the final manuscript.</div></section><section id="sec-6"><h3>Declaration of interests</h3><div id="p0380" role="paragraph">The antibodies reported in the article are in the process of being patented.</div></section></section><section id="supplementary-material" data-type="supplementary-materials"><h2>Supplemental information (4)</h2><div id="p0390" role="paragraph"><div class="core-supplementary-material"><div class="core-link"><button class="downloadAllSupplementary"><span>Download all</span></button></div></div><div id="mmc1" class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="/cms/10.1016/j.cell.2022.02.012/attachment/6cc377b6-c12b-43d0-b37a-9d7f9c3467d8/mmc1.pdf" download="mmc1.pdf" aria-labelledby="mmc1-heading mmc1-link"><span id="mmc1-link">PDF (96.34 KB)</span></a></div><div class="core-description"><div id="mmc1-heading" class="heading">Document S1. Tables S1–S3 and S5</div></div></div><div id="mmc2" class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="/cms/10.1016/j.cell.2022.02.012/attachment/acc23c81-0ca8-4361-bf73-e0551407c5d8/mmc2.xlsx" download="mmc2.xlsx" aria-labelledby="mmc2-heading mmc2-link"><span id="mmc2-link">Spreadsheet (34.90 KB)</span></a></div><div class="core-description"><div id="mmc2-heading" class="heading">Table S4. Sequences, genes, clones and reactivities of monoclonal antibodies, related to Figure&nbsp;3</div></div></div><div id="mmc3" class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="/cms/10.1016/j.cell.2022.02.012/attachment/2e1ace84-3cc0-40ad-93df-7f3e6fc36d28/mmc3.xlsx" download="mmc3.xlsx" aria-labelledby="mmc3-heading mmc3-link"><span id="mmc3-link">Spreadsheet (1.22 MB)</span></a></div><div class="core-description"><div id="mmc3-heading" class="heading">Table S6. Protein microarray data, related to Figure&nbsp;4</div></div></div><div id="mmc4" class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="/cms/10.1016/j.cell.2022.02.012/attachment/b7b2f16c-8f70-4aa4-bac0-4ffba658b9c2/mmc4.xlsx" download="mmc4.xlsx" aria-labelledby="mmc4-heading mmc4-link"><span id="mmc4-link">Spreadsheet (29.57 KB)</span></a></div><div class="core-description"><div id="mmc4-heading" class="heading">Table S7. Study participants, related to STAR methods</div></div></div></div></section></div></section><div class="core-linked-content">
    

        

</div><section id="backmatter" data-extent="backmatter"><div class="core-container"><section id="data-availability" class="core-data-availability"><h2>Data and code availability</h2><div id="p0030" role="paragraph"><div id="ulist0015" role="list"><div id="u0030" role="listitem"><div class="label">•</div><div class="content"><div id="p0035" role="paragraph">The sequences of monoclonal antibodies that were expressed in this study are available in <a id="crosref0215" href="#mmc2">Table S4</a>. These sequences were deposited in GenBank (OM628888-OM628942, OM628943-OM628997). The raw single-cell immunoglobulin sequencing data is available upon request from the <a id="crosref0220a" href="#sec-4-2-1">lead contact</a>. All clinical parameters for all four cohorts are reported in <a id="crosref0220" href="#mmc1">Tables S1–S3, S5</a>, and <a id="crosref0225" href="#mmc4">S7</a>. Due to study participant confidentiality concerns, per patient clinical data cannot be publicly released.</div></div></div><div id="u0035" role="listitem"><div class="label">•</div><div class="content"><div id="p0040" role="paragraph">This paper does not report an original code.</div></div></div><div id="u0040" role="listitem"><div class="label">•</div><div class="content"><div id="p0045" role="paragraph">Any additional information required to reanalyze the data reported in this work paper is available from the <a id="crosref0225a" href="#sec-4-2-1">lead contact</a> upon request.</div></div></div></div></div></section><section id="references"><h2>References</h2><div id="bibliography" role="doc-bibliography"><div role="list"><div role="listitem" data-has="label"><div id="bib1" class="citations"><div id="sref1" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref1" title="View in article">1.</a></div><div>Anderson, K.S. ∙ Cramer, D.W. ∙ Sibani, S. ...</div><div><strong>Autoantibody signature for the serologic detection of ovarian cancer</strong></div><div><em>J.&nbsp;Proteome Res.</em> 2015; <strong>14</strong>:578-586</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=K.S.AndersonD.W.CramerS.SibaniG.WallstromJ.WongJ.ParkJ.QiuA.VitonisJ.LaBaerAutoantibody+signature+for+the+serologic+detection+of+ovarian+cancerJ.%C2%A0Proteome+Res.14201557858610.1021%2Fpr500908n" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib2" class="citations"><div id="sref2" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref2" title="View in article">2.</a></div><div>Andreu, P. ∙ Johansson, M. ∙ Affara, N.I. ...</div><div><strong>FcRgamma activation regulates inflammation-associated squamous carcinogenesis</strong></div><div><em>Cancer Cell.</em> 2010; <strong>17</strong>:121-134</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.AndreuM.JohanssonN.I.AffaraF.PucciT.TanS.JunankarL.KoretsJ.LamD.TawfikD.G.DeNardoFcRgamma+activation+regulates+inflammation-associated+squamous+carcinogenesisCancer+Cell172010121134" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib3" class="citations"><div id="sref3" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref3" title="View in article">3.</a></div><div>Andrusier, N. ∙ Nussinov, R. ∙ Wolfson, H.J.</div><div><strong>FireDock: fast interaction refinement in molecular docking</strong></div><div><em>Proteins.</em> 2007; <strong>69</strong>:139-159</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.AndrusierR.NussinovH.J.WolfsonFireDock%3A+fast+interaction+refinement+in+molecular+dockingProteins692007139159" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib4" class="citations"><div id="sref4" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref4" title="View in article">4.</a></div><div>Ashkenazy, H. ∙ Avram, O. ∙ Ryvkin, A. ...</div><div><strong>Motifier: an IgOme profiler based on peptide motifs using machine learning</strong></div><div><em>J.&nbsp;Mol. Biol.</em> 2021; <strong>433</strong>:167071</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.AshkenazyO.AvramA.RyvkinA.Roitburd-BermanY.Weiss-OttolenghiS.Hada-NeemanJ.M.GershoniT.PupkoMotifier%3A+an+IgOme+profiler+based+on+peptide+motifs+using+machine+learningJ.%C2%A0Mol.+Biol.433202116707110.1016%2Fj.jmb.2021.167071" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib5" class="citations"><div id="sref5" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref5" title="View in article">5.</a></div><div>Auersperg, N.</div><div><strong>Ovarian surface epithelium as a source of ovarian cancers: unwarranted speculation or evidence-based hypothesis?</strong></div><div><em>Gynecol. Oncol.</em> 2013; <strong>130</strong>:246-251</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.AuerspergOvarian+surface+epithelium+as+a+source+of+ovarian+cancers%3A+unwarranted+speculation+or+evidence-based+hypothesis%3FGynecol.+Oncol.1302013246251" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib6" class="citations"><div id="sref6" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref6-1" title="View in article">6.</a></div><div>Balicer, R.D. ∙ Afek, A.</div><div><strong>Digital health nation: Israel’s global big data innovation hub</strong></div><div><em>Lancet.</em> 2017; <strong>389</strong>:2451-2453</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.D.BalicerA.AfekDigital+health+nation%3A+Israel%E2%80%99s+global+big+data+innovation+hubLancet389201724512453" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib7" class="citations"><div id="sref7" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref7" title="View in article">7.</a></div><div>Bankhead, P. ∙ Loughrey, M.B. ∙ Fernández, J.A. ...</div><div><strong>QuPath: open source software for digital pathology image analysis</strong></div><div><em>Sci. Rep.</em> 2017; <strong>7</strong>:16878</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.BankheadM.B.LoughreyJ.A.Fern%C3%A1ndezY.DombrowskiD.G.McArtP.D.DunneS.McQuaidR.T.GrayL.J.MurrayH.G.ColemanQuPath%3A+open+source+software+for+digital+pathology+image+analysisSci.+Rep.7201716878" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib8" class="citations"><div id="sref8" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref8" title="View in article">8.</a></div><div>Biram, A. ∙ Davidzohn, N. ∙ Shulman, Z.</div><div><strong>T cell interactions with B cells during germinal center formation, a three-step model</strong></div><div><em>Immunol. Rev.</em> 2019; <strong>288</strong>:37-48</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.BiramN.DavidzohnZ.ShulmanT+cell+interactions+with+B+cells+during+germinal+center+formation%2C+a+three-step+modelImmunol.+Rev.28820193748" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib9" class="citations"><div id="sref9" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref9" title="View in article">9.</a></div><div>Biswas, S. ∙ Mandal, G. ∙ Payne, K.K. ...</div><div><strong>IgA transcytosis and antigen recognition govern ovarian cancer immunity</strong></div><div><em>Nature.</em> 2021; <strong>591</strong>:464-470</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.BiswasG.MandalK.K.PayneC.M.AnadonC.D.GatenbeeR.A.ChaurioT.L.CostichC.MoranC.M.HarroK.E.RigolizzoIgA+transcytosis+and+antigen+recognition+govern+ovarian+cancer+immunityNature5912021464470" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib10" class="citations"><div id="sref10" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref10" title="View in article">10.</a></div><div>Boland, J.L. ∙ Zhou, Q. ∙ Martin, M. ...</div><div><strong>Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade</strong></div><div><em>Gynecol. Oncol.</em> 2019; <strong>152</strong>:251-258</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.L.BolandQ.ZhouM.MartinM.K.CallahanJ.KonnerR.E.O%E2%80%99CearbhaillC.F.FriedmanW.TewV.MakkerR.N.GrishamEarly+disease+progression+and+treatment+discontinuation+in+patients+with+advanced+ovarian+cancer+receiving+immune+checkpoint+blockadeGynecol.+Oncol.1522019251258" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib11" class="citations"><div id="sref11" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref11" title="View in article">11.</a></div><div>Bolotin, D.A. ∙ Poslavsky, S. ∙ Davydov, A.N. ...</div><div><strong>Antigen receptor repertoire profiling from RNA-Seq data</strong></div><div><em>Nat. Biotechnol.</em> 2017; <strong>35</strong>:908-911</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.A.BolotinS.PoslavskyA.N.DavydovF.E.FrenkelL.FanchiO.I.ZolotarevaS.HemmersE.V.PutintsevaA.S.ObraztsovaM.ShugayAntigen+receptor+repertoire+profiling+from+RNA-Seq+dataNat.+Biotechnol.352017908911" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib12" class="citations"><div id="sref12" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref12-1" title="View in article">12.</a></div><div>Bowtell, D.D.L.</div><div><strong>The genesis and evolution of high-grade serous ovarian cancer</strong></div><div><em>Nat. Rev. Cancer.</em> 2010; <strong>10</strong>:803-808</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.D.L.BowtellThe+genesis+and+evolution+of+high-grade+serous+ovarian+cancerNat.+Rev.+Cancer102010803808" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib13" class="citations"><div id="sref13" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref13" title="View in article">13.</a></div><div>Cabrita, R. ∙ Lauss, M. ∙ Sanna, A. ...</div><div><strong>Tertiary lymphoid structures improve immunotherapy and survival in melanoma</strong></div><div><em>Nature.</em> 2020; <strong>577</strong>:561-565</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.CabritaM.LaussA.SannaM.DoniaM.S.Skaarup+LarsenS.MitraI.JohanssonB.PhungK.HarbstJ.Vallon-ChristerssonTertiary+lymphoid+structures+improve+immunotherapy+and+survival+in+melanomaNature5772020561565" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib14" class="citations"><div id="sref14" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref14-1" title="View in article">14.</a></div><div>Cathcart, J.M. ∙ Banach, A. ∙ Liu, A. ...</div><div><strong>Interleukin-6 increases matrix metalloproteinase-14 (MMP-14) levels via down-regulation of p53 to drive cancer progression</strong></div><div><em>Oncotarget.</em> 2016; <strong>7</strong>:61107-61120</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.M.CathcartA.BanachA.LiuJ.ChenM.GoligorskyJ.CaoInterleukin-6+increases+matrix+metalloproteinase-14+%28MMP-14%29+levels+via+down-regulation+of+p53+to+drive+cancer+progressionOncotarget720166110761120" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib15" class="citations"><div id="sref15" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref15" title="View in article">15.</a></div><div>Cho, A. ∙ Howell, V.M. ∙ Colvin, E.K.</div><div><strong>The extracellular matrix in epithelial ovarian cancer - A piece of a puzzle</strong></div><div><em>Front. Oncol.</em> 2015; <strong>5</strong>:245</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.ChoV.M.HowellE.K.ColvinThe+extracellular+matrix+in+epithelial+ovarian+cancer+-+A+piece+of+a+puzzleFront.+Oncol.52015245" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib16" class="citations"><div id="sref16" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref16" title="View in article">16.</a></div><div>Cornaby, C. ∙ Gibbons, L. ∙ Mayhew, V. ...</div><div><strong>B cell epitope spreading: mechanisms and contribution to autoimmune diseases</strong></div><div><em>Immunol. Lett.</em> 2015; <strong>163</strong>:56-68</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.CornabyL.GibbonsV.MayhewC.S.SloanA.WellingB.D.PooleB+cell+epitope+spreading%3A+mechanisms+and+contribution+to+autoimmune+diseasesImmunol.+Lett.16320155668" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib17" class="citations"><div id="sref17" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref17-1" title="View in article">17.</a></div><div>Crowley, J.T. ∙ Strle, K. ∙ Drouin, E.E. ...</div><div><strong>Matrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory lyme arthritis</strong></div><div><em>J.&nbsp;Autoimmun.</em> 2016; <strong>69</strong>:24-37</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.T.CrowleyK.StrleE.E.DrouinA.PiantaS.L.ArvikarQ.WangC.E.CostelloA.C.SteereMatrix+metalloproteinase-10+is+a+target+of+T+and+B+cell+responses+that+correlate+with+synovial+pathology+in+patients+with+antibiotic-refractory+lyme+arthritisJ.%C2%A0Autoimmun.6920162437" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib18" class="citations"><div id="sref18" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref18" title="View in article">18.</a></div><div>Cui, C. ∙ Wang, J. ∙ Fagerberg, E. ...</div><div><strong>Neoantigen-driven B cell and CD4&nbsp;T follicular helper cell collaboration promotes robust anti-tumor CD8 T&nbsp;cell responses</strong></div><div><em>Cell.</em> 2021; <strong>184</strong>:6101-6118.e13</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.CuiJ.WangE.FagerbergP.M.ChenK.A.ConnollyM.DamoJ.F.CheungT.MaoA.S.AskariS.ChenNeoantigen-driven+B+cell+and+CD4%C2%A0T+follicular+helper+cell+collaboration+promotes+robust+anti-tumor+CD8+T%C2%A0cell+responsesCell184202161016118.e1310.1016%2Fj.cell.2021.11.007" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib19" class="citations"><div id="sref19" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref19" title="View in article">19.</a></div><div>Degn, S.E. ∙ van der Poel, C.E. ∙ Firl, D.J. ...</div><div><strong>Clonal evolution of autoreactive germinal centers</strong></div><div><em>Cell.</em> 2017; <strong>170</strong>:913-926.e19</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.E.DegnC.E.van+der+PoelD.J.FirlB.AyogluF.A.Al+QureshahG.BajicL.MesinC.A.ReynaudJ.C.WeillP.J.UtzClonal+evolution+of+autoreactive+germinal+centersCell1702017913926.e19" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib20" class="citations"><div id="sref20" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref20-1" title="View in article">20.</a></div><div>DeNardo, D.G. ∙ Ruffell, B.</div><div><strong>Macrophages as regulators of tumour immunity and immunotherapy</strong></div><div><em>Nat. Rev. Immunol.</em> 2019; <strong>19</strong>:369-382</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.G.DeNardoB.RuffellMacrophages+as+regulators+of+tumour+immunity+and+immunotherapyNat.+Rev.+Immunol.192019369382" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib21" class="citations"><div id="sref21" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref21" title="View in article">21.</a></div><div>DeWeerdt, S.</div><div><strong>The origins of ovarian cancer</strong></div><div><em>Nature.</em> 2021; <strong>600</strong>:S42-S44</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.DeWeerdtThe+origins+of+ovarian+cancerNature6002021S42S44" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib22" class="citations"><div id="sref22" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref22" title="View in article">22.</a></div><div>Di Zenzo, G. ∙ Di Lullo, G. ∙ Corti, D. ...</div><div><strong>Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2012; <strong>122</strong>:3781-3790</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.Di+ZenzoG.Di+LulloD.CortiV.CalabresiA.SinistroF.VanzettaB.DidonaG.CianchiniM.HertlR.EmingPemphigus+autoantibodies+generated+through+somatic+mutations+target+the+desmoglein-3+cis-interfaceJ.%C2%A0Clin.+Invest.122201237813790" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib23" class="citations"><div id="sref23" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref23" title="View in article">23.</a></div><div>DiLillo, D.J. ∙ Ravetch, J.V.</div><div><strong>Fc-receptor interactions regulate both cytotoxic and immunomodulatory therapeutic antibody effector functions</strong></div><div><em>Cancer Immunol. Res.</em> 2015; <strong>3</strong>:704-713</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.J.DiLilloJ.V.RavetchFc-receptor+interactions+regulate+both+cytotoxic+and+immunomodulatory+therapeutic+antibody+effector+functionsCancer+Immunol.+Res.3201570471310.1158%2F2326-6066.CIR-15-0120" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib24" class="citations"><div id="sref24" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref24" title="View in article">24.</a></div><div>Doo, D.W. ∙ Norian, L.A. ∙ Arend, R.C.</div><div><strong>Checkpoint inhibitors in ovarian cancer: a review of preclinical data</strong></div><div><em>Gynecol. Oncol. Rep.</em> 2019; <strong>29</strong>:48-54</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.W.DooL.A.NorianR.C.ArendCheckpoint+inhibitors+in+ovarian+cancer%3A+a+review+of+preclinical+dataGynecol.+Oncol.+Rep.2920194854" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib25" class="citations"><div id="sref25" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref25" title="View in article">25.</a></div><div>Duhovny, D. ∙ Nussinov, R. ∙ Wolfson, H.</div><div><strong>Efficient unbound docking of rigid molecules</strong></div><div><div>Guigó, R. ∙ Gusfield, D. (Editors)</div></div><div><strong>Proceedings of the 2’nd Workshop on Algorithms in Bioinformatics (WABI) Rome, Italy, Lecture Notes in Computer Science 2452</strong></div><div>2002</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.DuhovnyR.NussinovH.WolfsonEfficient+unbound+docking+of+rigid+moleculesR.Guig%C3%B3D.GusfieldProceedings+of+the+2%E2%80%99nd+Workshop+on+Algorithms+in+Bioinformatics+%28WABI%29+Rome%2C+Italy%2C+Lecture+Notes+in+Computer+Science+24522002" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib26" class="citations"><div id="sref26" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref26-1" title="View in article">26.</a></div><div>Felsenstein, J.</div><div><strong>PHYLIP (phylogeny Inference Package)</strong></div><div>2005</div><div>Distributed by the Author (Department of Genome Sciences, University of Washington). <a id="interref0010" href="http://evolution.genetics.washington.edu/phylip.html" target="_blank">http://evolution.genetics.washington.edu/phylip.html</a></div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.FelsensteinPHYLIP+%28phylogeny+Inference+Package%29version+3.62005Distributed+by+the+Author+%28Department+of+Genome+Sciences%2C+University+of+Washington%29.+http%3A%2F%2Fevolution.genetics.washington.edu%2Fphylip.html" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib27" class="citations"><div id="sref27" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref27-1" title="View in article">27.</a></div><div>Freund ∙ Tarnovitski, N. ∙ Enshell-Seijffers, D. ...</div><div><strong>Phage display selection, analysis, and prediction of B cell epitopes</strong></div><div><em>Curr. Protoc. Immunol.</em> 2009; <strong>9</strong>:8</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=FreundN.TarnovitskiD.Enshell-SeijffersJ.M.GershoniPhage+display+selection%2C+analysis%2C+and+prediction+of+B+cell+epitopesCurr.+Protoc.+Immunol.920098" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib28" class="citations"><div id="sref28" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref28" title="View in article">28.</a></div><div>Gnjatic, S. ∙ Ritter, E. ∙ Büchler, M.W. ...</div><div><strong>Seromic profiling of ovarian and pancreatic cancer</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2010; <strong>107</strong>:5088-5093</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.GnjaticE.RitterM.W.B%C3%BCchlerN.A.GieseB.BrorsC.FreiA.MurrayN.HalamaI.Z%C3%B6rnigY.T.ChenSeromic+profiling+of+ovarian+and+pancreatic+cancerProc.+Natl.+Acad.+Sci.+USA107201050885093" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib29" class="citations"><div id="sref29" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref29-1" title="View in article">29.</a></div><div>Gupta, N.T. ∙ Vander Heiden, J.A. ∙ Uduman, M. ...</div><div><strong>Change-O: A toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data</strong></div><div><em>Bioinformatics.</em> 2015; <strong>31</strong>:3356-3358</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.T.GuptaJ.A.Vander+HeidenM.UdumanD.Gadala-MariaG.YaariS.H.KleinsteinChange-O%3A+A+toolkit+for+analyzing+large-scale+B+cell+immunoglobulin+repertoire+sequencing+dataBioinformatics31201533563358" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib30" class="citations"><div id="sref30" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref30" title="View in article">30.</a></div><div>Helmink, B.A. ∙ Reddy, S.M. ∙ Gao, J. ...</div><div><strong>B cells and tertiary lymphoid structures promote immunotherapy response</strong></div><div><em>Nature.</em> 2020; <strong>577</strong>:549-555</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.A.HelminkS.M.ReddyJ.GaoS.ZhangR.BasarR.ThakurK.YizhakM.Sade-FeldmanJ.BlandoG.HanB+cells+and+tertiary+lymphoid+structures+promote+immunotherapy+responseNature5772020549555" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib31" class="citations"><div id="sref31" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref31-1" title="View in article">31.</a></div><div>Hu, X. ∙ Zhang, J. ∙ Wang, J. ...</div><div><strong>Landscape of B cell immunity and related immune evasion in human cancers</strong></div><div><em>Nat. Genet.</em> 2019; <strong>51</strong>:560-567</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=X.HuJ.ZhangJ.WangJ.FuT.LiX.ZhengB.WangS.GuP.JiangJ.FanLandscape+of+B+cell+immunity+and+related+immune+evasion+in+human+cancersNat.+Genet.512019560567" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib32" class="citations"><div id="sref32" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref32" title="View in article">32.</a></div><div>Jayson, G.C. ∙ Kohn, E.C. ∙ Kitchener, H.C. ...</div><div><strong>Ovarian cancer</strong></div><div><em>Lancet.</em> 2014; <strong>384</strong>:1376-1388</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.C.JaysonE.C.KohnH.C.KitchenerJ.A.LedermannOvarian+cancerLancet384201413761388" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib33" class="citations"><div id="sref33" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref33-1" title="View in article">33.</a></div><div>Jumper, J. ∙ Evans, R. ∙ Pritzel, A. ...</div><div><strong>Highly accurate protein structure prediction with AlphaFold</strong></div><div><em>Nature.</em> 2021; <strong>596</strong>:583-589</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.JumperR.EvansA.PritzelT.GreenM.FigurnovO.RonnebergerK.TunyasuvunakoolR.BatesA.%C5%BD%C3%ADdekA.PotapenkoHighly+accurate+protein+structure+prediction+with+AlphaFoldNature5962021583589" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib34" class="citations"><div id="sref34" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref34-1" title="View in article">34.</a></div><div>Kaimal, R. ∙ Aljumaily, R. ∙ Tressel, S.L. ...</div><div><strong>Selective blockade of matrix Metalloprotease-14 with a monoclonal antibody abrogates invasion, angiogenesis, and tumor growth in ovarian cancer</strong></div><div><em>Cancer Res.</em> 2013; <strong>73</strong>:2457-2467</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.KaimalR.AljumailyS.L.TresselR.V.PradhanL.CovicA.KuliopulosC.ZarwanY.B.KimS.SharifiA.AgarwalSelective+blockade+of+matrix+Metalloprotease-14+with+a+monoclonal+antibody+abrogates+invasion%2C+angiogenesis%2C+and+tumor+growth+in+ovarian+cancerCancer+Res.73201324572467" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib35" class="citations"><div id="sref35" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref35-1" title="View in article">35.</a></div><div>Kamel, H. ∙ Abdelazim, I. ∙ Habib, S.M. ...</div><div><strong>Immunoexpression of matrix metalloproteinase-2 (MMP-2) in malignant ovarian epithelial tumours</strong></div><div><em>J.&nbsp;Obstet. Gynaecol. Can.</em> 2010; <strong>32</strong>:580-586</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.KamelI.AbdelazimS.M.HabibM.A.A.El+ShourbagyN.S.AhmedImmunoexpression+of+matrix+metalloproteinase-2+%28MMP-2%29+in+malignant+ovarian+epithelial+tumoursJ.%C2%A0Obstet.+Gynaecol.+Can.32201058058610.1016%2FS1701-2163%2816%2934527-3" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib36" class="citations"><div id="sref36" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref36-1" title="View in article">36.</a></div><div>Kroeger, D.R. ∙ Milne, K. ∙ Nelson, B.H.</div><div><strong>Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer</strong></div><div><em>Clin. Cancer Res.</em> 2016; <strong>22</strong>:3005-3015</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.R.KroegerK.MilneB.H.NelsonTumor-infiltrating+plasma+cells+are+associated+with+tertiary+lymphoid+structures%2C+cytolytic+T-cell+responses%2C+and+superior+prognosis+in+ovarian+cancerClin.+Cancer+Res.22201630053015" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib37" class="citations"><div id="sref37" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref37" title="View in article">37.</a></div><div>Labidi-Galy, S.I. ∙ Papp, E. ∙ Hallberg, D. ...</div><div><strong>High grade serous ovarian carcinomas originate in the fallopian tube</strong></div><div><em>Nat. Commun.</em> 2017; <strong>8</strong>:1093</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.I.Labidi-GalyE.PappD.HallbergN.NiknafsV.AdleffM.NoeR.BhattacharyaM.NovakS.JonesJ.PhallenHigh+grade+serous+ovarian+carcinomas+originate+in+the+fallopian+tubeNat.+Commun.820171093" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib38" class="citations"><div id="sref38" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref38" title="View in article">38.</a></div><div>Ma, Y. ∙ Wang, X. ∙ Qiu, C. ...</div><div><strong>Using protein microarray to identify and evaluate autoantibodies to tumor-associated antigens in ovarian cancer</strong></div><div><em>Cancer Sci.</em> 2020; <strong>112</strong>:537-549</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.MaX.WangC.QiuJ.QinK.WangG.SunD.JiangJ.LiL.WangJ.ShiUsing+protein+microarray+to+identify+and+evaluate+autoantibodies+to+tumor-associated+antigens+in+ovarian+cancerCancer+Sci.112202053754910.1111%2Fcas.14732" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib39" class="citations"><div id="sref39" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref39" title="View in article">39.</a></div><div>Mahmood, R.D. ∙ Morgan, R.D. ∙ Edmondson, R.J. ...</div><div><strong>First-line management of advanced high-grade serous ovarian cancer</strong></div><div><em>Curr. Oncol. Rep.</em> 2020; <strong>22</strong>:64</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.D.MahmoodR.D.MorganR.J.EdmondsonA.R.ClampG.C.JaysonFirst-line+management+of+advanced+high-grade+serous+ovarian+cancerCurr.+Oncol.+Rep.22202064" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib40" class="citations"><div id="sref40" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref40" title="View in article">40.</a></div><div>Maletzki, C. ∙ Jahnke, A. ∙ Ostwald, C. ...</div><div><strong>Ex-vivo clonally expanded B lymphocytes infiltrating colorectal carcinoma are of mature immunophenotype and produce functional IgG</strong></div><div><em>PLoS One.</em> 2012; <strong>7</strong>:e32639</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.MaletzkiA.JahnkeC.OstwaldE.KlarF.PrallM.LinnebacherEx-vivo+clonally+expanded+B+lymphocytes+infiltrating+colorectal+carcinoma+are+of+mature+immunophenotype+and+produce+functional+IgGPLoS+One72012e32639" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib41" class="citations"><div id="sref41" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref41-1" title="View in article">41.</a></div><div>Mashiach, E. ∙ Schneidman-Duhovny, D. ∙ Andrusier, N. ...</div><div><strong>FireDock: A web server for fast interaction refinement in molecular docking</strong></div><div><em>Nucleic Acids Res.</em> 2008; <strong>36</strong>:W229-W232</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=E.MashiachD.Schneidman-DuhovnyN.AndrusierR.NussinovH.J.WolfsonFireDock%3A+A+web+server+for+fast+interaction+refinement+in+molecular+dockingNucleic+Acids+Res.362008W229W232" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib42" class="citations"><div id="sref42" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref42" title="View in article">42.</a></div><div>Mietzner, B. ∙ Tsuiji, M. ∙ Scheid, J. ...</div><div><strong>Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2008; <strong>105</strong>:9727-9732</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.MietznerM.TsuijiJ.ScheidK.VelinzonT.TillerK.AbrahamJ.B.GonzalezV.PascualD.StichwehH.WardemannM.C.NussenzweigAutoreactive+IgG+memory+antibodies+in+patients+with+systemic+lupus+erythematosus+arise+from+nonreactive+and+polyreactive+precursorsProc.+Natl.+Acad.+Sci.+USA105200897279732" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib43" class="citations"><div id="sref43" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref43" title="View in article">43.</a></div><div>Milne, K. ∙ Barnes, R.O. ∙ Girardin, A. ...</div><div><strong>Tumor-infiltrating T&nbsp;cells correlate with NY-ESO-1-Specific autoantibodies in ovarian cancer</strong></div><div><em>PLoS One.</em> 2008; <strong>3</strong>:e3409</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=K.MilneR.O.BarnesA.GirardinM.A.MawerN.J.NesslingerA.NgJ.S.NielsenR.SahotaE.TranJ.R.WebbTumor-infiltrating+T%C2%A0cells+correlate+with+NY-ESO-1-Specific+autoantibodies+in+ovarian+cancerPLoS+One32008e3409" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib44" class="citations"><div id="sref44" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref44" title="View in article">44.</a></div><div>Mirdita, Milot ∙ Schütze, K. ∙ Moriwaki, Y. ...</div><div><strong>ColabFold - making protein folding accessible to all</strong></div><div><em>Biorxiv.</em> 2021;</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=MilotMirditaK.Sch%C3%BCtzeY.MoriwakiL.HeoS.OvchinnikovM.SteineggerColabFold+-+making+protein+folding+accessible+to+allBiorxiv202110.21203%2Frs.3.rs-1032816%2Fv1" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib45" class="citations"><div id="sref45" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref45-1" title="View in article">45.</a></div><div>Montfort, A. ∙ Pearce, O. ∙ Maniati, E. ...</div><div><strong>A strong B-cell response is part of the immune landscape in human high-grade serous ovarian metastases</strong></div><div><em>Clin. Cancer Res.</em> 2017; <strong>23</strong>:250-262</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.MontfortO.PearceE.ManiatiB.G.VincentL.BixbyS.B%C3%B6hmT.DoweE.H.WilkesP.ChakravartyR.ThompsonA+strong+B-cell+response+is+part+of+the+immune+landscape+in+human+high-grade+serous+ovarian+metastasesClin.+Cancer+Res.232017250262" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib46" class="citations"><div id="sref46" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref46" title="View in article">46.</a></div><div>Mose, L.E. ∙ Selitsky, S.R. ∙ Bixby, L.M. ...</div><div><strong>Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V’DJer</strong></div><div><em>Bioinformatics.</em> 2016; <strong>32</strong>:3729-3734</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.E.MoseS.R.SelitskyL.M.BixbyD.L.MarronM.D.IglesiaJ.S.SerodyC.M.PerouB.G.VincentJ.S.ParkerAssembly-based+inference+of+B-cell+receptor+repertoires+from+short+read+RNA+sequencing+data+with+V%E2%80%99DJerBioinformatics32201637293734" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib47" class="citations"><div id="sref47" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref47" title="View in article">47.</a></div><div>Moss, N.M. ∙ Barbolina, M.V. ∙ Liu, Y. ...</div><div><strong>Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination</strong></div><div><em>Cancer Res.</em> 2009; <strong>69</strong>:7121-7129</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.M.MossM.V.BarbolinaY.LiuL.SunH.G.MunshiM.S.StackOvarian+cancer+cell+detachment+and+multicellular+aggregate+formation+are+regulated+by+membrane+type+1+matrix+metalloproteinase%3A+a+potential+role+in+I.p.+metastatic+disseminationCancer+Res.69200971217129" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib48" class="citations"><div id="sref48" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref48-1" title="View in article">48.</a></div><div>Nelson, B.H.</div><div><strong>CD20+ B cells: the other tumor-infiltrating lymphocytes</strong></div><div><em>J.&nbsp;Immunol.</em> 2010; <strong>185</strong>:4977-4982</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=B.H.NelsonCD20%2B+B+cells%3A+the+other+tumor-infiltrating+lymphocytesJ.%C2%A0Immunol.185201049774982" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib49" class="citations"><div id="sref49" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref49-1" title="View in article">49.</a></div><div>Nishijima, C. ∙ Hayakawa, I. ∙ Matsushita, T. ...</div><div><strong>Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis</strong></div><div><em>Clin. Exp. Immunol.</em> 2004; <strong>138</strong>:357-363</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.NishijimaI.HayakawaT.MatsushitaK.KomuraM.HasegawaK.TakeharaS.SatoAutoantibody+against+matrix+metalloproteinase-3+in+patients+with+systemic+sclerosisClin.+Exp.+Immunol.138200435736310.1111%2Fj.1365-2249.2004.02615.x" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib50" class="citations"><div id="sref50" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref50" title="View in article">50.</a></div><div>Nzula, S. ∙ Going, J.J. ∙ Stott, D.I.</div><div><strong>Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas</strong></div><div><em>Cancer Res.</em> 2003; <strong>63</strong>:3275-3280</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.NzulaJ.J.GoingD.I.StottAntigen-driven+clonal+proliferation%2C+somatic+hypermutation%2C+and+selection+of+B+lymphocytes+infiltrating+human+ductal+breast+carcinomasCancer+Res.63200332753280" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib51" class="citations"><div id="sref51" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref51" title="View in article">51.</a></div><div>O Donnell, R.L. ∙ McCormick, A. ∙ Mukhopadhyay, A. ...</div><div><strong>The use of ovarian cancer cells from patients undergoing surgery to generate primary cultures capable of undergoing functional analysis</strong></div><div><em>PLoS One.</em> 2014; <strong>9</strong>:e90604</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=R.L.O+DonnellA.McCormickA.MukhopadhyayL.C.WoodhouseM.MoatA.GrundyM.DixonA.KaufmanA.ElattarThe+use+of+ovarian+cancer+cells+from+patients+undergoing+surgery+to+generate+primary+cultures+capable+of+undergoing+functional+analysisPLoS+One92014e90604" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib52" class="citations"><div id="sref52" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref52" title="View in article">52.</a></div><div>Petitprez, F. ∙ de Reyniès, A. ∙ Keung, E.Z. ...</div><div><strong>B cells are associated with survival and immunotherapy response in sarcoma</strong></div><div><em>Nature.</em> 2020; <strong>577</strong>:556-560</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=F.PetitprezA.de+Reyni%C3%A8sE.Z.KeungT.W.ChenC.M.SunJ.CalderaroY.-M.JengL.P.HsiaoL.LacroixA.Bougo%C3%BCinB+cells+are+associated+with+survival+and+immunotherapy+response+in+sarcomaNature5772020556560" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib53" class="citations"><div id="sref53" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref53" title="View in article">53.</a></div><div>Piccoli, L. ∙ Campo, I. ∙ Fregni, C.S. ...</div><div><strong>Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis</strong></div><div><em>Nat. Commun.</em> 2015; <strong>6</strong>:7375</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.PiccoliI.CampoC.S.FregniB.M.RodriguezA.MinolaF.SallustoM.LuisettiD.CortiA.LanzavecchiaNeutralization+and+clearance+of+GM-CSF+by+autoantibodies+in+pulmonary+alveolar+proteinosisNat.+Commun.620157375" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib54" class="citations"><div id="sref54" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref54" title="View in article">54.</a></div><div>Pitzalis, C. ∙ Jones, G.W. ∙ Bombardieri, M. ...</div><div><strong>Ectopic lymphoid-like structures in infection, cancer and autoimmunity</strong></div><div><em>Nat. Rev. Immunol.</em> 2014; <strong>14</strong>:447-462</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.PitzalisG.W.JonesM.BombardieriS.A.JonesEctopic+lymphoid-like+structures+in+infection%2C+cancer+and+autoimmunityNat.+Rev.+Immunol.142014447462" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib55" class="citations"><div id="sref55" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref55" title="View in article">55.</a></div><div>Prigent, J. ∙ Lorin, V. ∙ Kök, A. ...</div><div><strong>Scarcity of autoreactive human blood IgA+ memory B cells</strong></div><div><em>Eur. J. Immunol.</em> 2016; <strong>46</strong>:2340-2351</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.PrigentV.LorinA.K%C3%B6kT.HieuS.BourgeauH.MouquetScarcity+of+autoreactive+human+blood+IgA%2B+memory+B+cellsEur.+J.+Immunol.46201623402351" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib56" class="citations"><div id="sref56" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref56" title="View in article">56.</a></div><div>Ramalingam, P.</div><div><strong>Morphologic, immunophenotypic, and molecular features of epithelial ovarian cancer</strong></div><div><em>Oncology (Williston Park).</em> 2016; <strong>30</strong>:166-176</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.RamalingamMorphologic%2C+immunophenotypic%2C+and+molecular+features+of+epithelial+ovarian+cancerOncology+%28Williston+Park%29302016166176" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib57" class="citations"><div id="sref57" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref57" title="View in article">57.</a></div><div>Ran, M. ∙ Klein, G. ∙ Witz, I.P.</div><div><strong>Tumor-bound immunoglobulins. Evidence for the in&nbsp;vivo coating of tumor cells by potentially cytotoxic anti-tumour antibodies</strong></div><div><em>Int. J. Cancer.</em> 1976; <strong>17</strong>:90-97</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.RanG.KleinI.P.WitzTumor-bound+immunoglobulins.+Evidence+for+the+in%C2%A0vivo+coating+of+tumor+cells+by+potentially+cytotoxic+anti-tumour+antibodiesInt.+J.+Cancer1719769097" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib58" class="citations"><div id="sref58" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref58-1" title="View in article">58.</a></div><div>Rao, G.S. ∙ Hanjani, P.</div><div><strong>Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid</strong></div><div><em>Am. J. Obstet. Gynecol.</em> 1988; <strong>159</strong>:94-98</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.S.RaoP.HanjaniDetection+of+human+ovarian+tumor-associated+antigens+by+antibodies+isolated+from+ovarian+carcinoma+ascitic+fluidAm.+J.+Obstet.+Gynecol.1591988949810.1016%2F0002-9378%2888%2990500-5" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib59" class="citations"><div id="sref59" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref59-1" title="View in article">59.</a></div><div>Sakata, K. ∙ Shigemasa, K. ∙ Nagai, N. ...</div><div><strong>Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary</strong></div><div><em>Int. J. Oncol.</em> 2000; <strong>17</strong>:673-681</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=K.SakataK.ShigemasaN.NagaiK.OhamaExpression+of+matrix+metalloproteinases+%28MMP-2%2C+MMP-9%2C+MT1-MMP%29+and+their+inhibitors+%28TIMP-1%2C+TIMP-2%29+in+common+epithelial+tumors+of+the+ovaryInt.+J.+Oncol.17200067368110.3892%2Fijo.17.4.673" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib60" class="citations"><div id="sref60" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref60-1" title="View in article">60.</a></div><div>Sato, S. ∙ Hayakawa, I. ∙ Hasegawa, M. ...</div><div><strong>Function blocking autoantibodies Against matrix metalloproteinase-1 in patients with systemic sclerosis</strong></div><div><em>J.&nbsp;Invest. Dermatol.</em> 2003; <strong>120</strong>:542-547</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.SatoI.HayakawaM.HasegawaM.FujimotoK.TakeharaFunction+blocking+autoantibodies+Against+matrix+metalloproteinase-1+in+patients+with+systemic+sclerosisJ.%C2%A0Invest.+Dermatol.120200354254710.1046%2Fj.1523-1747.2003.12097.x" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib61" class="citations"><div id="sref61" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref61" title="View in article">61.</a></div><div>Saul, L. ∙ Ilieva, K.M. ∙ Bax, H.J. ...</div><div><strong>IgG subclass switching and clonal expansion in cutaneous melanoma and normal skin</strong></div><div><em>Sci. Rep.</em> 2016; <strong>6</strong>:29736</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.SaulK.M.IlievaH.J.BaxP.KaragiannisI.CorreaI.Rodriguez-HernandezD.H.JosephsI.TosiI.U.EgbuniweS.LombardiIgG+subclass+switching+and+clonal+expansion+in+cutaneous+melanoma+and+normal+skinSci.+Rep.6201629736" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib62" class="citations"><div id="sref62" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref62-1" title="View in article">62.</a></div><div>Schneidman-Duhovny, D. ∙ Inbar, Y. ∙ Nussinov, R. ...</div><div><strong>PatchDock and SymmDock: servers for rigid and symmetric docking</strong></div><div><em>Nucleic Acids Res.</em> 2005; <strong>33</strong>:W363-W367</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.Schneidman-DuhovnyY.InbarR.NussinovH.J.WolfsonPatchDock+and+SymmDock%3A+servers+for+rigid+and+symmetric+dockingNucleic+Acids+Res.332005W363W367" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib63" class="citations"><div id="sref63" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref63" title="View in article">63.</a></div><div>Schroeder, K. ∙ Herrmann, M. ∙ Winkler, T.H.</div><div><strong>The role of somatic hypermutation in the generation of pathogenic antibodies in SLE</strong></div><div><em>Autoimmunity.</em> 2013; <strong>46</strong>:121-127</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=K.SchroederM.HerrmannT.H.WinklerThe+role+of+somatic+hypermutation+in+the+generation+of+pathogenic+antibodies+in+SLEAutoimmunity462013121127" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib64" class="citations"><div id="sref64" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref64-1" title="View in article">64.</a></div><div>Sharonov, G.V. ∙ Serebrovskaya, E.O. ∙ Yuzhakova, D.V. ...</div><div><strong>B cells, plasma cells and antibody repertoires in the tumour microenvironment</strong></div><div><em>Nat. Rev. Immunol.</em> 2020; <strong>20</strong>:294-307</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.V.SharonovE.O.SerebrovskayaD.V.YuzhakovaO.V.BritanovaD.M.ChudakovB+cells%2C+plasma+cells+and+antibody+repertoires+in+the+tumour+microenvironmentNat.+Rev.+Immunol.202020294307" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib65" class="citations"><div id="sref65" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref65-1" title="View in article">65.</a></div><div>Silburn, P.A. ∙ Khoo, S.K. ∙ Hill, R. ...</div><div><strong>Demonstration of tumor-associated immunoglobulin G isolated from immune complexes in ascitic fluid of ovarian cancer</strong></div><div><em>Diagn. Immunol.</em> 1984; <strong>2</strong>:30-35</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.A.SilburnS.K.KhooR.HillB.DaunterE.V.MackayDemonstration+of+tumor-associated+immunoglobulin+G+isolated+from+immune+complexes+in+ascitic+fluid+of+ovarian+cancerDiagn.+Immunol.219843035" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib66" class="citations"><div id="sref66" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref66-1" title="View in article">66.</a></div><div>Tiller, T. ∙ Meffre, E. ∙ Yurasov, S. ...</div><div><strong>Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expressionvector cloning</strong></div><div><em>J.&nbsp;Immunol. Methods.</em> 2008; <strong>329</strong>:112-124</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=T.TillerE.MeffreS.YurasovM.TsuijiM.C.NussenzweigH.WardemannEfficient+generation+of+monoclonal+antibodies+from+single+human+B+cells+by+single+cell+RT-PCR+and+expressionvector+cloningJ.%C2%A0Immunol.+Methods3292008112124" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib67" class="citations"><div id="sref67" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref67" title="View in article">67.</a></div><div>Tiller, T. ∙ Tsuiji, M. ∙ Yurasov, S. ...</div><div><strong>Autoreactivity in human IgG+ memory B cells</strong></div><div><em>Immunity.</em> 2007; <strong>26</strong>:205-213</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=T.TillerM.TsuijiS.YurasovK.VelinzonM.C.NussenzweigH.WardemannAutoreactivity+in+human+IgG%2B+memory+B+cellsImmunity262007205213" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib68" class="citations"><div id="sref68" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref68-1" title="View in article">68.</a></div><div>Udi, Y. ∙ Fragai, M. ∙ Grossman, M. ...</div><div><strong>Unraveling hidden allosteric regulatory sites in structurally homologues metalloproteases</strong></div><div><em>J.&nbsp;Mol. Biol.</em> 2013; <strong>425</strong>:2330-2346</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Y.UdiM.FragaiM.GrossmanS.MitternachtR.Arad-YellinV.CalderoneM.MelikianM.ToccafondiI.N.BerezovskyC.LauchinatI.SagoUnraveling+hidden+allosteric+regulatory+sites+in+structurally+homologues+metalloproteasesJ.%C2%A0Mol.+Biol.42520132330234610.1016%2Fj.jmb.2013.04.009" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib69" class="citations"><div id="sref69" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref69" title="View in article">69.</a></div><div>Uppendahl, L.D. ∙ Dahl, C.M. ∙ Miller, J.S. ...</div><div><strong>Natural killer cell-based immunotherapy in gynecologic malignancy: a review</strong></div><div><em>Front. Immunol.</em> 2017; <strong>8</strong>:1825</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.D.UppendahlC.M.DahlJ.S.MillerM.FelicesM.A.GellerNatural+killer+cell-based+immunotherapy+in+gynecologic+malignancy%3A+a+reviewFront.+Immunol.820171825" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib70" class="citations"><div id="sref70" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref70" title="View in article">70.</a></div><div>Victora, G.D. ∙ Nussenzweig, M.C.</div><div><strong>Germinal centers</strong></div><div><em>Annu. Rev. Immunol.</em> 2022; <strong>30</strong>:429-457</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.D.VictoraM.C.NussenzweigGerminal+centersAnnu.+Rev.+Immunol.302022429457" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib71" class="citations"><div id="sref71" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref71" title="View in article">71.</a></div><div>Vinuesa, C.G. ∙ Sanz, I. ∙ Cook, M.C.</div><div><strong>Dysregulation of germinal centres in autoimmune disease</strong></div><div><em>Nat. Rev. Immunol.</em> 2009; <strong>9</strong>:845-857</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=C.G.VinuesaI.SanzM.C.CookDysregulation+of+germinal+centres+in+autoimmune+diseaseNat.+Rev.+Immunol.92009845857" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib72" class="citations"><div id="sref72" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref72-1" title="View in article">72.</a></div><div>Vos, M.C. ∙ van der Wurff, A.A.M. ∙ van Kuppevelt, T.H. ...</div><div><strong>The role of MMP-14 in ovarian cancer: a systematic review</strong></div><div><em>J.&nbsp;Ovarian Res.</em> 2021; <strong>14</strong>:1-13</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.C.VosA.A.M.van+der+WurffT.H.van+KuppeveltL.A.F.G.MassugerThe+role+of+MMP-14+in+ovarian+cancer%3A+a+systematic+reviewJ.%C2%A0Ovarian+Res.142021113" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib73" class="citations"><div id="sref73" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref73-1" title="View in article">73.</a></div><div>Vos, M.C. ∙ Hollemans, E. ∙ Ezendam, N. ...</div><div><strong>MMP-14 and CD44 in epithelial-to-mesenchymal transition (EMT) in ovarian cancer</strong></div><div><em>J.&nbsp;Ovarian Res.</em> 2016; <strong>9</strong>:53</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=M.C.VosE.HollemansN.EzendamH.FeijenD.BollB.PijlmanH.van+der+PuttenP.KlinkhamerT.H.van+KuppeveltA.A.van+der+WurffL.F.MassugerMMP-14+and+CD44+in+epithelial-to-mesenchymal+transition+%28EMT%29+in+ovarian+cancerJ.%C2%A0Ovarian+Res.9201653" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib74" class="citations"><div id="sref74" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref74-1" title="View in article">74.</a></div><div>Wang, E.Y. ∙ Mao, T. ∙ Klein, J. ...</div><div><strong>Diverse functional autoantibodies in patients with COVID-19</strong></div><div><em>medRxiv.</em> 2021;</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=E.Y.WangT.MaoJ.KleinYileDaiJ.D.HuckFeimeiLiuN.S.ZhengT.ZhouB.IsraelowP.WongDiverse+functional+autoantibodies+in+patients+with+COVID-19medRxiv202110.1101%2F2020.12.10.20247205" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib75" class="citations"><div id="sref75" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref75-1" title="View in article">75.</a></div><div>Wardemann, H. ∙ Yurasov, S. ∙ Schaefer, A. ...</div><div><strong>Predominant autoantibody production by early human B cell precursors</strong></div><div><em>Science.</em> 2003; <strong>301</strong>:1374-1377</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=H.WardemannS.YurasovA.SchaeferJ.W.YoungE.MeffreM.C.NussenzweigPredominant+autoantibody+production+by+early+human+B+cell+precursorsScience301200313741377" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib76" class="citations"><div id="sref76" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref76-1" title="View in article">76.</a></div><div>Webb, N.E. ∙ Bernshtein, B. ∙ Alter, G.</div><div><strong>Tissues: the unexplored frontier of antibody mediated immunity</strong></div><div><em>Curr. Opin. Virol.</em> 2021; <strong>47</strong>:52-67</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=N.E.WebbB.BernshteinG.AlterTissues%3A+the+unexplored+frontier+of+antibody+mediated+immunityCurr.+Opin.+Virol.4720215267" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib77" class="citations"><div id="sref77" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref77" title="View in article">77.</a></div><div>Wieland, A. ∙ Ahmed, R.</div><div><strong>Fc receptors in antimicrobial protection</strong></div><div><em>Curr. Top. Microbiol. Immunol.</em> 2019; <strong>423</strong>:119-150</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.WielandR.AhmedFc+receptors+in+antimicrobial+protectionCurr.+Top.+Microbiol.+Immunol.4232019119150" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib78" class="citations"><div id="sref78" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref78-1" title="View in article">78.</a></div><div>Wieland, A. ∙ Patel, M.R. ∙ Cardenas, M.A. ...</div><div><strong>Defining HPV-specific B cell responses in patients with head and neck cancer</strong></div><div><em>Nature.</em> 2021; <strong>597</strong>:274-278</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=A.WielandM.R.PatelM.A.CardenasC.S.EberhardtW.H.HudsonR.C.ObengC.C.GriffithX.WangZ.G.ChenH.T.KissickDefining+HPV-specific+B+cell+responses+in+patients+with+head+and+neck+cancerNature597202127427810.1038%2Fs41586-020-2931-3" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib79" class="citations"><div id="sref79" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref79" title="View in article">79.</a></div><div>Witz, I.P.</div><div><strong>Tumor-bound immunoglobulins: in&nbsp;situ expressions of humoral immunity</strong></div><div><em>Adv. Cancer Res.</em> 1977; <strong>25</strong>:95-148</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=I.P.WitzTumor-bound+immunoglobulins%3A+in%C2%A0situ+expressions+of+humoral+immunityAdv.+Cancer+Res.25197795148" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib80" class="citations"><div id="sref80" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref80-1" title="View in article">80.</a></div><div>Yaari, G. ∙ Uduman, M. ∙ Kleinstein, S.H.</div><div><strong>Quantifying selection in high-throughput immunoglobulin sequencing data sets</strong></div><div><em>Nucleic Acids Res.</em> 2012; <strong>40</strong>:e134</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=G.YaariM.UdumanS.H.KleinsteinQuantifying+selection+in+high-throughput+immunoglobulin+sequencing+data+setsNucleic+Acids+Res.402012e134" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib81" class="citations"><div id="sref81" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref81" title="View in article">81.</a></div><div>Yang, F. ∙ Nielsen, S.C.A. ∙ Hoh, R.A. ...</div><div><strong>Shared B cell memory to coronaviruses and other pathogens varies in human age groups and tissues</strong></div><div><em>Science.</em> 2021; <strong>372</strong>:738-741</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=F.YangS.C.A.NielsenR.A.HohK.R%C3%B6ltgenO.F.WirzE.HaraguchiG.H.JeanJ.Y.LeeT.D.PhamK.J.L.JacksonShared+B+cell+memory+to+coronaviruses+and+other+pathogens+varies+in+human+age+groups+and+tissuesScience372202173874110.1126%2Fscience.abf6648" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib82" class="citations"><div id="sref82" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref82-1" title="View in article">82.</a></div><div>Ye, J. ∙ Ma, N. ∙ Madden, T.L. ...</div><div><strong>IgBLAST: an immunoglobulin variable domain sequence analysis tool</strong></div><div><em>Nucleic Acids Res.</em> 2013; <strong>41</strong>:W34-W40</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=J.YeN.MaT.L.MaddenJ.M.OstellIgBLAST%3A+an+immunoglobulin+variable+domain+sequence+analysis+toolNucleic+Acids+Res.412013W34W40" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib83" class="citations"><div id="sref83" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref83-1" title="View in article">83.</a></div><div>Zaenker, P. ∙ Gray, E.S. ∙ Ziman, M.R.</div><div><strong>Autoantibody production in cancer—the humoral immune response toward autologous antigens in cancer patients</strong></div><div><em>Autoimmun. Rev.</em> 2016; <strong>15</strong>:477-483</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=P.ZaenkerE.S.GrayM.R.ZimanAutoantibody+production+in+cancer%E2%80%94the+humoral+immune+response+toward+autologous+antigens+in+cancer+patientsAutoimmun.+Rev.152016477483" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div></div></div></section></div></section><div class="core-linked-content">
    

        


    

            

            

            <div data-widget-id="8633d695-b258-4908-b86f-e2c268ec3c6b" data-widget-name="UX3HTMLWidget"><script type="text/javascript">
if($('.content-navigation__body__title').length){
$('.content-navigation__body__title').each(function(){
var html=this.innerHTML;
var div = document.createElement("div");
div.innerHTML = html;
var text = div.textContent || div.innerText || "";
this.innerHTML=text;
});
}
</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="393effff-5b44-4681-a9b4-4f029b3540b7" data-widget-name="UX3HTMLWidget"><style>
.linkback-ad .pb-ad {
    display: block;
   height: auto;
    margin-left: 0px;
    margin-right: auto;
}
</style></div>

            

        

    

        

</div></div></div><div class="core-collateral-aside"><section id="core-collateral-figures"><h2>Figures (13)<button class="js--openFigureViewer"><span>Figure Viewer</span></button></h2><div class="core-collateral-aside-wrapper"><div class="grid"><a class="figure__open__ctrl" href="#fig1" aria-label="Go to Figure&amp;nbsp;1"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.02.012/asset/3ca36bca-33aa-4bbb-afd5-6e32ca183739/main.assets/gr1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs1" aria-label="Go to Figure&amp;nbsp;S1"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.02.012/asset/abc4e542-8e25-4a72-9910-d7644aa2dac1/main.assets/figs1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig2" aria-label="Go to Figure&amp;nbsp;2"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.02.012/asset/3d818ee0-cfee-4544-8e86-cdc4b9661ca3/main.assets/gr2.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs2" aria-label="Go to Figure&amp;nbsp;S2"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.02.012/asset/da5fc878-5642-4571-9313-f211370aae96/main.assets/figs2.jpg" aria-hidden="true"></a></div><div id="collapsible-figures" data-expandable="item"><div class="content grid" style="display:none;" role="region" id="collapsible-figures_content"><a class="figure__open__ctrl" href="#fig3" aria-label="Go to Figure&amp;nbsp;3"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.02.012/asset/1cff7633-e4d8-4fb8-9cde-ab0a1bd5d104/main.assets/gr3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs3" aria-label="Go to Figure&amp;nbsp;S3"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.02.012/asset/93376182-23c7-4a3d-a9a8-2d1a79a2ee49/main.assets/figs3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs4" aria-label="Go to Figure&amp;nbsp;S4"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.02.012/asset/39fdaa23-36b8-4b7d-9f91-d5c0d7ee2d0e/main.assets/figs4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs5" aria-label="Go to Figure&amp;nbsp;S5"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.02.012/asset/d7425a97-e5b9-46f9-8ba0-11eb80fbe237/main.assets/figs5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs6" aria-label="Go to Figure&amp;nbsp;S6"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.02.012/asset/e6a15bc8-21df-41d0-b177-a31551d89397/main.assets/figs6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig4" aria-label="Go to Figure&amp;nbsp;4"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.02.012/asset/f9cd5f0a-12e8-40c5-b327-1083226a2c05/main.assets/gr4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs7" aria-label="Go to Figure&amp;nbsp;S7"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.02.012/asset/26eb6dbf-6689-4ad2-bb32-a2dba8ac915b/main.assets/figs7.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig5" aria-label="Go to Figure&amp;nbsp;5"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.02.012/asset/e57ccc3f-3dfc-47cd-816f-98f06dc80542/main.assets/gr5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig6" aria-label="Go to Figure&amp;nbsp;6"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.02.012/asset/a36e83af-a86c-41e8-8e98-4be76e080ec7/main.assets/gr6.jpg" aria-hidden="true"></a></div><button class="trigger" aria-controls="collapsible-figures_content" aria-expanded="false" tabindex="0" role="button"><span class="expand">Show all figures</span><span class="collapse">Hide figures</span><i class="icon-section_arrow_d" aria-hidden="true"></i></button></div></div></section>
    

        


    

            

            

            <section id="core-collateral-metrics" class="publication-list__axel-section"><h2>Article metrics</h2><div><ul class="publication-list rlist publication-list--list plum-x--lazy-load publication-list--axel" data-plum-x-url="/pb/widgets/ux3/publicationList/plumx?widgetId=66dd7e11-7768-4006-93d8-a72b60e2a264&amp;pbContext=%3Bproduct%3Aproduct%3Aelsevier%5C%3Aproduct%5C%3Acell%3Bwebsite%3Awebsite%3Acell-site%3Bctype%3Astring%3AJournal+Content%3Bjournal%3Ajournal%3Acell%3BpageGroup%3Astring%3AArticle+View%3Bissue%3Aissue%3Apii%5C%3AS0092867421X00086%3Bpage%3Astring%3AShow+Full+Text%3BrequestedJournal%3Ajournal%3Acell%3Bwgroup%3Astring%3ADefault+Website+Group%3Barticle%3Aarticle%3Apii%5C%3AS0092867422001921%3BsubPage%3Astring%3AFull+Text" data-pb-mode-enabled="false"><li aria-label="loading articles" role="alert" class="js--loading plum-x--spinner hidden"></li></ul></div></section>

            

        
<section id="core-collateral-supplementary"><h2>Supplemental information (4)</h2><div class="core-collateral-aside-wrapper"><div class="core-supplementary-material"><div class="core-link"><button class="downloadAllSupplementary"><span>Download all</span></button></div></div><div class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2022.02.012/attachment/6cc377b6-c12b-43d0-b37a-9d7f9c3467d8/mmc1.pdf" download="mmc1.pdf"><span id="mmc1-link">PDF (96.34 KB)</span></a><div class="core-description">Document S1. Tables S1–S3 and S5</div></div></div><div class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2022.02.012/attachment/acc23c81-0ca8-4361-bf73-e0551407c5d8/mmc2.xlsx" download="mmc2.xlsx"><span id="mmc2-link">Spreadsheet (34.90 KB)</span></a><div class="core-description">Table S4. Sequences, genes, clones and reactivities of monoclonal antibodies, related to Figure&nbsp;3</div></div></div><div class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2022.02.012/attachment/2e1ace84-3cc0-40ad-93df-7f3e6fc36d28/mmc3.xlsx" download="mmc3.xlsx"><span id="mmc3-link">Spreadsheet (1.22 MB)</span></a><div class="core-description">Table S6. Protein microarray data, related to Figure&nbsp;4</div></div></div><div class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2022.02.012/attachment/b7b2f16c-8f70-4aa4-bac0-4ffba658b9c2/mmc4.xlsx" download="mmc4.xlsx"><span id="mmc4-link">Spreadsheet (29.57 KB)</span></a><div class="core-description">Table S7. Study participants, related to STAR methods</div></div></div></div></section>
    

        


    

            

            

            <section id="core-collateral-relatedArticles" class="axel-related-articles"><h2 id="relatedArticles" class="top axel-related-articles__title" data-title="Related articles">Related Articles</h2><div data-pb-widget-type="ux3-relatedArticles" data-widget-id="8d3844d1-450e-497c-ab75-a63fc41750ac" data-widget-name="AtyponTempUX3RelatedArticlesWidget" data-article-pii="S0092867422001921" class="ux3DeferredOnScrollWidget axel-related-articles__body ux3DeferredLoaded" data-show-more="true">We haven't found any related articles.</div></section>

            

        
</div></div><aside data-core-aside="right-rail"><div class="inner-wrapper">

    

        


    

            

            

            <div data-widget-id="dca7470d-9085-4d21-a6f4-a66397718146" data-widget-name="UX3HTMLWidget"><input type="hidden" id="gptPage" value="cell-videos"></div>

            

        











        <div data-widget-def="literatumAd" data-widget-id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc" class="adplaceholders" style="right: 0px; position: static;">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd alignCenter  widget-verticalAd" id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc">
                
                
                    
                

                <div class="wrapped " id="Marketplace-Recs">
                    
                    <div class="widget-body body body-verticalAd "><div class="verticalAdContainer">
    <div class="verticalAdLabelContainer">
        <div class="verticalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adVert.gif" alt="Advertisement">
        </div>
    </div>
    <div class="verticalAd">
        





        <div class="pb-ad">
            <script src="//cdn.pbgrd.com/core-cell.js" async=""></script>
<div id="pbgrd-skyr-c"><div id="pbgrd-skyr" style="width: inherit; position: relative; background: transparent;"></div></div>
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

        </div>
    

</div></aside><div class="core-authors-details" style="display:none"><section class="core-authors"></section></div></article><div data-extent="article-wrapper"><div class="core-container"></div></div><script id="axel-publication-metadata" type="application/json">{"doi":"10.1016/j.cell.2022.02.012","data-is-retraction":false,"data-is-retired":false}
</script><script type="text/javascript" data-ot-ignore="data-ot-ignore" defer="defer" src="https://static.addtoany.com/menu/page.js" class="optanon-category-C0004 ot-vscat-C0004"></script><template id="figure_nav_template"><a href="#" class="open-in-viewer btn btn-dark figure-pop-btn"><i aria-hidden="true" class="icon-export_citation"></i><span>Open in viewer</span></a></template><div id="figure-viewer" role="dialog" aria-modal="true" aria-label="Figure Viewer" class="showCaption showThumbstrip figure-viewer"><nav class="nav-bar figure-viewer__top"><a href="#" title="Close Figure Viewer" role="button" class="figure-viewer__close"><i aria-hidden="true" class="icon-tools_close"></i></a><div class="figure-viewer__title">Tumor-reactive antibodies evolve from non-binding and autoreactive precursors</div></nav><div class="frames"><ul class="frames__list"><li><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2022.02.012/asset/3ca36bca-33aa-4bbb-afd5-6e32ca183739/main.assets/gr1.jpg" height="940" width="625" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/c00807e2-2dec-4359-9ebb-b5632f0e86ae/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2022.02.012/asset/abc4e542-8e25-4a72-9910-d7644aa2dac1/main.assets/figs1.jpg" height="899" width="356" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/4a51e9d0-c767-4520-bdd1-dbc11b98e989/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2022.02.012/asset/3d818ee0-cfee-4544-8e86-cdc4b9661ca3/main.assets/gr2.jpg" height="622" width="656" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/8cf0dce4-e01e-4911-8444-23084c758357/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2022.02.012/asset/da5fc878-5642-4571-9313-f211370aae96/main.assets/figs2.jpg" height="842" width="656" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/701c3a02-6e9f-43a7-bd9f-3949e96dad55/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2022.02.012/asset/1cff7633-e4d8-4fb8-9cde-ab0a1bd5d104/main.assets/gr3.jpg" height="854" width="656" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/72039b34-3391-4bf5-b7dc-36aecae84363/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2022.02.012/asset/93376182-23c7-4a3d-a9a8-2d1a79a2ee49/main.assets/figs3.jpg" height="839" width="656" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/fe87081a-7096-49d6-84b4-d16aae5f40ae/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2022.02.012/asset/39fdaa23-36b8-4b7d-9f91-d5c0d7ee2d0e/main.assets/figs4.jpg" height="451" width="656" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/d542b641-7020-4a5f-ac1f-16c7150d891d/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2022.02.012/asset/d7425a97-e5b9-46f9-8ba0-11eb80fbe237/main.assets/figs5.jpg" height="896" width="656" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/3d3b63d9-11b2-4210-9a66-ccf13a2c332f/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2022.02.012/asset/e6a15bc8-21df-41d0-b177-a31551d89397/main.assets/figs6.jpg" height="907" width="656" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/e88e8096-3255-49e4-94f3-9f3b2a487403/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2022.02.012/asset/f9cd5f0a-12e8-40c5-b327-1083226a2c05/main.assets/gr4.jpg" height="555" width="656" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/cf4befcd-ea6f-460d-9c9d-d90a09579606/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2022.02.012/asset/26eb6dbf-6689-4ad2-bb32-a2dba8ac915b/main.assets/figs7.jpg" height="669" width="656" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/daffeab7-3300-4576-9d92-0c828adc4c61/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2022.02.012/asset/e57ccc3f-3dfc-47cd-816f-98f06dc80542/main.assets/gr5.jpg" height="698" width="759" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/9807afa2-990b-4a2e-8144-3a9990a45f9d/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2022.02.012/asset/a36e83af-a86c-41e8-8e98-4be76e080ec7/main.assets/gr6.jpg" height="332" width="656" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/7eeb36ce-a292-4072-9aff-b88697a28c2b/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li></ul><a href="#" title="Previous Frame" class="frameButton previousFrameButton frames__prev"><!--span Previous Frame--><i class="icon-arrow_l"></i></a><a href="#" title="Next Frame" class="frameButton nextFrameButton frames__next"><!--span Next Frame--><i class="icon-arrow_r"></i></a></div><div class="caption"><div class="figure-viewer__caption-body"></div></div><div class="toolbar figure-viewer__toolbar"><span class="figure-viewer__counter"></span><a href="#" class="button toggle-caption-button figure-viewer__caption__ctrl"><i aria-hidden="true" class="icon icon-info"></i><span class="label">Hide Caption</span></a><a href="#" class="button download-options-button"><i aria-hidden="true" class="icon icon-gizmo-folder-in download-size-icon"></i><span class="label">Download</span></a><a href="#figures" class="button see-figures figure-viewer__see-figure__ctrl"><i aria-hidden="true" class="icon icon-gizmo-image_figure viewer-size-icon"></i><span class="label">See figure in Article</span></a></div><div class="thumbstrip"><a href="#" class="toggleButton thumbstrip__ctrl"><span>Toggle Thumbstrip</span></a><a href="#" title="Previous Thumbnails" class="thumbstripButton previousThumbstripButton thumbstrip__prev"><i aria-hidden="true" class="icon-arrow_l"></i></a><a href="#" title="Next Thumbnails" class="thumbstripButton nextThumbstripButton thumbstrip__next"><i aria-hidden="true" class="icon-arrow_r"></i></a><div class="thumbstrip__wrapper"><ul class="rlist figure-viewer__thumbslist"><li><div class="thumbnail__label">Figure&nbsp;1</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2022.02.012/asset/3ca36bca-33aa-4bbb-afd5-6e32ca183739/main.assets/gr1.jpg" height="940" width="625" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/c00807e2-2dec-4359-9ebb-b5632f0e86ae/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S1</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2022.02.012/asset/abc4e542-8e25-4a72-9910-d7644aa2dac1/main.assets/figs1.jpg" height="899" width="356" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/4a51e9d0-c767-4520-bdd1-dbc11b98e989/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;2</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2022.02.012/asset/3d818ee0-cfee-4544-8e86-cdc4b9661ca3/main.assets/gr2.jpg" height="622" width="656" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/8cf0dce4-e01e-4911-8444-23084c758357/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S2</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2022.02.012/asset/da5fc878-5642-4571-9313-f211370aae96/main.assets/figs2.jpg" height="842" width="656" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/701c3a02-6e9f-43a7-bd9f-3949e96dad55/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;3</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2022.02.012/asset/1cff7633-e4d8-4fb8-9cde-ab0a1bd5d104/main.assets/gr3.jpg" height="854" width="656" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/72039b34-3391-4bf5-b7dc-36aecae84363/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S3</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2022.02.012/asset/93376182-23c7-4a3d-a9a8-2d1a79a2ee49/main.assets/figs3.jpg" height="839" width="656" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/fe87081a-7096-49d6-84b4-d16aae5f40ae/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S4</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2022.02.012/asset/39fdaa23-36b8-4b7d-9f91-d5c0d7ee2d0e/main.assets/figs4.jpg" height="451" width="656" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/d542b641-7020-4a5f-ac1f-16c7150d891d/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S5</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2022.02.012/asset/d7425a97-e5b9-46f9-8ba0-11eb80fbe237/main.assets/figs5.jpg" height="896" width="656" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/3d3b63d9-11b2-4210-9a66-ccf13a2c332f/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S6</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2022.02.012/asset/e6a15bc8-21df-41d0-b177-a31551d89397/main.assets/figs6.jpg" height="907" width="656" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/e88e8096-3255-49e4-94f3-9f3b2a487403/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;4</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2022.02.012/asset/f9cd5f0a-12e8-40c5-b327-1083226a2c05/main.assets/gr4.jpg" height="555" width="656" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/cf4befcd-ea6f-460d-9c9d-d90a09579606/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S7</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2022.02.012/asset/26eb6dbf-6689-4ad2-bb32-a2dba8ac915b/main.assets/figs7.jpg" height="669" width="656" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/daffeab7-3300-4576-9d92-0c828adc4c61/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;5</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2022.02.012/asset/e57ccc3f-3dfc-47cd-816f-98f06dc80542/main.assets/gr5.jpg" height="698" width="759" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/9807afa2-990b-4a2e-8144-3a9990a45f9d/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;6</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2022.02.012/asset/a36e83af-a86c-41e8-8e98-4be76e080ec7/main.assets/gr6.jpg" height="332" width="656" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2022.02.012/asset/7eeb36ce-a292-4072-9aff-b88697a28c2b/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li></ul></div></div><div class="download figure-viewer__download"><div class="pointer"></div><ul class="rlist downlad__wrapper"><li class="hidden-xs hidden-sm"><a href="/action/downloadFigures?pii=e00489&amp;id=" class="downloadAllButton"><i class="icon icon-gizmo-ppt figure-viewer__download__viewer-size-icon figure-viewer__download__viewer-size-icon--ppt"></i><span class="figure-viewer__download__text"> Download .PPT</span></a></li></ul></div></div><template id="toCitationLink" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></a></div></template><template id="toCitationButton" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><button class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></button></div></template><template id="toCitationAccordion" data-collapse-citation="Hide Citations" data-expand-citation="Show Citations" data-collapse-footnote="Hide Footnotes" data-expand-footnote="Show Footnotes"><div class="to-citation__wrapper"><button aria-controls="aria-controls" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="data-expand-title" data-collapsed-title="data-collapsed-title" class="accordion__toggle__title"></span></button><div role="menu" aria-label="links" class="to-citation__accordion no-separator"><ul></ul></div></div></template><template id="toCitationAccordionItem"><li><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span></span></a></li></template><template id="citations_truncate_template"><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--inverse"><span>Show all references</span></button></div></template><template id="collateral_texts_template" data-do="Digital Object" data-figures="Figures" data-metrics="Article Metrics" data-related="Related articles" data-supplementary="Supplemental information"></template><template id="collapsible_authors_template"><button aria-expanded="false" data-expandable="all" data-label-expand="Expand All" data-label-collapse="Collapse All" class="collateral-contributors-control"><span>Expand All</span></button></template>
<template id="collapsible_tables_collapse_template"><div class="collapsible-figure-btn__wrapper expanded"><button aria-expanded="true" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-up"></i><span class="text-uppercase">Collapse</span></button></div></template>
<template id="collapsible_tables_expand_template"><div class="collapsible-figure-btn__wrapper collapsed"><button aria-expanded="false" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-down"></i><span class="text-uppercase">Expand Table</span></button></div></template><template id="authorsAffiliationsLink"><a href="#tab-contributors" class="to-authors-affiliations">Authors Info &amp; Affiliations</a></template></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-  widget-compact-all" id="756cf18d-e910-4468-936c-0225ae7c669f">
                
                
                    
                

                <div class="wrapped " id="ad for nucleus-single-molecule-technologies">
                    
                    <div class="widget-body body body-  body-compact-all"><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(22)00192-1';

if(URL_var.indexOf("S0165-6147(17)30205-5") > -1
|| URL_var.indexOf("S0167-7799(18)30204-X") > -1 
|| URL_var.indexOf("S0092-8674(18)31649-0") > -1 
|| URL_var.indexOf("S0092-8674(19)30404-0") > -1 
|| URL_var.indexOf("S1097-2765(18)30756-1") > -1 
|| URL_var.indexOf("S0092-8674(18)31452-1") > -1 
|| URL_var.indexOf("S1097-2765(19)30175-3") > -1 
|| URL_var.indexOf("S0092-8674(18)30852-3") > -1 
|| URL_var.indexOf("S0006-3495(18)30295-9") > -1 
|| URL_var.indexOf("S1097-2765(19)30063-2") > -1 
|| URL_var.indexOf("S0006-3495(17)33208-3") > -1 
|| URL_var.indexOf("S2211-1247(18)31639-5") > -1 
|| URL_var.indexOf("S1097-2765(18)30978-X") > -1 
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-single-molecule-technologies" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-" id="754b1780-1117-4371-9285-9cd7020963d5">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body- "><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(22)00192-1';

if(URL_var.indexOf("S1535-6108(19)30104-7") > -1
|| URL_var.indexOf("S0092-8674(18)31394-1") > -1
|| URL_var.indexOf("S1074-7613(19)30033-0") > -1
|| URL_var.indexOf("S1535-6108(18)30473-2") > -1
|| URL_var.indexOf("S0092-8674(19)30154-0") > -1
|| URL_var.indexOf("S1550-4131(18)30178-5") > -1
|| URL_var.indexOf("S1535-6108(19)30242-9") > -1
|| URL_var.indexOf("S1074-7613(18)30431-X") > -1
|| URL_var.indexOf("S0092-8674(19)30618-X") > -1
|| URL_var.indexOf("S1535-6108(18)30472-0") > -1
|| URL_var.indexOf("S1535-6108(18)30120-X") > -1
|| URL_var.indexOf("S0092-8674(18)31247-9") > -1
|| URL_var.indexOf("S1074-7613(18)30085-2") > -1
|| URL_var.indexOf("S1074-7613(18)30080-3") > -1
|| URL_var.indexOf("S1471-4906(18)30210-2") > -1
|| URL_var.indexOf("S1550-4131(19)30304-3") > -1
|| URL_var.indexOf("S1934-5909(18)30599-X") > -1
|| URL_var.indexOf("S2405-8033(19)30024-X") > -1
|| URL_var.indexOf("S1535-6108(18)30109-0") > -1
|| URL_var.indexOf("S0962-8924(18)30127-2") > -1
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-tumor-immune-microenvironment" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="9c9ff7a1-a035-49f6-a336-600c9419c518" data-widget-name="UX3HTMLWidget"><!-- Start of HubSpot Embed Code --> 

<script type="text/plain" class="optanon-category-4" id="hs-script-loader" async="" defer="" src="//js.hs-scripts.com/519224.js"></script> 

<!-- End of HubSpot Embed Code --></div>

            

        

    

        


    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget sessionValidationWidget none  widget-none  widget-compact-all" id="0257aef7-6074-4898-a989-1c3f693225a2">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><script>
    $.ajax({
        url: "https://www.cell.com/ssoSessionCheck",
        type: "GET",
        dataType: "jsonp",
        success: function (data) {
            if(data.RefreshSession) {
                location.reload();
            }
        },
        error : function (){
            console.warn("can't validate CSAS session.");
        }
    });
</script></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasSsoUrls none  widget-none  widget-compact-all" id="948bc5c4-8b0d-47be-b5ad-6570559802d1">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><!-- clear SSO URLs after all iFrames are rendered or after passing a time out-->
<script>
    setTimeout(clearSsoUrlsFun,10000);
    var iFramesList = document.getElementById("sso-urls-div").getElementsByTagName("iframe");
    var renderedIFramesCount = 0;
    var numberOfIFrames = iFramesList.length;
    var skipRefresh = false;
    for (var i = 0; i < iFramesList.length; i++) {
        var iFrame = iFramesList[i];
        iFrame.addEventListener("load", function() {
            renderedIFramesCount = renderedIFramesCount + 1;
            if (renderedIFramesCount >= numberOfIFrames)
            {
                clearSsoUrlsFun();
            }
        });
    }

    function clearSsoUrlsFun() {
        if (skipRefresh == false && numberOfIFrames > 0)
        {
            skipRefresh = true;
            $.ajax({
                url: "https://www.cell.com/action/clearSsoUrls",
                type: "GET",
                dataType: "jsonp",
                error : errorCallingAjx
            });
        }
    }

    function errorCallingAjx(){
        console.log("can't delete sso urls .")
    }
</script></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" class="ux3 ">
        
    

        


    

            

            

            <div data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" data-widget-name="ux3-layout-widget" class="fonts-loaded"><div class="footer clearfix">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header widget-horizontalAd" id="a07ee92b-3942-49f8-9186-a2a08fc3fc56">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 4 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="4"></div>
<!-- End AdSlot 4 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="23703bbc-af46-4f3f-a5bb-dd52891ff0ff" data-widget-name="UX3HTMLWidget"><div class="footer__top">
    <div class="footer__logo centered"><a href="/home" title="Cell Press"><!-- Generator: Adobe Illustrator 25.2.1, SVG Export Plug-In . SVG Version: 6.00 Build 0)  -->
<svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 300 72" style="enable-background:new 0 0 300 72;" xml:space="preserve">
<style type="text/css">
	.st0{fill:#007DBC;}
</style>
<g>
	<path class="st0" d="M39.4,7.5c-2.3-0.3-4.4,1.1-4.9,3.3l-1.8,7.4c-0.4,1.8-1.9,3.1-3.8,3.3l-10.5,1.2C7.1,24-1,34.3,0.7,45.6
		c1.3,9,8.6,15.7,17.2,17c2.3,0.3,4.4-1.1,4.9-3.3l1.8-7.4c0.4-1.8,1.9-3.1,3.8-3.3l10.5-1.2c11.3-1.2,19.4-11.6,17.8-22.9
		C55.3,15.4,48.1,8.8,39.4,7.5z M37.1,34l-6.6,0.8c-1.1,0.1-2,0.9-2.3,2l-1.9,8.1c-0.6,2.4-2.5,4.2-5,4.5c-3.8,0.4-7.1-2.4-7.4-6.2
		c-0.3-3.7,2.6-6.8,6.3-7.2l6.6-0.8c1.1-0.1,2-0.9,2.3-2l1.9-8.1c0.6-2.4,2.5-4.2,5-4.5c3.8-0.4,7.1,2.4,7.4,6.2
		C43.7,30.5,40.8,33.6,37.1,34z"></path>
	<rect x="153.1" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M90.2,20.4c7.3,0,8.6,4.8,9.4,7.3h8.8c-0.5-6.2-5.6-14.9-18.2-14.9c-10.9,0-19.4,7.5-19.4,22.3
		c0,14.6,8.1,22.2,19.3,22.2c10.6,0,16.6-6.4,18.4-15.6h-8.8c-1.1,5.2-4.5,7.9-9.4,7.9c-7.5,0-10.5-6.8-10.5-14.4
		C79.7,23.3,85.9,20.4,90.2,20.4z"></path>
	<path class="st0" d="M125.2,24c-13.7,0-15,12.1-15,15.8c0,12.9,6.8,17.1,15.6,17.1c5.4,0,11.6-2.5,13.8-10H131
		c-0.7,2.2-3,3.4-5.3,3.4c-6.6,0-7.1-5.3-7.3-7.7h21.5v-1.5C139.9,27,131.3,24,125.2,24z M118.6,37.4c0.5-4.1,2.5-6.6,6.4-6.6
		c2.6,0,5.9,1.5,6.4,6.6H118.6z"></path>
	<rect x="142" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M174,13.8h-9.8V21h7.2c4.3,0,8.2,0.9,8.2,6.4c0,5.4-3.9,6.4-8.2,6.4h-7.2V41h9.8c10.6,0,14.7-6.7,14.7-13.6
		C188.7,20.5,184.6,13.8,174,13.8z"></path>
	<path class="st0" d="M210.5,24.9c-0.5-0.2-1.2-0.3-1.8-0.3c-4.1,0-8.3,2.7-9.8,6.5h-0.1v-5.7h-8v30.7h8.4V42.3
		c0-5.4,2.1-9.9,8.3-9.9c1,0,2.3,0.1,3,0.3V24.9z"></path>
	<path class="st0" d="M225.6,24.6c-9.3,0-15.7,7-15.7,16.2c0,9.5,6,16.1,15.7,16.1c6.9,0,12-3.1,14.4-10.3h-7.4
		c-0.5,1.9-3.3,4-6.6,4c-4.7,0-7.3-2.4-7.5-7.8h22.1C241.1,33.4,236,24.6,225.6,24.6z M218.4,37.5c0.1-2.4,1.7-6.5,7-6.5
		c4.1,0,5.9,2.3,6.7,6.5H218.4z"></path>
	<path class="st0" d="M260.3,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		C242,54.3,248.9,57,256,57c7,0,14-2.6,14-10.7C270.1,40.6,265.2,38.8,260.3,37.7z"></path>
	<path class="st0" d="M289.8,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		c0.4,8.1,7.3,10.8,14.4,10.8c7,0,14-2.6,14-10.7C299.6,40.6,294.7,38.8,289.8,37.7z"></path>
	<path class="st0" d="M34.1,57.6c0.3-0.2,0.4-0.6,0.4-1c0-0.5-0.2-0.9-0.5-1.1c-0.3-0.2-0.8-0.3-1.4-0.3h-1.9v5.1h0.8V58h0.8
		l1.3,2.2h0.9l-1.4-2.2C33.6,57.9,33.9,57.8,34.1,57.6z M32.5,57.3h-0.9v-1.5h1c0.1,0,0.3,0,0.4,0c0.1,0,0.3,0,0.4,0.1
		c0.1,0,0.2,0.1,0.3,0.2c0.1,0.1,0.1,0.2,0.1,0.4c0,0.2,0,0.3-0.1,0.4c-0.1,0.1-0.2,0.2-0.3,0.2c-0.1,0.1-0.2,0.1-0.4,0.1
		C32.8,57.3,32.6,57.3,32.5,57.3z"></path>
	<path class="st0" d="M35.6,54.2c-0.4-0.4-0.9-0.7-1.4-0.9c-0.5-0.2-1.1-0.3-1.7-0.3c-0.6,0-1.2,0.1-1.7,0.3c-0.6,0.2-1,0.5-1.4,0.9
		c-0.4,0.4-0.7,0.9-1,1.5c-0.2,0.6-0.4,1.2-0.4,1.9c0,0.7,0.1,1.3,0.3,1.8c0.2,0.6,0.5,1,0.9,1.5c0.4,0.4,0.9,0.7,1.4,1
		c0.6,0.2,1.2,0.4,1.8,0.4c0.6,0,1.2-0.1,1.7-0.3c0.5-0.2,1-0.5,1.4-0.9c0.4-0.4,0.7-0.9,1-1.5c0.2-0.6,0.4-1.2,0.4-1.9
		c0-0.7-0.1-1.3-0.4-1.9C36.4,55.1,36,54.6,35.6,54.2z M35.7,59.1c-0.2,0.5-0.4,0.9-0.8,1.2c-0.3,0.3-0.7,0.6-1.1,0.8
		c-0.4,0.2-0.9,0.3-1.4,0.3c-0.6,0-1-0.1-1.5-0.3c-0.4-0.2-0.8-0.5-1.1-0.8c-0.3-0.3-0.5-0.7-0.7-1.2c-0.2-0.5-0.2-1-0.2-1.5
		c0-0.6,0.1-1.1,0.3-1.5c0.2-0.5,0.4-0.9,0.8-1.2c0.3-0.3,0.7-0.6,1.1-0.8c0.4-0.2,0.9-0.3,1.4-0.3c0.5,0,1,0.1,1.4,0.3
		c0.4,0.2,0.8,0.4,1.1,0.8c0.3,0.3,0.6,0.7,0.8,1.2c0.2,0.5,0.3,1,0.3,1.5C36,58.1,35.9,58.6,35.7,59.1z"></path>
</g>
</svg></a></div>
    <div class="footer__social-links">
        <ul class="rlist rlist--inline centered">
            <li><a href="http://on.fb.me/1tgHakh" title="Facebook" target="_blank"><i aria-hidden="true" class="icon-Icon_Facebook"></i></a></li>

            <li><a href="https://www.instagram.com/cellpress/" title="Instagram" target="_blank"><svg width="18px" height="18px" viewBox="0 0 18 18" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-147.000000, -16.000000)" fill-rule="nonzero" fill="#969696"> <g id="Instagram-Logo" transform="translate(147.000000, 16.000000)"> <path d="M9,1.62580645 C11.4096774,1.62580645 11.7,1.62580645 12.6290323,1.68387097 C13.5,1.71290323 13.9935484,1.85806452 14.3129032,2.00322581 C14.7193548,2.17741935 15.0387097,2.3516129 15.3580645,2.67096774 C15.6774194,2.99032258 15.8806452,3.28064516 16.0258065,3.71612903 C16.1419355,4.03548387 16.2870968,4.5 16.3451613,5.4 C16.3741935,6.35806452 16.4032258,6.61935484 16.4032258,9.02903226 C16.4032258,11.4387097 16.4032258,11.7290323 16.3451613,12.6580645 C16.316129,13.5290323 16.1709677,14.0225806 16.0258065,14.3419355 C15.8516129,14.7483871 15.6774194,15.0677419 15.3580645,15.3870968 C15.0387097,15.7064516 14.7483871,15.9096774 14.3129032,16.0548387 C13.9935484,16.1709677 13.5290323,16.316129 12.6290323,16.3741935 C11.6709677,16.4032258 11.4096774,16.4322581 9,16.4322581 C6.59032258,16.4322581 6.3,16.4322581 5.37096774,16.3741935 C4.5,16.3451613 4.00645161,16.2 3.68709677,16.0548387 C3.28064516,15.8806452 2.96129032,15.7064516 2.64193548,15.3870968 C2.32258065,15.0677419 2.11935484,14.7774194 1.97419355,14.3419355 C1.85806452,14.0225806 1.71290323,13.5580645 1.65483871,12.6580645 C1.62580645,11.7 1.62580645,11.4096774 1.62580645,9 C1.62580645,6.59032258 1.62580645,6.3 1.68387097,5.37096774 C1.71290323,4.5 1.85806452,4.00645161 2.00322581,3.68709677 C2.17741935,3.28064516 2.3516129,2.96129032 2.67096774,2.64193548 C2.99032258,2.32258065 3.28064516,2.11935484 3.71612903,1.97419355 C4.03548387,1.85806452 4.5,1.71290323 5.4,1.65483871 C6.3,1.62580645 6.59032258,1.62580645 9,1.62580645 L9,1.62580645 Z M9,0 C6.56129032,0 6.24193548,0 5.28387097,0.0580645161 C4.32580645,0.116129032 3.65806452,0.261290323 3.10645161,0.464516129 C2.52580645,0.696774194 2.00322581,1.01612903 1.50967742,1.50967742 C1.01612903,2.00322581 0.696774194,2.52580645 0.464516129,3.10645161 C0.232258065,3.68709677 0.0870967742,4.32580645 0.0580645161,5.28387097 C0,6.24193548 0,6.56129032 0,9 C0,11.4387097 0,11.7580645 0.0580645161,12.716129 C0.116129032,13.6741935 0.261290323,14.3419355 0.464516129,14.8935484 C0.696774194,15.4741935 1.01612903,15.9967742 1.50967742,16.4903226 C2.00322581,16.983871 2.52580645,17.3032258 3.10645161,17.5354839 C3.68709677,17.7677419 4.32580645,17.9129032 5.28387097,17.9419355 C6.24193548,18 6.56129032,18 9,18 C11.4387097,18 11.7580645,18 12.716129,17.9419355 C13.6741935,17.883871 14.3419355,17.7387097 14.8935484,17.5354839 C15.4741935,17.3032258 15.9967742,16.983871 16.4903226,16.4903226 C16.983871,15.9967742 17.3032258,15.4741935 17.5354839,14.8935484 C17.7677419,14.3129032 17.9129032,13.6741935 17.9419355,12.716129 C18,11.7580645 18,11.4387097 18,9 C18,6.56129032 18,6.24193548 17.9419355,5.28387097 C17.883871,4.32580645 17.7387097,3.65806452 17.5354839,3.10645161 C17.3032258,2.52580645 16.983871,2.00322581 16.4903226,1.50967742 C15.9967742,1.01612903 15.4741935,0.696774194 14.8935484,0.464516129 C14.3129032,0.232258065 13.6741935,0.0870967742 12.716129,0.0580645161 C11.7580645,0 11.4387097,0 9,0 L9,0 Z"></path> <path d="M9,4.38387097 C6.44516129,4.38387097 4.38387097,6.44516129 4.38387097,9 C4.38387097,11.5548387 6.44516129,13.616129 9,13.616129 C11.5548387,13.616129 13.616129,11.5548387 13.616129,9 C13.616129,6.44516129 11.5548387,4.38387097 9,4.38387097 Z M9,11.9903226 C7.34516129,11.9903226 6.00967742,10.6548387 6.00967742,9 C6.00967742,7.34516129 7.34516129,6.00967742 9,6.00967742 C10.6548387,6.00967742 11.9903226,7.34516129 11.9903226,9 C11.9903226,10.6548387 10.6548387,11.9903226 9,11.9903226 Z"></path> <circle id="Oval" cx="13.7903226" cy="4.20967742" r="1.07419355"></circle> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.linkedin.com/company/cell-press/" title="LinkedIn" target="_blank"><i aria-hidden="true" class="icon-linkedin"></i></a></li>
            
                        <li><a href="http://bit.ly/1zq7Q5T" title="Twitter" target="_blank">
                <!--<i aria-hidden="true" class="icon-Icon_Twitter"></i></a>-->
                
                <svg id="xicon" viewBox="0 0 1200 1227" xmlns="http://www.w3.org/2000/svg" aria-hidden="true" role="none"><path fill="#969696" d="M714.163 519.284L1160.89 0H1055.03L667.137 450.887L357.328 0H0L468.492 681.821L0 1226.37H105.866L515.491 750.218L842.672 1226.37H1200L714.137 519.284H714.163ZM569.165 687.828L521.697 619.934L144.011 79.6944H306.615L611.412 515.685L658.88 583.579L1055.08 1150.3H892.476L569.165 687.854V687.828Z"></path></svg> 

                    <style>
                    .footer svg#xicon {
                      height: 16px;
                    }
                    </style>
            </a></li>

            
            <li><a href="/pb-assets/marketing/WeChat/WeChat-1557753222727.jpg" title="WeChat" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-122.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="wechat" transform="translate(122.000000, 17.000000)"> <path d="M12.375,4.5 L12.375,4.5 L12.4875,4.5 L12.4875,4.5 C12.6898579,4.48604473 12.8520408,4.32704187 12.87,4.125 C12.8705905,4.04725572 12.8470025,3.9712499 12.8025,3.9075 C11.94,1.5675 9.4425,0 6.5625,0 C2.9475,0 0,2.52 0,5.625 C0.0313772094,7.34410122 0.895513317,8.94093526 2.3175,9.9075 L1.5675,11.46 C1.49009368,11.6087816 1.52088865,11.7908702 1.64291494,11.9059236 C1.76494122,12.0209769 1.94852501,12.0410168 2.0925,11.955 L4.08,10.8225 C4.61861992,11.0129999 5.17724298,11.1413322 5.745,11.205 C5.86564124,11.2178337 5.98503738,11.1715098 6.06545426,11.0806685 C6.14587113,10.9898272 6.17737153,10.865694 6.15,10.7475 C6.06148727,10.4219419 6.01114891,10.0871918 6,9.75 C6,6.855 8.8575,4.5 12.375,4.5 Z M8.25,3 C8.66421356,3 9,3.33578644 9,3.75 C9,4.16421356 8.66421356,4.5 8.25,4.5 C7.83578644,4.5 7.5,4.16421356 7.5,3.75 C7.5,3.33578644 7.83578644,3 8.25,3 Z M4.5,4.5 C4.08578644,4.5 3.75,4.16421356 3.75,3.75 C3.75,3.33578644 4.08578644,3 4.5,3 C4.91421356,3 5.25,3.33578644 5.25,3.75 C5.25,4.16421356 4.91421356,4.5 4.5,4.5 Z"></path> <path d="M18,9.75 C18,7.2675 15.48,5.25 12.375,5.25 C9.27,5.25 6.75,7.2675 6.75,9.75 C6.75,12.2325 9.27,14.25 12.375,14.25 C12.9568557,14.2502837 13.5364258,14.1772075 14.1,14.0325 L15.96,14.9625 C16.0114248,14.9874074 16.0678613,15.0002339 16.125,15 C16.2497193,14.9993787 16.3659682,14.9367912 16.4351508,14.8330172 C16.5043335,14.7292432 16.5173955,14.5978644 16.47,14.4825 L15.96,13.2075 C17.1784092,12.4716325 17.9450305,11.1723221 18,9.75 L18,9.75 Z M10.5,9 C10.0857864,9 9.75,8.66421356 9.75,8.25 C9.75,7.83578644 10.0857864,7.5 10.5,7.5 C10.9142136,7.5 11.25,7.83578644 11.25,8.25 C11.25,8.66421356 10.9142136,9 10.5,9 Z M14.25,9 C13.8357864,9 13.5,8.66421356 13.5,8.25 C13.5,7.83578644 13.8357864,7.5 14.25,7.5 C14.6642136,7.5 15,7.83578644 15,8.25 C15,8.66421356 14.6642136,9 14.25,9 Z" opacity="0.959999979"></path> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.weibo.com/CellPress" title="Weibo" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-99.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="weibo" transform="translate(99.000000, 14.000000)"> <g transform="translate(0.000000, 3.000000)"> <path d="M13.2402211,7.47054172 C12.9918392,7.39866484 12.821608,7.34902326 12.9514975,7.03290287 C13.232804,6.34602189 13.2622915,5.75359781 12.9571055,5.33095486 C12.3847236,4.5380684 10.8191759,4.58064295 9.02514573,5.30975376 C9.02514573,5.30889193 8.46144724,5.54882627 8.60544724,5.11515185 C8.88150754,4.25435294 8.83953769,3.53386047 8.41043216,3.11759508 C7.43716583,2.17285363 4.84824121,3.15344733 2.62745729,5.3059617 C0.964944724,6.9186238 0,8.62798358 0,10.105855 C0,12.9324952 3.73748744,14.8235294 7.39429146,14.8235294 C12.1877186,14.8235294 15.3768844,11.9501778 15.3768844,9.80576471 C15.3768844,8.50974008 14.2514774,7.77442408 13.2402211,7.47054172 Z M7.40424121,13.5561176 C4.48625126,13.8315595 1.9678794,12.5686293 1.77811055,10.7327524 C1.58870352,8.89773735 3.80098492,7.18579207 6.71861307,6.90948837 C9.63678392,6.63266758 12.1556985,7.89663201 12.3447437,9.73164706 C12.533608,11.5675239 10.3227739,13.2796416 7.40424121,13.5561176 Z M18,5.16875787 C17.9985528,2.31402189 15.5695477,0 12.5728643,0 C12.222995,0 11.9396985,0.270098495 11.9396985,0.603283174 C11.9396985,0.936640219 12.222995,1.20656635 12.5728643,1.20656635 C14.8708945,1.20656635 16.7336683,2.98159781 16.7336683,5.17099863 C16.7336683,5.50435568 17.0173266,5.77428181 17.3668342,5.77428181 C17.7167035,5.77428181 18,5.50435568 18,5.17099863 C18,5.17099863 18,5.1696197 18,5.16875787 Z M15.4841608,5.08016142 C15.1948945,3.73415048 14.0812462,2.67323393 12.6683819,2.39744733 C12.3262915,2.33039672 11.9914372,2.54051163 11.9212462,2.86680164 C11.8506935,3.19309166 12.0712161,3.51179754 12.4133065,3.57919289 C13.3319397,3.75845417 14.0559196,4.44774829 14.2438794,5.32302599 C14.3146131,5.64931601 14.6491055,5.85925855 14.9915578,5.7923803 C15.3338291,5.72498495 15.5541709,5.40627907 15.4841608,5.08016142 Z M5.90761809,8.7069275 C4.7321005,8.9320383 3.93901508,9.87126402 4.1358392,10.8044569 C4.33248241,11.7378222 5.44504523,12.311803 6.62056281,12.0865198 C7.79571859,11.861409 8.58916583,10.922528 8.3921608,9.98899042 C8.19569849,9.0559699 7.08277387,8.48181669 5.90761809,8.7069275 Z"></path> </g> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.youtube.com/user/cellvideoabstracts" title="YouTube" target="_blank"><svg width="18px" height="13px" viewBox="0 0 18 13" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-76.000000, -19.000000)" fill-rule="nonzero" fill="#969696"> <g id="youtube" transform="translate(76.000000, 14.000000)"> <path d="M17.2984219,6.41974219 C16.6486641,5.64735937 15.4490625,5.33232422 13.1580703,5.33232422 L4.84175391,5.33232422 C2.49834375,5.33232422 1.27838672,5.66771484 0.631089844,6.49001953 C0,7.29172266 0,8.47304297 0,10.1080547 L0,13.2243047 C0,16.3917773 0.748792969,18 4.84175391,18 L13.1581055,18 C15.1448555,18 16.2457383,17.7219844 16.9579688,17.040375 C17.688375,16.3413984 18,15.2001211 18,13.2243047 L18,10.1080547 C18,8.38381641 17.951168,7.19553516 17.2984219,6.41974219 Z M11.5560703,12.0963867 L7.77965625,14.0700586 C7.69524609,14.1141797 7.60289062,14.136082 7.51071094,14.136082 C7.40629687,14.136082 7.30212891,14.1079922 7.20987891,14.0521289 C7.03613672,13.9468711 6.93007031,13.7585391 6.93007031,13.5554414 L6.93007031,9.62075391 C6.93007031,9.41800781 7.03585547,9.22985156 7.20924609,9.12452344 C7.38267187,9.01919531 7.59839062,9.01198828 7.77832031,9.10546875 L11.5547344,11.0664141 C11.7468633,11.1661523 11.8675195,11.3645039 11.8678008,11.5809258 C11.8680469,11.7975586 11.747918,11.9961914 11.5560703,12.0963867 Z"></path> </g> </g> </g></svg></a></li>
            
        </ul>
    </div>
</div>

<style>

.ux3 .footer__logo svg {
    max-width: 160px !important;
}

.ux3 .footer__social-links a svg {
    max-width: 26px;
    height: 1.15rem;
    width: auto;
}

.ux3 .footer__social-links a:hover svg path {
    fill: #353535;
}

</style></div>

            

        

    

        


    

            

            
                <div class="footer__bottom text-onDark">
            

            <div data-widget-id="06227714-c621-4651-9879-b0ce5176cccc" data-widget-name="ux3-layout-widget"><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="07e1d276-b4dd-4870-b858-ed74e70d64ef" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Life &amp; medical sciences journals</h2>
		<ul class="rlist clearfix sided">
		<li>
			<a alt="Cell" href="/cell/home">Cell</a>
		</li>
		<li>
			<a alt="Cancer Cell" href="/cancer-cell/home">Cancer Cell</a>
		</li>
		<li>
			<a alt="Cell Chemical Biology" href="/cell-chemical-biology">Cell Chemical Biology</a>
		</li>
		<li>
			<a alt="Cell Genomics" href="/cell-genomics/home">Cell Genomics</a>
		</li>
		<li>
			<a alt="Cell Host and Microbe" href="/cell-host-microbe/home">Cell Host &amp; Microbe</a>
		</li>
		<li>
			<a alt="Cell Metabolism" href="/cell-metabolism/home">Cell Metabolism</a>
		</li>
		<li>
			<a alt="Cell Reports" href="/cell-reports/home">Cell Reports</a>
		</li>
		<li>
			<a alt="Cell Reports Medicine" href="/cell-reports-medicine/home">Cell Reports Medicine</a>
		</li>
		<li>
			<a alt="Cell Stem Cell" href="/cell-stem-cell/home">Cell Stem Cell</a>
		</li>
		<li>
			<a alt="Cell Systems" href="/cell-systems/home">Cell Systems</a>
		</li>
		<li>
			<a alt="Current Biology" href="/current-biology/home">Current Biology</a>
		</li>
		<li>
			<a alt="Developmental Cell" href="/developmental-cell/home">Developmental Cell</a>
		</li>
		<li>
			<a alt="Immunity" href="/immunity/home">Immunity</a>
		</li>
		<li>
			<a alt="Med" href="/med/home">Med</a>
		</li>
		<li>
			<a alt="Molecular Cell" href="/molecular-cell/home">Molecular Cell</a>
		</li>
		<li>
			<a alt="Neuron" href="/neuron/home">Neuron</a>
		</li>
		<li>
			<a alt="Structure" href="/structure/home">Structure</a>
		</li>
		<li>
			<a alt="American Journal of Human Genetics" href="/ajhg/home">American Journal of Human Genetics (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Journal" href="/biophysj/home">Biophysical Journal (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Reports" href="/biophysreports/home">Biophysical Reports (<i>partner</i>)</a>
		</li>	
		<li>
			<a alt="HGG Advances" href="/hgg-advances/home">Human Genetics and Genomics Advances (<i>partner</i>)</a></li>
		<li>
			<a alt="Molecular Plant" href="/molecular-plant/home">Molecular Plant (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy" href="/molecular-therapy-family/molecular-therapy/home">Molecular Therapy (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Methods and Clinical Development" href="/molecular-therapy-family/methods/home">Molecular Therapy Methods &amp; Clinical Development (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Nucleic Acids" href="/molecular-therapy-family/nucleic-acids/home">Molecular Therapy Nucleic Acids (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Oncology" href="/molecular-therapy-family/oncology/home">Molecular Therapy Oncology (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Plant Communications" href="/plant-communications/home">Plant Communications (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Stem Cell Reports" href="/stem-cell-reports/home">Stem Cell Reports (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biochemical Sciences" href="/trends/biochemical-sciences/home">Trends in Biochemical Sciences</a>
		</li>
		<li>
		</li><li>
			<a alt="Trends in Cancer" href="/trends/cancer/home">Trends in Cancer</a>
		</li>
		<li>
			<a alt="Trends in Cell Biology" href="/trends/cell-biology/home">Trends in Cell Biology</a>
		</li>
		<li>
			<a alt="Trends in Ecology and Evolution" href="/trends/ecology-evolution/home">Trends in Ecology &amp; Evolution</a>
		</li>
		<li>
			<a alt="Trends in Endocrinology and Metabolism" href="/trends/endocrinology-metabolism/home">Trends in Endocrinology &amp; Metabolism</a>
		</li>
		<li>
			<a alt="Trends in Genetics" href="/trends/genetics/home">Trends in Genetics</a>
		</li>
		<li>
			<a alt="Trends in Immunology" href="/trends/immunology/home">Trends in Immunology</a>
		</li>
		<li>
			<a alt="Trends in Microbiology" href="/trends/microbiology/home">Trends in Microbiology</a>
		</li>
		<li>
			<a alt="Trends in Molecular Medicine" href="/trends/molecular-medicine/home">Trends in Molecular Medicine</a>
		</li>
		<li>
			<a alt="Trends in Neurosciences" href="/trends/neurosciences/home">Trends in Neurosciences</a>
		</li>
		<li>
			<a alt="Trends in Parasitology" href="/trends/parasitology/home">Trends in Parasitology</a>
		</li>
		<li>
			<a alt="Trends in Pharmacological Sciences" href="/trends/pharmacological-sciences/home">Trends in Pharmacological Sciences</a>
		</li>
		<li>
			<a alt="Trends in Plant Science" href="/trends/plant-science/home">Trends in Plant Science</a>
		</li>
		</ul>
	</div>

	<div class="group">
		<h2 class="group__title">Physical sciences &amp; engineering journals</h2>
		<ul class="rlist clearfix sided">
		  <li><a alt="Cell Biomaterials" href="/cell-biomaterials/home">Cell Biomaterials</a></li>
		  <li>
			<a alt="Cell Reports Physical Science" href="/cell-reports-physical-science/home">Cell Reports Physical Science</a>
		</li>
		<li>
			<a alt="Chem" href="/chem/home">Chem</a>
		</li>
		<li>
			<a alt="Chem Catalysis" href="/chem-catalysis/home">Chem Catalysis</a>
		</li>
		<li>
			<a alt="Device" href="/device/home">Device</a>
		</li>
		<li>
			<a alt="Joule" href="/joule/home">Joule</a>
		</li>
		<li>
			<a alt="Matter" href="/matter/home">Matter</a>
		</li>	
		<li><a alt="Matter" href="/newton/home">Newton</a></li>
		<li>
			<a alt="Trends in Chemistry" href="/trends/chemistry/home">Trends in Chemistry</a>
		</li>			
		</ul>
	</div>

<div class="group">
	<h2 class="group__title">Multidisciplinary journals</h2>
	<ul class="rlist clearfix sided">
	  		<li>
			<a alt="Cell Reports Methods" href="/cell-reports-methods/home">Cell Reports Methods</a>
		</li>
		<li>
			<a alt="Cell Reports Sustainability" href="/cell-reports-sustainability/home">Cell Reports Sustainability</a>
		</li>
		<li>
			<a alt="Heliyon" href="/heliyon/home">Heliyon</a>
		</li>	
		<li>
			<a alt="iScience" href="/iscience/home">iScience</a>
		</li>
		<li>
			<a alt="One Earth" href="/one-earth/home">One Earth</a>
		</li>
		<li>
			<a alt="Patterns" href="/patterns/home">Patterns</a>
		</li>
		<li>
			<a alt="STAR Protocols" href="/star-protocols/home">STAR Protocols</a>
		</li>
		<li>
			<a alt="Nexus" href="/nexus/home">Nexus (<i>partner</i>)</a>
		</li>			
        <li>
			<a alt="The Innovation" href="/the-innovation/home">The Innovation (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biotechnology" href="/trends/biotechnology/home">Trends in Biotechnology</a>
		</li>
		<li>
			<a alt="Trends in Cognitive Sciences" href="/trends/cognitive-sciences/home">Trends in Cognitive Sciences</a>
		</li>
	</ul>
</div>

</div>
</div>

            

        
</div><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="850476de-00cb-4c0d-943c-bf1881da24f9" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="clearfix">
		<div class="group sided">
			<h2 class="group__title">Authors</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Submit article" href="/submit-to-cell-press">Submit article</a>
				</li>
				<li>
					<a alt="Multi-Journal Submission" href="/multi-journal-submission">Multi-Journal Submission</a>
				</li>
				<li>
					<a alt="STAR Methods" href="/star-authors-guide">STAR Methods</a>
				</li>
				<li>
					<a alt="Sneak Peek – Preprints" href="/sneakpeek">Sneak Peek – Preprints</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Reviewers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Reviewers" href="/reviewers">Information for reviewers</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">News &amp; events</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Newsroom" href="/newsroom">Newsroom</a>
				</li>
				<li>
					<a alt="Events" href="/events">Events</a>
				</li>
				<li>
					<a alt="Cell Symposia" href="/symposia">Cell Symposia</a>
				</li>
				<li>
					<a alt="Consortia Hub" href="/consortia">Consortia Hub</a>
				</li>
				<li>
					<a alt="Webinars" href="/webinars">Webinars</a>
				</li>
								<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Multimedia</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Podcast" href="/podcast">Cell Press Podcast</a>
				</li>
				<li>
					<a alt="Cell Press Videos" href="/video">Cell Press Videos</a>
				</li>
				<li>
					<a alt="Color and Comics" href="/comics">Coloring and Comics</a>
				</li>
				<li>
					<a alt="Figure360" href="/video-guidelines">Figure360</a>
				</li>
				<li>
					<a alt="Cell Picture Show" href="/pictureshow">Cell Picture Show</a>
				</li>
				<li>
					<a alt="Research Arc" href="/research-arc">Research Arc</a>
				</li>
			</ul>
		</div>

		<div class="group sided">
			<h2 class="group__title">About</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="About Cell Press" href="/about">About Cell Press</a>
				</li>

				<li>
					<a alt="Open access" href="/open-access">Open access</a>
				</li>
				<li>
					<a alt="COVID Hub" href="/covid-19">COVID Hub</a>
				</li>
				<li>
					<a alt="Sustainability" href="/sustainability">Sustainability hub</a>
				</li>
				<li>
					<a alt="Inclusion and diversity" href="/diversity">Inclusion and diversity</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Contact</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Contact us" href="/contact">Contact us</a>
				</li>
				<li>
					<a alt="Help and Support" href="https://service.elsevier.com/app/overview/cell-press/" target="_blank">Help &amp; Support</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Careers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Careers" href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" target="_blank">Cell Press Careers</a>
				</li>
			</ul>
		</div>
	</div>
</div></div>

            

        
</div><div class="col-sm-4 col-md-2 clearfix">
    

        


    

            

            

            <div data-widget-id="beafac41-1cfc-440b-9b55-74aba4a5612c" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Access</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Subscribe" href="/subscribe">Subscribe</a>
			</li>
			<li>
				<a alt="Claim" href="/activate">Claim</a>
			</li>
			<li>
				<a alt="Read It Now" href="/read-it-now">Read-It-Now</a>
			</li>
			<li>
				<a alt="Recommend to Librarian" href="http://info.cell.com/request-access-to-cell-press-content" target="_blank">Recommend to Librarian</a>
			</li>
			<li>
				<a alt="Publication Alerts" href="/action/showPreferences?menuTab=Alerts">Publication Alerts</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Collections</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Best of Cell Press" href="/bestof">Best of Cell Press</a>
			</li>
			<li>
				<a alt="Cell Press Reviews" href="/reviews">Cell Press Reviews</a>
			</li>
			<li>
				<a alt="Cell Selections" href="/selections">Cell Press Selections</a>
			</li>
			<li>
				<a alt="Nucleus Collections" href="/nucleus">Nucleus Collections</a>
			</li>
			<li>
				<a alt="SnapShots" href="/snapshots">SnapShot Archive</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Information</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="For Advertisters" href="/media-kit">For Advertisers</a>
			</li>
			<li>
				<a alt="For Recruiters" target="_blank" href="/pb-assets/Cell/common/CP-RecruitmentKit-US-2018-LowRes-1712070648.pdf">For Recruiters</a>
			</li>
			<li>
				<a alt="For Librarians" target="_blank" href="https://www.elsevier.com/products/sciencedirect/journals/direct-subscription-journals">For Librarians</a>
			</li>
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms and Conditions</a>
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>
			</li>
		</ul>
	</div>
</div></div>

            

        
</div></div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="779ad11f-7bcd-4a2a-a2cd-8c67b649cbb2" data-widget-name="UX3HTMLWidget"><style>
 
button#cookieBtn {
   text-decoration: none;
   background-color: transparent;
   color: #005789;
   font-weight: bold;
   padding: 0;
   margin: 0;
   font-size: 14px;
}
 
button#cookieBtn:hover {
   text-decoration: underline;
}

</style>
<script>
// HIDE ONETRUST BACKGROUND AFTER USER PRESSES ESCAPE KEY
setTimeout(function(){ 
   $("#onetrust-pc-sdk").on("keydown", function(e) { 
      if (e.keyCode == 27) {  // ESC key
         setTimeout(function(){ 
            $(".onetrust-pc-dark-filter").css("display","none");
         }, 100); 
      }
   });
}, 5000);
</script>

<span class="align-center copy-right">
<hr>
<p align="center"><b>The content on this site is intended for healthcare professionals and researchers across all fields of science.</b></p>
<hr>
<div>
<p>We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the 
      <b><button id="cookieBtn" class="ot-sdk-show-settings" type="button" aria-label="Manage cookie consent preferences">Cookie Settings</button></b> for this site.<br>

All content on this site: Copyright © 2025 Elsevier Inc., its licensors, and contributors. <br>All rights are reserved, including those for text and data mining, AI training, and similar technologies. <br>For all open access content, the relevant licensing terms apply.
</p>
<ul class="rlist--inline">
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms &amp; Conditions</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Help and Support" target="_blank" href="https://service.elsevier.com/app/overview/cell-press/">Help &amp; Support</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Contact" href="/contact">Contact</a>
			</li>
			</ul>
<p>
<a href="https://www.relx.com"><img src="/pb/assets/raw/Health%20Advance/images/relx-1554393210983.png" alt="RELX" rel="nofollow" target="_new"></a></p>
</div>

</span></div>

            

        

    

        


    

            

            

            <div data-widget-id="c5e179c1-156e-41e3-af7f-5e307efa8acf" data-widget-name="UX3HTMLWidget"><style>#brandingRow{
    background-color:#fff;
    padding:7px 26px 7px 30px;
    color:#007DBC;
    font-size:14px;
    clear:both;
    width:100%
}
#brandingRow a{
    text-decoration:none;
    color:#007DBC
}
#brandingRow a:hover{
    text-decoration:underline
}
#brandingRowRight{
    display:inline;
    float:right;
    width:auto;
    padding:0;
    margin:0
}
svg#cp_logo {
  float: none;
  height: 36px;
  width: 36px;
  margin-left: 0px;
  margin-top: 0px;
}

footer hr {
  display: block;
}

@media screen and (max-width: 600px){
    #brandingRow{
        font-size:12px
    }
}
@media screen and (max-width: 750px){
    #brandingRow{
        padding:7px 18px 7px 16px
    }
    svg#cp_logo{
        margin-right:10px
    }
}
@media screen and (max-width: 800px) {
   a#cpIconLnk {
      display: none;
   }
}

.header__wrapper.clearfix .col-xs-6:first-of-type{
    width:55%
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2){
    width:45%
}
@media screen and (min-width: 800px) and (max-width: 1000px){
    .header__wrapper.clearfix .col-xs-6:first-of-type{
        width:75%
    }
    .header__wrapper.clearfix .col-xs-6:nth-of-type(2){
        width:25%
    }
}

</style>

<script>
var partnerx = false;
var overrideEndorsement = "";
var tmpj = $("input[name='journalCode']").attr("value");
	
if (window.location.pathname == "/molecular-therapy-family/home") {
	tmpj = "ymthe";
}
	
var ribbonx = "";
if (tmpj == "ajhg" || tmpj == "bpj" || tmpj == "molp" || tmpj == "xplc" || tmpj == "stemcr" || tmpj == "ymthe" || tmpj == "xhgg" || tmpj == "omtn" || tmpj == "omto" || tmpj == "omtm" || tmpj == "biophysreports" ||  tmpj == "bpr" || tmpj == "xinn" || tmpj == "omton") {
	partnerx = true;
	ribbonx = "<a href='https://www.cell.com' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press partner journal</a>";
} else if (tmpj != "" && tmpj != "undefined" && tmpj != undefined) {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press journal</a>";
} else {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press resource</a>";
}
	
if (window.location.pathname == "/") {
	ribbonx = "";
}
if (overrideEndorsement != "") {
	ribbonx = overrideEndorsement;
}

$(".header__wrapper.clearfix").prepend("<div id='brandingRow'><a href='/' data-aa-name='science that inspires' data-aa-region='cp global header' title='Visit Cell.com'>Science that inspires</a><p id='brandingRowRight'>" + ribbonx + "</p></div>");
	
// handle scrolling effect on article pages
if ($("article").length > 0) {
	var scrollx;
	$(window).scroll(function() {
		scrollx = $(window).scrollTop();
		if (scrollx > 0) { 
			$("#brandingRow").css("display","none"); 
		} else {
			$("#brandingRow").css("display","block");
		}
	});
}

if (window.location.pathname == "/" || partnerx == false) {
               $("<a href='/home' id='cpIconLnk' data-aa-name='cell press logo' data-aa-region='cp global header' title='Cell Press' target='_blank'><svg id='cp_logo' version='1.1' xmlns='http://www.w3.org/2000/svg' xmlns:xlink='http://www.w3.org/1999/xlink' x='0px' y='0px' viewBox='0 0 100 98.1' style='enable-background:new 0 0 100 98.1;' xml:space='preserve' height='100' width='98.1'><path style='fill:#FFFFFF;' d='M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z'/></svg></a>").insertBefore(".header__wrapper.clearfix .journal-logos:eq(0)");
}


</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="1af759b7-9bb6-4413-ada9-51a8333e8fb8" data-widget-name="UX3HTMLWidget"><style>
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-444969 - c#4]*/
    [data-tab-id="changelogTab"] {
        display: none !important;
    }
    
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-518839]*/
    @media (min-width: 769px) {
        .ux3 .quick-search .dropBlock [data-db-target-of],
        .quick-search .dropBlock [data-db-target-of] {
            width: 100vw !important;
        }
    }
</style></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="d7e0813b-a300-497a-ab37-9c3ddaf03e71" data-widget-name="UX3HTMLWidget"><!--
<div class="session-reminder hidden">
    <div class="session-reminder__overlay">
        <div class="session-reminder__dialog">
            <div class="session-reminder__dialog-inner">
                <div class="dialog-header" role="dialog" aria-labelledby="dialog-title" aria-describedby="dialog-desc">
                    <h2 class="dialog-header-title" id="dialog-title">
                        <span>Session Timeout</span>
                        <div class="dialog-timer">(2:00)</div>
                    </h2>
                    <button class="dialog-close" type="button" aria-label="close dialog">
                        <i class="icon-tools_close" aria-hidden="true"></i>
                    </button>
                </div>
                <div class="dialog-body">
                    <p class="dialog-desc" id="dialog-desc">Your session will expire shortly. If you are still working, click the ‘Keep Me Logged In’ button below. If you do not respond within the next minute, you will be automatically logged out.</p>
                    <p class="dialog-expired sr-only" aria-live="polite"></p>
                </div>
                <div class="dialog-footer">
                    <button class="session-reset" type="button">Keep Me Logged In</button>
                </div>
            </div>
        </div>
    </div>
</div>
<a class="sr-only" href="javascript:void(0)" aria-hidden="true"></a>
--></div>

            

        
        </div>
    </div>


































    



















        
        
            
                <script src="/products/marlin/cell/releasedAssets/js/main.bundle-90475670808d5d3eee41.js"></script>
            
        
        
        

    




<script type="text/javascript">
    var pageData =  {"journal":{"specialty":"Cell Press","issn":"0092-8674","name":"Cell"},"page":{"loadTimestamp":"1749593039221","server":"cell","environment":"prod","businessUnit":"ELS:RAP:JBS","noTracking":"","name":"fulltext:html","section":"Cell","language":"en","type":"CP-CA","productName":"JB"},"visitor":{"departmentName":"|ae:ScienceDirect Guests","accessType":"ae:ANON_GUEST|ae:ANON_GUEST","accountId":"ae:838949|ae:228598","accountName":"ae:Cell Guest Account|ae:ScienceDirect Guests","departmentId":"ae:977212|ae:291352","ipAddress":"189.120.74.179","loginStatus":"anonymous","userId":"ae:246228266|ae:12975512"},"content":[{"accessType":"article:free:openarchive","volumeNumber":"185","issueNumber":"7","viewState":"fulltext","format":"MIME-HTML","id":"pii:S0092867422001921","coverDate":"202203","type":"XOCS-JOURNAL:SCOPE-FULL","title":"Tumorreactive antibodies evolve from nonbinding and autoreactive precursors","status":"S300"}]};
</script>

<script type="text/javascript">
    if(typeof pageDataTracker !== "undefined") {
        pageDataTracker.trackPageLoad();
    }
</script>
<script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'94dc296779624287',t:'MTc0OTU5MzAzOC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script><iframe height="1" width="1" style="position: absolute; top: 0px; left: 0px; border: none; visibility: hidden;"></iframe><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js/vcd15cbe7772f49c399c6a5babf22c1241717689176015" integrity="sha512-ZpsOmlRQV6y907TI0dKBHq9Md29nnaEIPlkf84rnaERnq6zvWvPUqr2ft8M1aS28oN72PdrCzSjY4U6VaAw1EQ==" data-cf-beacon="{&quot;rayId&quot;:&quot;94dc296779624287&quot;,&quot;serverTiming&quot;:{&quot;name&quot;:{&quot;cfExtPri&quot;:true,&quot;cfEdge&quot;:true,&quot;cfOrigin&quot;:true,&quot;cfL4&quot;:true,&quot;cfSpeedBrain&quot;:true,&quot;cfCacheStatus&quot;:true}},&quot;version&quot;:&quot;2025.5.0&quot;,&quot;token&quot;:&quot;57a02315956f4b2e82817b3dfa99b1a2&quot;}" crossorigin="anonymous"></script>


<div id="addtoany" style="position: static;"><div class="a2a_overlay" id="a2a_overlay"></div><div id="a2a_modal" class="a2a_modal a2a_hide" role="dialog" tabindex="-1" aria-label=""><div class="a2a_modal_body a2a_menu a2a_hide" id="a2a_copy_link"><label for="a2a_copy_link_text" id="a2a_copy_link_icon" class="a2a_svg a2a_s_link a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><title>Copy link</title><path fill="#FFF" d="M7.591 21.177c0-.36.126-.665.377-.917l2.804-2.804a1.235 1.235 0 0 1 .913-.378c.377 0 .7.144.97.43-.026.028-.11.11-.255.25-.144.14-.24.236-.29.29a2.82 2.82 0 0 0-.2.256 1.056 1.056 0 0 0-.177.344 1.43 1.43 0 0 0-.046.37c0 .36.126.666.377.918a1.25 1.25 0 0 0 .918.377c.126.001.251-.015.373-.047.125-.037.242-.096.345-.175.09-.06.176-.127.256-.2.1-.094.196-.19.29-.29.14-.142.223-.23.25-.254.297.28.445.607.445.984 0 .36-.126.664-.377.916l-2.778 2.79a1.242 1.242 0 0 1-.917.364c-.36 0-.665-.118-.917-.35l-1.982-1.97a1.223 1.223 0 0 1-.378-.9l-.001-.004Zm9.477-9.504c0-.36.126-.665.377-.917l2.777-2.79a1.235 1.235 0 0 1 .913-.378c.35 0 .656.12.917.364l1.984 1.968c.254.252.38.553.38.903 0 .36-.126.665-.38.917l-2.802 2.804a1.238 1.238 0 0 1-.916.364c-.377 0-.7-.14-.97-.418.026-.027.11-.11.255-.25a7.5 7.5 0 0 0 .29-.29c.072-.08.139-.166.2-.255.08-.103.14-.22.176-.344.032-.12.048-.245.047-.37 0-.36-.126-.662-.377-.914a1.247 1.247 0 0 0-.917-.377c-.136 0-.26.015-.37.046-.114.03-.23.09-.346.175a3.868 3.868 0 0 0-.256.2c-.054.05-.15.148-.29.29-.14.146-.222.23-.25.258-.294-.278-.442-.606-.442-.983v-.003ZM5.003 21.177c0 1.078.382 1.99 1.146 2.736l1.982 1.968c.745.75 1.658 1.12 2.736 1.12 1.087 0 2.004-.38 2.75-1.143l2.777-2.79c.75-.747 1.12-1.66 1.12-2.737 0-1.106-.392-2.046-1.183-2.818l1.186-1.185c.774.79 1.708 1.186 2.805 1.186 1.078 0 1.995-.376 2.75-1.13l2.803-2.81c.751-.754 1.128-1.671 1.128-2.748 0-1.08-.382-1.993-1.146-2.738L23.875 6.12C23.13 5.372 22.218 5 21.139 5c-1.087 0-2.004.382-2.75 1.146l-2.777 2.79c-.75.747-1.12 1.66-1.12 2.737 0 1.105.392 2.045 1.183 2.817l-1.186 1.186c-.774-.79-1.708-1.186-2.805-1.186-1.078 0-1.995.377-2.75 1.132L6.13 18.426c-.754.755-1.13 1.672-1.13 2.75l.003.001Z"></path></svg></label><input id="a2a_copy_link_text" type="text" title="Copy link" readonly=""><div id="a2a_copy_link_copied">✓</div></div><div class="a2a_modal_body a2a_menu a2a_thanks a2a_hide" id="a2a_thanks"><div class="a2a_localize" data-a2a-localize="inner,ThanksForSharing">Thanks for sharing!</div></div></div><div class="a2a_menu a2a_full a2a_localize" id="a2apage_full" role="dialog" tabindex="-1" aria-label="Share" data-a2a-localize="title,Share"><div class="a2a_full_header"><div id="a2apage_find_container" class="a2a_menu_find_container"><label for="a2apage_find" id="a2apage_find_icon" class="a2a_svg a2a_s_find"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" aria-hidden="true"><title>Find any service</title><path fill="#CCC" d="M19.7 18.2l-4.5-4.5c.7-1.1 1.2-2.3 1.2-3.6 0-3.5-2.8-6.3-6.3-6.3s-6.3 2.8-6.3 6.3 2.8 6.3 6.3 6.3c1.4 0 2.6-.4 3.6-1.2l4.5 4.5c.6.6 1.3.7 1.7.2.5-.4.4-1.1-.2-1.7zm-9.6-3.6c-2.5 0-4.5-2.1-4.5-4.5 0-2.5 2.1-4.5 4.5-4.5 2.5 0 4.5 2.1 4.5 4.5s-2 4.5-4.5 4.5z"></path></svg></label><input id="a2apage_find" class="a2a_menu_find a2a_localize" type="text" autocomplete="off" title="Find any service" data-a2a-localize="title,FindAnyServiceToAddTo"></div></div><div class="a2a_full_services" id="a2apage_full_services" role="presentation"></div><div class="a2a_full_footer"><a href="https://www.addtoany.com" title="Share Buttons" rel="noopener" target="_blank"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span>AddToAny</a></div></div><div id="a2apage_dropdown" class="a2a_menu a2a_mini a2a_localize a2a_hide" tabindex="-1" aria-label="Share" data-a2a-localize="label,Share"><div class="a2a_mini_services" id="a2apage_mini_services"></div><div id="a2apage_cols_container" class="a2a_cols_container"><div class="a2a_col1" id="a2apage_col1"></div><div id="a2apage_2_col1" class="a2a_hide"></div><div class="a2a_clear"></div></div><div class="a2apage_wide a2a_wide"><a href="#addtoany" id="a2apage_show_more_less" class="a2a_more a2a_localize" title="Show all" data-a2a-localize="title,ShowAll"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span><span class="a2a_localize" data-a2a-localize="inner,More">More…</span></a></div></div><div style="height: 1px; width: 1px; position: absolute; z-index: 100000; top: 0px; visibility: hidden;"><iframe id="a2a_sm_ifr" title="AddToAny Utility Frame" aria-hidden="true" src="https://static.addtoany.com/menu/sm.25.html#type=core&amp;event=load" style="height: 1px; width: 1px; border: 0px; left: 0px; top: 0px; position: absolute; z-index: 100000; display: none;"></iframe></div></div><div role="status" aria-live="assertive" aria-relevant="additions" class="ui-helper-hidden-accessible"></div><div id="onetrust-consent-sdk" data-nosnippet="true"><div class="onetrust-pc-dark-filter ot-fade-in" style="z-index:2147483645;"></div><div id="onetrust-banner-sdk" class="otFlat bottom ot-wo-title ot-buttons-fw" tabindex="0" role="region" aria-label="Cookie banner"><div role="dialog" aria-modal="true" aria-label="Privacy"><div class="ot-sdk-container"><div class="ot-sdk-row"><div id="onetrust-group-container" class="ot-sdk-eight ot-sdk-columns"><div class="banner_logo"></div><div id="onetrust-policy"><div id="onetrust-policy-text">We use cookies that are necessary to make our site work. We may also use additional cookies to analyze, improve, and personalize our content and your digital experience. For more information, see our<a class="ot-cookie-policy-link" href="https://www.elsevier.com/legal/cookienotice" target="_blank" aria-label=", opens in a new tab" rel="noopener">Cookie Policy</a></div></div></div><div id="onetrust-button-group-parent" class="ot-sdk-three ot-sdk-columns"><div id="onetrust-button-group"><button id="onetrust-pc-btn-handler" class="cookie-setting-link">Cookie Settings</button>  <button id="onetrust-accept-btn-handler">Accept all cookies</button></div></div></div></div><!-- Close Button --><div id="onetrust-close-btn-container"></div><!-- Close Button END--></div></div><div id="onetrust-pc-sdk" class="otPcCenter ot-hide ot-fade-in" lang="en" aria-label="Preference center" role="region"><div role="dialog" aria-modal="true" style="height: 100%;" aria-label="Cookie Preference Center"><!-- Close Button --><div class="ot-pc-header"><!-- Logo Tag --><div class="ot-pc-logo" role="img" aria-label="Company Logo"><img alt="Company Logo" src="https://cdn.cookielaw.org/logos/static/ot_company_logo.png"></div></div><!-- Close Button --><div id="ot-pc-content" class="ot-pc-scrollbar"><div class="ot-optout-signal ot-hide"><div class="ot-optout-icon"><svg xmlns="http://www.w3.org/2000/svg"><path class="ot-floating-button__svg-fill" d="M14.588 0l.445.328c1.807 1.303 3.961 2.533 6.461 3.688 2.015.93 4.576 1.746 7.682 2.446 0 14.178-4.73 24.133-14.19 29.864l-.398.236C4.863 30.87 0 20.837 0 6.462c3.107-.7 5.668-1.516 7.682-2.446 2.709-1.251 5.01-2.59 6.906-4.016zm5.87 13.88a.75.75 0 00-.974.159l-5.475 6.625-3.005-2.997-.077-.067a.75.75 0 00-.983 1.13l4.172 4.16 6.525-7.895.06-.083a.75.75 0 00-.16-.973z" fill="#FFF" fill-rule="evenodd"></path></svg></div><span></span></div><h2 id="ot-pc-title">Cookie Preference Center</h2><div id="ot-pc-desc">We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our <a href="https://www.elsevier.com/legal/cookienotice/_nocache" target="_blank">Cookie Policy</a> and the list of <a href="https://support.google.com/admanager/answer/9012903" target="_blank">Google Ad-Tech Vendors</a>.
<br>
<br>
You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer. See the different category headings below to find out more or change your settings.
<br>
</div><button id="accept-recommended-btn-handler">Allow all</button><section class="ot-sdk-row ot-cat-grp"><h3 id="ot-category-title"> Manage Consent Preferences</h3><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="1"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-1" aria-labelledby="ot-header-id-1 ot-status-id-1"></button><!-- Accordion header --><div class="ot-acc-hdr ot-always-active-group"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-1">Strictly Necessary Cookies</h4><div id="ot-status-id-1" class="ot-always-active">Always active</div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-1">These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
<br><br></p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="1">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="3"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-3" aria-labelledby="ot-header-id-3"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-3">Functional Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-3" id="ot-group-id-3" role="switch" class="category-switch-handler" data-optanongroupid="3" aria-labelledby="ot-header-id-3"> <label class="ot-switch" for="ot-group-id-3"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Functional Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-3">These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="3">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="2"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-2" aria-labelledby="ot-header-id-2"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-2">Performance Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-2" id="ot-group-id-2" role="switch" class="category-switch-handler" data-optanongroupid="2" aria-labelledby="ot-header-id-2"> <label class="ot-switch" for="ot-group-id-2"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Performance Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-2">These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="2">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="4"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-4" aria-labelledby="ot-header-id-4"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-4">Targeting Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-4" id="ot-group-id-4" role="switch" class="category-switch-handler" data-optanongroupid="4" aria-labelledby="ot-header-id-4"> <label class="ot-switch" for="ot-group-id-4"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Targeting Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-4">These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. If you do not allow these cookies, you will experience less targeted advertising.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="4">Cookie Details List‎</button></div></div></div><!-- Groups sections starts --><!-- Group section ends --><!-- Accordion Group section starts --><!-- Accordion Group section ends --></section></div><section id="ot-pc-lst" class="ot-hide ot-hosts-ui ot-pc-scrollbar"><div id="ot-pc-hdr"><div id="ot-lst-title"><button class="ot-link-btn back-btn-handler" aria-label="Back"><svg id="ot-back-arw" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 444.531 444.531" xml:space="preserve"><title>Back Button</title><g><path fill="#656565" d="M213.13,222.409L351.88,83.653c7.05-7.043,10.567-15.657,10.567-25.841c0-10.183-3.518-18.793-10.567-25.835
                    l-21.409-21.416C323.432,3.521,314.817,0,304.637,0s-18.791,3.521-25.841,10.561L92.649,196.425
                    c-7.044,7.043-10.566,15.656-10.566,25.841s3.521,18.791,10.566,25.837l186.146,185.864c7.05,7.043,15.66,10.564,25.841,10.564
                    s18.795-3.521,25.834-10.564l21.409-21.412c7.05-7.039,10.567-15.604,10.567-25.697c0-10.085-3.518-18.746-10.567-25.978
                    L213.13,222.409z"></path></g></svg></button><h3>Cookie List</h3></div><div class="ot-lst-subhdr"><div class="ot-search-cntr"><p role="status" class="ot-scrn-rdr"></p><input id="vendor-search-handler" type="text" name="vendor-search-handler" placeholder="Search…" aria-label="Cookie list search"> <svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 -30 110 110" aria-hidden="true"><title>Search Icon</title><path fill="#2e3644" d="M55.146,51.887L41.588,37.786c3.486-4.144,5.396-9.358,5.396-14.786c0-12.682-10.318-23-23-23s-23,10.318-23,23
            s10.318,23,23,23c4.761,0,9.298-1.436,13.177-4.162l13.661,14.208c0.571,0.593,1.339,0.92,2.162,0.92
            c0.779,0,1.518-0.297,2.079-0.837C56.255,54.982,56.293,53.08,55.146,51.887z M23.984,6c9.374,0,17,7.626,17,17s-7.626,17-17,17
            s-17-7.626-17-17S14.61,6,23.984,6z"></path></svg></div><div class="ot-fltr-cntr"><button id="filter-btn-handler" aria-label="Filter" aria-haspopup="true"><svg role="presentation" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 402.577 402.577" xml:space="preserve"><title>Filter Icon</title><g><path fill="#fff" d="M400.858,11.427c-3.241-7.421-8.85-11.132-16.854-11.136H18.564c-7.993,0-13.61,3.715-16.846,11.136
      c-3.234,7.801-1.903,14.467,3.999,19.985l140.757,140.753v138.755c0,4.955,1.809,9.232,5.424,12.854l73.085,73.083
      c3.429,3.614,7.71,5.428,12.851,5.428c2.282,0,4.66-0.479,7.135-1.43c7.426-3.238,11.14-8.851,11.14-16.845V172.166L396.861,31.413
      C402.765,25.895,404.093,19.231,400.858,11.427z"></path></g></svg></button></div><div id="ot-anchor"></div><section id="ot-fltr-modal"><div id="ot-fltr-cnt"><button id="clear-filters-handler">Clear</button><div class="ot-fltr-scrlcnt ot-pc-scrollbar"><div class="ot-fltr-opts" role="list"><div class="ot-fltr-opt" role="listitem"><div class="ot-chkbox"><input id="chkbox-id" type="checkbox" class="category-filter-handler"> <label for="chkbox-id"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div><div class="ot-fltr-btns"><button id="filter-apply-handler">Apply</button> <button id="filter-cancel-handler">Cancel</button></div></div></div></section></div></div><section id="ot-lst-cnt" class="ot-host-cnt ot-pc-scrollbar"><div id="ot-sel-blk"><div class="ot-sel-all"><div class="ot-sel-all-hdr"><span class="ot-consent-hdr">Consent</span> <span class="ot-li-hdr">Leg.Interest</span></div><div class="ot-sel-all-chkbox"><div class="ot-chkbox" id="ot-selall-hostcntr"><input id="select-all-hosts-groups-handler" type="checkbox"> <label for="select-all-hosts-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-vencntr"><input id="select-all-vendor-groups-handler" type="checkbox"> <label for="select-all-vendor-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-licntr"><input id="select-all-vendor-leg-handler" type="checkbox"> <label for="select-all-vendor-leg-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div></div><div class="ot-sdk-row"><div class="ot-sdk-column"><ul id="ot-host-lst"></ul></div></div></section></section><div class="ot-pc-footer ot-pc-scrollbar"><div class="ot-btn-container"> <button class="save-preference-btn-handler onetrust-close-btn-handler">Confirm my choices</button></div><!-- Footer logo --><div class="ot-pc-footer-logo"><a href="https://www.onetrust.com/products/cookie-consent/" target="_blank" rel="noopener noreferrer" aria-label="Powered by OneTrust Opens in a new Tab"><img alt="Powered by Onetrust" src="https://cdn.cookielaw.org/logos/static/powered_by_logo.svg" title="Powered by OneTrust Opens in a new Tab"></a></div></div><!-- Cookie subgroup container --><!-- Vendor list link --><!-- Cookie lost link --><!-- Toggle HTML element --><!-- Checkbox HTML --><!-- plus minus--><!-- Arrow SVG element --><!-- Accordion basic element --><span class="ot-scrn-rdr" aria-atomic="true" aria-live="polite"></span><!-- Vendor Service container and item template --></div><iframe class="ot-text-resize" sandbox="allow-same-origin" title="onetrust-text-resize" style="position: absolute; top: -50000px; width: 100em;" aria-hidden="true"></iframe></div></div><div id="crossmark-widget" style="display: none;"><div class="crossmark-reset crossmark-overlay"></div><div class="crossmark-reset crossmark-popup"><div class="crossmark-reset crossmark-popup__offset"><div class="crossmark-reset crossmark-popup__inner"><div class="crossmark-reset crossmark-popup__header"><button class="crossmark-reset crossmark-popup__btn-close"><span class="sr-only">__("articleCrossmark.closePopup")</span></button></div><div class="crossmark-reset crossmark-popup__content-wrapper"><iframe class="crossmark-reset crossmark-popup__content" title="Crossmark service - Intentionally blank" aria-hidden="false" tabindex="0" src="https://crossmark.crossref.org/dialog?doi=10.1016%2Fj.cell.2022.02.012&amp;domain=www.cell.com&amp;uri_scheme=https%3A&amp;cm_version=v2.0"></iframe></div></div></div></div></div></body></html>